DICOM PS3.16 2024d - Content Mapping Resource

D DICOM Controlled Terminology Definitions (Normative) (Current)
Prev		Next

>

D DICOM Controlled Terminology Definitions (Normative)

This Annex specifies the meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard.

The contents of this table are available in OWL, XRDF and CSV format at ftp://medical.nema.org/medical/dicom/resources/ontology/dcm/dcm.owl and in Bioportal.

Table D-1. DICOM Controlled Terminology Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")

Code Value	Code Meaning	Definition	Notes
ANN	Annotation	A device, process or method that produces annotations.
AR	Autorefraction	An acquisition device, process or method that measures autorefraction.
ARCHIVE	Archive	A device, process or method that stores images and other objects for a prolonged period of time.
AS	Angioscopy	An acquisition device, process or method that records images during angioscopy.	Retired
ASMT	Content Assessment Result	A device, process or method that produces assessments of the content of other instances, e.g., for quality or suitability.
AU	Audio	An acquisition device, process or method that records audio.
BDUS	Ultrasound Bone Densitometry	An acquisition device, process or method that performs ultrasound bone densitometry.
BI	Biomagnetic imaging	An acquisition device, process or method that performs biomagnetic imaging.
BMD	Bone Mineral Densitometry	An acquisition device, process or method that performs bone mineral densitometry by X-Ray, including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA).
CAD	Computer Assisted Detection/Diagnosis	An image processing device, process or method that performs computer assisted detection or diagnosis.
CAPTURE	Image Capture	An acquisition device, process or method that performs image capture, includes video capture.
CD	Color flow Doppler	An acquisition device, process or method that performs color flow Doppler.	Retired Replaced by (US, DCM, "Ultrasound")
CF	Cinefluorography	An acquisition device, process or method that performs cinefluorography.	Retired Replaced by (RF, DCM, "Radiofluoroscopy")
CFM	Confocal Microscopy	An acquisition device, process or method that performs imaging using a confocal microscope.
COMP	Computation Server	A device, process or method that performs computation as a service; includes radiotherapy planning.
CP	Culposcopy	An acquisition device, process or method that records images during culposcopy.	Retired
CR	Computed Radiography	An acquisition device, process or method that performs computed radiography.
CS	Cystoscopy	An acquisition device, process or method that records images during cystoscopy.	Retired
CT	Computed Tomography	An acquisition device, process or method that performs computed tomography.
CTPROTOCOL	CT Protocol	A device, process or method that produces CT device acquisition protocols.
DD	Duplex Doppler	An acquisition device, process or method that performs duplex Doppler.	Retired Replaced by (US, DCM, "Ultrasound")
DF	Digital fluoroscopy	An acquisition device, process or method that performs digital fluoroscopy.	Retired Replaced by (RF, DCM, "Radiofluoroscopy")
DG	Diaphanography	An acquisition device, process or method that performs diaphanography.
DM	Digital microscopy	An acquisition device, process or method that performs digital microscopy.	Retired
DMS	Dermoscopy	An acquisition device, process or method that performs imaging of the surface of the skin using epiluminescence microscopy.
DOC	Document	A device, process or method that produces documents. i.e., representations of documents as images, whether by scanning or other means.
DOCD	Document Digitizer Equipment	A device, process or method that digitizes hardcopy documents and imports them.
DS	Digital Subtraction Angiography	An acquisition device, process or method that performs digital subtraction angiography.	Retired Replaced by (XA, DCM, "X-Ray Angiography")
DSS	Department System Scheduler	A department-based information system (for instance, Radiology or Laboratory) that provides functions related to the management of orders received from external systems or through the department system’s user interface. This definition matches that of the DSS/OF Actor in the IHE Scheduled Workflow (SWF) Profile.
DX	Digital Radiography	An acquisition device, process or method that performs digital radiography.
EC	Echocardiography	An acquisition device, process or method that performs echocardiography.	Retired Replaced by (US, DCM, "Ultrasound")
ECG	Electrocardiography	An acquisition device, process or method that performs electrocardiography.
EEG	Electroencephalography	An acquisition device, process or method that performs electroencephalography.
EMG	Electromyography	An acquisition device, process or method that performs electromyography.
EOG	Electrooculography	An acquisition device, process or method that performs electrooculography.
EPS	Cardiac Electrophysiology	An acquisition device, process or method that performs cardiac electrophysiology.
ES	Endoscopy	An acquisition device, process or method that records images during endoscopy.
F	Female	Female sex.
FA	Fluorescein angiography	An acquisition device, process or method that performs fluorescein angiography.	Retired Replaced by (OP, DCM, "Ophthalmic photography")
FC	Female changed to Male	Female sex changed to Male sex.
FID	Spatial Fiducials	A device, process or method that identifies features or landmarks used to establish spatial correlation between objects or frames of reference.
FILMD	Film Digitizer	A device, process or method that performs film digitization.
FP	Female Pseudohermaphrodite	Female Pseudohermaphrodite.
FS	Fundoscopy	An acquisition device, process or method that records images during fundoscopy.	Retired
GM	General Microscopy	An acquisition device, process or method that performs general microscopy.
H	Hermaphrodite	Hermaphrodite.
HC	Hard Copy	A device, process or method that creates images to be printed as hard copy.
HD	Hemodynamic	An acquisition device, process or method that records hemodynamic waveforms.
IO	Intra-oral Radiography	An acquisition device, process or method that performs intra-oral radiography.
IOL	Intraocular Lens Calculation	A device, process or method that encodes calculations for an intraocular lens.
IVOCT	Intravascular Optical Coherence Tomography	An acquisition device, process or method that performs intravascular optical coherence tomography
IVUS	Intravascular Ultrasound	An acquisition device, process or method that performs intravascular ultrasound.
KER	Keratometry	An acquisition device, process or method that performs keratometry.
KO	Key Object Selection	A device, process or method that creates Key Object Selection objects.
LEN	Lensometry	An acquisition device, process or method that performs lensometry.
LOG	Procedure Logging	A device, process or method that performs procedure Logging; includes cath lab logging.
LP	Laparoscopy	An acquisition device, process or method that records images during laparoscopy.	Retired
LS	Laser surface scan	An acquisition device, process or method that performs laser surface scanning.
M	Male	Male sex.
M3D	3D Manufacturing Modeling System	A device, process or method that produces data (models) for use in 3D manufacturing.
MA	Magnetic resonance angiography	An acquisition device, process or method that performs magnetic resonance angiography.	Retired Replaced by (MR, DCM, "Magnetic resonance")
MC	Male changed to Female	Male sex changed to Female sex.
MCD	Media Creation Device	A device, process or method that creates DICOM PS3.10 interchange media. E.g., a CD creator that is managed by the Media Creation Management Service Class.
MEDIM	Portable Media Importer Equipment	A device, process or method that retrieves and imports objects from Interchange Media.
MG	Mammography	An acquisition device, process or method that performs mammography.
MP	Male Pseudohermaphrodite	Male Pseudohermaphrodite.
MR	Magnetic Resonance	An acquisition device, process or method that performs magnetic resonance imaging.
MS	Magnetic resonance spectroscopy	An acquisition device, process or method that performs magnetic resonance spectroscopy.	Retired Replaced by (MR, DCM, "Magnetic resonance")
NEARLINE	Nearline	Instances need to be retrieved from relatively slow media such as optical disk or tape.
NM	Nuclear Medicine	An acquisition device, process or method that performs nuclear medicine imaging.
OAM	Ophthalmic Axial Measurements	An acquisition device, process or method that measures the axial length of the eye.
OCT	Optical Coherence Tomography	An acquisition device, process or method that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies.
OFFLINE	Offline	Instances need to be retrieved by manual intervention.
ONLINE	Online	Instances are immediately available.
OP	Ophthalmic photography	An acquisition device, process or method that performs ophthalmic photography.
OPM	Ophthalmic Mapping	An acquisition device, process or method that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps.
OPR	Ophthalmic Refraction	An acquisition device, process or method that measures the refractive characteristics of the eye.
OPT	Ophthalmic Tomography	An acquisition device, process or method that performs tomography of the eye that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded.
OPTBSV	Ophthalmic Tomography B-scan Volume Analysis	An acquisition device, process or method that performs B-scan volume analysis of tomography images of the eye based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded.
OPTENF	Ophthalmic Tomography En Face	An acquisition device, process or method that creates en face tomography images of the eye based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded.
OPV	Ophthalmic Visual Field	An acquisition device, process or method that measures visual fields and perform visual perimetry.
OSS	Optical Surface Scanner	An acquisition device, process or method that performs optical surface scanning.
OT	Other Modality	Other Modality device.
PA	Photoacoustic	An acquisition device, process or method that performs imaging by means of tissue excitation through the absorption of short light pulses and detection of the resultant acoustic emission.
PLAN	Plan	A device, process or method that produces treatment plans, e.g., delivery instructions for RT.
POS	Position Sensor	A device or sensor measuring the orientation of the patient’s body.
PR	Presentation State	A device, process or method that creates Presentation State objects.
PRINT	Hard Copy Print Server	Hard Copy Print Server; includes printers with embedded DICOM print server.
PT	Positron emission tomography	An acquisition device, process or method that performs positron emission tomography (PET).
PX	Panoramic X-Ray	An acquisition device, process or method that performs panoramic X-Rays.
REG	Registration	An image processing device, process or method that creates Registration objects.
RESP	Respiratory	A device, process or method that produces waveforms of electrical signals from the patient’s respiratory system.
RF	Radiofluoroscopy	An acquisition device, process or method that performs radiofluoroscopy.
RG	Radiographic imaging	An acquisition device, process or method that performs radiographic imaging (conventional film/screen).
RT	Radiation Therapy Device	A device, process or method that delivers radiation therapy; includes linear accelerator, proton therapy.
RTDOSE	Radiotherapy Dose	A device, process or method that records radiotherapy dose.
RTIMAGE	Radiotherapy Image	An acquisition device, process or method that performs radiotherapy imaging; includes portal imaging.
RTPLAN	Radiotherapy Plan	A device, process or method that produces radiotherapy plans.
RTRECORD	Radiotherapy Treatment Record	A device, process or method that records radiotherapy treatment records.
RTSTRUCT	Radiotherapy Structure Set	A device, process or method that produces Radiotherapy Structure Sets.
RWV	Real World Value Map	A device, process or method that produces mappings between image pixel values and some real-world values.
SEG	Segmentation	An image processing device, process or method that performs segmentation.
SM	Slide Microscopy	An acquisition device, process or method that performs slide microscopy.
SMR	Stereometric Relationship	A device, process or method that records relationships between stereometric image pairs.
SR	Structured Report Document	A device, process or method that creates Structured Report documents.
SRF	Subjective Refraction	An acquisition device, process or method that records subjective refraction.
ST	Single-photon emission computed tomography	An acquisition device, process or method that performs single-photon emission computed tomography (SPECT).	Retired Replaced by (NM, DCM, "Nuclear Medicine")
STAIN	Automated Slide Stainer	A device, process or method that applies, in an automated manner, a stain, or reagent, to microscopy slides in preparation for imaging.
TEXTUREMAP	Texture Map	A device, process or method that produces texture maps. E.g., for use in 3D manufacturing.
TG	Thermography	An acquisition device, process or method that performs thermography.
U	Unknown Sex	Unknown Sex.
UNAVAILABLE	Unavailable	Instances cannot be retrieved.
US	Ultrasound	An acquisition device, process or method that performs ultrasound.
VA	Visual Acuity	An acquisition device, process or method that measures visual acuity.
VF	Videofluorography	An acquisition device, process or method that measures videofluorography.	Retired Replaced by (RF, DCM, "Radiofluoroscopy")
VIDD	Video Tape Digitizer Equipment	A device, process or method that digitizes video tape and imports it.
WSD	Workstation	A networked computer equipped with a display and software for performing specific types of work, generally intended to be operated by a single user.
XA	X-Ray Angiography	An acquisition device, process or method that performs X-Ray angiography.
XC	External-camera Photography	An acquisition device, process or method that performs photography with an external camera.
109001	Digital timecode (NOS)	A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology.
109002	ECG-based gating signal, processed	A signal that is generated for each detection of a heart beat.
109003	IRIG-B timecode	A signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks.
109004	X-Ray Fluoroscopy On Signal	A signal that indicates that X-Ray source has been activated for fluoroscopy use.
109005	X-Ray On Trigger	A signal that indicated that the X-Ray source has been activated for image recording.
109006	Differential signal	An electrical signal derived from two electrodes.
109007	His bundle electrogram	An electrophysiological recording from the HIS nerve bundle.
109008	Monopole signal	An electrical signal from one electrode relative to an indifferent potential.
109009	Pacing (electrical) stimulus, voltage	The voltage stimulus during cardiac pacing.
109010	Radio frequency ablation, power	The power injected during RF ablation procedure.
109011	Voltage measurement by basket catheter	Electrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes.
109012	Voltage measurement by mapping catheter	Electrophysiological signals acquired using a steerable catheter.
109013	Voltage measurement	A voltage measurement not otherwise specified.
109014	35% of thermal CO	A signal point that is 35% of the peak thermal cardiac output signal.
109015	70% of thermal CO	A signal point that is 70% of the peak thermal cardiac output signal.
109016	A wave peak pressure	The peak pressure of each heart beat in the atrium caused by the atrial contraction.
109017	A wave pressure, average	The average of several A wave pressure measurements.
109018	Beat detected (accepted)	An identified cardiac beat used in the determination of a measurement.
109019	Beat detected (rejected)	An identified cardiac beat not used in the determination of a measurement.
109020	Diastolic pressure, average	The average of several diastolic pressure measurements	Retired. Replaced by (314453003, SCT, "Average diastolic blood pressure")
109021	Diastolic pressure nadir	The lowest pressure value excluding any undershoot artifact.	Retired. Replaced by (314451001, SCT, "Minimum diastolic blood pressure")
109022	End diastole	The moment at the end of the diastolic phase of the cardiac cycle.	Retired. Replaced by (416190007, SCT, "End diastole")
109023	End of expiration	The moment at the end of respiratory expiration.
109024	End of inspiration	The moment at the end of respiratory inspiration.
109025	Max dp/dt	The maximum positive rate of change of pressure.
109026	Max neg dp/dt	The maximum negative rate of change of pressure.
109027	Mean blood pressure	The average blood pressure value, generally over 2 or more seconds	Retired. Replaced by (6797001, SCT, "Mean blood pressure")
109028	Peak of thermal cardiac output bolus	The peak change in blood temperature during a thermal cardiac output measurement.
109029	Start of expiration	The moment respiratory expiration begins.
109030	Start of inspiration	The moment of respiratory inspiration begins.
109031	Start of thermal cardiac output bolus	The first discernible blood temperature change following the injectate during a thermal cardiac output measurement.
109032	Systolic pressure, average	The average of several systolic blood pressure measurements.	Retired. Replaced by (314440001, SCT, "Average systolic blood pressure")
109033	Systolic peak pressure	The highest systolic blood pressure value excluding any overshoot artifact	Retired. Replaced by (314439003, SCT, "Maximum systolic blood pressure")
109034	V wave peak pressure	The peak pressure of each heart beat in the atrium caused by the filling of the atrium.
109035	V wave pressure, average	The average of several V wave pressure measurements.
109036	Valve close	The moment at which a heart valve closes.
109037	Valve open	The moment at which a heart valve opens.
109038	Ablation off	The moment when RF ablation current is turned off.
109039	Ablation on	The moment when RF ablation current is turned on.
109040	HIS bundle wave	The moment in the cardiac cycle when the HIS bundle nerves depolarize.
109041	P wave	The surface electrocardiogram of the atrial contraction.
109042	Q wave	The first negative deflection of the electrocardiogram cause by ventricular depolarization.
109043	R wave	The first positive deflection the electrocardiogram cause by ventricular depolarization.
109044	S wave	The first negative deflection after the R wave.
109045	Start of atrial contraction	The beginning of the atrial contraction.
109046	Start of atrial contraction (subsequent)	The beginning of the second atrial contraction of two consecutive beats.
109047	Stimulation at rate 1 interval	The stimulation interval during cardiac stimulation first used in a pacing train.
109048	Stimulation at rate 2 interval	The stimulation interval different from the first stimulation interval used in a pacing train.
109049	Stimulation at rate 3 interval	A stimulation interval different from and subsequent to the second interval in a pacing train.
109050	Stimulation at rate 4 interval	Describes a stimulation interval different from and subsequent to the third interval in a pacing train.
109051	T wave	The electrocardiogram deflection caused by ventricular repolarization.
109052	V wave	The peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium.
109053	V wave of next beat	The second V wave measurement of two consecutive beats.
109054	Patient State	A description of the physiological condition of the patient.
109055	Protocol Stage	The exercise level during a progressive cardiac stress test.
109056	Stress Protocol	A series of physiological challenges designed to progressively increase the work of the heart.
109057	Catheterization Procedure Phase	A subpart of a cardiac catheterization procedure	Retired. Replaced by (129085009, SCT, "Catheterization Procedure Phase")
109058	Contrast Phase	The subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient.
109059	Physiological challenges	Physical changes administered to a patient in order to elicit an physiological response.
109060	Procedure Step Number	Enumeration of a subpart of a catheterization procedure.
109061	EP Procedure Phase	A subpart of en electrophysiological procedure.
109063	Pulse train definition	A means of defining a series of cardiac stimulation pulses.
109070	End of systole		Retired. Replaced by (416430001, SCT, "End systole")
109071	Indicator mean transit time	Time for a median particle to travel from point of injection to point of detection.
109072	Tau	The time constant of isovolumic pressure fall.
109073	V max myocardial	Maximum velocity of myocardial contractility.
109080	Real time acquisition	Total time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037).
109081	Prospective gating	Certain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037).
109082	Retrospective gating	Certain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037).
109083	Paced	There is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037). E.g., Pacemaker.
109091	Cardiac Stress State	Imaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means.	Retired. Replaced by (432655005, SCT, "Cardiac stress state").
109092	Reinjection State	Imaging after injection of additional tracer under resting conditions.
109093	Redistribution State	Imaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection.
109094	Delayed Redistribution State	Imaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection.
109095	Peak stress state	Peak Cardiac stress state	Retired. Replaced by (434161005, SCT, "Peak stress state")
109096	Recovery state	Recovery from cardiac stress	Retired. Replaced by (432554001, SCT, "Cardiac stress Recovery state")
109100	Synthesizing Equipment	Equipment that created artificial data.
109101	Acquisition Equipment	Equipment that originally acquired the data stored within composite instances. E.g., a CT, MR or Ultrasound modality.
109102	Processing Equipment	Equipment that has processed composite instances to create new composite instances. E.g., a workstation or software component that performs 3D construction, segmentation or applies an AI model.
109103	Modifying Equipment	Equipment that has modified existing composite instances (without creating new composite instances). E.g., a QA Station or Archive.
109104	De-identifying Equipment	Equipment that has modified an existing composite instance to remove patient identifying information.
109105	Frame Extracting Equipment	Equipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance.
109106	Enhanced Multi-frame Conversion Equipment	Equipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity.
109110	Voice	The sound of a human's speech, recorded during a procedure.	May include the patient's voice, or the voice of staff present in the room, or an operator's voice (whether for the purpose of recording a narrative accompanying a procedure or not).
109111	Operator's narrative	The voice of a device operator, recorded during a procedure.
109112	Ambient room environment	The ambient sound recorded during a procedure, which may or may not include voice and other types of sound.
109113	Doppler audio	The Doppler waveform recorded as an audible signal.
109114	Phonocardiogram	The sound of the human heart beating.	Such as might be recorded from an electronic stethoscope.
109115	Physiological audio signal	Any sound made by the human body.	May include the sound of the heart, but also sound from other organs, such as bowel sounds or bruits from vessels, or sounds of respiration. Not intended to include voice.
109116	Arterial Pulse Waveform	A digitized signal from the patient arterial system collected through pulse oximetry or other means.
109117	Respiration Waveform	A digitized signal from the patient respiratory system representing respiration.
109120	On admission to unit	The occasion on which a procedure was performed on admission to a specialist unit. E.g., intensive care.
109121	On discharge	The occasion on which a procedure was performed on discharge from hospital as an in-patient.
109122	On discharge from unit	The occasion on which a procedure was performed on discharge from a specialist unit. E.g., intensive care.
109123	Pre-intervention	The occasion on which a procedure was performed immediately prior to non-surgical intervention. E.g, percutaneous angioplasty, biopsy.
109124	Post-intervention	The occasion on which a procedure was performed immediately after to non-surgical intervention. E.g, percutaneous angioplasty, biopsy.
109125	At last appointment	The occasion on which a procedure was performed at the most recent outpatient visit.
109132	Joint position method	The active or passive joint positioning during acquisition.
109133	Physical force	A physical force applied during acquisition.
109134	Prior to voiding	Prior to voiding urine from the bladder.
109135	Post voiding	Post voiding urine from the bladder.
109136	Neutral musculoskeletal position	Neutral musculoskeletal position.
109137	During voiding	During voiding urine from the bladder.
109200	America Kennel Club	America Kennel Club.
109201	America's Pet Registry Inc.	America's Pet Registry Inc.
109202	American Canine Association	American Canine Association.
109203	American Purebred Registry	American Purebred Registry.
109204	American Rare Breed Association	American Rare Breed Association.
109205	Animal Registry Unlimited	Animal Registry Unlimited.
109206	Animal Research Foundation	Animal Research Foundation.
109207	Canadian Border Collie Association	Canadian Border Collie Association.
109208	Canadian Kennel Club	Canadian Kennel Club.
109209	Canadian Livestock Records Association	Canadian Livestock Records Association.
109210	Canine Federation of Canada	Canine Federation of Canada.
109211	Continental Kennel Club	Continental Kennel Club.
109212	Dog Registry of America	Dog Registry of America.
109213	Federation of International Canines	Federation of International Canines.
109214	International Progressive Dog Breeders' Alliance	International Progressive Dog Breeders' Alliance.
109215	National Kennel Club	National Kennel Club.
109216	North American Purebred Dog Registry	North American Purebred Dog Registry.
109217	United All Breed Registry	United All Breed Registry.
109218	United Kennel Club	United Kennel Club.
109219	Universal Kennel Club International	Universal Kennel Club International.
109220	Working Canine Association of Canada	Working Canine Association of Canada.
109221	World Kennel Club	World Kennel Club.
109222	World Wide Kennel Club	World Wide Kennel Club.
109701	Overall image quality evaluation	Evaluation of overall image quality as described in section 7.3.2 of [IEC 62563-1].
109702	Grayscale resolution evaluation	Visual verification of sufficient grayscale resolution based on 8 and 10-bit markers as described in section 7.3.3 of [IEC 62563-1].
109703	Luminance response evaluation	Visual evaluation of luminance response using the TG18-CT test pattern as described in section 7.3.4 of [IEC 62563-1].
109704	Luminance uniformity evaluation	Visual detection of luminance non-uniformities as described in section 7.3.5 of [IEC 62563-1].
109705	Chromaticity evaluation	Visual verification of color uniformity as described in section 7.3.6 of [IEC 62563-1].
109706	Pixel faults evaluation	Visual detection of defective pixels on dark (TG18-UN80) and bright (TG18-UN10) images as described in section 7.3.7 of [IEC 62563-1].
109707	Veiling glare evaluation	Visual evaluation of veiling glare by looking at low contrast objects on 2 test patterns as described in section 7.3.8 of [IEC 62563-1].
109708	Geometrical image evaluation	Visual evaluation of geometry, phase/clock correction and clipping as described in section 7.3.9 of [IEC 62563-1].
109709	Angular viewing evaluation	Visual evaluation of viewing angle as described in section 7.3.10 of [IEC 62563-1].
109710	Clinical evaluation	Visual evaluation of the appearance of clinical images as described in section 7.3.11 of [IEC 62563-1].
109801	TG18-QC Pattern	AAPM TG18-QC Pattern used for evaluation of resolution, luminance, distortion, artifacts. See [AAPM OR 03].
109802	TG18-BR Pattern	AAPM TG18-BR Pattern used for the evaluation of the display of low-contrast, fine-detail image structures See [AAPM OR 03].
109803	TG18-PQC Pattern	AAPM TG18-PQC Pattern used for evaluation of resolution, luminance, contrast transfer for prints. See [AAPM OR 03].
109804	TG18-CT Pattern	AAPM TG18-CT Pattern used for evaluation of luminance response. See [AAPM OR 03].
109805	TG18-LN8-01 Pattern	The 1^st image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109806	TG18-LN8-02 Pattern	The 2^nd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109807	TG18-LN8-03 Pattern	The 3^rd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109808	TG18-LN8-04 Pattern	The 4^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109809	TG18-LN8-05 Pattern	The 5^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109810	TG18-LN8-06 Pattern	The 6^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109811	TG18-LN8-07 Pattern	The 7^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109812	TG18-LN8-08 Pattern	The 8^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109813	TG18-LN8-09 Pattern	The 9^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109814	TG18-LN8-10 Pattern	The 10^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration series. See [AAPM OR 03].
109815	TG18-LN8-11 Pattern	The 11^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109816	TG18-LN8-12 Pattern	The 12^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109817	TG18-LN8-13 Pattern	The 13^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109818	TG18-LN8-14 Pattern	The 14^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109819	TG18-LN8-15 Pattern	The 15^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109820	TG18-LN8-16 Pattern	The 16^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109821	TG18-LN8-17 Pattern	The 17^th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03].
109822	TG18-LN8-18 Pattern	The 18^th image in the AAPM TG18-LN8- set used for DICOM grayscale calibration. See [AAPM OR 03].
109823	TG18-LN12-01 Pattern	The 1^st image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109824	TG18-LN12-02 Pattern	The 2 ^nd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109825	TG18-LN12-03 Pattern	The 3^rd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109826	TG18-LN12-04 Pattern	The 4^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109827	TG18-LN12-05 Pattern	The 5^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109828	TG18-LN12-06 Pattern	The 6^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109829	TG18-LN12-07 Pattern	The 7^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109830	TG18-LN12-08 Pattern	The 8^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109831	TG18-LN12-09 Pattern	The 9^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109832	TG18-LN12-10 Pattern	The 10^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109833	TG18-LN12-11 Pattern	The 11^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109834	TG18-LN12-12 Pattern	The 12^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109835	TG18-LN12-13 Pattern	The 13^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109836	TG18-LN12-14 Pattern	The 14^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109837	TG18-LN12-15 Pattern	The 15^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109838	TG18-LN12-16 Pattern	The 16^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109839	TG18-LN12-17 Pattern	The 17^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109840	TG18-LN12-18 Pattern	The 18^th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03].
109841	TG18-UN10 Pattern	The AAPM TG18-UN10 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03].
109842	TG18-UN80 Pattern	The AAPM TG18-UN80 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03].
109843	TG18-UNL10 Pattern	The AAPM TG18-UNL10 Pattern is the AAPM TG-18 UN10 Pattern with added defining lines. See [AAPM OR 03].
109844	TG18-UNL80 Pattern	The AAPM TG18-UNL80 Pattern is the AAPM TG-18 UN80 Pattern with added defining lines. See [AAPM OR 03].
109845	TG18-AD Pattern	The AAPM TG18-AD Pattern used for visual evaluation of the reflection of ambient light from the display. See [AAPM OR 03].
109846	TG18-MP Pattern	The AAPM TG18-MP Pattern used for evaluation of Luminance response (bit-depth resolution). See [AAPM OR 03].
109847	TG18-RH10 Pattern	The AAPM TG18-RH10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 10% luminance level. See [AAPM OR 03].
109848	TG18-RH50 Pattern	The AAPM TG18-RH50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 50% luminance level. See [AAPM OR 03].
109849	TG18-RH89 Pattern	The AAPM TG18-RH89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 89% luminance level. See [AAPM OR 03].
109850	TG18-RV10 Pattern	The AAPM TG18-RV10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 10% luminance level. See [AAPM OR 03].
109851	TG18-RV50 Pattern	The AAPM TG18-RV50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 50% luminance level. See [AAPM OR 03].
109852	TG18-RV89 Pattern	The AAPM TG18-RV89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 89% luminance level. See [AAPM OR 03].
109853	TG18-PX Pattern	The AAPM TG18-PX Pattern used for the assessment of display resolution. See [AAPM OR 03].
109854	TG18-CX Pattern	The AAPM TG18-CX Pattern used to assess display resolution and resolution uniformity. See [AAPM OR 03].
109855	TG18-LPH10 Pattern	The AAPM TG18-LPH10 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03].
109856	TG18-LPH50 Pattern	The AAPM TG18-LPH50 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 50% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03].
109857	TG18-LPH89 Pattern	The AAPM TG18-LPH89 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03].
109858	TG18-LPV10 Pattern	The AAPM TG18-LPV10 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03].
109859	TG18-LPV50 Pattern	The AAPM TG18-LPV50 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 50% background level of the maximum pixel value. See [AAPM OR 03].
109860	TG18-LPV89 Pattern	The AAPM TG18-LPV89 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03].
109861	TG18-AFC Pattern	The AAPM TG18-AFC Pattern used to assess display noise. See [AAPM OR 03]
109862	TG18-NS10 Pattern	The AAPM TG18-NS10 Pattern is AAPM TG18-RV10/RH10 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03].
109863	TG18-NS50 Pattern	The AAPM TG18-NS50 Pattern is AAPM TG18-RV50/RH50 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03].
109864	TG18-NS89 Pattern	The AAPM TG18-NS89 Pattern is AAPM TG18-RV89/RH89 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03].
109865	TG18-GV Pattern	The TG18-GV Pattern used to assess display veiling. See [AAPM OR 03].
109866	TG18-GVN Pattern	The TG18-GVN Pattern used to assess display veiling. This pattern is identical to AAPM TG18-GV Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03].
109867	TG18-GQ Pattern	The TG18-GQ Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GV except that is lacks the central low-contrast objects. See [AAPM OR 03].
109868	TG18-GQN Pattern	TG18-GQN Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03].
109869	TG18-GQB Pattern	The TG18-GQB Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except eliminating the central black circle. See [AAPM OR 03].
109870	TG18-GA03 Pattern	The TG18-GA03 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 3. See [AAPM OR 03].
109871	TG18-GA05 Pattern	The TG18-GA05 Pattern This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 5. See [AAPM OR 03].
109872	TG18-GA08 Pattern	The TG18-GA08 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 8. See [AAPM OR 03].
109873	TG18-GA10 Pattern	The TG18-GA10 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 10. See [AAPM OR 03].
109874	TG18-GA15 Pattern	The TG18-GA15 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 15.
109875	TG18-GA20 Pattern	The TG18-GA20 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 20. See [AAPM OR 03].
109876	TG18-GA25 Pattern	The TG18-GA25 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 25. See [AAPM OR 03].
109877	TG18-GA30 Pattern	The TG18-GA30 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 30. See [AAPM OR 03].
109878	TG18-CH Image	The AAPM TG18-CH Image is a reference anatomical PA chest image. See [AAPM OR 03].
109879	TG18-KN Image	The AAPM TG18-KN Image is a reference anatomical knee image. See [AAPM OR 03].
109880	TG18-MM1 Image	The AAPM TG18-MM1 Image is a reference anatomical mammogram image. See [AAPM OR 03].
109881	TG18-MM2 Image	The AAPM TG18-MM2 Image is a reference anatomical mammogram image. See [AAPM OR 03].
109901	OIQ Pattern	The IEC OIQ Pattern is used as an alternative to the TG18-QC Pattern. See [IEC 62563-1].
109902	ANG Pattern	The IEC ANG Pattern used for angular viewing evaluation. See [IEC 62563-1].
109903	GD Pattern	The IEC GD Pattern used for geometrical image evaluation. See [IEC 62563-1].
109904	BN01 Pattern	The IEC BN01 Pattern is used as an alternative to the TG18-LN-01 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109905	BN02 Pattern	The IEC BN02 Pattern is used as an alternative to the TG18-LN-02 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109906	BN03 Pattern	The IEC BN03 Pattern is used as an alternative to the TG18-LN-03 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109907	BN04 Pattern	The IEC BN04 Pattern is used as an alternative to the TG18-LN-04 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109908	BN05 Pattern	The IEC BN05 Pattern is used as an alternative to the TG18-LN-05 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109909	BN06 Pattern	The IEC BN06 Pattern is used as an alternative to the TG18-LN-06 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109910	BN07 Pattern	The IEC BN07 Pattern is used as an alternative to the TG18-LN-07 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109911	BN08 Pattern	The IEC BN08 Pattern is used as an alternative to the TG18-LN-08 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109912	BN09 Pattern	The IEC BN09 Pattern is used as an alternative to the TG18-LN-09 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109913	BN10 Pattern	The IEC BN10 Pattern is used as an alternative to the TG18-LN-10 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109914	BN11 Pattern	The IEC BN11 Pattern is used as an alternative to the TG18-LN-11 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109915	BN12 Pattern	The IEC BN12 Pattern is used as an alternative to the TG18-LN-12 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109916	BN13 Pattern	The IEC BN13 Pattern is used as an alternative to the TG18-LN-13 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109917	BN14 Pattern	The IEC BN14 Pattern is used as an alternative to the TG18-LN-14 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109918	BN15 Pattern	The IEC BN15 Pattern is used as an alternative to the TG18-LN-15 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109919	BN16 Pattern	The IEC BN16 Pattern is used as an alternative to the TG18-LN-16 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109920	BN17 Pattern	The IEC BN17 Pattern is used as an alternative to the TG18-LN-17 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109921	BN18 Pattern	The IEC BN18 Pattern is used as an alternative to the TG18-LN-18 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1].
109931	DIN Grayscale Pattern	Test image "Bild 2" for the gray-scale reproduction of imaging devices. See [DIN 6868-57].
109932	DIN Geometry Pattern	Test image "Bild 3" for the geometrical imaging properties of imaging devices. See [DIN 6868-57].
109933	DIN Resolution Pattern	Test image "Bild 5" for displaying the spatial and contrast resolution as well as the line structure of imaging devices. See [DIN 6868-57].
109941	White Pattern	An alternative to AAPM TG18-UN80, specified at 100% of maximum pixel value.
109943	SMPTE Pattern	A standard display test pattern. See [SMPTE RP133]. A pattern is available at http://www.dclunie.com/images/smpte.512.512.8.gif.
109991	CRT Display	A Display Device that displays images on a Cathode Ray Tube.
109992	Liquid Crystal Display	A Display Device that displays images on a Liquid Crystal Display.
109993	Plasma Display	A Display Device that displays images on a Plasma Display.
109994	OLED	A Display Device that displays images on an Organic Light Emitting Diode based display.
109995	DLP Rear Projection System	A Display Device that projects images on a surface from behind using a Digital Light Processing Projector.
109996	DLP Front Projection System	A Display Device that projects images on a surface from in front using a Digital Light Processing Projector.
109997	CRT Rear Projection System	A Display Device that projects images on a surface from behind using a Cathode Ray Tube.
109998	CRT Front Projection System	A Display Device that projects images on a surface from in front using a Cathode Ray Tube.
109999	Other Projection System	A Display Device that projects images on a surface from an unspecified direction using an unspecified means.
110001	Image Processing	Image processing work item.
110002	Quality Control	Quality control work item.
110003	Computer Aided Diagnosis	Computer aided diagnosis work item.
110004	Computer Aided Detection	Computer aided detection work item.
110005	Interpretation	The work item task is to prepare a report that contains the interpretation of an imaging study.
110006	Transcription	Transcription work item.
110007	Report Verification	Report verification work item.
110008	Print	Print work item.
110009	No subsequent Workitems	There will be no more work items scheduled.
110010	Film	Film type of output.
110011	Dictation	Dictation type of output.
110012	Transcription	Transcription type of output.
110013	Media Import	The procedure to read DICOM instances from DICOM interchange media, coerce identifying Attributes into the local namespace if necessary, and make the instances available.
110020	Sheet Film Digitized	Digitization of Sheet Film.
110021	Cine Film Digitized	Digitization of Cine Film.
110022	Video Tape Digitized	Digitization of Video Tape.
110023	Paper Digitized	Digitization of pages of a paper document (Units may be specified as Pages, Documents).
110024	CD Imported	Importation of CD.
110025	DVD Imported	Importation of DVD.
110026	MOD Imported	Importation of MOD.
110027	Studies Imported	Importation of DICOM Studies.
110028	Instances Imported	Importation of DICOM Composite Instances.
110030	USB Disk Emulation	A device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies.
110031	Email	Email and email attachments used as a media for data transport.
110032	CD	CD-R, CD-ROM, and CD-RW media used for data transport.
110033	DVD	DVD, DVD-RAM, and other DVD formatted media used for data transport.
110034	Compact Flash	Media that comply with the Compact Flash standard.
110035	Multi-media Card	Media that comply with the Multi-media Card standard.
110036	Secure Digital Card	Media that comply with the Secure Digital Card standard.
110037	URI	URI Identifier for network or other resource, see RFC3968.
110038	Paper Document	Any paper or similar document.
110100	Application Activity	Audit event: Application Activity has taken place.
110101	Audit Log Used	Audit event: Audit Log has been used.
110102	Begin Transferring DICOM Instances	Audit event: Storage of DICOM Instances has begun.
110103	DICOM Instances Accessed	Audit event: DICOM Instances have been created, read, updated, or deleted -audit event.
110104	DICOM Instances Transferred	Audit event: Storage of DICOM Instances has been completed.
110105	DICOM Study Deleted	Audit event: Entire Study has been deleted.
110106	Export	Audit event: Data has been exported out of the system.
110107	Import	Audit event: Data has been imported into the system.
110108	Network Entry	Audit event: System has joined or left network.
110109	Order Record	Audit event: Order has been created, read, updated or deleted.
110110	Patient Record	Audit event: Patient Record has been created, read, updated, or deleted.
110111	Procedure Record	Audit event: Procedure Record has been created, read, updated, or deleted.
110112	Query	Audit event: Query has been made.
110113	Security Alert	Audit event: Security Alert has been raised.
110114	User Authentication	Audit event: User Authentication has been attempted.
110119	Station AE Title	Application Entity Title of a device.
110120	Application Start	Audit event: Application Entity has started.
110121	Application Stop	Audit event: Application Entity has stopped.
110122	Login	Audit event: User login has been attempted.
110123	Logout	Audit event: User logout has been attempted.
110124	Attach	Audit event: Node has been attached.
110125	Detach	Audit event: Node has been detached.
110126	Node Authentication	Audit event: Node Authentication has been attempted.
110127	Emergency Override Started	Audit event: Emergency Override has started.
110128	Network Configuration	Audit event: Network configuration has been changed.
110129	Security Configuration	Audit event: Security configuration has been changed.
110130	Hardware Configuration	Audit event: Hardware configuration has been changed.
110131	Software Configuration	Audit event: Software configuration has been changed.
110132	Use of Restricted Function	Audit event: A use of a restricted function has been attempted.
110133	Audit Recording Stopped	Audit event: Audit recording has been stopped.
110134	Audit Recording Started	Audit event: Audit recording has been started.
110135	Object Security Attributes Changed	Audit event: Security attributes of an object have been changed.
110136	Security Roles Changed	Audit event: Security roles have been changed.
110137	User security Attributes Changed	Audit event: Security attributes of a user have been changed.
110138	Emergency Override Stopped	Audit event: Emergency Override has Stopped.
110139	Remote Service Operation Started	Audit event: Remote Service Operation has Begun.
110140	Remote Service Operation Stopped	Audit event: Remote Service Operation has Stopped.
110141	Local Service Operation Started	Audit event: Local Service Operation has Begun.
110142	Local Service Operation Stopped	Audit event: Local Service Operation Stopped.
110143	Authentication Decision	Audit event: An authentication decision has been made.
110144	Authorization Decision	Audit event: An authorization decision has been made.
110145	Session start	Audit event: A persistent session has started.
110146	Session stop	Audit event: A persistent session has stopped.
110147	Access Control Decision	Audit event: An access control decision has been made.
110150	Application	Audit participant role ID of software application.
110151	Application Launcher	Audit participant role ID of software application launcher, i.e., the entity that started or stopped an application.
110152	Destination Role ID	Audit participant role ID of the receiver of data.
110153	Source Role ID	Audit participant role ID of the sender of data.
110154	Destination Media	Audit participant role ID of media receiving data during an export.
110155	Source Media	Audit participant role ID of media providing data during an import.
110180	Study Instance UID	ParticipantObjectID type: Study Instance UID.
110181	SOP Class UID	ParticipantObjectID type: SOP Class UID.
110182	Node ID	ID of a node that is a participant object of an audit message.
110190	Issuer of Identifier	System, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.).
110500	Doctor canceled procedure	Procedure order canceled by requesting physician or other authorized physician.
110501	Equipment failure	Equipment failure prevented completion of procedure.
110502	Incorrect procedure ordered	Procedure discontinued due to incorrect procedure being ordered.
110503	Patient allergic to media/contrast	Procedure discontinued due to patient allergy to media/contrast (reported or reaction).
110504	Patient died	Procedure discontinued due to death of Patient.
110505	Patient refused to continue procedure	Procedure discontinued due to patient refusal to continue procedure.
110506	Patient taken for treatment or surgery	Procedure discontinued due to patient being taken for treatment or surgery.
110507	Patient did not arrive	Patient did not arrive for procedure.
110508	Patient pregnant	Procedure discontinued due to patient pregnancy (reported or determined).
110509	Change of procedure for correct charging	Procedure discontinued to restart with new procedure code for correct charging.
110510	Duplicate order	Procedure discontinued due to duplicate orders received for same procedure.
110511	Nursing unit cancel	Procedure order canceled by nursing unit.
110512	Incorrect side ordered	Procedure discontinued due to incorrect side (laterality) being ordered.
110513	Discontinued for unspecified reason	Procedure discontinued for unspecified reason.
110514	Incorrect worklist entry selected	Procedure discontinued due to incorrect patient or procedure step selected from modality worklist.
110515	Patient condition prevented continuing	Patient condition prevented continuation of procedure.
110516	Equipment change	Procedure step is discontinued to change to other equipment or modality.
110518	Patient Movement	A movement of the patient preventing continuation of procedure or affecting result quality.
110519	Operator Error	An error of the operator preventing continuation of procedure or affecting result quality.
110520	Channel Obstruction	The brachytherapy channel is obstructed and the treatment in this channel cannot proceed.
110521	Objects incorrectly formatted	One or more of the objects is malformed.
110522	Object Types not supported	Receiving System is unable to accept the object type.
110523	Object Set incomplete	One or more objects associated with the object set is missing.
110524	Media Failure	The contents of the Media could not be accessed properly.
110526	Resource pre-empted	Procedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure.
110527	Resource inadequate	Procedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure.
110528	Discontinued Procedure Step rescheduled	A new Procedure Step has been scheduled to replace the Discontinued Procedure Step.
110529	Discontinued Procedure Step rescheduling recommended	It is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step.
110530	Workitem assignment rejected by assigned resource	The resource to which a workitem has been assigned has rejected the assignment.
110531	Insufficient quality for interpretation	Reporting not possible due to lack of quality of the images provided.
110532	Interpretation requires specialist expertise	The nature of the clinical problem means that reporting of the study requires a subject matter expert.
110533	Workitem expired	The expiration date/time of the workitem has been exceeded.
110700	Ventral Diencephalon	Ventral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract. See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html and http://www.cma.mgh.harvard.edu/manuals/segmentation/.
110701	White Matter T1 Hypointensity	Area(s) of reduced intensity on T1 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images.
110702	White Matter T2 Hyperintensity	Area(s) of increased intensity on T2 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images.
110703	superior longitudinal fasciculus I	The dorsal component of the SLF originating from the medial and dorsal parietal cortex and ending in the dorsal and medial part of the frontal lobe. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186.
110704	superior longitudinal fasciculus II	The major component of the SLF, derived from the caudal-inferior parietal region corresponding to the angular gyrus in the human and terminating within the dorsolateral frontal region. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186.
110705	superior longitudinal fasciculus III	The ventral component of the SLF, originating from the supramarginal gyrus and terminating predominantly in the ventral premotor and prefrontal areas. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186.
110706	Perilesional White Matter	White matter that surrounds a lesion of interest. E.g., to identify the otherwise unclassified white matetr that surrounds a tumor to be surgically resected.
110800	Spin Tagging Perfusion MR Signal Intensity	Signal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer.
110801	Contrast Agent Angio MR Signal Intensity	Signal intensity of a Contrast Agent Angio MR image.
110802	Time Of Flight Angio MR Signal Intensity	Signal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins.
110803	Proton Density Weighted MR Signal Intensity	Signal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'.
110804	T1 Weighted MR Signal Intensity	Signal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times.
110805	T2 Weighted MR Signal Intensity	Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest.
110806	T2* Weighted MR Signal Intensity	Signal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies.
110807	Field Map MR Signal Intensity	Signal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B ₀ inhomogeneity at each point in the image.
110808	Fractional Anisotropy	Coefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values.	Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996 Jun;111(3):209-19. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.162.2222&rep=rep1&type=pdf
110809	Relative Anisotropy	Coefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image.	Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996 Jun;111(3):209-19. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.162.2222&rep=rep1&type=pdf
110810	Volumetric Diffusion Dxx Component	Dxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis.
110811	Volumetric Diffusion Dxy Component	Dxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions.
110812	Volumetric Diffusion Dxz Component	Dxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions.
110813	Volumetric Diffusion Dyy Component	Dyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis.
110814	Volumetric Diffusion Dyz Component	Dyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions.
110815	Volumetric Diffusion Dzz Component	Dzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis.
110816	T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity	Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels.
110817	T2 Weighted Dynamic Contrast Enhanced MR Signal Intensity	Signal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain.
110818	T2* Weighted Dynamic Contrast Enhanced MR Signal Intensity	Signal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain.
110819	Blood Oxygenation Level	Signal intensity of a Blood Oxygenation Level image. Used in Photoacoustic Imaging and functional MR. In functional MR BOLD imaging it is used for detecting brain activation and is sensitive to blood oxygenation (but also to cerebral blood flow and volume).
110820	Nuclear Medicine Projection Activity	Accumulated decay event counts in a nuclear medicine projection image.
110821	Nuclear Medicine Tomographic Activity	Accumulated decay event counts in a Nuclear Medicine Tomographic image (including PET).
110822	Spatial Displacement X Component	Spatial Displacement along axis X of a non linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient.
110823	Spatial Displacement Y Component	Spatial Displacement along axis Y of a non linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient.
110824	Spatial Displacement Z Component	Spatial Displacement along axis Z of a Non linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient.
110825	Hemodynamic Resistance	Measured resistance to the flow of blood. E.g., through the vasculature or through a heart value.
110826	Indexed Hemodynamic Resistance	Measured resistance to the flow of blood. E.g., through the vasculature or through a heart value, normalized to a particular indexed scale.
110827	Tissue Velocity	Velocity of tissue based on Doppler measurements.
110828	Flow Velocity	Velocity of blood flow based on Doppler measurements.
110829	Flow Variance	Statistical variance of blood velocity relative to mean.
110830	Elasticity	Scalar value related to the elastic properties of the tissue.
110831	Perfusion	Scalar value related to the volume of blood perfusing into tissue.
110832	Speed of sound	Speed of sound in tissue.
110833	Ultrasound Attenuation	Reduction in strength of ultrasound signal as the wave.
110834	RGB R Component	Red component of a true color image (RGB).
110835	RGB G Component	Green component of a true color image (RGB).
110836	RGB B Component	Blue component of a true color image (RGB).
110837	YBR FULL Y Component	Y (Luminance) component of a YBR FULL image, as defined in JPEG 2000.
110838	YBR FULL CB Component	CB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000.
110839	YBR FULL CR Component	CR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000.
110840	YBR PARTIAL Y Component	Y (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000.
110841	YBR PARTIAL CB Component	CB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000.
110842	YBR PARTIAL CR Component	CR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000.
110843	YBR ICT Y Component	Y (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.
110844	YBR ICT CB Component	CB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.
110845	YBR ICT CR Component	CR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.
110846	YBR RCT Y Component	Y (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.
110847	YBR RCT CB Component	CB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.
110848	YBR RCT CR Component	CR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.
110849	Echogenicity	The ability of a material to create an ultrasound return echo.
110850	X-Ray Attenuation	Decrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering.
110851	X-Ray Attenuation Coefficient	Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms.	Retired. Replaced by (112031, DCM, "Attenuation Coefficient").
110852	MR signal intensity	Signal intensity of an MR image, not otherwise specified.
110853	Binary Segmentation	Binary value denoting that the segmented property is present.
110854	Fractional Probabilistic Segmentation	Probability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel.
110855	Fractional Occupancy Segmentation	Percentage of the voxel area occupied by the segmented property.
110856	Linear Displacement	Spatial dimension, denoting a linear displacement.
110857	Photon Energy	Dimension denoting the energy (frequency or wavelength) of photons.
110858	Time	Dimension used to sequence events, to compare the duration of events and the intervals between events.
110859	Angle	Spatial dimension, denoting an angle.
110860	Left-Right Axis	A spatial dimension axis running along a line between the patient's left and right side.
110861	Head-Foot Axis	A spatial dimension axis running along a line between the patient's head and foot.
110862	Anterior-Posterior Axis	A spatial dimension axis running along a line between the patient's anterior and posterior sides.
110863	Apex-Base Axis	A spatial dimension axis running along a line between the apex and base of an organ, object, or chamber.
110864	Anterior-Inferior Axis	A spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber.
110865	Septum-Wall Axis	A spatial dimension axis running along a line between the septum and wall of a chamber.
110866	Right To Left	Orientation of a spatial dimension where increasing values run from the right to the left side of the patient.
110867	Left To Right	Orientation of a spatial dimension where increasing values run from the left to the right side of the patient.
110868	Head To Foot	Orientation of a spatial dimension where increasing values run from the head to the foot of the patient.
110869	Foot To Head	Orientation of a spatial dimension where increasing values run from the foot to the head of the patient.
110870	Anterior To Posterior	Orientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient.
110871	Posterior To Anterior	Orientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient.
110872	Apex To Base	Orientation of a spatial dimension where increasing values run from the apex to the base.
110873	Base To Apex	Orientation of a spatial dimension where increasing values run from the base to the apex.
110874	Anterior To Inferior	Orientation of a spatial dimension where increasing values run from the anterior to the inferior.
110875	Inferior To Anterior	Orientation of a spatial dimension where increasing values run from the inferior to the anterior.
110876	Septum To Wall	Orientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall.
110877	Wall To Septum	Orientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber.
110901	Image Position (Patient) X	The x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system.
110902	Image Position (Patient) Y	The y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system.
110903	Image Position (Patient) Z	The z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system.
110904	Image Orientation (Patient) Row X	The x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system.
110905	Image Orientation (Patient) Row Y	The y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system.
110906	Image Orientation (Patient) Row Z	The z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system.
110907	Image Orientation (Patient) Column X	The x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system.
110908	Image Orientation (Patient) Column Y	The y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system.
110909	Image Orientation (Patient) Column Z	The z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system.
110910	Pixel Data Rows	Number of rows in the pixel data of the image.
110911	Pixel Data Columns	Number of columns in the pixel data of the image.
111000	Algorithm Family	The family of algorithm(s) that best describes the software algorithm used.
111001	Algorithm Name	The name assigned by a manufacturer to a specific software algorithm.
111002	Algorithm Parameters	The input parameters used by a manufacturer to configure the behavior of a specific software algorithm.
111003	Algorithm Version	The software version identifier assigned by a manufacturer to a specific software algorithm.
111004	Analysis Performed	The type of correlation applied to detection results. E.g., temporal, spatial.
111005	Assessment Category	Assignment of intermediate or overall interpretation results to a general category.
111006	Breast composition	Assessment of annotating tissues in breast; generally including fatty, mixed or dense	Retired. Replaced by (129715009, SCT, "Breast composition").
111007	Breast Outline including Pectoral Muscle Tissue	Purpose of reference for an SCOORD Content Item that is an outline of the breast that includes the pectoral muscle tissue	Purpose of Reference for Content Item of value type COMPOSITE or SCOORD
111008	Calcification Distribution	The type of distribution associated with detected calcifications.
111009	Calcification Type	Identification of the morphology of detected calcifications.
111010	Center	The central point of a finding or feature.	May be used as the Purpose of Reference for Content Item of value type COMPOSITE or SCOORD, or a qualitative observation on an ROI.
111011	Certainty of Feature	The likelihood that the feature analyzed is in fact the type of feature identified.
111012	Certainty of Finding	The likelihood that the finding detected is in fact the type of finding identified.
111013	Certainty of Impression	The certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty.
111014	Clockface or region	A location identifier based on clockface numbering or anatomic subregion.
111015	Composite Feature	An item that is an inferred correlation relating two or more individual findings or features.
111016	Composite type	The inferred relationship between the findings or features making up a composite feature.
111017	CAD Processing and Findings Summary	General assessment of whether or not CAD processing was successful, and whether any findings resulted.
111018	Content Date	The date the data creation started.
111019	Content Time	The time the data creation started.
111020	Depth	A location identifier based on a feature's inferred distance from the surface of the associated anatomy.
111021	Description of Change	A textual description of the change that occurred over time in a qualitative characteristic of a feature.
111022	Detection Performed	The type of finding sought after by a specific algorithm applied to one image.
111023	Differential Diagnosis/Impression	A general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure.
111024	Failed Analyses	A group of analysis algorithms that were attempted, but failed.
111025	Failed Detections	A group of detection algorithms that were attempted, but failed.
111026	Horizontal Pixel Spacing	For projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel (spacing between the centers of adjacent columns). For tomographic images, the horizontal physical distance in the patient between the center of each pixel.
111027	Image Laterality	Laterality of (possibly paired) body part contained in an image.
111028	Image Library	A container that references all image data used as evidence to produce a report.
111029	Image Quality Rating	A numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality.
111030	Image Region	Purpose of reference for an SCOORD Content Item that identifies a specific region of interest within an image	Purpose of Reference for Content Item of value type COMPOSITE or SCOORD
111031	Image View	The projection of the anatomic region of interest on an image receptor.
111032	Image View Modifier	Modifier for Image View.
111033	Impression Description	Free-form text describing the overall or an individual impression.
111034	Individual Impression/Recommendation	A container for a group of related results from interpretation of one or more images and associated clinical information.
111035	Lesion Density	The X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue.
111036	Mammography CAD Report	A structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information.
111037	Margins	The characteristic of the boundary, edges or border of a detected lesion.
111038	Number of calcifications	The quantity of calcifications detected within an identified group or cluster.
111039	Object type	A non-lesion object identified within one or more images.
111040	Original Source	Purpose of reference for a COMPOSITE Content Item that identifies it as the original source of evidence for another Content Item in the report	Purpose of Reference for Content Item of value type COMPOSITE or SCOORD
111041	Outline	The outline of a finding or feature.	May be used as the Purpose of Reference for Content Item of value type COMPOSITE or SCOORD, or a qualitative observation on an ROI.
111042	Pathology	The inferred type of disease associated with an identified feature.
111043	Patient Orientation Column	The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom).
111044	Patient Orientation Row	The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right).
111045	Pectoral Muscle Outline	Purpose of reference for an SCOORD Content Item that is an outline of the pectoral muscle tissue only	Purpose of Reference for Content Item of value type COMPOSITE or SCOORD
111046	Percent Fibroglandular Tissue	Percent of breast area that is mammographically dense, excluding pectoralis muscle.
111047	Probability of cancer	The likelihood that an identified finding or feature is cancerous.
111048	Quadrant location	A location identifier based on the division of an area into four regions.
111049	Qualitative Difference	A qualitative characteristic of a feature that has changed over time.
111050	Quality Assessment	The effect of the quality of an image on its usability.
111051	Quality Control Standard	The quality control standard used to make a quality assessment.
111052	Quality Finding	A specific quality related deficiency detected within an image.
111053	Recommended Follow-up	Recommended type of follow-up to an imaging procedure, based on interpreted results.
111054	Recommended Follow-up Date	Recommended follow-up date to an imaging procedure, based on interpreted results.
111055	Recommended Follow-up Interval	Recommended follow-up interval to an imaging procedure, based on interpreted results.
111056	Rendering Intent	The recommendation of the producer of a Content Item regarding presentation of the Content Item by recipients of the report.
111057	Scope of Feature	An indication of how widespread the detection of a feature is within the analyzed image data.
111058	Selected Region Description	A textual description of the contents of a selected region identified within an image.
111059	Single Image Finding	An item that was detected on one image.
111060	Study Date	Date on which the acquisition of the study information was started.
111061	Study Time	Time at which the acquisition of the study information was started.
111062	Successful Analyses	A group of analysis algorithms that were attempted and completed successfully.
111063	Successful Detections	A group of detection algorithms that were attempted and completed successfully.
111064	Summary of Detections	An overall indication of whether the CAD detection algorithms applied were completed successfully.
111065	Summary of Analyses	An overall indication of whether the CAD analysis algorithms applied were completed successfully.
111066	Vertical Pixel Spacing	For projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel (spacing between the centers of adjacent rows). For tomographic images, the vertical physical distance in the patient between the center of each pixel.
111069	Crosstable	A radiographic projection that has been with the patient lying on a table with the X-Ray source on one side of the table and the detector on the other. E.g., may describe a cross-table cervical spine, chest or pelvis X-Ray image.
111071	CAD Operating Point	One of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point.
111072	Maximum CAD Operating Point	The maximum value of CAD Operating Point for the specific CAD algorithm used.
111081	CAD Operating Point Description	The intended interpretation of a CAD Operating Point.
111086	False Markers per Image	The number of false CAD markers per image. Correlates to inverse of Image Specificity.
111087	False Markers per Case	The number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity.
111088	Case Sensitivity	The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view.
111089	Lesion Sensitivity	The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view.
111090	Case Specificity	The percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case.
111091	Image Specificity	The percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image.
111092	Recommended CAD Operating Point	The CAD operating point that is recommended for initial display by the creator of the structured report.
111093	CAD Operating Point Table	A list of CAD operating points including their corresponding characteristics.
111099	Selected region	A specific area of interest noted within an image.
111100	Breast geometry	The surface shape of all or a portion of breast related anatomy.
111101	Image Quality	Image quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling.
111102	Non-lesion	A finding or feature that is identified as a non-anatomic foreign object.
111103	Density	A space-occupying lesion identified in a single image or projection	Retired. Replaced by (129793001, SCT, "Mammography breast density").
111104	Individual Calcification	A single identified calcification	Retired. Replaced by (129770007, SCT, "Individual Calcification").
111105	Calcification Cluster	Multiple calcifications identified as occupying a small area of tissue (less than 2 cc)	Retired. Replaced by (129769006, SCT, "Calcification Cluster").
111111	Cooper's ligament changes	Straightening or thickening of Cooper's ligaments.
111112	Mass in the skin	An abnormality noted at imaging within the dermis of the breast.
111113	Mass on the skin	An abnormality noted at imaging on the epidermis of the breast.
111120	Post Procedure Mammograms for Marker Placement	An assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure.
111121	Follow-up post biopsy as directed by clinician	An indication that the patient should seek post procedural follow-up directives from a clinical health care provider.
111122	Known biopsy proven malignancy - take appropriate action	A recommendation on a patient with known cancer to take steps appropriate to the diagnosis.
111123	Marker placement	Positioning of a radiopaque marker.
111124	Personal history of breast cancer with mastectomy	Patient has previous diagnosis of breast cancer resulting in mastectomy.
111125	Known biopsy proven malignancy	Patient has had biopsy containing proven malignancy.
111126	Image detected mass	Patient has a finding of mass reported on a prior imaging study.
111127	Targeted	A breast imaging procedure performed on a specific area of the breast.
111128	Survey	A breast imaging procedure performed on the entire breast.
111129	Clustered microcysts	A cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components.
111130	Complicated cyst	A fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound.
111135	Additional projections	Views not inclusive of MLO and CC (BI-RADS®).
111136	Spot magnification view(s)	A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue.
111137	Ultrasound		Retired. Replaced by (16310003, SCT, "Diagnostic ultrasonography").
111138	Old films for comparison	Obtain previous mammography studies to compare to present study.
111139	Ductography	A medical procedure used for the sampling of mammary duct tissue	Retired. Replaced by (18102001, SCT, "Mammary ductogram").
111140	Normal interval follow-up	Follow up study at 12 months for women ≥ 40 years of age having a prior negative study and no mitigating risk factors for breast cancer.
111141	Any decision to biopsy should be based on clinical assessment	Any decision to perform tissue acquisition should be based on clinical assessment.
111142	Follow-up at short interval (1-11 months)	Follow-up at short interval (1-11 months).
111143	Biopsy should be considered	Tissue acquisition should be considered.
111144	Needle localization and biopsy	Breast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly.
111145	Histology using core biopsy	Pathologic analysis of breast tissue and lesions using core tissue samples.
111146	Suggestive of malignancy - take appropriate action	Lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy.
111147	Cytologic analysis	Cellular analysis of specimen.
111148	Biopsy should be strongly considered	Tissue acquisition should be strongly considered.
111149	Highly suggestive of malignancy - take appropriate action	Lesions have a high probability of being cancer, which require additional action.
111150	Presentation Required: Rendering device is expected to present	The producer of a report intends for a recipient of the report to present or display the associated Content Item.
111151	Presentation Optional: Rendering device may present	The producer of a report considers the presentation or display of the associated Content Item by a recipient to be optional.
111152	Not for Presentation: Rendering device expected not to present	The producer of a report intends for a recipient of the report NOT to present or display the associated Content Item.
111153	Target Content Items are related temporally	The associated Content Items are identified as being the same finding or feature at different points in time.
111154	Target Content Items are related spatially	The associated Content Items are identified as being the same finding or feature on different projections taken at the same point in time.
111155	Target Content Items are related contra-laterally	The associated Content Items are identified as being related side-to-side.
111156	Feature detected on the only image	There is one image in the interpreted data.
111157	Feature detected on only one of the images	There is more than one image of the same modality in the interpreted data.
111158	Feature detected on multiple images	There is more than one image of the same modality in the interpreted data.
111159	Feature detected on images from multiple modalities	The interpreted data contains images from multiple modalities.
111168	Scar tissue	The fibrous tissue replacing normal tissues destroyed by disease or injury	Retired. Replaced by (12402003, SCT, "Scar tissue").
111170	J Wire	A medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy	Retired. Replaced by (129463006, SCT, "J Wire").
111171	Pacemaker	A medical appliance used for regulating cardiac rhythms	Retired. Replaced by (14106009, SCT, "Cardiac Pacemaker").
111172	Paddle	A compression device used for obtaining mammographic images	Retired. Replaced by (129460009, SCT, "Compression paddle").
111173	Collimator	A device used for restricting an X-Ray beam	Retired. Replaced by (228761004, SCT, "Collimator").
111174	ID Plate	An area designated on a radiographic film for facility and patient ID information	Retired. Replaced by (129467007, SCT, "ID Plate").
111175	Other Marker	Site specific markers.
111176	Unspecified	The value of the concept is not specified	This term may not be used in Context Group Extensions; see Section 7.2.3
111177	View and Laterality Marker is missing	Image quality deficiency according to MQSA.
111178	View and Laterality Marker does not have both view and laterality	Image quality deficiency according to MQCM.
111179	View and Laterality Marker does not have approved codes	Image quality deficiency according to MQCM.
111180	View and Laterality Marker is not near the axilla	Image quality deficiency according to MQCM.
111181	View and Laterality Marker overlaps breast tissue	Image quality deficiency according to MQCM.
111182	View and Laterality Marker is partially obscured	Image quality deficiency according to MQCM.
111183	View and Laterality Marker is incorrect	Image quality deficiency.
111184	View and Laterality Marker is off image	Image quality deficiency.
111185	Flash is not near edge of film	Image quality deficiency according to MQCM.
111186	Flash is illegible, does not fit, or is lopsided	Image quality deficiency according to MQSA.
111187	Flash doesn't include patient name and additional patient id	Image quality deficiency according to MQCM.
111188	Flash doesn't include date of examination	Image quality deficiency according to MQCM.
111189	Flash doesn't include facility name and location	Image quality deficiency according to MQSA.
111190	Flash doesn't include technologist identification	Image quality deficiency according to MQCM.
111191	Flash doesn't include cassette/screen/detector identification	Image quality deficiency according to MQCM.
111192	Flash doesn't include mammography unit identification	Image quality deficiency according to MQCM.
111193	Date sticker is missing	Image quality deficiency according to MQCM.
111194	Technical factors missing	Image quality deficiency according to MQCM.
111195	Collimation too close to breast	Image quality deficiency according to MQCM.
111196	Inadequate compression	Image quality deficiency according to MQCM.
111197	MLO Insufficient pectoral muscle	Image quality deficiency according to MQCM.
111198	MLO No fat is visualized posterior to fibroglandular tissues	Image quality deficiency according to MQCM.
111199	MLO Poor separation of deep and superficial breast tissues	Image quality deficiency according to MQCM.
111200	MLO Evidence of motion blur	Image quality deficiency according to MQCM.
111201	MLO Inframammary fold is not open	Image quality deficiency according to MQCM.
111202	CC Not all medial tissue visualized	Image quality deficiency according to MQCM.
111203	CC Nipple not centered on image	Image quality deficiency according to MQCM.
111204	CC Posterior nipple line does not measure within 1 cm of MLO	Image quality deficiency according to MQCM.
111205	Nipple not in profile	Image quality deficiency.
111206	Insufficient implant displacement incorrect	Image quality deficiency according to MQCM.
111207	Image artifact(s)	Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information.
111208	Grid artifact(s)	Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity.
111209	Positioning	Inadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image.
111210	Motion blur	Unacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure.
111211	Under exposed	Inadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest.
111212	Over exposed	An excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector.
111213	No image	No evidence of a patient exposure.
111214	Detector artifact(s)	Superposed features or flaws of the detector.
111215	Artifact(s) other than grid or detector artifact	Features or discontinuities arising from causes other than the anti-scatter grid and image detector.
111216	Mechanical failure	Failure of the device to operate according to mechanical design specifications.
111217	Electrical failure	Failure of a device to operate according to electrical design specifications.
111218	Software failure	Attributable to software used in generation or handling of image.
111219	Inappropriate image processing	Images processed inappropriately, not following appropriate protocol.
111220	Other failure	Failure that is not mechanical or electrical or otherwise described.
111221	Unknown failure	Unidentified or unknown cause of failure.
111222	Succeeded	The attempted process was completely successful.
111223	Partially Succeeded	The attempted process succeeded in some ways, but failed in others.
111224	Failed	The attempted process completely failed.
111225	Not Attempted	No process was performed.
111233	Individual Impression/Recommendation Analysis	Analysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation.
111234	Overall Impression/Recommendation Analysis	Analysis of all groups of findings or features, to produce a single impression and/or recommendation.
111235	Unusable - Quality renders image unusable	Quality of an image renders it unusable for the intended purpose.
111236	Usable - Does not meet the quality control standard	Quality of an image is usable for the intended purpose, but does not meet the quality control standard.
111237	Usable - Meets the quality control standard	Quality of an image is usable for the intended purpose and meets the quality control standard.
111238	Mammography Quality Control Manual 1999, ACR	An image quality control standard specified by the American College of Radiology.
111239	Title 21 CFR Section 900, Subpart B	An image quality control standard in the US Code of Federal Regulations.
111240	Institutionally defined quality control standard	An image quality control standard specified or adopted by the institution responsible for the document.
111241	All algorithms succeeded; without findings	No findings resulted upon successful completion of all attempted computer-aided detection and/or analysis.
111242	All algorithms succeeded; with findings	One or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis.
111243	Not all algorithms succeeded; without findings	No findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process.
111244	Not all algorithms succeeded; with findings	One or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process.
111245	No algorithms succeeded; without findings	All of the attempted computer-aided detection and/or analysis failed, so there could be no findings.
111248	Adenolipoma	A benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts	Retired. Replaced by (22024005, SCT, "Adenolipoma").
111249	Ductal hyperplasia		Retired. Replaced by (67617000, SCT, "Ductal hyperplasia, Usual").
111250	Adenomyoepithelioma	Neoplasms composed of myoepithelial cells	Retired. Replaced by (128765009, SCT, "Adenomyoepithelioma").
111251	Normal axillary node	Axillary node that is normal in appearance with no associated pathology.
111252	Axillary node with calcifications	Axillary node containing calcifications.
111253	Axillary node hyperplasia	Excessive proliferation of normal tissue arrangement of the axillary node.
111254	Asynchronous involution		Retired. Replaced by (130963002, SCT, "Asynchronous involution of breast").
111255	Benign cyst with blood	Cyst with benign morphology containing blood.
111256	Benign Calcifications	Calcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy.
111257	Intracystic papilloma	Growing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes	Retired. Replaced by (47488001, SCT, "Intracystic papilloma").
111258	Ductal adenoma	Adenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple.
111259	Diabetic fibrous mastopathy	The occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus.
111260	Extra abdominal desmoid	A deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize	Retired. Replaced by (47284001, SCT, "Extra abdominal desmoid").
111262	Epidermal inclusion cyst	A cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin	Retired. Replaced by (419670003, SCT, "Epidermal inclusion cyst").
111263	Fibroadenomatoid hyperplasia	Excessive proliferation of fibroadenoma tissue.
111264	Fibroadenolipoma	A lipoma with an abundant stroma of fibrous tissue.
111265	Foreign body (reaction)		Retired. Replaced by (37058002, SCT, "Foreign body (reaction)").
111269	Galactocele	Retention cyst caused by occlusion of a lactiferous duct	Retired. Replaced by (42385006, SCT, "Galactocele").
111271	Hemangioma - nonparenchymal, subcutaneous	A congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous	Retired. Replaced by (93473009, SCT, "Hemangioma of subcutaneous tissue").
111273	Hyperplasia, usual		Retired. Replaced by (76197007, SCT, "Hyperplasia, usual").
111277	Juvenile papillomatosis	A form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma.
111278	Lactating adenoma	Enlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct	Retired. Replaced by (128651002, SCT, "Lactating adenoma").
111279	Lactational change	Changes related to the process of lactation.
111281	Large duct papilloma	A papilloma pertaining to large mammary duct.
111283	Myofibroblastoma	Solitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts	Retired. Replaced by (128738002, SCT, "Myofibroblastoma").
111284	Microglandular adenosis	Irregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation.
111285	Multiple Intraductal Papillomas	Papilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems.
111286	No abnormality	No abnormality.
111287	Normal breast tissue	Normal breast tissue.
111288	Neurofibromatosis	Condition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas	Retired. Replaced by (81669005, SCT, "Neurofibromatosis").
111290	Oil cyst (fat necrosis cyst)	A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst.
111291	Post reduction mammoplasty	Breast tissue with characteristics of a benign nature, following breast reduction surgery.
111292	Pseudoangiomatous stromal hyperplasia	A benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation.
111293	Radial scar	An nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia	Retired. Replaced by (133855003, SCT, "Radial scar").
111294	Sclerosing adenosis	Prominent interductal fibrosis of the terminal ductules	Retired. Replaced by (50916005, SCT, "Sclerosing adenosis").
111296	Silicone granuloma	Nodular inflammatory lesions due to the presence of silicone in the breast tissue.
111297	Nipple Characteristic	The morphologic status of the nipple.
111298	Virginal hyperplasia	Spontaneous excessive proliferation of breast tissue, usually found in younger women.
111299	Peripheral duct papillomas	Papilloma(s) pertaining the peripheral ducts.
111300	Axillary node with lymphoma	Axillary node with lymphoid tissue neoplasm.
111301	Axillary nodal metastases	Metastatic disease to the axillary node.
111302	Angiosarcoma	A malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts	Retired. Replaced by (39000009, SCT, "Angiosarcoma").
111303	Blood vessel (vascular) invasion	Histological changes to the vascular system related to an invasive process.
111304	Carcinoma in children	Carcinoma of the breast found in patients less than 20 years of age.
111305	Carcinoma in ectopic breast	A carcinoma found in supernumerary breasts and aberrant breast tissue.
111306	Carcinoma with endocrine differentiation	A carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast.
111307	Basal cell carcinoma of nipple	A basal cell carcinoma that arises in the nipple of the breast.
111308	Carcinoma with metaplasia		Retired. Replaced by (22694002, SCT, "Carcinoma with metaplasia").
111309	Cartilaginous and osseous change	Tissue changes to bones and cartilage.
111310	Carcinoma in pregnancy and lactation	Carcinoma of the breast presenting during pregnancy or lactation.
111311	Carcinosarcoma	A malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue	Retired. Replaced by (63264007, SCT, "Carcinosarcoma").
111312	Intraductal comedocarcinoma with necrosis	Comedocarcinoma of a duct with areas of necrotic tissue.
111313	Intraductal carcinoma, low grade	A non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior.
111314	Intraductal carcinoma micro-papillary		Retired. Replaced by (128696009, SCT, "Intraductal carcinoma micro-papillary").
111315	Intracystic papillary carcinoma	A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst.
111316	Invasive and in-situ carcinoma	Carcinoma with both characteristics of localized and spreading disease.
111317	Invasive lobular carcinoma		Retired. Replaced by (89740008, SCT, "Invasive lobular carcinoma").
111318	Leukemic infiltration	Mammary infiltrates as a secondary manifestation in patients with established leukemia.
111320	Lympathic vessel invasion	Histological changes to the lymphatic system related to an invasive process.
111321	Lymphoma	A heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systems	Retired. Replaced by (1163043007, SCT, "Lymphoma").
111322	Occult carcinoma presenting with axillary lymph node metastases	A small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes.
111323	Metastatic cancer to the breast	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm.
111324	Metastatic cancer to the breast from the colon	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon.
111325	Metastatic cancer to the breast from the lung	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung.
111326	Metastatic melanoma to the breast	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma.
111327	Metastatic cancer to the breast from the ovary	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary.
111328	Metastatic sarcoma to the breast	A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma.
111329	Multifocal intraductal carcinoma	Multiple foci of non-invasive carcinoma restricted to the glandular lumen.
111330	Metastatic disease to axillary node	A malignant lesion in an axillary node arising from a non-axillary neoplasm.
111331	Malignant fibrous histiocytoma		Retired. Replaced by (34360000, SCT, "Malignant fibrous histiocytoma").
111332	Multifocal invasive ductal carcinoma	Multiple sites of ductal carcinoma.
111333	Metastasis to an intramammary lymph node	A malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm.
111334	Malignant melanoma of nipple	A malignant melanoma of the skin that arises in the nipple of the breast.
111335	Neoplasm of the mammary skin		Retired. Replaced by (126510002, SCT, "Neoplasm of the mammary skin").
111336	Papillary carcinoma in-situ		Retired. Replaced by (10376009, SCT, "Papillary carcinoma in-situ").
111338	Recurrent malignancy	Recurrent malignancy.
111340	Squamous cell carcinoma of the nipple	Squamous cell carcinoma to the terminal portion of the alveolar.
111341	Intraductal carcinoma, high grade	A non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior.
111342	Invasive cribriform carcinoma		Retired. Replaced by (30156004, SCT, "Invasive cribriform carcinoma").
111343	Angular margins	An indication that some or all of the margin of a lesion has sharp corners, often forming acute angles.
111344	Fine pleomorphic calcification	Calcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter.
111345	Macrocalcifications	Coarse calcifications that are 0.5 mm or greater in size.
111346	Calcifications within a mass	An indicator that calcifications are imbedded within a mass.
111347	Calcifications outside of a mass	An indicator that calcifications are imaged outside of a mass finding.
111350	Breast background echotexture	Tissue composition of the breast noted on sonography.
111351	Homogeneous fat echotexture	Fat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue.
111352	Homogeneous fibroglandular echotexture	A uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat.
111353	Heterogeneous echotexture	The breast texture is characterized by multiple small areas of increased and decreased echogenicity.
111354	Orientation	Referential relationship of the finding to the imaging device as noted on sonography.
111355	Parallel	The long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation).
111356	Not parallel	The anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension.
111357	Lesion boundary	The lesion boundary describes the transition zone between the mass and the surrounding tissue.
111358	Abrupt interface	The sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness.
111359	Echogenic halo	There is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone.
111360	Echo pattern	An imaging characteristic of resonance noted during sonography.
111361	Anechoic	Without internal echoes.
111362	Hyperechoic	Having increased echogenicity relative to fat or equal to fibroglandular tissue.
111363	Complex	Mass contains both anechoic and echogenic components.
111364	Hypoechoic	Defined relative to fat; masses are characterized by low-level echoes throughout. E.g., appearance of a complicated cyst or fibroadenoma.
111365	Isoechoic	Having the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic).
111366	Posterior acoustic features	The attenuation characteristics of a mass with respect to its acoustic transmission.
111367	No posterior acoustic features	No posterior shadowing or enhancement.
111368	Posterior enhancement	Increased posterior echoes.
111369	Posterior shadowing	Decreased posterior echoes; edge shadows are excluded.
111370	Combined posterior enhancement and shadowing	More than one pattern of posterior attenuation, both shadowing and enhancement.
111371	Identifiable effect on surrounding tissues	Sonographic appearance of adjacent structures relative to a mass finding.
111372	Vascularity	Characterization of vascularization in region of interest.
111373	Vascularity not present	Vascularity not evident, such as on ultrasound.
111374	Vascularity not assessed	Vascularity not evaluated.
111375	Vascularity present in lesion	Vascularity on imaging is seen within a lesion.
111376	Vascularity present immediately adjacent to lesion	Vascularity on imaging is seen immediately adjacent to a lesion.
111377	Diffusely increased vascularity in surrounding tissue	Vascularity on imaging is considered diffusely elevated within the surrounding breast tissue.
111380	Correlation to other Findings	Relationship of the new anomaly to other clinical or imaging anomalies.
111381	Correlates to physical examination findings	An indication that the current imaging finding relates to a finding from a clinical breast examination.
111382	Correlates to mammography findings	An indication that the current imaging finding relates to a finding from a mammography study.
111383	Correlates to MRI findings	An indication that the current imaging finding relates to a finding from a breast MRI study.
111384	Correlates to ultrasound findings	An indication that the current imaging finding relates to a finding from a breast ultrasound study.
111385	Correlates to other imaging findings	An indication that the current imaging finding relates to a finding from an imaging study.
111386	No correlation to other imaging findings	An indication that the current imaging finding has no relation to findings from any other imaging study.
111387	No correlation to clinical findings	An indication that the current imaging finding has no relation to any other clinical findings.
111388	Malignancy Type	Classification of the cancer as invasive, DCIS, or other.
111389	Invasive breast carcinoma	A malignancy that has spread beyond an area of focus.
111390	Other malignancy type	A breast cancer with malignant pathology findings that are not classified as invasive or in situ.
111391	Menstrual Cycle Phase	A specific timeframe during menses.
111392	1st week	In the first week of the menstrual cycle phase, that is, one week following menses.
111393	2nd week	In the second week of the menstrual cycle phase, that is, two weeks following menses.
111394	3rd week	In the third week of the menstrual cycle phase, that is, three weeks following menses.
111395	Estimated Timeframe	An estimated period of time.
111396	< 3 months ago	An event occurred less than 3 months ago.
111397	4 months to 1 year ago	An event occurred between 4 months and 1 year ago.
111398	> 1 year ago	An event occurred longer than 1 year ago.
111399	Timeframe uncertain	The timing of an event is not recalled.
111400	Breast Imaging Report	Report title for the diagnostic report for one or more breast imaging or intervention procedures.
111401	Reason for Procedure	Concept name for the description of why a procedure has been performed.	Retired. Replaced by (18785-6, LN, "Indications for Procedure").
111402	Clinical Finding	A finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge.
111403	Baseline screening mammogram	First screening mammogram taken for patient that is used as a comparison baseline for further examinations.
111404	First mammogram ever	First mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure.
111405	Implant type	Concept name for the material of which a breast prosthetic device is constructed.
111406	Number of similar findings	A numeric count of findings classified as similar in nature.
111407	Implant finding	Concept name for the status of a breast prosthetic device as noted by imaging.
111408	Film Screen Mammography	Mammogram using traditional X-Ray film.
111409	Digital Mammography	Mammogram using a digital image acquisition system.	Retired Replaced by (46342-2, LN, "breast ffd mammogram").
111410	Surgical consult	Referred for evaluation by a surgeon.
111411	Mammography CAD	Computer aided detection and/or computer aided diagnosis for mammography.
111412	Narrative Summary	Concept name for a text-based section of a report.
111413	Overall Assessment	A title for a report section that summarizes all interpretation results for a report with one overriding assessment. E.g., benign or negative.
111414	Supplementary Data	Concept name for a collection of supporting evidence for a report.
111415	Additional evaluation requested from prior study	Prior study indicates that additional imaging be performed to further evaluate a suspicious or questionable anatomic region.
111416	Follow-up at short interval from prior study	The prior study recommended a follow-up breast imaging study in 1 to 11 months (generally in 6 months).
111417	History of breast augmentation, asymptomatic	Prior breast augmentation (breast enlargement) and is not presenting with any symptoms.
111418	Review of an outside study	Review or second opinion made on an image performed outside of the facility.
111419	Additional evaluation requested from abnormal screening study	Additional breast imaging performed at the time of the patient's screening mammogram.
111420	History of benign breast biopsy	Patient has had previous benign breast biopsies.
111421	Personal history of breast cancer with breast conservation therapy	Patient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains.
111423	Physical Examination Results	The results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion.
111424	Comparison to previous studies	The result of assessing the current imaging study in comparison to previous imaging studies.
111425	Intraluminal filling defect	An abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging study in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained.
111426	Multiple filling defect	During ductography an observation of more than one filling abnormality within the breast ductal system.
111427	Abrupt duct termination	An abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion.
111428	Extravasation	Abnormal flowage of contrast media within the breast noted on ductography.
111429	Duct narrowing	An abnormality observed during ductography where the ductal system within the breast appears narrow.
111430	Cyst fill	During ductography an observation of the contrast media filling a cyst within the breast.
111431	Instrument Approach	The area and line within the anatomy through which a needle or instrument passes during an interventional procedure.
111432	Inferolateral to superomedial	The line within the anatomy from the lower outer to the upper inner aspect. E.g., through which a needle or instrument passes in an interventional procedure.
111433	Inferomedial to superolateral	The line within the anatomy from the lower inner to the upper outer aspect. E.g., through which a needle or instrument passes in an interventional procedure.
111434	Superolateral to inferomedial	The line within the anatomy from the upper outer to the lower inner aspect. E.g., through which a needle or instrument passes in an interventional procedure.
111435	Superomedial to inferolateral	The line within the anatomy from the upper inner to the lower outer aspect. E.g., through which a needle or instrument passes in an interventional procedure.
111436	Number of passes	The number of times a biopsy instrument is passed through an area of interest.
111437	Number of specimens	The number of biopsy specimens obtained from an interventional procedure.
111438	Needle in target	An indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest.
111439	Number of needles around target	The number of localizing needles placed around the area of interest in an interventional procedure.
111440	Incision made	An indicator of whether or not an incision was made in the anatomy during an interventional procedure.
111441	Microclip placed	An indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedure.	Retired. Replaced by (111123, DCM, "Marker placement")
111442	Confirmation of target	An indicator of the degree of success of an interventional procedure.
111443	Target completely contained in the specimen	An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen.
111444	Target partially obtained in the specimen	An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen.
111445	Target not in the specimen	An indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen.
111446	Calcifications seen in the core	An indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen.
111447	Lesion completely removed	An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen.
111448	Lesion partially removed	An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen.
111449	Fluid obtained	An indicator that during an interventional procedure fluid was successfully aspirated.
111450	Light brown color	Color that is a light shade of brown.
111451	Dark red color	Color that is a dark shade of red.
111452	Dark brown color	Color that is a dark shade of brown.
111453	Bright red color	Color that is a bright shade of red.
111454	Blood tinged color	Color that is tinged with the color of blood.
111455	Occult blood test result	An indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells.
111456	Action on fluid	An indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded.
111457	Sent for analysis	An indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis.
111458	Discarded	An indicator that fluid obtained during an interventional procedure was discarded.
111459	Mass with calcifications	A radiopaque density noted during diagnostic imaging that has associated calcific densities.
111460	Complex cyst	A fluid-filled sac with greater than normal characteristics.
111461	Intracystic lesion	A tumor within a cyst.
111462	Solid mass	A tumor or lesion.
111463	Supplementary Data for Intervention	Supporting evidence for interpretation results of an interventional procedure.
111464	Procedure Modifier	A descriptor that further qualifies or characterizes a type of procedure.
111465	Needle Gauge	Needle size (diameter) characterization. E.g., of a biopsy needle.
111466	Severity of Complication	An indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed.
111467	Needle Length	Distance from the hub or bushing to the tip of the needle.
111468	Pathology Results	The collection of observations and findings from pathologic analysis.
111469	Sampling DateTime	The date and time that the sample was collected from the patient.
111470	Uninvolved	Indicates that the margin of the biopsy specimen was not involved with the tumor.
111471	Involved	Indicates that the margin of the biopsy specimen was involved with the tumor.
111472	Nipple involved	Indicates whether the nipple was involved in an interventional procedure or pathologic analysis.
111473	Number of nodes removed	Indicates the number of lymph nodes removed.
111474	Number of nodes positive	Indicates the number of lymph nodes removed that contain cancer cells.
111475	Estrogen receptor	The result of a test for the presence of a protein that binds with estrogen.
111476	Progesterone receptor	The result of a test for the presence of a protein that binds with progesterone.
111477	S Phase	Indicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates.
111478	Non-bloody discharge (from nipple)	The visible emission of non-bloody fluid from the nipple.
111479	Difficult physical/clinical examination	The inability to discern normal versus abnormal breast tissue during palpation.
111480	Cancer elsewhere	An indication that a patient has or had a malignant occurrence in an area of the body other than the breast.
111481	Saline implant	A salt water filled prosthetic device implanted in the breast.
111482	Polyurethane implant	A polymer based (plastic) prosthetic device implanted in the breast.
111483	Percutaneous silicone injection	The introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction.
111484	Combination implant	A prosthetic device that contains more than one material implanted in the breast.
111485	Pre-pectoral implant	A breast implant placed in front of the pectoralis major muscle.
111486	Retro-pectoral implant	A breast implant placed behind the pectoralis major muscle.
111487	Mammographic (crosshair)	Using X-Ray technique and a superimposed set of crossed lines for detection or placement.
111488	Mammographic (grid)	Using X-Ray technique and a superimposed aperture for detection or placement.
111489	Palpation guided	Using physical touch for detection or placement.
111490	Vacuum assisted	The performance of a biopsy procedure using a vacuum device attached to the biopsy needle.
111491	Abnormal discharge	Unusual or unexpected emission of fluid.
111492	No complications	Having experienced no adverse medical conditions related to or resulting from an interventional procedure.
111494	Stage 0	TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0.
111495	Stage I	TNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0.
111496	Stage IIA	TNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0.
111497	Stage IIB	TNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0.
111498	Stage IIIA	TNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0.
111499	Stage IIIB	TNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0.
111500	Stage IIIC	TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0.
111501	Stage IV	TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1.
111502	Bloom-Richardson Grade	Histologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count).
111503	Normal implants	Breast prosthetic devices are intact, not leaking, and are in a normal shape and form.
111504	Asymmetric implants	Breast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral).
111505	Calcified implant	Fibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device.
111506	Distorted implant	Breast prosthetic device is twisted out of normal shape or form.
111507	Silicone-laden lymph nodes	Silicone from breast prosthetic device found in lymphatic tissue.
111508	Free silicone	Silicone found in breast tissue outside of the prosthetic capsule or implant membrane.
111509	Herniated implant	Protrusion of part of the structure normally encapsulating the content of the breast prosthetic device.
111510	Explantation	Evidence of removal of a breast prosthetic device.
111511	Relevant Patient Information for Breast Imaging	Historical patient health information of interest to the breast health clinician.
111512	Medication History	Information regarding usage by the patient of certain medications, such as hormones.	Retired. Replaced by (10160-0, LN, "History Of Medication Use")
111513	Relevant Previous Procedures	Interventional or non-interventional procedures previously performed on the patient, such as breast biopsies.
111514	Relevant Indicated Problems	Abnormal conditions experienced by the patient that serve as the reason for performing a procedure, such as a physical breast examination.	Retired. Replaced by (11450-4, LN, "Problem List")
111515	Relevant Risk Factors	Personal, familial, and other health factors that may indicate an increase in the patient's chances of developing a health condition or disease, such as breast cancer.
111516	Medication Type	A classification of a medicinal substance, such as hormonal contraceptive or antibiotic.
111517	Relevant Patient Information	Historical patient health information for general purpose use.
111518	Age when first menstrual period occurred	The age of the patient at the first occurrence of menses.
111519	Age at First Full Term Pregnancy	The age of the patient at the time of her first full term pregnancy.
111520	Age at Menopause	The age of the patient at the cessation of menses.
111521	Age when hysterectomy performed	The age of the patient at the time her uterus was removed.
111522	Age when left ovary removed	The age of the patient at the time she had her left ovary removed.
111523	Age when right ovary removed	The age of the patient at the time she had her right ovary removed.
111524	Age Started	The age of a patient on the first occurrence of an event, such as the first use of a medication.
111525	Age Ended	The age of a patient on the last occurrence of an event, such as the last use of a medication.
111526	DateTime Started	The date and time of the first occurrence of an event, such as the first use of a medication.
111527	DateTime Ended	The date and time of the last occurrence of an event, such as the last use of a medication.
111528	Ongoing	An indicator of whether an event is still in progress, such as the use of a medication or substance, or environmental exposure.
111529	Brand Name	Product name of a device or substance, such as medication, to identify it as the product of a single firm or manufacturer.
111530	Risk Factor modifier	A descriptor that further qualifies or characterizes a risk factor.
111531	Previous Procedure	A prior non-interventional study or interventional procedure performed on a patient.
111532	Pregnancy Status	Describes the pregnancy state of a referenced subject.	Retired. Replaced by (364320009, SCT, "Pregnancy observable").
111533	Indicated Problem	A symptom experienced by a patient that is used as the reason for performing a study or procedure.
111534	Role of person reporting	The function of the individual who is reporting information on a patient, which could be a specific health care related profession, the patient him/herself, or a relative or friend.
111535	DateTime problem observed	The date and time that a symptom was noted.
111536	DateTime of last evaluation	The date and time of the most recent evaluation of an indicated problem.
111537	Family Member with Risk Factor	A patient's biological relative who exhibits a health factor that may indicate an increase in the patient's chances of developing a particular disease or medical problem.
111538	Age at Occurrence	The age at which an individual experienced a specific event, such as breast cancer.
111539	Menopausal phase	The current stage of an individual in her gynecological development.
111540	Side of Family	An indicator of paternal or maternal relationship.
111541	Maternal	Relating to biological female parentage.
111542	Unspecified gynecological hormone	A gynecological hormone for which the specific type is not specified. E.g., contraceptive, estrogen, Tamoxifen.
111543	Breast feeding history	An indicator of whether or not a patient ever provided breast milk to her offspring.
111544	Average breast feeding period	The average length of time that a patient provided breast milk to her offspring.
111545	Substance Use History	Information regarding usage by the patient of certain legal or illicit substances.
111546	Used Substance Type	A classification of a substance, such as alcohol or a legal or illicit drug.
111547	Environmental Exposure History	Information regarding exposure of the patient to potentially harmful environmental factors.
111548	Environmental Factor	A classification of a potentially harmful substance or gas in a subject's environment, such as asbestos, lead, or carcinogens.
111549	Previous Reports	Previous Structured Reports that could have relevant information for a current imaging service request.
111550	Personal breast cancer history	An indication that a patient has had a previous malignancy of the breast.
111551	History of endometrial cancer	Indicates a previous occurrence of cancer of the lining of the uterus.
111552	History of ovarian cancer	Indicates a previous occurrence of cancer of the lining of the ovary.
111553	History of high risk lesion on previous biopsy	Indicates a prior diagnosis of pre-cancerous cells or tissue removed for pathologic evaluation.
111554	Post menopausal patient	A female patient whose menstrual periods have ceased.
111555	Late child bearing (after 30)	A female patient whose first child was born after the patient was 30 years old.
111556	BRCA1 breast cancer gene	The first level genetic marker indicating risk for breast cancer.
111557	BRCA2 breast cancer gene	The second level genetic marker indicating risk for breast cancer.
111558	BRCA3 breast cancer gene	The third level genetic marker indicating risk for breast cancer.
111559	Weak family history of breast cancer	A patient's biological aunt, grandmother, or female cousin was diagnosed with breast cancer. Definition from BI-RADS®.
111560	Intermediate family history of breast cancer	A patient's biological mother or sister was diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.
111561	Very strong family history of breast cancer	A patient's biological mother or sister was diagnosed with breast cancer before they had gone through menopause, or more than one of the patient's first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.
111562	Family history of prostate cancer	Previous diagnosis of a malignancy of the prostate gland in a biological relative.
111563	Family history unknown	The health record of a patient's biological relatives is not known.
111564	Nipple discharge cytology	The study of cells obtained from fluid emitted from the breast.
111565	Uterine malformations	A developmental abnormality resulting in an abnormal shape of the uterus.
111566	Spontaneous Abortion	A naturally occurring premature expulsion from the uterus of the products of conception - the embryo or a nonviable fetus.
111567	Gynecologic condition	An ailment/abnormality or state of the female reproductive tract.
111568	Gynecologic surgery	A surgical operation performed on any portion of the female reproductive tract.
111569	Previous LBW or IUGR birth	Prior pregnancy with a low birth weight baby or a fetus with Intrauterine Growth Restriction or Retardation.
111570	Previous fetal malformation/syndrome	History of at least one prior pregnancy with fetal anatomic abnormality(s).
111571	Previous RH negative or blood dyscrasia at birth	History of delivering a Rhesis Isoimmunization affected child(ren) or a child(ren) with another blood disorder.
111572	History of multiple fetuses	History of at least one pregnancy that contained more than one fetus. E.g., twins, triplets, etc.
111573	Current pregnancy, known or suspected malformations/syndromes	At least one fetus of this pregnancy has an anatomic abnormality(s) that is known to exist, or a "marker" is present that suggests the abnormality(s) may be present.
111574	Family history, fetal malformation/syndrome	Biological relatives have previously conceived a fetus with an anatomic abnormality(s).
111575	High	A subjective descriptor for an elevated amount of exposure, use, or dosage, incurring high risk of adverse effects.
111576	Medium	A subjective descriptor for a moderate amount of exposure, use, or dosage, incurring medium risk of adverse effects.
111577	Low	A subjective descriptor for a limited amount of exposure, use, or dosage, incurring low risk of adverse effects.
111578	Dose frequency	A measurement of the rate of occurrence of which a patient takes a certain medication.
111579	Rate of exposure	The quantity per unit of time that a patient was or is being exposed to an environmental irritant.
111580	Volume of use	The quantity per unit of time that a medication or substance was or is being used.
111581	Relative dose amount	A qualitative descriptor for the amount of a medication that was or is being taken.
111582	Relative amount of exposure	A qualitative descriptor for the amount of present or past exposure to an environmental irritant.
111583	Relative amount of use	A qualitative descriptor for the amount of a medication or substance that was or is being used.
111584	Relative dose frequency	A qualitative descriptor for the frequency with which a medication was or is being taken.
111585	Relative frequency of exposure	A qualitative descriptor for the frequency of present or past exposure to an environmental irritant.
111586	Relative frequency of use	A qualitative descriptor for the frequency with which a medication or substance was or is being used.
111587	No known exposure	Patient is not known to have been exposed to or used the substance or medication.
111590	Recall for technical reasons	Patient returns for additional images to improve the quality of the most recent study.
111591	Recall for imaging findings	Patient returns for additional images to clarify findings from the most recent study.
111592	Recall for patient symptoms/ clinical findings	Patient returns for additional images to clarify symptoms or signs reported by the patient or a healthcare professional at the time of the most recent study.
111593	LBW or IUGR	Number of births with low birth weight or intrauterine growth restriction.
111601	Green filter	Filter that transmits green light while blocking the other colors, typically centered at 510-540 nm	Retired. Replaced by (445465004, SCT, "Green optical filter")
111602	Red filter	Filter that transmits red light while blocking the other colors, typically centered at 630-680 nm	Retired. Replaced by (445279009, SCT, "Red optical filter")
111603	Blue filter	Filter that transmits blue while blocking the other colors, typically centered at 460-480 nm	Retired. Replaced by (445084008, SCT, "Blue optical filter")
111604	Yellow-green filter	A filter of 560nm that is used for retinal imaging and can provide good contrast and good visibility of the retinal vasculature	Retired. Replaced by (445340000, SCT, "Yellow-green optical filter")
111605	Blue-green filter	A filter of 490nm that is used for retinal imaging because of excessive scattering of some retinal structures at very short wavelengths	Retired. Replaced by (422915004, SCT, "Blue-green optical filter")
111606	Infrared filter	Filter that transmits the infrared spectrum, which is light that lies outside of the visible spectrum, with wavelengths longer than those of red light, while blocking visible light	Retired. Replaced by (445169002, SCT, "Infrared optical filter")
111607	Polarizing filter	A filter that reduces reflections from non-metallic surfaces such as glass or water by blocking light waves that are vibrating at selected angles to the filter.	Retired. Replaced by (445391002, SCT, "Polarizing optical filter")
111609	No filter	No filter used.
111621	Field 1 for Joslin 3 field	Joslin NM-1 is a 45 degree field focused centrally between the temporal margin of optic disc and the center of the macula: Center the camera on the papillomacular bundle midway between the temporal margin of the optic disc and the center of the macula. The horizontal centerline of the image should pass directly through the center of the disc.
111622	Field 2 for Joslin 3 field	Joslin NM-2 is a 45 degree field focused superior temporal to the optic disc: Center the camera laterally approximately one-half disc diameter temporal to the center of the macula. The lower edge of the field is tangent to a horizontal line passing through the upper edge of the optic disc. The image is taken temporal to the macula but includes more retinal nasal and superior to the macula than standard field 2.
111623	Field 3 for Joslin 3 field	Joslin NM-3 is a 45 degree field focused nasal to the optic disc: This field is nasal to the optic disc and may include part of the optic disc. The horizontal centerline of the image should pass tangent to the lower edge of the optic disc.
111625	Diffuse direct illumination	A broad or "soft" light supplied from a single source.
111626	Scheimpflug Camera	A slit reflected light microscope, which has the ability to form an image of the back scattered light from the eye in a sagittal plane. Scheimpflug cameras are able to achieve a wide depth of focus by employing the "Sheimpflug principle" where the lens and image planes are not parallel with each other. Rotating Sheimplug cameras are able to generate three-dimensional images and calculate measurements of the anterior chamber of the eye.
111627	Scotopic light	Lighting condition approximately 0.04 lux.
111628	Mesopic light	Lighting condition approximately 4 lux.
111629	Photopic light	Lighting condition approximately 40 lux.
111630	Dynamic light	Acquisition preceded by intense light.
111631	Average Glandular Dose	Calculated from values of entrance exposure in air, the X-Ray beam quality (half-value layer), and compressed breast thickness, is the energy deposited per unit mass of glandular tissue averaged over all the glandular tissue in the breast.
111632	Anode Target Material	The primary material in the anode of an X-Ray source.
111633	Compression Thickness	The average thickness of the body part examined when compressed, if compression has been applied during X-Ray exposure.
111634	Half Value Layer	Thickness of Aluminum required to reduce the X-Ray output at the patient entrance surface by a factor of two.
111635	X-Ray Grid	An anti-scatter device based on radiation absorbing strips above the detector. E.g., in the patient support.
111636	Entrance Exposure at RP	Exposure measurement in air at the reference point that does not include back scatter, according to MQCM 1999.
111637	Accumulated Average Glandular Dose	Average Glandular Dose to a single breast accumulated over multiple images.
111638	Patient Equivalent Thickness	Value of the control variable used to parametrize the Automatic Exposure Control (AEC) closed loop. E.g., "Water Value".
111640	Virtual grid	A processing algorithm used to reduce the effect of X-Ray scatter on image quality, similar to the use of a physical X-Ray anti-scatter grid.	This does not include processing for removal of physical anti-scatter grid lines.
111641	Fixed grid	A physical X-Ray anti-scatter grid that does not move during exposure.
111642	Focused grid	A physical X-Ray anti-scatter grid with radiation absorbing strips that are focused toward the focal spot, to eliminate grid cutoff.
111643	Reciprocating grid	A physical X-Ray anti-scatter grid that is designed to move during exposure, to eliminate the appearance of grid lines on the image.
111644	Parallel grid	A physical X-Ray anti-scatter grid with radiation absorbing strips that are parallel to each other and that is used only with long source to image distances.
111645	Crossed grid	A physical X-Ray anti-scatter grid with crossed radiation absorbing strips used for more complete cleanup of scatter radiation.
111646	No grid	No physical X-Ray anti-scatter grid was used due to low scatter conditions.
111647	Compression Force	The compression force applied to the body part during exposure.
111648	Compression Pressure	The average compression pressure applied to the body part during exposure.
111649	Compression Contact Area	The area of the body part to which compression has been applied during exposure.
111671	Spectacle Prescription Report	The spectacle prescription for a patient.
111672	Add Near	Refractive measurements of the eye to correct for inability to focus at near while wearing the distance prescription.
111673	Add Intermediate	Refractive measurements of the eye to correct for inability to focus at intermediate distance while wearing the distance prescription.
111674	Add Other	Refractive measurements of the eye to correct for inability to focus at the specified distance while wearing the distance prescription.
111675	Horizontal Prism Power	The power of a prism to bend light in the horizontal direction, in prism diopters.
111676	Horizontal Prism Base	Direction of the base of a horizontal prism -- either in (toward the nose), or out (away from the nose).
111677	Vertical Prism Power	The power of a prism to bend light in the vertical direction, in prism diopters.
111678	Vertical Prism Base	Direction of the base of a vertical prism -- either up, or down.
111679	Distance Pupillary Distance	Distance in mm between the pupils when the patient's object of regard is in the distance.
111680	Near Pupillary Distance	Distance in mm between the pupils when the patient's object of regard is at near.
111681	SMILE	Small Incision Lenticule Extraction. Refractive surgery procedure where a thin lenticule is cleaved from the corneal stroma using a femtosecond laser and then extracted through a small incision in the corneal periphery.
111685	Autorefraction Visual Acuity	A patient's vision with the correction measured by an autorefractor in place.
111686	Habitual Visual Acuity	A patient's vision with whichever vision correction the patient customarily wears.
111687	Prescription Visual Acuity	A patient's vision with the final spectacle prescription in place.
111688	Right Eye Rx	The spectacle prescription for the right eye.
111689	Left Eye Rx	The spectacle prescription for the left eye.
111690	Macular Grid Thickness and Volume Report	A macular grid thickness and volume report for a patient. The macular grid is an analytic tool described in PS3.17.
111691	Number of Images Used for Macular Measurements	Number of images used for the macular grid measurement.
111692	Number of Samples Used per Image	Number of samples used per Image for analysis.
111693	Analysis Quality Rating	A numeric rating of the quality of the entire analysis with respect to grading and diagnostic purposes. Higher numbers indicate greater quality.
111694	Image Set Quality Rating	A numeric rating of the quality of an entire image set with respect to grading and diagnostic purposes. Higher numbers indicate greater quality.
111695	Interfering Tears or Drops	Tear film or drops affecting test quality.
111696	Visual Fixation Quality During Acquisition	The assessment of the centricity and persistence of the visual fixation (direction of gaze) during the acquisition.
111697	Visual Fixation Quality Problem	The reason why the patient's visual fixation was not steady or was indeterminate.
111698	Ophthalmic Macular Grid Problem	The reason why the macular grid measurements may be questionable.
111700	Specimen Container Identifier	Identifier of container (box, block, microscope slide, etc.) for the specimen under observation.
111701	Processing type	Type of processing that tissue specimen underwent.
111702	DateTime of processing	Date and time of processing step.
111703	Processing step description	Description of the individual step in the tissue processing sequence.
111704	Sampling Method	Method of sampling used to derive specimen from its parent.
111705	Parent Specimen Identifier	Identifier of the parent specimen that gave rise to the current specimen.
111706	Issuer of Parent Specimen Identifier	Assigning authority for parent specimen's identifier.
111707	Parent specimen type	Parent specimen type that gave rise to current specimen.
111708	Position Frame of Reference	Description of coordinate system and origin reference point on parent specimen, or parent specimen container, or image used for localizing the sampling site or location within container or image.
111709	Location of sampling site	Reference to image of parent specimen localizing the sampling site; may include referenced Presentation State object.
111710	Location of sampling site X offset	Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.
111711	Location of sampling site Y offset	Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.
111712	Location of sampling site Z offset	Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.
111718	Location of Specimen	Description of specimen location, either in absolute terms or relative to the Position Frame of Reference.
111719	Location of Specimen X offset	Location of specimen (nominal center) relative to the Position Frame of Reference in the X dimension.
111720	Location of Specimen Y offset	Location of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension.
111721	Location of Specimen Z offset	Location of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension.
111723	Visual Marking of Specimen	Description of visual distinguishing identifiers. E.g., ink, or a particular shape of the specimen.
111724	Issuer of Specimen Identifier	Assigning authority for specimen identifier.
111726	Dissection with entire specimen submission	Dissection of specimen with submission of all its sections for further processing or examination.
111727	Dissection with representative sections submission	Dissection of specimen with submission of representative sections for further processing or examination.
111729	Specimen storage	A workflow step, during which tissue specimens are stored in a climate-controlled environment.
111741	Transmission illumination	Transmission illumination method for specimen microscopy.
111742	Reflection illumination	Reflection illumination method for specimen microscopy.
111743	Epifluorescence illumination	Epifluorescence illumination method for specimen microscopy.
111744	Brightfield illumination	Brightfield illumination method for specimen microscopy.
111745	Darkfield illumination	Darkfield illumination method for specimen microscopy.
111746	Oblique illumination	Oblique illumination method for specimen microscopy.
111747	Phase contrast illumination	Phase contrast illumination method for specimen microscopy.
111748	Differential interference contrast	Differential interference contrast method for specimen microscopy.
111749	Total internal reflection fluorescence	Total internal reflection fluorescence method for specimen microscopy.
111750	Ultrasound Contact	A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires applanation of the cornea.
111751	Ultrasound Immersion	A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires immersion of the patient's eye in fluid as he lies in a supine position.
111752	Optical	A method of obtaining ophthalmic axial measurements that uses light.
111753	Manual Keratometry	Measurements taken of the corneal curvature using a manual keratometer.
111754	Auto Keratometry	Measurements taken of the corneal curvature using an automated keratometer.
111755	Simulated Keratometry	Simulated Keratometry measurements derived from corneal topography.
111756	Equivalent K-reading	Corneal power measurements using Scheimpflug camera.
111757	Keratometry Measurements SOP Instance	Keratometry Measurements DICOM SOP Instance.
111758	Total Cornea Power Measurement Method	Method of determining the total cornea power from measuring the curvature of both anterior and posterior surface of the cornea.
111759	Posterior Cornea Surface Measurement Method	Method of measuring the curvature of posterior surface of the cornea and determining its refractive power.
111760	Haigis	The Haigis IOL calculation formula. Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765-73.
111761	Haigis-L	The Haigis-L IOL calculation formula. Haigis W. Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg. 2008 Oct;34(10):1658-63.
111762	Holladay 1	The Holladay 1 IOL calculation formula. Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988; 14:17-24.
111763	Holladay 2	The Holladay 2 IOL calculation formula.
111764	Hoffer Q	The Hoffer Q IOL calculation formula. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 1993;19:700-12. Errata. J Cataract Refract Surg 1994;20:677 and 2007;33:2-3.
111765	Olsen	The Olsen IOL calculation formula. Olsen T. Calculation of intraocular lens power: a review. Acta Ophthalmol. Scand. 2007: 85: 472-485.
111766	SRKII	The SRKII IOL calculation formula. Sanders DR, Retzlaff J, Kraff MC. Comparison of the SRK II formula and other second generation formulas. J Cataract Refract Surg. 1988 Mar;14(2):136-41.
111767	SRK-T	The SRK-T IOL calculation formula. Retzlaff JA, Sanders DR, Kraff MC. Development of the SRK/T intraocular lens implant power calculation formula. J Cataract Refract Surg 1990;16:333-40. Erratum 1990;16:528.
111768	ACD Constant	The "ACD Constant" used in IOL calculation.
111769	Haigis a0	The "Haigis a0" constant used in IOL calculation.
111770	Haigis a1	The "Haigis a1" constant used in IOL calculation.
111771	Haigis a2	The "Haigis a2" constant used in IOL calculation.
111772	Hoffer pACD Constant	The "Hoffer pACD Constant" used in IOL calculation.
111773	Surgeon Factor	The "Surgeon Factor" constant used in IOL calculation.
111776	Front Of Cornea To Front Of Lens	Anterior chamber depth defined as the front of the cornea to the front of the lens.
111777	Back Of Cornea To Front Of Lens	Anterior chamber depth defined as the back of the cornea to the front of the lens.
111778	Single or Anterior Lens	Refers to the anterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens.
111779	Posterior Lens	Refers to the posterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens.
111780	Measurement From This Device	Value obtained from measurements taken by the device creating this SOP Instance.
111781	External Data Source	Value obtained by data transfer from an external source - not from measurements taken by the device providing the value.
111782	Axial Measurements SOP Instance	Axial Measurements DICOM SOP Instance.
111783	Refractive Measurements SOP Instance	Refractive Measurements DICOM SOP Instance.
111784	Autorefraction Measurements SOP Instance	Autorefraction Measurements DICOM SOP Instance.
111786	Standard Deviation of measurements used	Standard Deviation is a simple measure of the variability of data.
111787	Signal to Noise Ratio	Signal to Noise Ratio of the data samples taken to create a measurement.
111791	Spherical projection	Projection from 2D image pixels to 3D Cartesian coordinates based on a spherical mathematical model.
111792	Surface contour mapping	Mapping from 2D image pixels to 3D Cartesian coordinates based on measurements of the retinal surface. E.g., of the retina, derived via a measurement technology such as Optical Coherence Tomography, Ultrasound etc.
111800	Visual Field 24-2 Test Pattern	Test pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 24° pattern (no longer supported).
111801	Visual Field 10-2 Test Pattern	Test pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart. The "-2" in this case indicates its point layout to be similar to the 30-2 and 24-2.
111802	Visual Field 30-2 Test Pattern	Test pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart. The "-2" distinguishes this from another 30° pattern (no longer supported).
111803	Visual Field 60-4 Test Pattern	Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart. The "-4" distinguishes this from a similar 60° pattern having 4 additional points.
111804	Visual Field Macula Test Pattern	Test pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart.
111805	Visual Field Central 40 Point Test Pattern	Test pattern consisting of 40 test point locations within 30° of fixation that spread out radially from fixation.
111806	Visual Field Central 76 Point Test Pattern	Test pattern consisting of 76 test point locations within 30° of fixation a minimum of 3° from each meridian and placed 6° apart.
111807	Visual Field Peripheral 60 Point Test Pattern	Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart.
111808	Visual Field Full Field 81 Point Test Pattern	Test pattern consisting of 81 test point locations within 60° of fixation that spread out radially from fixation.
111809	Visual Field Full Field 120 Point Test Pattern	Test pattern consisting of 120 test point locations within 60° of fixation that spread out radially from fixation, concentrated in the nasal hemisphere.
111810	Visual Field G Test Pattern	Test pattern for Glaucoma and general visual field assessment with 59 test locations of which 16 test locations are in the macular area (up to 10° eccentricity) and where the density of test location is reduced with eccentricity. The test can be extended with the inclusion of 14 test locations between 30° and 60° eccentricity, 6 of which are located at the nasal step.
111811	Visual Field M Test Pattern	Test pattern for the macular area. Orthogonal test pattern with 0.7° spacing within the central 4° of eccentricity and reduced density of test locations between 4 and 10, 5° of eccentricity. 81 test locations over all. The test can be extended to include the test locations of the Visual Field G Test Pattern between 10, 5° and 60°.
111812	Visual Field 07 Test Pattern	Full field test pattern with 48 test locations from 0-30° and 82 test locations from 30-70°. Reduced test point density with increased eccentricity. Can be combined with screening and threshold strategies.
111813	Visual Field LVC Test Pattern	Low Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V.
111814	Visual Field Central Test Pattern	General test corresponding to the 30-2 but excluding the 2 test locations in the blind spot area, hence with 74 instead of 76 test locations.
111815	Visual Field SITA-Standard Test Strategy	Swedish Interactive Thresholding Algorithm (SITA). Strategy gains testing efficiency through use of visual field and information theory models. In: Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmologica Scandinavica, 1997, 75: 368-375.
111816	Visual Field SITA-SWAP Test Strategy	Adaptation of SITA testing methods to Blue-Yellow testing.
111817	Visual Field SITA-Fast Test Strategy	Similar to SITA-Standard but with less strict criteria for closing test points. Intended for patients who must be tested in the shortest possible time. In: Bengtsson B, Hejl A. SITA Fast, a new rapid perimetric threshold test. Description of methods and evaluation in patients with manifest and suspect glaucoma. Acta Ophthalmologica Scandinavica, 1998, 76: 431-437.
111818	Visual Field Full Threshold Test Strategy	Threshold test algorithm that determines a patient's sensitivity at each test point in the threshold test pattern by adjusting intensity by 4 dB steps until the patient changes their response, and then adjusts the intensity in the opposite direction by 2 dB steps until the patient changes their response again. The last stimulus seen by the patient is recognized as the threshold for that point. The starting values are determined by first thresholding a "primary" point in each quadrant then using the results of each primary point to determine the starting values for neighboring points.
111819	Visual Field FastPac Test Strategy	Similar to the Full Threshold algorithm except that it steps by 3 dB and only crosses the threshold only once. In: Flanagan JG, Wild JM, Trope GE. Evaluation of FASTPAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population. Ophthalmology, 1993, 100: 949-954.
111820	Visual Field Full From Prior Test Strategy	Identical to Full Threshold except that starting values are determined by the results of a previous test performed using the same test pattern and the Full Threshold test strategy.
111821	Visual Field Optima Test Strategy	Similar to FastPac except that the steps are pseudo-dynamic (differ based on the intensity of the last presentation).
111822	Visual Field Two-Zone Test Strategy	Suprathreshold testing strategy, in which each point is initially tested using stimulus that is 6 dB brighter than the expected hill of vision. If the patient does not respond, the stimulus is presented a second time at the same brightness. If the patient sees either presentation, the point is marked as "seen"; otherwise it is marked as "not seen".
111823	Visual Field Three-Zone Test Strategy	An extension of the two-zone strategy in which test points where the second stimulus is not seen are presented with a third stimulus at maximum brightness.
111824	Visual Field Quantify-Defects Test Strategy	An extension of the two-zone strategy, in which test points where the second stimulus is not seen receive threshold testing to quantify the depth of any detected scotomas.
111825	Visual Field TOP Test Strategy	Tendency Oriented Perimetry. Fast thresholding algorithm. Test strategy makes use of the interaction between neighboring test locations to reduce the test time compared to normal full threshold strategy by 60-80%. In: Morales J, Weitzman ML, Gonzalez de la Rosa M. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry. Ophthalmology, 2000, 107: 134-142.
111826	Visual Field Dynamic Test Strategy	Dynamic strategy is a fast thresholding strategy reducing test duration by adapting the dB step sizes according to the frequency-of-seeing curve of the threshold. Reduction of test time compared to normal full threshold strategy 30-50%.
111827	Visual Field Normal Test Strategy	Traditional full threshold staircase strategy. Initial intensities are presented, based on anchor point sensitivities in each quadrant and based on already known neighboring sensitivities. In a first run, thresholds are changed in 4dB steps until the first response reversal. Then the threshold is changed in 2 dB steps until the second response reversal. The threshold is calculated as the average between the last seen and last not-seen stimulus, supposed to correspond with the 50% point in the frequency-of-seeing curve.
111828	Visual Field 1-LT Test Strategy	One level screening test: Each test location is tested with a single intensity. The result is shown as seen or not-seen. The intensity can either be a 0 dB stimulus or a predefined intensity.
111829	Visual Field 2-LT Test Strategy	Two level screening test: Each test location is initially tested 6 dB brighter than the age corrected normal value.
111830	Visual Field LVS Test Strategy	Low Vision Strategy is a full threshold normal strategy with the exception that it starts at 0 dB intensity and applies stimulus area V.
111831	Visual Field GATE Test Strategy	German Adaptive Threshold Estimation is a fast strategy based on a modified 4-2 staircase algorithm, using prior visual fields to calculate the starting intensity. In: Chiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagreze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Investigative Ophthalmology and Visual Science, 2009, 51: 488-494.
111832	Visual Field GATEi Test Strategy	Similar to GATE. The i stands for initial. If there was no prior visual field test to calculate the starting values, an anchor point method is used to define the local start values.
111833	Visual Field 2LT-Dynamic Test Strategy	A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the dynamic threshold strategy.
111834	Visual Field 2LT-Normal Test Strategy	A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the normal full threshold strategy.
111835	Visual Field Fast Threshold Test Strategy	Takes neighborhood test point results into account and offers stimuli with an adapted value to save time.
111836	Visual Field CLIP Test Strategy	Continuous Luminance Incremental Perimetry, which measures at first the individual reaction time of the patient and threshold values in every quadrant. The starting value for the main test is slightly below in individual threshold.
111837	Visual Field CLASS Strategy	A supra threshold screening strategy. The starting stimuli intensities depend on the classification of the patient's visual hill by measuring the central (fovea) or peripheral (15° meridian) threshold. The result of each dot slightly underestimates the sensitivity value (within 5 dB).
111838	Age corrected	Mode for determining the starting luminance for screening test points - the starting luminance s is chosen based on the age of the patient.
111839	Threshold related	Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the results of thresholding a set of "primary" test points (one in each quadrant).
111840	Single luminance	Mode for determining the starting luminance for screening test points - in this case, all starting luminance is set to the same value.
111841	Foveal sensitivity related	Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of the foveal threshold value.
111842	Related to non macular sensitivity	Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of four threshold values measured near the 15° meridian (one in each quadrant).
111843	Automated Optical	Real time evaluation of the camera image to recognize blinks and fixation losses with influence on the test procedure. Blinks that interfere with stimuli presentation cause the automated repetition of such stimulus presentations. Fixation losses can be used to delay the stimulus presentation until correct fixation is regained.
111844	Blind Spot Monitoring	A method of monitoring the patient's fixation by periodically presenting stimulus in a location on the background surface that corresponds to the patient's blind spot.
111845	Macular Fixation Testing	A method of monitoring the patient's fixation by presenting the stimulus to the patient's macula.
111846	Observation by Examiner	A method of monitoring the patient's fixation by observation from the examiner of the patient.
111847	Outside normal limits	Analysis Results are outside normal limits.
111848	Borderline	Analysis Results are borderline.
111849	Abnormally high sensitivity	Analysis Results identify abnormally high sensitivity.
111850	General reduction in sensitivity	Analysis Results identify general reduction in sensitivity.
111851	Borderline and general reduction in sensitivity	Analysis Results identify Borderline and general reduction in sensitivity.
111852	Visual Field Index	Index of a patient's remaining visual field normalized for both age and generalized defect.
111853	Visual Field Loss Due to Diffuse Defect	Estimate of the portion of a patient's visual field loss that is diffuse (i.e., spread evenly across all portions of the visual field).
111854	Visual Field Loss Due to Local Defect	Estimate of the portion of a patient's visual field loss that is local (i.e., not spread evenly across all portions of the visual field).
111855	Glaucoma Hemifield Test Analysis	An analysis of asymmetry between zones of the superior and inferior visual field. It is designed to be specific for defects due to glaucoma.
111856	Optical Fixation Measurements	The data output of an optical fixation monitoring process, consisting of a list of positive and negative numbers indicating the quality of patient fixation over the course of a visual field test. The value 0 represents the initial fixation. Negative numbers indicate a measuring error (i.e., the patient blinked). Positive numbers quantify the degree of eccentricity from initial fixation.
111860	Haigis Toric	The Haigis Toric IOL calculation formula. Haigis, Wolfgang. Toric Iol Power Calculation. 2014. http://www.semanticscholar.org/paper/Toric-Iol-Power-Calculation-Haigis/033838182a57a1d2948ac7d3b115855e29d03fad
111861	Haigis-L Toric	The Haigis-L Toric IOL calculation formula. Haigis W, Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg, 2008. 34(10): 1658-63. doi:10.1016/j.jcrs.2008.06.029
111862	Barrett Toric	The Barrett Toric IOL calculation formula. Abulafia, A., et al., Prediction of refractive outcomes with toric intraocular lens implantation. J Cataract Refract Surg, 2015. 41(5): p. 936-44. doi:10.1016/j.jcrs.2014.08.036
111863	Barrett True-K	The Barrett True-K IOL calculation formula. Abulafia, A., et al., Accuracy of the Barrett True-K formula for intraocular lens power prediction after laser in situ keratomileusis or photorefractive keratectomy for myopia. J Cataract Refract Surg, 2016. 42(3): p. 363-9. doi:10.1016/j.jcrs.2015.11.039
111864	Barrett True-K Toric	The Barrett True-K Toric IOL calculation formula. Barrett G.D., Barrett True-K toric calculator. http://www.apacrs.org/TrueKToric105/TrueKToric.aspx
111865	Barrett Universal II	The Barrett Universal II IOL calculation formula. Barrett, G.D., An improved universal theoretical formula for intraocular lens power prediction. J Cataract Refract Surg, 1993. 19: p. 713-720. doi:10.1016/S0886-3350(13)80339-2
111866	Barrett Lens Factor	The "Barrett Lens Factor" constant used in IOL calculation.
111867	Barrett Design Factor	The "Barrett Design Factor" constant used in IOL calculation.
111900	Macula centered	An image of at least 15° angular subtend that is centered on the macula; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111901	Disc centered	An image of at least 15° angular subtend that is centered on the optic disc; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111902	Lesion centered	An image of any angular subtend that is centered on a lesion located in any region of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111903	Disc-macula centered	An image of at least 15° angular subtend centered midway between the disc and macula and containing at least a portion of the disc and both the disc and the macula; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111904	Mid-peripheral-superior	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and superior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111905	Mid-peripheral-superior temporal	An image of at least 15° angular subtend positioned between the central zone and the equator in the superior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111906	Mid-peripheral-temporal	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111907	Mid-peripheral-inferior temporal	An image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111908	Mid-peripheral-inferior	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111909	Mid-peripheral-inferior nasal	An image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111910	Mid-peripheral-nasal	An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111911	Mid-peripheral-superior nasal	An image of at least 15° angular subtend positioned between the central zone and the equator in the superior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111912	Peripheral-superior	An image of at least 15° angular subtend positioned between the equator and the ora serrata, and spanning both the superior temporal and superior nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111913	Peripheral-superior temporal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111914	Peripheral-temporal	An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111915	Peripheral-inferior temporal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111916	Peripheral-inferior	An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111917	Peripheral-inferior nasal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111918	Peripheral-nasal	An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111919	Peripheral-superior nasal	An image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .
111920	Time domain	Identifies the use of physical signals with respect to time to capture information.
111921	Spectral domain	Identifies the use of physical signals with respect to multiple frequencies to capture information.
111922	No corneal compensation	No compensation algorithm for corneal birefringence.
111923	Corneal birefringence compensation	Algorithm to compensate for variability in corneal birefringence.
111924	Retinal topography	Measurement of the retinal surface contour relative to an assigned datum plane.
111925	Retinal nerve fiber layer thickness	Measurement approximating the distance related to the structure between the internal limiting membrane (ILM) and the outer boarder of the retinal nerve fiber layer (RNFL); see Section III.6 “Retinal Thickness Definition” in PS3.17 .
111926	Ganglion cell complex thickness	Measurement approximating the distance related to the structure between the ILM and the outer border of the inner plexiform layer (IPL), called the ganglion cell complex (GCC); see Section III.6 “Retinal Thickness Definition” in PS3.17 .
111927	Total retinal thickness (ILM to IS-OS)	Measurement approximating the distance related to the structure between the ILM and the inner-outer segment junction (IS-OS); see Section III.6 “Retinal Thickness Definition” in PS3.17 .
111928	Total retinal thickness (ILM to RPE)	Measurement approximating the distance related to the structure between the ILM and the retinal pigment epithelium (RPE); see Section III.6 “Retinal Thickness Definition” in PS3.17 .
111929	Total retinal thickness (ILM to BM)	Measurement approximating the distance related to the structure between the ILM and the Bruch's membrane (BM); see Section III.6 “Retinal Thickness Definition” in PS3.17 .
111930	Absolute ophthalmic thickness	Thickness of a component of the posterior segment of the eye. E.g., thickness of retina, choroid, etc.
111931	Thickness deviation category from normative data	Ophthalmic Thickness map based upon statistical significance category (such as percentile) from normative data.
111932	Thickness deviation from normative data	Ophthalmic Thickness map based upon deviation (such as microns) from normative data.
111933	Related ophthalmic thickness map	Ophthalmic Thickness Map related to another Ophthalmic Thickness Map or another SOP Instance.
111934	Disc-Fovea	An anatomic point centered midway between the disc and fovea centralis.
111935	p>5%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is not statistically significant.
111936	p<5%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 95% unlikely to happen by chance.
111937	p<2%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 98% unlikely to happen by chance.
111938	p<1%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99% unlikely to happen by chance.
111939	p<0.5%	Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99.5% unlikely to happen by chance.
111940	Corneal axial power map	A two dimensional representation of the axial curvature of the cornea. Axial curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the corneal topographer axis. Also known as sagittal curvature.
111941	Corneal instantaneous power map	A two dimensional representation of the instantaneous curvature of the cornea. Instantaneous curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the center of curvature of that point. Also called tangential curvature.
111942	Corneal refractive power map	A two dimensional representation of the refractive power of the cornea. Corneal refractive power is calculated using Snell's Law.
111943	Corneal elevation map	A two dimensional representation of the elevation of the cornea. Elevation is calculated as the distance from a point on the corneal surface to a point on a reference surface along a line parallel to the corneal topographer axis. For the purpose of visualization the reference surface is usually a sphere or an ellipse.
111944	Corneal wavefront map	A two dimensional representation of a wavefront aberration surface of the cornea. Wavefront aberration surface is calculated from the corneal elevation data fit with either the Zernike polynomial series or the Fourier Series. Maps generally display total aberrations and selectable higher order aberrations.
111945	Elevation-based corneal tomographer	A device that measures corneal anterior surface shape using elevation-based methods (stereographic and light slit-based). Rasterstereography images a grid pattern illuminating the fluorescein dyed tear film with 2 cameras to produce 3D. Slit-based devices scan the cornea, usually by rotation about the instrument axis centered on the cornea vertex.
111946	Reflection-based corneal topographer	A reflection-based device that projects a pattern of light onto the cornea and an image of the reflection of that pattern from the tear film is recorded in one video frame. Light patterns include the circular mire pattern (Placido disc) and spot matrix patterns. Sequential scanning of light spots reflected from the corneal surface is also used requiring multiple video frames for recording.
111947	Interferometry-based corneal tomographer	An Interference-based device that projects a beam of light onto and through the cornea. Light reflected from within the cornea is combined with a reference beam giving rise to an interference pattern. Appropriately scanned, this imaging is used to construct 3-dimensional images of the cornea from anterior to posterior surfaces. E.g., swept source OCT.
112000	Chest CAD Report	A structured report containing the results of computer-aided detection or diagnosis applied to chest imaging and associated clinical information.
112001	Opacity	The shadow of an absorber that attenuates the X-Ray beam more effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly white (of lesser photometric density) than its surround [Fraser and Pare].
112002	Series Instance UID	A unique identifier for a series of DICOM SOP instances.
112003	Associated Chest Component	A named anatomic region within the chest cavity.
112004	Abnormal interstitial pattern	A collection of opacities detected within the continuum of loose connective tissue throughout the lung, that is not expected in a diagnostically normal radiograph.
112005	Radiographic anatomy	A type of anatomy that is expected to be detectable on a radiographic (X-Ray based) image.
112006	Distribution Descriptor	Characteristic of the extent of spreading of a finding or feature.
112007	Border definition	Characteristic of the clarity of the boundary or edges of a finding or feature.
112008	Site involvement	The part(s) of the anatomy affected or encompassed by a finding or feature.
112009	Type of Content	Characteristic of the matter or substance within a finding or feature.
112010	Texture Descriptor	Characteristic of the surface or consistency of a finding or feature.
112011	Positioner Primary Angle	Position of the X-Ray beam about the patient from the RAO to LAO direction where movement from RAO to vertical is positive.
112012	Positioner Secondary Angle	Position of the X-Ray beam about the patient from the caudal to cranial direction where movement from caudal to vertical is positive.
112013	Location in Chest	The zone, lobe or segment within the chest cavity in which a finding or feature is situated.
112014	Orientation Descriptor	Vertical refers to orientation parallel to the superior-inferior (cephalad-caudad) axis of the body, with horizontal being perpendicular to this, and an oblique orientation having projections in both the horizontal and vertical.
112015	Border shape	Characteristic of the shape formed by the boundary or edges of a finding or feature.
112016	Baseline Category	Indicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST.
112017	Cavity extent as percent of volume	The extent of a detected cavity, represented as the percent of the surrounding volume that it occupies.
112018	Calcification extent as percent of surface	The extent of a detected calcification, represented as the percent of the surrounding surface that it occupies.
112019	Calcification extent as percent of volume	The extent of a detected calcification, represented as the percent of the surrounding volume that it occupies.
112020	Response Evaluation	A heading for the reporting of response evaluation for treatment of solid tumors.
112021	Response Evaluation Method	The system applied in the reporting of response evaluation for treatment of solid tumors.
112022	RECIST	Response Evaluation Criteria In Solid Tumors; see Normative References.
112023	Composite Feature Modifier	A term that further specifies the name of an item that is an inferred correlation relating two or more individual findings or features.
112024	Single Image Finding Modifier	A term that further specifies the name of an item that was detected on one image.
112025	Size Descriptor	A qualitative descriptor for the extent of a finding or feature.
112026	Width Descriptor	A qualitative descriptor for the thickness of tubular structures, such as blood vessels.
112027	Opacity Descriptor	A characteristic that further describes the nature of an opacity.
112028	Abnormal Distribution of Anatomic Structure	The type of adverse affect that a finding or feature is having on the surrounding anatomy.
112029	WHO	Response evaluation method as defined in chapter 5, "Reporting of Response" of the WHO Handbook for Reporting Results for Cancer Treatment; see Normative References.
112030	Calcification Descriptor	Identification of the morphology of detected calcifications.
112031	Attenuation Coefficient	A quantitative numerical statement of the relative attenuation of the X-Ray beam at a specified point. Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms. Usually expressed in Hounsfield units [referred to as CT Number in Fraser and Pare].
112032	Threshold Attenuation Coefficient	An X-Ray attenuation coefficient that is used as a threshold. E.g., in calcium scoring.
112033	Abnormal opacity	An opacity that is not expected in a diagnostically normal radiograph.
112034	Calculation Description	A textual description of the mathematical method of calculation that resulted in a calculated value.
112035	Performance of Pediatric and Adult Chest Radiography, ACR	American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Chest Radiography. In: Standards. Reston, Va: 2001:95-98.
112036	ACR Position Statement	American College of Radiology. ACR Position Statement for Quality Control and Improvement, Safety, Infection Control, and Patient Concerns. In: Practice Guidelines and Technical Standards. Reston, Va: 2001:iv.
112037	Non-lesion Modifier	A descriptor for a non-lesion object finding or feature, used to indicate whether the object was detected as being internal or external to the patient's body.
112038	Osseous Modifier	A concept modifier for an Osseous Anatomy, or bone related, finding.
112039	Tracking Identifier	A text label used for tracking a finding or feature, potentially across multiple reporting objects, over time. This label shall be unique within the domain in which it is used. Corresponds to Tracking ID (0062,0020).
112040	Tracking Unique Identifier	A unique identifier used for tracking a finding or feature, potentially across multiple reporting objects, over time. Corresponds to Tracking UID (0062,0021).
112041	Target Lesion Complete Response	Disappearance of all target lesions.
112042	Target Lesion Partial Response	At least a 30% decrease in the sum of the Longest Diameter of target lesions, taking as reference the baseline sum Longest Diameter.
112043	Target Lesion Progressive Disease	At least a 20% increase in the sum of the Longest Diameter of target lesions, taking as reference the smallest sum Longest Diameter recorded since the treatment started, or the appearance of one or more new lesions.
112044	Target Lesion Stable Disease	Neither sufficient shrinkage to qualify for Partial Response nor sufficient increase to qualify for Progressive Disease, taking as reference the smallest sum Longest Diameter since the treatment started.
112045	Non-Target Lesion Complete Response	Disappearance of all non-target lesions and normalization of tumor marker level.
112046	Non-Target Lesion Incomplete Response or Stable Disease	Persistence of one or more non-target lesions and/or maintenance of tumor marker level above the normal limits.
112047	Non-Target Lesion Progressive Disease	Appearance of one or more new lesions and/or unequivocal progression of existing non-target lesions.
112048	Current Response	The current response evaluation for treatment of solid tumors, according to a method such as RECIST.
112049	Best Overall Response	Best response recorded from the start of the treatment until disease progression/recurrence, taking as reference for Progressive Disease the smallest measurements recorded since the treatment started, according to a method such as RECIST.
112050	Anatomic Identifier	A text identifier of an anatomic feature when a multiplicity of features of that type may be present, such as "Rib 1", "Rib 2" or thoracic vertebrae "T1" or "T2".
112051	Measurement of Response	A measured or calculated evaluation of response. E.g., according to a method such as RECIST, the value would be the calculated sum of the lengths of the longest axes of a set of target lesions.
112052	Bronchovascular	Of or relating to a bronchial (lung) specific channel for the conveyance of a body fluid.
112053	Osseous	Of, relating to, or composed of bone.
112054	Secondary pulmonary lobule	The smallest unit of lung surrounded by connective tissue septa; the unit of lung subtended by any bronchiole that gives off three to five terminal bronchioles [Fraser and Pare].
112055	Agatston scoring method	A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the maximum X-Ray attenuation coefficient and the area of calcium deposits.
112056	Volume scoring method	A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the volume of each calcification, typically expressed in mm3.
112057	Mass scoring method	A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the total mass of calcification, typically expressed in mg.
112058	Calcium score	A measure often arrived at through calculation of findings from CT examination, which is a common predictor of significant stenosis of the coronary arteries.	Retired. Replaced by (450360000, SCT, "Coronary artery calcium score")
112059	Primary complex	The combination of a focus of pneumonia due to a primary infection with granulomas in the draining hilar or mediastinal lymph nodes [Fraser and Pare].
112060	Oligemia	General or local decrease in the apparent width of visible pulmonary vessels, suggesting less than normal blood flow (reduced blood flow) [Fraser and Pare].
112061	Abnormal lines (1D)	Linear opacity of very fine width, i.e., a nearly one dimensional opacity.
112062	Abnormal lucency	Area of abnormal very low X-Ray attenuation, typically lower than aerated lung when occurring in or projecting over lung, or lower than soft tissue when occurring in or projecting over soft tissue.
112063	Abnormal calcifications	A calcific opacity within the lung that may be organized, but does not display the trabecular organization of true bone [Fraser and Pare].
112064	Abnormal texture	Relatively homogeneous, extended, pattern of abnormal opacity in the lung, typically low in contrast.
112065	Reticulonodular pattern	A collection of innumerable small, linear, and nodular opacities that together produce a composite appearance resembling a net with small superimposed nodules. The reticular and nodular elements are dimensionally of similar magnitude [Fraser and Pare].
112066	Beaded septum sign	Irregular septal thickening that suggests the appearance of a row of beads; usually a sign of lymphangitic carcinomatosis, but may also occur rarely in sarcoidosis [Fraser and Pare].
112067	Nodular pattern	A collection of innumerable, small discrete opacities ranging in diameter from 2-10 mm, generally uniform in size and widespread in distribution, and without marginal spiculation [Fraser and Pare].
112068	Pseudoplaque	An irregular band of peripheral pulmonary opacity adjacent to visceral pleura that simulates the appearance of a pleural plaque and is formed by coalescence of small nodules [Fraser and Pare] .
112069	Signet-ring sign	A ring of opacities (usually representing a dilated, thick-walled bronchus) in association with a smaller, round, soft tissue opacity (the adjacent pulmonary artery) suggesting a "signet ring" [Fraser and Pare].
112070	Air bronchiologram	Equivalent of air bronchogram, but in airways assumed to be bronchioles because of peripheral location and diameter [Fraser and Pare].
112071	Air bronchogram	Radiographic shadow of an air-containing bronchus; presumed to represent an air-containing segment of the bronchial tree (identity often inferred) [Fraser and Pare].
112072	Air crescent	Air in a crescentic shape in a nodule or mass, in which the air separates the outer wall of the lesion from an inner sequestrum, which most commonly is a fungus ball of Aspergillusspecies [Fraser and Pare].
112073	Halo sign	Ground-glass opacity surrounding the circumference of a nodule or mass. May be a sign of invasive aspergillosis or hemorrhage of various causes [Fraser and Pare].
112074	Target Lesion at Baseline	Flag denoting that this lesion was identified, at baseline, as a target lesion intended for tracking over time [RECIST].
112075	Non-Target Lesion at Baseline	Flag denoting that this lesion was not identified, at baseline, as a target lesion, and was not intended for tracking over time [RECIST].
112076	Non-Lesion at Baseline	Flag denoting that this finding was identified, at baseline, as a category other than a lesion, and was not intended for tracking over time [RECIST].
112077	Vasoconstriction	Local or general reduction in the caliber of visible pulmonary vessels, presumed to result from decreased flow occasioned by contraction of muscular pulmonary arteries [Fraser and Pare].
112078	Vasodilation	Local or general increase in the width of visible pulmonary vessels resulting from increased pulmonary blood flow [Fraser and Pare].
112079	Architectural distortion	A manifestation of lung disease in which bronchi, pulmonary vessels, a fissure or fissures, or septa of secondary pulmonary lobules are abnormally displaced [Fraser and Pare].
112080	Mosaic perfusion	A patchwork of regions of varied attenuation, interpreted as secondary to regional differences in perfusion [Fraser and Pare].
112081	Pleonemia	Increased blood flow to the lungs or a portion thereof, manifested by a general or local increase in the width of visible pulmonary vessels [Fraser and Pare].
112082	Interface	The common boundary between the shadows of two juxtaposed structures or tissues of different texture or opacity (edge, border) [Fraser and Pare].
112083	Line	A longitudinal opacity no greater than 2 mm in width [Fraser and Pare].
112084	Lucency	The shadow of an absorber that attenuates the primary X-Ray beam less effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly black (of greater photometric density) than its surround [Fraser and Pare].
112085	Midlung window	A midlung region, characterized by the absence of large blood vessels and by a paucity of small blood vessels, that corresponds to the minor fissure and adjacent peripheral lung [Fraser and Pare].
112086	Carina angle	The angle formed by the right and left main bronchi at the tracheal bifurcation [Fraser and Pare].
112087	Centrilobular structures	The pulmonary artery and its immediate branches in a secondary lobule; HRCT depicts these vessels in certain cases; a.k.a. core structures or lobular core structures [Fraser and Pare].
112088	Anterior junction line	A vertically oriented linear or curvilinear opacity approximately 1-2 mm wide, commonly projected on the tracheal air shadow [Fraser and Pare].
112089	Posterior junction line	A vertically oriented, linear or curvilinear opacity approximately 2 mm wide, commonly projected on the tracheal air shadow, and usually slightly concave to the right [Fraser and Pare].
112090	Azygoesophageal recess interface	A space in the right side of the mediastinum into which the medial edge of the right lower lobe extends [Fraser and Pare].
112091	Paraspinal line	A vertically oriented interface usually seen in a frontal chest radiograph to the left of the thoracic vertebral column [Fraser and Pare].
112092	Posterior tracheal stripe	A vertically oriented linear opacity ranging in width from 2-5 mm, extending from the thoracic inlet to the bifurcation of the trachea, and visible only on lateral radiographs of the chest [Fraser and Pare].
112093	Right tracheal stripe	A vertically oriented linear opacity approximately 2-3 mm wide extending from the thoracic inlet to the right tracheobronchial angle [Fraser and Pare].
112094	Stripe	A longitudinal composite opacity measuring 2-5 mm in width; acceptable when limited to anatomic structures within the mediastinum [Fraser and Pare].
112095	Hiatus	A gap or passage through an anatomical part or organ; especially: a gap through which another part or organ passes.
112096	Rib Scalene Tubercle	A small rounded elevation or eminence on the first rib for the attachment of the scalenus anterior.
112097	Vertebral Intervertebral Notch	A groove that serves for the transmission of the vertebral artery.
112098	Subscapular Fossa	The concave depression of the anterior surface of the scapula.
112099	Scapular Spine	A sloping ridge dividing the dorsal surface of the scapula into the supraspinatous fossa (above), and the infraspinatous fossa (below).
112100	Scapular Supraspinatus Fossa	The portion of the dorsal surface of the scapula above the scapular spine.
112101	Scapular Infraspinatus Fossa	The portion of the dorsal surface of the scapula below the scapular spine.
112102	Aortic knob	The portion of the aortic arch that defines the transition between its ascending and descending limbs.
112103	Arch of the Azygos vein	Section of Azygos vein near the fourth thoracic vertebra, where it arches forward over the root of the right lung, and ends in the superior vena cava, just before that vessel pierces the pericardium.
112104	Air-fluid level	A local collection of gas and liquid that, when traversed by a horizontal X-Ray beam, creates a shadow characterized by a sharp horizontal interface between gas density above and liquid density below [Fraser and Pare].
112105	Corona radiata	A circumferential pattern of fine linear spicules, approximately 5 mm long, extending outward from the margin of a solitary pulmonary nodule through a zone of relative lucency [Fraser and Pare].
112106	Honeycomb pattern	A number of closely approximated ring shadows representing air spaces 5-10 mm in diameter with walls 2-3 mm thick that resemble a true honeycomb; implies "end-stage" lung [Fraser and Pare].
112107	Fleischner's line(s)	A straight, curved, or irregular linear opacity that is visible in multiple projections; usually situated in the lower half of the lung; vary markedly in length and width [Fraser and Pare].
112108	Intralobular lines	Fine linear opacities present in a lobule when the intralobular interstitium is thickened. When numerous, they may appear as a fine reticular pattern [Fraser and Pare].
112109	Kerley A line	Essentially straight linear opacity 2-6 cm in length and 1-3 mm in width, usually in an upper lung zone [Fraser and Pare].
112110	Kerley B line	A straight linear opacity 1.5-2 cm in length and 1-2 mm in width, usually at the lung base [Fraser and Pare].
112111	Kerley C lines	A group of branching, linear opacities producing the appearing of a fine net, at the lung base [Fraser and Pare].
112112	Parenchymal band	Elongated opacity, usually several millimeters wide and up to about 5 cm long, often extending to the pleura, which may be thickened and retracted at the site of contact [Fraser and Pare].
112113	Reticular pattern	A collection of innumerable small linear opacities that together produce an appearance resembling a net [Fraser and Pare].
112114	Septal line(s)	Usually used in the plural, a generic term for linear opacities of varied distribution produced when the interstitium between pulmonary lobules is thickened [Fraser and Pare].
112115	Subpleural line	A thin curvilinear opacity, a few millimeters or less in thickness, usually less than 1 cm from the pleural surface and paralleling the pleura [Fraser and Pare].
112116	Tramline shadow	Parallel or slightly convergent linear opacities that suggest the planar projection of tubular structures and that correspond in location and orientation to elements of the bronchial tree [Fraser and Pare].
112117	Tubular shadow	Paired, parallel, or slightly convergent linear opacities presumed to represent the walls of a tubular structure seen en face; used if the anatomic nature of a shadow is obscure [Fraser and Pare].
112118	Density	The opacity of a radiographic shadow to visible light; film blackening; the term should never be used to mean an "opacity" or "radiopacity" [Fraser and Pare].
112119	Dependent opacity	Subpleural increased attenuation in dependent lung. The increased attenuation disappears when the region of lung is nondependent; a.k.a. dependent increased attenuation [Fraser and Pare].
112120	Ground glass opacity	Hazy increased attenuation of lung, but with preservation of bronchial and vascular margins; caused by partial filling of air spaces, interstitial thickening, partial collapse of alveoli, normal expiration, or increased capillary blood volume [Fraser and Pare].
112121	Infiltrate	Any ill-defined opacity in the lung [Fraser and Pare].
112122	Micronodule	Discrete, small, round, focal opacity of at least soft tissue attenuation and with a diameter no greater than 7 mm [Fraser and Pare].
112123	Phantom tumor (pseudotumor)	A shadow produced by a local collection of fluid in one of the interlobar fissures, usually elliptic in one radiographic projection and rounded in the other, resembling a tumor [Fraser and Pare].
112124	Shadow	Any perceptible discontinuity in film blackening attributed to the attenuation of the X-Ray beam by a specific anatomic absorber or lesion on or within the body of the patient; to be employed only when more specific identification is not possible [Fraser and Pare].
112125	Small irregular opacities	Term used to define a reticular pattern specific to pneumoconioses [Fraser and Pare].
112126	Small rounded opacities	Term used to define a nodular pattern specific to pneumoconioses [Fraser and Pare].
112127	Tree-in-bud sign	Nodular dilation of centrilobular branching structures that resembles a budding tree and represents exudative bronchiolar dilation [Fraser and Pare].
112128	Granular pattern	Any extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured [Fraser and Pare].
112129	Miliary pattern	A collection of tiny discrete opacities in the lungs, each measuring 2 mm or less in diameter, generally uniform in size and widespread in distribution [Fraser and Pare].
112130	Mosaic pattern	Generalized pattern of relatively well defined areas in the lung having different X-Ray attenuations due to a longstanding underlying pulmonary disease.
112131	Extremely small	A qualitative descriptor of a size that is dramatically less than typical.
112132	Very small	A qualitative descriptor of a size that is considerably less than typical.
112133	Too small	A qualitative descriptor of a size that is so small as to be abnormal versus expected size.
112134	Elliptic	Shaped like an ellipse (oval).
112135	Lobulated	A border shape that is made up of, provided with, or divided into lobules (small lobes, curved or rounded projections or divisions).
112136	Spiculated	Radially orientated border shape.
112137	Sharply defined	The border of a shadow (opacity) is sharply defined [Fraser and Pare].
112138	Distinctly defined	The border of a shadow (opacity) is distinctly defined [Fraser and Pare].
112139	Well demarcated	The border of a shadow (opacity) is well distinct from adjacent structures [Fraser and Pare].
112140	Sharply demarcated	The border of a shadow (opacity) is sharply distinct from adjacent structures [Fraser and Pare].
112141	Poorly demarcated	The border of a shadow (opacity) is poorly distinct from adjacent structures [Fraser and Pare].
112142	Circumscribed	A shadow (opacity) possessing a complete or nearly complete visible border [Fraser and Pare].	Retired. Replaced by (263706005, SCT, "Circumscribed")
112143	Air	Inspired atmospheric gas. The word is sometimes used to describe gas within the body regardless of its composition or site [Fraser and Pare].
112144	Soft tissue	Material having X-Ray attenuation properties similar to muscle.	Retired. Replaced with (87784001, SCT, "Soft tissue").
112145	Calcium	Material having X-Ray attenuation properties similar to calcium, a silver-white bivalent metallic element occurring in plants and animals.
112146	Acinar	A pulmonary opacity 4-8 mm in diameter, presumed to represent anatomic acinus, or a collection of opacities in the lung, each measuring 4-8 mm in diameter, and together producing an extended, homogeneous shadow [Fraser and Pare].
112147	Air space	The gas-containing portion of the lung parenchyma, including the acini and excluding the interstitium [Fraser and Pare].
112148	Fibronodular	Sharply defined, approximately circular opacities occurring singly or in clusters, usually in the upper lobes [Fraser and Pare].
112149	Fluffy	A shadow (opacity) that is ill-defined, lacking clear-cut margins [Fraser and Pare].
112150	Linear	A shadow resembling a line; any elongated opacity of approximately uniform width [Fraser and Pare].
112151	Profusion	The number of small opacities per unit area or zone of lung. In the International Labor Organization (ILO) classification of radiographs of the pneumoconioses, the qualifiers 0 through 3 subdivide the profusion into 4 categories. The profusion categories may be further subdivided by employing a 12-point scale [Fraser and Pare].
112152	Silhouette sign	The effacement of an anatomic soft tissue border by either a normal anatomic structure or a pathologic state such as airlessness of adjacent lung or accumulation of fluid in the contiguous pleural space; useful in detecting and localizing an opacity along the axis of the X-Ray beam [Fraser and Pare].
112153	Subpleural	Situated or occurring between the pleura and the body wall.	Retired. Replaced by (68599007, SCT, "Subpleural")
112154	Bat's wing distribution	Spatial arrangement of opacities that bears vague resemblance to the shape of a bat in flight; bilaterally symmetric [Fraser and Pare].
112155	Butterfly distribution	Spatial arrangement of opacities that bears vague resemblance to the shape of a butterfly in flight; bilaterally symmetric [Fraser and Pare].
112156	Centrilobular	Referring to the region of the bronchioloarteriolar core of a secondary pulmonary lobule [Fraser and Pare].
112157	Coalescent	The joining together of a number of opacities into a single opacity [Fraser and Pare].
112158	Lobar	Of or relating to a lobe (a curved or rounded projection or division). E.g., involving an entire lobe of the lung.
112159	Hyper-acute	Extremely or excessively acute, as a qualitative measure of severity.
112160	Homogeneous	Of uniform opacity or texture throughout [Fraser and Pare].
112161	Inhomogeneous	Lack of homogeneity in opacity or texture.
112162	Target	Discrete opacity centrally within a larger opacity, as a calcification descriptor.
112163	Fibrocalcific	Pertaining to sharply defined, linear, and/or nodular opacities containing calcification(s) [Fraser and Pare].
112164	Flocculent	Calcifications made up of loosely aggregated particles, resembling wool.
112165	Difference in border shape	A change in the shape formed by the boundary or edges of a finding or feature.	Retired. Replaced by (442755000, SCT, "Difference in border shape")
112166	Difference in border definition	A change in the clarity of the boundary or edges of a finding or feature.	Retired. Replaced by (442688001, SCT, "Difference in border definition")
112167	Difference in distribution	A change in the extent of spreading of a finding or feature.	Retired. Replaced by (442704007, SCT, "Difference in distribution")
112168	Difference in site involvement	A change in the part(s) of the anatomy affected or encompassed by a finding or feature.	Retired. Replaced by (442711006, SCT, "Difference in site involvement")
112169	Difference in Type of Content	A change in the matter or substance within a finding or feature.	Retired. Replaced by (442691001, SCT, "Difference in substance")
112170	Difference in Texture	A change in the surface or consistency of a finding or feature.	Retired. Replaced by (442700003, SCT, "Difference in texture")
112171	Fiducial mark	A location in image space, which may or may not correspond to an anatomical reference, which is often used for registering data.
112172	Portacath	Connected to an injection chamber placed under the skin in the upper part of the chest. When it is necessary to inject some drug, a specific needle is put in the chamber through the skin and a silicon membrane. The advantage of a portacath is that it may be left in place several months contrarily of "classical" catheters.
112173	Chest tube	A tube inserted into the chest wall from outside the body, for drainage. Sometimes used for collapsed lung. Usually connected to a receptor placed lower than the insertion site.
112174	Central line	A tube placed into the subclavian vein to deliver medication directly into the venous system.
112175	Kidney stent	A stent is a tube inserted into another tube. Kidney stent is a tube that is inserted into the kidney, ureter, and bladder, to help drain urine. Usually inserted through a scoping device presented through the urethra.
112176	Pancreatic stent	A stent is a tube inserted into another tube. Pancreatic stent is inserted through the common bile duct to the pancreatic duct, to drain bile.
112177	Nipple ring	A non-lesion object that appears to be a circular band, attached to the body via pierced nipple.
112178	Coin	A non-lesion object that appears to be a flat round piece of metal.
112179	Minimum Attenuation Coefficient	The least quantity assignable, admissible, or possible; the least of a set of X-Ray attenuation coefficients.
112180	Maximum Attenuation Coefficient	The greatest quantity or value attainable or attained; the largest of a set of X-Ray attenuation coefficients.
112181	Mean Attenuation Coefficient	The value that is computed by dividing the sum of a set of X-Ray attenuation coefficients by the number of values .
112182	Median Attenuation Coefficient	The value in an ordered set of X-Ray attenuation coefficients, below and above which there is an equal number of values.
112183	Standard Deviation of Attenuation Coefficient	For a set of X-Ray attenuation coefficients: 1) a measure of the dispersion of a frequency distribution that is the square root of the arithmetic mean of the squares of the deviation of each of the class frequencies from the arithmetic mean of the frequency distribution; 2) a parameter that indicates the way in which a probability function or a probability density function is centered around its mean and that is equal to the square root of the moment in which the deviation from the mean is squared.
112184	Performance of Pediatric and Adult Thoracic CT	American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Thoracic Computed Tomography (CT). In: Standards. Reston, Va: 2001:103-107.
112185	Performance of CT for Detection of Pulmonary Embolism in Adults	American College of Radiology. ACR Standard for the Performance of Computed Tomography for the Detection of Pulmonary Embolism in Adults. In: Standards. Reston, Va: 2001:109-113.
112186	Performance of High-Resolution CT of the Lungs in Adults	American College of Radiology. ACR Standard for the Performance of High-Resolution Computed Tomography (HRCT) of the Lungs in Adults. In: Standards. Reston, Va: 2001:115-118.
112187	Unspecified method of calculation	The method of calculation of a measurement or other type of numeric value is not specified.
112188	Two-dimensional method	The calculation method was performed in two-dimensional space.
112189	Three-dimensional method	The calculation method was performed in three-dimensional space.
112191	Breast tissue density	The relative density of parenchymal tissue as a proportion of breast volume.
112192	Volume of parenchymal tissue	The volume of parenchymal tissue.
112193	Volume of breast	The volume of the breast.
112194	Mass of parenchymal tissue	The mass of parenchymal tissue.
112195	Mass of breast	The mass of the breast.
112196	Area of Vascular Calcification	A measured or calculated area of vascular calcification.
112197	Volume of Vascular Calcification	A measured or calculated volume of vascular calcification.
112198	Percentage of Vascular Calcification	A measured or calculated percentage of vascular calcification.
112199	Mass of Vascular Calcification	A measured or calculated mass of vascular calcification.
112200	Average calcification distance in a calcification cluster	The average nearest neighbor distance of all individual microcalcifications in a cluster.
112201	Standard deviation distance of calcifications in a cluster	The standard deviation of nearest neighbor distance of all individual microcalcifications in a cluster.
112220	Colon CAD Report	A structured report containing the results of computer-aided detection or diagnosis applied to colon imaging and associated clinical information.
112222	Colon Overall Assessment	Overall interpretation of the colon using C-RADS categorization system.
112224	Image Set Properties	Characteristics of a set of images.
112225	Slice Thickness	Nominal slice thickness, in mm.
112226	Spacing between slices	Distance between contiguous images, measured from the center-to-center of each image.
112227	Frame of Reference UID	Uniquely identifies groups of composite instances that have the same coordinate system that conveys spatial and/or temporal information.
112228	Recumbent Patient Position with respect to gravity	Patient orientation with respect to downward direction (gravity).
112229	Identifying Segment	Distinguishes a part of a segmentation.
112232	Polyp stalk width	The diameter of a polyp stalk measured perpendicular to the axis of the stalk.
112233	Distance from anus	The length of the path following the centerline of the colon from the anus to the area of interest.
112238	Anatomic non-colon	A location in the body that is outside the colon.
112240	C0 - Inadequate Study/Awaiting Prior Comparisons	An inadequate study or a study that is awaiting prior comparisons. The study may have inadequate preparation and cannot exclude lesions greater than or equal to ten millimeters owing to presence of fluid or feces. The study may have inadequate insufflation where one or more colonic segments collapsed on both views. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9.
112241	C1 - Normal Colon or Benign Lesion	The study has a normal colon or benign lesion, with the recommendation to continue routine screening. The study has no visible abnormalities of the colon. The study has no polyps greater than six millimeters. The study may have lipoma, inverted diverticulum, or nonneoplastic findings, such as colonic diverticula. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9.
112242	C2 - Intermediate Polyp or Indeterminate Finding	The study has an intermediate polyp or indeterminate finding and surveillance or colonoscopy is recommended. There may be intermediate polyps between six and nine millimeters and there are less than three in number. The study may have an intermediate finding and cannot exclude a polyp that is greater than or equal to six millimeters in a technically adequate study. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9.
112243	C3 - Polyp, Possibly Advanced Adenoma	The study has a polyp, possibly advanced adenoma, and a follow-up colonoscopy is recommended. The study has a polyp greater than or equal to ten millimeters or the study has three or more polyps that are each between six to nine millimeters. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9.
112244	C4 - Colonic Mass, Likely Malignant	The study has a colonic mass, likely malignant, and surgical consultation is recommended. The lesion compromises bowel lumen and demonstrates extracolonic invasion. Based on "CT Colonography Reporting and Data System: A Consensus Proposal", Radiology, July 2005; 236:3-9.
112248	ACR Guideline, Performance of Adult CT Colonography	American College of Radiology Practice Guideline for the Performance of Computed Tomography (CT) Colonography in Adults. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:371-376.
112249	ACR Standard, CT medical physics performance monitoring	American College of Radiology Technical Standard for Diagnostic Medical Physics Performance Monitoring of Computed Tomography (CT) Equipment. In: Practice Guidelines and Technical Standards.Reston, Va: American College of Radiology;2006:945-948.
112300	AP+45	View Orientation Modifier indicates that the view orientation of the imaging plane is rotated +45° along the cranial-caudal axis.
112301	AP-45	View Orientation Modifier indicates that the view orientation of the imaging plane is rotated -45° along the cranial-caudal axis.
112302	Anatomical axis of femur	The axis following the shaft of the femur.
112303	Acetabular Center of Rotation	Center of Rotation of the natural Acetabulum.
112304	Femur Head Center of Rotation	Center of Rotation of the natural femur head.
112305	Acetabular Cup Shell	Prosthetic component implanted into the acetabulum. Provides hold for the insert that is mounted inside the cup.
112306	Acetabular Cup Insert	Prosthetic pelvic joint component. Inserted into the cup, takes in the femoral head replacement.
112307	Acetabular Cup Monoblock	Prosthetic pelvic joint cup including insert.
112308	Femoral Head Ball Component	Component for Femoral Head Prosthesis where the conic intake for the stem neck can be exchanged. Combined with a Femoral Head Cone Taper Component.
112309	Femoral Head Cone Taper Component	Exchangeable neck intake for composite femoral head prosthesis. Combined with a Femoral Head Ball Component.
112310	Femoral Stem	Prosthesis Implanted into the femoral bone to provide force transmission between joint replacement and bone. On the proximal end a conic neck holds the femoral head replacement.
112311	Femoral Stem Distal Component	Distal half of a modular stem prosthesis system. Combined with a Stem Proximal Component.
112312	Femoral Stem Proximal Component	Proximal half of a modular stem prosthesis system. Combined with a Stem Distal Component.
112313	Femoral Stem Component	Stem prosthetic component with a modular insert for an exchangeable neck component. Combined with a Neck Component.
112314	Neck Component	Prosthetic Neck to be combined with a Stem Component.
112315	Monoblock Stem	Prosthetic Stem and Femoral Head in one piece.
112316	Prosthetic Shaft Augment	A proximal attachment to the shaft used to compensate for bone deficiencies or bone loss.
112317	Femoral Head Resurfacing Component	Artificial femur head surface needed for the partial replacement of the femoral head where only the surface is replaced.
112318	Pinning	Fixation using a pin.
112319	Sewing	Fixation sewing several objects together.
112320	Bolting	Fixation using a bolt.
112321	Wedging	Fixation due to forcing an object into a narrow space.
112325	Distal Centralizer	Attachment to the distal end of a cemented stem assuring that the stem is in a central position inside the drilled femoral canal before cementation.
112340	Generic 2D Planning	Planning by an unspecified 2D method.
112341	Generic 3D Planning	Planning by an unspecified 3D method.
112342	Generic Planning for Hip Replacement	Planning of a Hip Replacement, by an unspecified method.
112343	Generic Planning for Knee Replacement	Planning of Knee Replacement, by an unspecified method.
112344	Müller Method Planning for Hip Replacement	Planning of Hip Replacement according to the procedure of M. E. Müller [Eggli et. al.1998].
112345	Implantation Plan	A Report containing the results of an Implantation Planning Activity.
112346	Selected Implant Component	A selection of one Implant Component.
112347	Component ID	Identification ID of an Implant Component.
112348	Implant Template	An implant template describing the properties (2D/3D geometry and other data) of one Implant Component.
112350	Component Connection	A connection of two Connected Implantation Plan Components.
112351	Mating Feature Set ID	ID of a Mating Feature Set in an Implant Component.
112352	Mating Feature ID	ID of the Mating Feature in a Mating Feature Set in an Implant Component.
112353	Spatial Registration	The Spatial Registration of one or more Implant Components.
112354	Patient Image	Patient Images used for an implantation planning activity.
112355	Assembly	A collection of Component Connections of Implant Components.
112356	User Selected Fiducial	Fiducials that are selected by the user and may or may not belong to anatomical landmarks.
112357	Derived Fiducial	Fiducials that represent geometric characteristics, such as center of rotation, and are derived from other fiducials.
112358	Information used for planning	All parameters and data that were used for the planning activity.
112359	Supporting Information	A description of the plan as encapsulated PDF SOP Instance.
112360	Implant Component List	A list of all Implant Components selected for an implantation.
112361	Patient Data Used During Planning	Reference to objects containing patient data that is used for planning.
112362	Degrees of Freedom Specification	A specification of the values from one or more Degrees of Freedom.
112363	Degree of Freedom ID	ID of one Degree of Freedom.
112364	Related Patient Data Not Used During Planning	Reference to objects containing patient data that were not used for planning but are somehow related.
112365	Related Implantation Reports	Implantation Reports that are somehow related. E.g., contemporaneous implantations that are independent.
112366	Implant Assembly Template	Implant Assembly Template.
112367	Planning Information for Intraoperative Usage	Information that is intended to be used intra-operatively.
112368	Implantation Patient Positioning	Position of the patient on the operating room table.
112369	Fiducial Intent	Intended use of the fiducial.
112370	Component Type	Type of an Implant Component.
112371	Manufacturer Implant Template	Implant Template released by the Manufacturer.
112372	Derived Planning Images	Images that are created by a planning application.
112373	Other Derived Planning Data	Data that is created by a planning application.
112374	Connected Implantation Plan Component	One Implant Component that is connected to another Implant Component.
112375	Planning Method	The method used for planning.
112376	Degree of Freedom Exact Translational Value	Defines the exact value that was planned for translation.
112377	Degree of Freedom Minimum Translational Value	Defines the minimum value that was planned for translation.
112378	Degree of Freedom Maximum Translational Value	Defines the maximum value that was planned for translation.
112379	Degree of Freedom Exact Rotational Translation Value	Defines the exact value that was planned for rotation.
112380	Degree of Freedom Minimum Rotational Value	Defines the minimum value that was planned for rotation.
112381	Degree of Freedom Maximum Rotational Value	Defines the maximum value that was planned for rotation.
112700	Peri-operative Photographic Imaging	Procedure step protocol for photographic imaging of surgical procedures, including photography of specimens collected.
112701	Gross Specimen Imaging	Procedure step protocol for imaging gross specimens, typically with a photographic camera (modality XC), and planning further dissection.	Retired. Replaced with (168456004, SCT, "Gross pathology request")
112702	Slide Microscopy	Procedure step protocol for imaging slide specimens.
112703	Whole Slide Imaging	Procedure step protocol for imaging slide specimens using a whole slide scanner.
112704	WSI 20X RGB	Procedure step protocol for imaging slide specimens using a whole slide scanner with a 20X nominal objective lens, in full color, with a single imaging focal plane across the image.
112705	WSI 40X RGB	Procedure step protocol for imaging slide specimens using a whole slide scanner with a 40X nominal objective lens, in full color, with a single imaging focal plane across the image.
112706	Illumination Method	Technique of illuminating specimen.
112707	Number of focal planes	Number of focal planes for a microscopy image acquisition.
112708	Focal plane Z offset	Nominal distance above a reference plane (typically a slide glass substrate top surface) of the focal plane.
112709	Magnification selection	Microscope magnification based on nominal objective lens power.
112710	Illumination wavelength	Nominal center wavelength for an imaging spectral band.
112711	Illumination spectral band	Name (coded) for an imaging spectral band.
112712	Optical filter type	Type of filter inserted into the optical imaging path.
112713	Tissue selection method	Technique for identifying tissue to be imaged versus area of slide not to be imaged.
112714	Multiple planes	Imaging performed at multiple imaging (focal) planes.
112715	5X	Nominal 5 power objective lens, resulting in a digital image at approximately 2 um/pixel spacing.
112716	10X	Nominal 10 power objective lens, resulting in a digital image at approximately 1 um/pixel spacing.
112717	20X	Nominal 20 power microscope objective lens, resulting in a digital image at approximately 0.5 um/pixel spacing.
112718	40X	Nominal 40 power microscope objective lens, with a combined condenser and objective lens numerical aperture of approximately 1.3, resulting in a digital image at approximately 0.25 um/pixel spacing.
112719	Nominal empty tile suppression	Equipment-specific nominal or default method for identifying tiles without tissue imaged for suppression from inclusion in image object.
112720	High threshold empty tile suppression	Equipment-specific high threshold method for identifying tiles without tissue imaged for suppression from inclusion in image object.
112721	No empty tile suppression	Tiles without tissue imaged are not suppressed from inclusion in image object.
113000	Of Interest	Of Interest.
113001	Rejected for Quality Reasons	Rejected for Quality Reasons.
113002	For Referring Provider	For Referring Provider.
113003	For Surgery	For Surgery.
113004	For Teaching	For Teaching.
113005	For Conference	For Conference.
113006	For Therapy	For Therapy.
113007	For Patient	For Patient.
113008	For Peer Review	For Peer Review.
113009	For Research	For Research.
113010	Quality Issue	Quality Issue.
113011	Document Title Modifier	Document Title Modifier.
113012	Key Object Description	Key Object Description.
113013	Best In Set	A selection that represents the "best" chosen from a larger set of items. E.g., the best images within a Study or Series. The criteria against which "best" is measured is not defined. Contrast this with the more specific term "Best illustration of finding".
113014	Study	A study is a collection of one or more series of medical images, presentation states, and/or SR documents that are logically related for the purpose of diagnosing a patient. A study may include composite instances that are created by a single modality, multiple modalities or by multiple devices of the same modality. [From Section A.1.2.2 “Study IE” in PS3.3 ]
113015	Series	A distinct logical set used to group composite instances. All instances within a Series are of the same modality, in the same Frame of Reference (if any), and created by the same equipment. [See Section A.1.2.3 “Series IE” in PS3.3 ]
113016	Performed Procedure Step	An arbitrarily defined unit of service that has actually been performed (not just scheduled). [From Section 7.3.1.9 “Modality Performed Procedure Step” in PS3.3 ]
113017	Stage-View	An image or set of images illustrating a specific stage (phase in a stress echo study protocol) and view (combination of the transducer position and orientation at the time of image acquisition).
113018	For Printing	For Printing.
113020	For Report Attachment	Selection of information objects for attachment to the clinical report of the Current Requested Procedure.
113021	For Litigation	List of objects that are related to litigation and should be specially handled. E.g., may apply if a complaint has been received regarding a patient, or a specific set of images has been the subject of a subpoena, and needs to be sequestered or excluded from automatic purging according to retention policy.
113022	Collection of Presentation States	This Key Object Selection Document references Presentation State instances that are related, which may or may not share a value of Presentation Display Collection UID (0070,1101) or Presentation Sequence Collection UID (0070,1102).
113026	Double exposure	Double exposure.
113030	Manifest	A list of objects that have been exported out of one organizational domain into another domain. Typically, the first domain has no direct control over what the second domain will do with the objects.
113031	Signed Manifest	A signed list of objects that have been exported out of one organizational domain into another domain, referenced securely with either Digital Signatures or MACs. Typically, the first domain has no direct control over what the second domain will do with the objects.
113032	Complete Study Content	The list of objects that constitute a study at the time that the list was created.
113033	Signed Complete Study Content	The signed list of objects that constitute a study at the time that the list was created, referenced securely with either Digital Signatures or MACs.
113034	Complete Acquisition Content	The list of objects that were generated in a single procedure step.
113035	Signed Complete Acquisition Content	The signed list of objects that were generated in a single procedure step, referenced securely with either Digital Signatures or MACs.
113036	Group of Frames for Display	A list of frames or single-frame or entire multi-frame instances that together constitute a set for some purpose, such as might be displayed together in the same viewport, as distinct from another set that might be displayed in a separate viewport.
113037	Rejected for Patient Safety Reasons	List of objects whose use is potentially harmful to the patient. E.g., an improperly labeled image could lead to dangerous surgical decisions.
113038	Incorrect Modality Worklist Entry	List of objects that were acquired using an incorrect modality worklist entry, and that should not be used, since they may be incorrectly identified.
113039	Data Retention Policy Expired	List of objects that have expired according to a defined data retention policy.
113040	Lossy Compression	Lossy compression has been applied to an image.
113041	Apparent Diffusion Coefficient	Values are derived by calculation of the apparent diffusion coefficient. This concept may be used for the diffusion coefficient of various different models, e.g., mono-exponential (ADC_m), kurtosis (ADC_k), stretched-exponential (ADC_s). The "apparent" appellation is because the diffusion images from which the ADC is computed may also be affected by T2 contrast (T2 "shine-through"), so this concept is distinguished from a "pure" diffusion coefficient that is not so affected.	Graessner J. Frequently Asked Questions: Diffusion-Weighted Imaging (DWI). MAGNETOM Flash. Siemens. 2011 Jan. http://clinical-mri.com/wp-content/uploads/software_hardware_updates/Graessner.pdf Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113042	Pixel by pixel addition	Values are derived by the pixel by pixel addition of two images.
113043	Diffusion weighted	Values are derived by calculation of the diffusion weighting.
113044	Diffusion Anisotropy	Values are derived by calculation of the diffusion anisotropy.
113045	Diffusion Attenuated	Values are derived by calculation of the diffusion attenuation.
113046	Pixel by pixel division	Values are derived by the pixel by pixel division of two images.
113047	Pixel by pixel mask	Values are derived by the pixel by pixel masking of one image by another.
113048	Pixel by pixel Maximum	Values are derived by calculating the pixel by pixel maximum of two or more images.
113049	Pixel by pixel mean	Values are derived by calculating the pixel by pixel mean of two or more images.
113050	Metabolite Maps from spectroscopy data	Values are derived by calculating from spectroscopy data pixel values localized in two dimensional space based on the concentration of specific metabolites (i.e, at specific frequencies).
113051	Pixel by pixel Minimum	Values are derived by calculating the pixel by pixel minimum of two or more images.
113052	Mean Transit Time	The time required for blood to pass through a region of tissue.
113053	Pixel by pixel multiplication	Values are derived by the pixel by pixel multiplication of two images.
113054	Negative Enhancement Integral	The area described by the baseline and the signal loss due to passage of contrast bolus in tissue in a perfusion experiment. Abbreviated NEI or N1.
113055	Regional Cerebral Blood Flow	The absolute flow rate of blood perfusing a region of the brain as volume per mass per unit of time. The mass divisor may be approximated by a measurement of volume assuming a tissue density of 1.	Retired.
113056	Regional Cerebral Blood Volume	The absolute volume of blood perfusing a region of brain as volume per mass. The mass divisor may be approximated by a measurement of volume assuming a tissue density of 1.	Retired.
113057	R-Coefficient	Correlation Coefficient, r.
113058	Proton Density	Values are derived by calculating proton density values.
113059	Signal Change	The relative change in signal.
113060	Signal to Noise	The ratio of the desired signal to the level of noise.
113061	Standard Deviation	Values are derived by calculating the standard deviation of two or more images.
113062	Pixel by pixel subtraction	Values are derived by the pixel by pixel subtraction of two images.
113063	T1	The time constant for the decay of longitiudinal magnetization caused by spin-lattice relaxation. The inverse of the longitudinal relaxation rate constant, i.e., T1 = 1/R1.
113064	T2*	The time constant for the decay of transverse magnetization caused by a combination of spin-spin relaxation and magnetic field inhomogeneity. The inverse of the transverse relaxation rate constant, i.e., T2* = 1/R2*.
113065	T2	The time constant for the decay of transverse magnetization caused by spin-spin relaxation. The inverse of the transverse relaxation rate constant, i.e., T2 = 1/R2.
113066	Time Course of Signal	The time course of signal.
113067	Temperature encoded	Values are derived by calculating values based on temperature encoding.
113068	Student's T-Test	Values are derived by calculating the value of the Student's T-Test statistic from multiple image samples.
113069	Time To Peak	The time from the start of the contrast agent injection to the maximum enhancement value.
113070	Velocity encoded	Values are derived by calculating values based on velocity encoded. E.g., phase contrast.
113071	Z-Score	Values are derived by calculating the value of the Z-Score statistic from multiple image samples.
113072	Multiplanar reformatting	Values are derived by reformatting in a flat plane other than that originally acquired.
113073	Curved multiplanar reformatting	Values are derived by reformatting in a curve plane other than that originally acquired.
113074	Volume rendering	Values are derived by volume rendering of acquired data.
113075	Surface rendering	Values are derived by surface rendering of acquired data.
113076	Segmentation	Values are derived by segmentation (classification into tissue types) of acquired data.
113077	Volume editing	Values are derived by selectively editing acquired data (removing values from the volume), such as in order to remove obscuring structures or noise.
113078	Maximum intensity projection	Values are derived by maximum intensity projection of acquired data.
113079	Minimum intensity projection	Values are derived by minimum intensity projection of acquired data.
113080	Glutamate and glutamine	For single-proton MR spectroscopy, the resonance peak corresponding to glutamate and glutamine.
113081	Choline/Creatine Ratio	For single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peaks.
113082	N-acetylaspartate /Creatine Ratio	For single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Creatine resonance peaks.
113083	N-acetylaspartate /Choline Ratio	For single-proton MR spectroscopy, the ratio between the N-acetylaspartate and Choline resonance peaks.
113084	Tmax	The time delay to the maximum of the residue function after deconvolution. Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, et al. Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue. Stroke. 2003 Jun 1;34(6):1425-30. doi:10.1161/01.STR.0000072998.70087.E9. http://stroke.ahajournals.org/content/34/6/1425.abstract Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magnetic Resonance in Medicine. 1996;36(5):715-25. doi:10.1002/mrm.1910360510. http://onlinelibrary.wiley.com/doi/10.1002/mrm.1910360510/abstract
113085	Spatial resampling	Values are derived by spatial resampling of acquired data.
113086	Edge enhancement	Values are derived by edge enhancement.
113087	Smoothing	Values are derived by smoothing.
113088	Gaussian blur	Values are derived by Gaussian blurring.
113089	Unsharp mask	Values are derived by unsharp masking.
113090	Image stitching	Values are derived by stitching two or more images together.
113091	Spatially-related frames extracted from the volume	Spatially-related frames in this image are representative frames from the referenced 3D volume data.
113092	Temporally-related frames extracted from the set of volumes	Temporally-related frames in this image are representative frames from the referenced 3D volume data.
113093	Polar to Rectangular Scan Conversion	Conversion of a polar coordinate image to rectangular (Cartesian) coordinate image.
113094	Creatine and Choline	For single-proton MR spectroscopy, the resonance peak corresponding to creatine and choline.
113095	Lipid and Lactate	For single-proton MR spectroscopy, the resonance peak corresponding to lipid and lactate.
113096	Creatine+Choline/ Citrate Ratio	For single-proton MR spectroscopy, the ratio between the Choline and Creatine resonance peak and the Citrate resonance peak.
113097	Multi-energy proportional weighting	Image pixels created through proportional weighting of multiple acquisitions at distinct X-Ray energies.
113098	Magnetization Transfer Ratio	Magnetization Transfer Ratio (MTR) is the ratio of magnetization transfer, Mo - Ms/Mo, where Ms represents the magnitude of signal of tissues with the saturation pulse used to saturate macromolecular protons on, and Mo is the magnitude of signal without saturation. See Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology. 1992 Feb 1;182(2):483-91. http://dx.doi.org/10.1148/radiology.182.2.1732968
113100	Basic Application Confidentiality Profile	De-identification using a profile defined in PS3.15 that requires removing all information related to the identity and demographic characteristics of the patient, any responsible parties or family members, any personnel involved in the procedure, the organizations involved in ordering or performing the procedure, additional information that could be used to match instances if given access to the originals, such as UIDs, dates and times, and Private Attributes, when that information is present in the non-Pixel Data Attributes, including graphics or overlays.
113101	Clean Pixel Data Option	Additional de-identification according to an option defined in PS3.15 that requires any information burned in to the Pixel Data corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113102	Clean Recognizable Visual Features Option	Additional de-identification according to an option defined in PS3.15 that requires that sufficient removal or distortion of the Pixel Data shall be applied to prevent recognition of an individual from the instances themselves or a reconstruction of a set of instances.
113103	Clean Graphics Option	Additional de-identification according to an option defined in PS3.15 that requires that any information encoded in graphics, text annotations or overlays corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113104	Clean Structured Content Option	Additional de-identification according to an option defined in PS3.15 that requires that any information encoded in SR Content Items or Acquisition Context Sequence Items corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113105	Clean Descriptors Option	Additional de-identification according to an option defined in PS3.15 that requires that any information that is embedded in text or string Attributes corresponding to the Attribute information specified to be removed by the Profile and any other Options specified also be removed.
113106	Retain Longitudinal Temporal Information Full Dates Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be retained,.
113107	Retain Longitudinal Temporal Information Modified Dates Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any dates and times be modified in a manner that preserves temporal relationships. E.g., Study Date and Time.
113108	Retain Patient Characteristics Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any physical characteristics of the patient, which are descriptive rather than identifying information per se, be retained. E.g., Patient's Age, Sex, Size (height) and Weight.
113109	Retain Device Identity Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any information that identifies a device be retained. E.g., Device Serial Number.
113110	Retain UIDs Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that UIDs be retained. E.g., SOP Instance UID.
113111	Retain Safe Private Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that Private Attributes that are known not to contain identity information be retained. E.g., private SUV scale factor.
113112	Retain Institution Identity Option	Retention of information that would otherwise be removed during de-identification according to an option defined in PS3.15 that requires that any information that identifies an institution be retained. E.g., Institution Name.
113130	Predecessor containing group of imaging subjects	Images used as the source for an image processing operation that extracts data for a single subject from an image containing data for multiple subjects (e.g., a group of animals imaged simultaneously).
113131	Extraction of individual subject from group	An image processing operation that extracts data for a single subject from an image containing data for multiple subjects (e.g., a group of animals imaged simultaneously).
113132	Single subject selected from group	A single subject that has been selected from amongst multiple subjects (e.g., a group of animals imaged simultaneously).
113201	Trace	Sum of the diffusion tensor eigenvalues. I.e.: Tr = λ1+ λ2+ λ3, where λ1 ≥ λ2 ≥ λ3. Reference: Winston GP. The physical and biological basis of quantitative parameters derived from diffusion MRI. Quantitative Imaging in Medicine and Surgery. 2012;2(4) :254-265. doi:10.3978/j.issn.2223-4292.2012.12.05. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533595/)
113202	Mean Diffusivity	Average of the diffusion tensor eigenvalues in all directions. I.e.: MD = (λ1+ λ2+ λ3) /3 Reference: Winston GP. The physical and biological basis of quantitative parameters derived from diffusion MRI. Quantitative Imaging in Medicine and Surgery. 2012;2(4) :254-265. doi:10.3978/j.issn.2223-4292.2012.12.05. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533595/)
113203	Radial Diffusivity	Average of the two non-principal (i.e., perpendicular) diffusion tensor eigenvalues(also known as transverse diffusivity, perpendicular diffusivity). I.e.: DR= (λ2+ λ3) /2 Reference: Winston GP. The physical and biological basis of quantitative parameters derived from diffusion MRI. Quantitative Imaging in Medicine and Surgery. 2012;2(4) :254-265. doi:10.3978/j.issn.2223-4292.2012.12.05. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533595/)
113204	Axial Diffusivity	Diffusion tensor eigenvalue of the principal axis (also known as longitudinal diffusivity, parallel diffusivity). I.e.: DA = λ1 Reference: Winston GP. The physical and biological basis of quantitative parameters derived from diffusion MRI. Quantitative Imaging in Medicine and Surgery. 2012;2(4) :254-265. doi:10.3978/j.issn.2223-4292.2012.12.05. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533595/)
113205	Mean Kurtosis	MK = diffusional kurtosis averaged over all gradient directions Reference: Tabesh A, Jensen JH, Ardekani BA, Helpern JA. Estimation of Tensors and Tensor-Derived Measures in Diffusional Kurtosis Imaging. Magnetic Resonance in Medicine. 2011;65(3) :823-836. doi:10.1002/mrm.22655. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042509/) Reference: Liu C, Mang SC, Moseley ME. In VivoGeneralized Diffusion Tensor Imaging (GDTI) Using Higher-Order Tensors (HOT). Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2010;63(1) :243-252. doi:10.1002/mrm.22192. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824337/)
113206	Apparent Kurtosis Coefficient	AKC = diffusional kurtosis in a given direction Reference: Liu C, Mang SC, Moseley ME. In VivoGeneralized Diffusion Tensor Imaging (GDTI) Using Higher-Order Tensors (HOT). Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2010;63(1) :243-252. doi:10.1002/mrm.22192. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824337/)
113207	Radial Kurtosis	KR = diffusional kurtosis perpendicular to the direction of the highest diffusion (also known as transverse kurtosis, perpendicular kurtosis) Reference: Tabesh A, Jensen JH, Ardekani BA, Helpern JA. Estimation of Tensors and Tensor-Derived Measures in Diffusional Kurtosis Imaging. Magnetic Resonance in Medicine. 2011;65(3) :823-836. doi:10.1002/mrm.22655. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042509/)
113208	Axial Kurtosis	KA = diffusional kurtosis in the direction of the highest diffusion (also known as longitudinal kurtosis, parallel kurtosis) Reference: Tabesh A, Jensen JH, Ardekani BA, Helpern JA. Estimation of Tensors and Tensor-Derived Measures in Diffusional Kurtosis Imaging. Magnetic Resonance in Medicine. 2011;65(3) :823-836. doi:10.1002/mrm.22655. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042509/)
113209	Fractional Kurtosis Anisotropy	FKA = fractional kurtosis of diffusion in tissues Reference: Liu C, Mang SC, Moseley ME. In VivoGeneralized Diffusion Tensor Imaging (GDTI) Using Higher-Order Tensors (HOT). Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2010;63(1) :243-252. doi:10.1002/mrm.22192. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824337/)
113211	Deterministic Tracking Algorithm	Tracking based on local directionality Reference: Descoteaux M, Deriche R, Knösche TR, Anwander A. Deterministic and probabilistic tractography based on complex fibre orientation distributions. IEEE Trans Med Imaging.2009; 28(2) :269-86 (http://www.ncbi.nlm.nih.gov/pubmed/19188114)
113212	Probabilistic Tracking Algorithm	Tracking using local fiber orientation likelihood derive global connectivity likelihood Reference: Descoteaux M, Deriche R, Knösche TR, Anwander A. Deterministic and probabilistic tractography based on complex fibre orientation distributions. IEEE Trans Med Imaging.2009; 28(2) :269-86 (http://www.ncbi.nlm.nih.gov/pubmed/19188114)
113213	Global Tracking Algorithm	Tracking allfibers simultaneously, searching for a global optimum. Reference: Reisert M, Mader I, Anastasopoulos C, Weigel M, Schnell S, Kiselev V. Global fiber reconstruction becomes practical. NeuroImage. 2011 Jan 15;54(2) :955-62. (http://www.ncbi.nlm.nih.gov/pubmed/20854913)
113214	FACT	Fiber Assessment by Continuous Tracking Reference: Mori S, Crain BJ, Chacko VP, van Zijl PC. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol . 1999 Feb;45(2) :265-9 (http://www.ncbi.nlm.nih.gov/pubmed/9989633) Reference: Descoteaux M, Deriche R, Knösche TR, Anwander A. Deterministic and probabilistic tractography based on complex fibre orientation distributions. IEEE Trans Med Imaging.2009; 28(2) :269-86 (http://www.ncbi.nlm.nih.gov/pubmed/19188114)
113215	Streamline	Streamline tracking techniques (STT) Reference: Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn Reson Med. 2000 Oct;44(4) :625-32 (http://www.ncbi.nlm.nih.gov/pubmed/11025519)
113216	TEND	Tensor Deflection Reference: Lazar M, Weinstein DM, Tsuruda JS, Hasan KM, Arfanakis K, Meyerand ME, Badie B, Rowley HA, Haughton V, Field A, Alexander AL. White matter tractography using diffusion tensor deflection. Hum Brain Mapp.2003 Apr;18(4) :306-21. (http://www.ncbi.nlm.nih.gov/pubmed/12632468)
113217	Bootstrap Tracking Algorithm	Non-parametric estimation of fiber tracking dispersion Reference: Lazar M, Alexander AL. Bootstrap white matter tractography (BOOT-TRAC). Neuroimage. 2005 Jan 15;24(2) :524-32. Epub 2004 Nov 24. (http://www.ncbi.nlm.nih.gov/pubmed/15627594) Reference: Jones DK, Pierpaoli C. Confidence mapping in diffusion tensor magnetic resonance imaging tractography using a bootstrap approach. Magn Reson Med.2005 May;53(5) :1143-9. (http://www.ncbi.nlm.nih.gov/pubmed/15844149)
113218	Euler	Integration method, 1^st order Reference: Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn Reson Med. 2000 Oct;44(4) :625-32 (http://www.ncbi.nlm.nih.gov/pubmed/11025519) Reference: Descoteaux M, Deriche R, Knösche TR, Anwander A. Deterministic and probabilistic tractography based on complex fibre orientation distributions. IEEE Trans Med Imaging.2009; 28(2) :269-86 (http://www.ncbi.nlm.nih.gov/pubmed/19188114)
113219	Runge-Kutta	Integration method, 2^nd or 4^th order Reference: Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn Reson Med. 2000 Oct;44(4) :625-32 (http://www.ncbi.nlm.nih.gov/pubmed/11025519)
113221	HARDI	High Angular Resolution Diffusion Imaging Reference: Tuch DS, Reese TG, Wiegell MR, Makris N, Belliveau JW, Wedeen VJ. High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity. Magn Reson Med.2002 Oct;48(4) :577-82. (http://www.ncbi.nlm.nih.gov/pubmed/12353272) Reference: Descoteaux M, Deriche R, Knösche TR, Anwander A. Deterministic and probabilistic tractography based on complex fibre orientation distributions. IEEE Trans Med Imaging.2009; 28(2) :269-86 (http://www.ncbi.nlm.nih.gov/pubmed/19188114)
113222	DKI	Diffusion(al) Kurtosis Imaging Reference: Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005 Jun;53(6) :1432-40. (http://www.ncbi.nlm.nih.gov/pubmed/15906300)
113223	DTI	Diffusion Tensor Imaging Reference: Winston GP. The physical and biological basis of quantitative parameters derived from diffusion MRI. Quantitative Imaging in Medicine and Surgery. 2012;2(4) :254-265. doi:10.3978/j.issn.2223-4292.2012.12.05. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533595/)
113224	DSI	Diffusion Spectrum Imaging Reference: Wedeen VJ, Wang RP, Schmahmann JD, Benner T, Tseng WY, Dai G, Pandya DN, Hagmann P, D'Arceuil H, de Crespigny AJ. Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers. Neuroimage. 2008 Jul 15;41(4) :1267-77. doi:10.1016/j.neuroimage.2008.03.036. (http://www.ncbi.nlm.nih.gov/pubmed/18495497) Reference: Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics.2006 Oct;26 Suppl 1:S205-23. (http://www.ncbi.nlm.nih.gov/pubmed/17050517)
113225	LSDI	Line Scan Diffusion Imaging sequence Reference: Gudbjartsson H, Maier SE, Mulkern RV, Mórocz IA, Patz S, Jolesz FA. Line scan diffusion imaging. Magn Reson Med.1996 Oct;36(4) :509-19. (http://www.ncbi.nlm.nih.gov/pubmed/8892201)
113226	Single Shot EPI	An Echo Planar Imaging sequence in which the entire range of phase encoding steps is acquired in one repetition. Reference: Turner R, Le Bihan D, Chesnick AS. Echo-planar imaging of diffusion and perfusion. Magn Reson Med.1991 Jun;19(2) :247-53. (http://www.ncbi.nlm.nih.gov/pubmed/1881311)
113227	Multi Shot EPI	An Echo Planar Imaging sequence in which separate parts of the range of phase encoding steps are acquired in multiple repetitions. Reference: Robson MD, Anderson AW, Gore JC. Diffusion-weighted multiple shot echo planar imaging of humans without navigation. Magn Reson Med.1997 Jul;38(1) :82-8. (http://www.ncbi.nlm.nih.gov/pubmed/9211383)
113228	Parallel Imaging	A imaging sequence that uses a subset of k-space data from an array of receiver coils, e.g., Sensitivity Encoding. Reference: Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med.1999 Nov;42(5) :952-62. (http://www.ncbi.nlm.nih.gov/pubmed/10542355) Reference: Deshmane A, Gulani V, Griswold MA, Seiberlich N. Parallel MR imaging. J Magn Reson Imaging. 2012 Jul;36(1) :55-72. (http://www.ncbi.nlm.nih.gov/pubmed/22696125)
113231	Single Tensor	Modeling anisotropic diffusion in a volume with a tensor following a Gaussian distribution (six degrees of freedom) Reference: Basser PJ, Mattiello J, LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B.1994 Mar;103(3) :247-54. (http://www.ncbi.nlm.nih.gov/pubmed/8019776) Reference: Hagmann P1, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics.2006 Oct;26 Suppl 1:S205-23. (http://www.ncbi.nlm.nih.gov/pubmed/17050517)
113232	Multi Tensor	Modeling anisotropic diffusion in a volume by fitting of multiple tensors Reference: Ozarslan E, Mareci TH. Generalized diffusion tensor imaging and analytical relationships between diffusion tensor imaging and high angular resolution diffusion imaging. Magn Reson Med.2003 Nov;50(5) :955-65. (http://www.ncbi.nlm.nih.gov/pubmed/14587006) Reference: Pasternak O, Assaf Y, Intrator N, Sochen N. Variational multiple-tensor fitting of fiber-ambiguous diffusion-weighted magnetic resonance imaging voxels. Magn Reson Imaging.2008 Oct;26(8) :1133-44. doi:10.1016/j.mri.2008.01.006. (http://www.ncbi.nlm.nih.gov/pubmed/18524529)
113233	Model Free	Reconstruction of anisotropic diffusion in a volume without imposing an underlying statistical model (data-driven approach) Reference: Wedeen VJ, Hagmann P, Tseng WY, Reese TG, Weisskoff RM. Mapping complex tissue architecture with diffusion spectrum magnetic resonance imaging. Magn Reson Med.2005 Dec;54(6) :1377-86. (http://www.ncbi.nlm.nih.gov/pubmed/16247738) Reference: Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics.2006 Oct;26 Suppl 1:S205-23. (http://www.ncbi.nlm.nih.gov/pubmed/17050517)
113234	CHARMED	Composite Hindered and Restricted Model of Diffusion Reference: Assaf Y, Basser PJ. Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain. Neuroimage.2005 Aug 1;27(1) :48-58. (http://www.ncbi.nlm.nih.gov/pubmed/17050517)
113236	DOT	Diffusion Orientation Transform Reference: Ozarslan E, Shepherd TM, Vemuri BC, Blackband SJ, Mareci TH. Resolution of complex tissue microarchitecture using the diffusion orientation transform (DOT). Neuroimage. 2006 Jul 1;31(3) :1086-103. Epub 2006 Mar 20. (http://www.ncbi.nlm.nih.gov/pubmed/16546404)
113237	PAS	Persistent Angular Structure Reference: Jansons KM, Alexander DC. Persistent Angular Structure: new insights from diffusion MRI data. Dummy version. Inf Process Med Imaging.2003 Jul;18:672-83. (http://www.ncbi.nlm.nih.gov/pubmed/15344497)
113238	Spherical Deconvolution	A method to estimate the distribution of fiber orientations by deconvolution of the diffusion-weighted signal attenuation measured over the surface of a sphere expressed as the convolution over the sphere of a response function. Reference: Tournier JD, Calamante F, Gadian DG, Connelly A. Direct estimation of the fiber orientation density function from diffusion-weighted MRI data using spherical deconvolution. NeuroImage. 2004 Nov;23(3) :1176-85. (http://www.ncbi.nlm.nih.gov/pubmed/15528117)
113240	Source image diffusion b-value	The diffusion sensitization factor (b value) used during acquisition of the source image used for a diffusion model.
113241	Model fitting method	The method used to fit a set of data to a mathematical model. E.g., least squares.
113250	Mono-exponential diffusion model	Mono-exponential (single compartment) Apparent Diffusion Coefficient (ADC) model.	Burdette JH, Elster AD, Ricci PE. Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput Assist Tomogr. 1998 Oct;22(5):792-4. http://journals.lww.com/jcat/pages/articleviewer.aspx?year=1998&issue=09000&article=00023&type=abstract Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113251	Bi-exponential (IVIM) diffusion model	Bi-exponential intravoxel incoherent motion (IVIM) model.	Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, et al. Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction. Magnetic Resonance in Medicine. 2016. http://dx.doi.org/10.1002/mrm.26169 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482 Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113252	Kurtosis diffusion model	.	Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113253	Gamma distribution model	.	Oshio K, Shinmoto H, Mulkern RV. Interpretation of diffusion MR imaging data using a gamma distribution model. Magn Reson Med Sci. 2014;13: 191-195. http://dx.doi.org/10.2463/mrms.2014-0016
113254	Stretched exponential diffusion model	.	Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med. 2003;50: 727-734. http://dx.doi.org/10.1002/mrm.10581 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113255	Truncated Gaussian diffusion model	.	Yablonskiy DA, Bretthorst GL, Ackerman JJH. Statistical model for diffusion attenuated MR signal. Magnetic Resonance in Medicine. 2003;50(4):664-9. http://dx.doi.org/10.1002/mrm.10578
113260	Log of ratio of two samples	Model fitting by using the log of the ratio of the two samples.	Burdette JH, Elster AD, Ricci PE. Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput Assist Tomogr. 1998 Oct;22(5):792-4. http://journals.lww.com/jcat/pages/articleviewer.aspx?year=1998&issue=09000&article=00023&type=abstract
113261	Least squares fit of multiple samples	Model fitting by least squares method from more than two samples.	Burdette JH, Elster AD, Ricci PE. Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput Assist Tomogr. 1998 Oct;22(5):792-4. http://journals.lww.com/jcat/pages/articleviewer.aspx?year=1998&issue=09000&article=00023&type=abstract
113265	Levenberg-Marquardt	Model fitting by Levenberg-Marquardt method.	Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113266	Trust-Region	Model fitting by Trust-Region method.	Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113267	Fixed-Dp	Model fitting by Fixed-Dp method.	Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113268	Segmented-Unconstrained	Model fitting by Segmented-Unconstrained method.	Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113269	Segmented-Constrained	Model fitting by Segmented-Constrained method.	Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113270	Bayesian-Probability	Model fitting by Bayesian-Probability method.	Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765 Neil JJ, Bretthorst GL. On the use of bayesian probability theory for analysis of exponential decay date: An example taken from intravoxel incoherent motion experiments. Magnetic Resonance in Medicine. 1993;29(5):642-7. http://dx.doi.org/10.1002/mrm.1910290510
...	...	...	...
113285	Voxelwise selection of b-value	Diffusion modeling by voxelwise selection of b-values.	Gatidis S, Schmidt H, Martirosian P, Nikolaou K, Schwenzer NF. Apparent diffusion coefficient-dependent voxelwise computed diffusion-weighted imaging: An approach for improving SNR and reducing T2 shine-through effects. Journal of Magnetic Resonance Imaging. 2016;43(4):824-32. http://dx.doi.org/10.1002/jmri.25044
113288	Volume Ratio	Coefficient reflecting the anisotropy of the tissues, derived from a diffusion weighted MR image. It represents the volume of an ellipsoid whose semimajor axes are the three eigenvalues of the diffusion tensor divided by the volume of a sphere whose radius is the mean diffusivity.	Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med. 1996 Dec 1;36(6):893-906. http://onlinelibrary.wiley.com/doi/10.1002/mrm.1910360612/abstract
113289	Diffusion Coefficient	The pure diffusion coefficient, i.e., one that is not affected by T2 contrast effects.	Graessner J. Frequently Asked Questions: Diffusion-Weighted Imaging (DWI). MAGNETOM Flash. Siemens. 2011 Jan. http://clinical-mri.com/wp-content/uploads/software_hardware_updates/Graessner.pdf
113290	Mono-exponential Apparent Diffusion Coefficient	The diffusion coefficient of a mono-exponential diffusion model (ADC_m).	Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113291	Slow Diffusion Coefficient	The slow diffusion coefficient (D_s) of a bi-exponential intravoxel incoherent motion (IVIM) diffusion model.	Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, et al. Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction. Magnetic Resonance in Medicine. 2016. http://dx.doi.org/10.1002/mrm.26169 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482 Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113292	Fast Diffusion Coefficient	The fast diffusion coefficient (D_f) of a bi-exponential intravoxel incoherent motion (IVIM) diffusion model.	Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, et al. Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction. Magnetic Resonance in Medicine. 2016. http://dx.doi.org/10.1002/mrm.26169 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482 Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113293	Fast Diffusion Coefficient Fraction	The fast diffusion fraction of a bi-exponential intravoxel incoherent motion (IVIM) diffusion model.	Merisaari H, Movahedi P, Perez IM, Toivonen J, Pesola M, Taimen P, et al. Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction. Magnetic Resonance in Medicine. 2016. http://dx.doi.org/10.1002/mrm.26169 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482 Barbieri S, Donati OF, Froehlich JM, Thoeny HC. Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs. Magnetic Resonance in Medicine. 2016;75(5):2175-84. http://dx.doi.org/10.1002/mrm.25765
113294	Kurtosis Diffusion Coefficient	The diffusion coefficient of a kurtosis diffusion model (ADC_k).	Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113295	Gamma Distribution Scale Parameter	The scale (theta) parameter of a gamma distribution diffusion model.	Oshio K, Shinmoto H, Mulkern RV. Interpretation of diffusion MR imaging data using a gamma distribution model. Magn Reson Med Sci. 2014;13: 191-195. http://dx.doi.org/10.2463/mrms.2014-0016
113296	Gamma Distribution Shape Parameter	The shape (k) parameter of a gamma distribution diffusion model.	Oshio K, Shinmoto H, Mulkern RV. Interpretation of diffusion MR imaging data using a gamma distribution model. Magn Reson Med Sci. 2014;13: 191-195. http://dx.doi.org/10.2463/mrms.2014-0016
113297	Gamma Distribution Mode	The mode (maximum value of probability density function) of a gamma distribution diffusion model. Computed as (k-1)*theta, for k >= 1.	http://en.wikipedia.org/wiki/Gamma_distribution
113298	Distributed Diffusion Coefficient	The distributed diffusion coefficient of a stretched-exponential diffusion model (ADC_s).	Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med. 2003;50: 727-734. http://dx.doi.org/10.1002/mrm.10581 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113299	Anomalous Exponent Parameter	The anomalous exponent (stretching, alpha) parameter of a stretched-exponential diffusion model. This describes the deviation of the signal attenuation from mono-exponential behavior	Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med. 2003;50: 727-734. http://dx.doi.org/10.1002/mrm.10581 Toivonen J, Merisaari H, Pesola M, Taimen P, Boström PJ, Pahikkala T, et al. Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis. Magnetic Resonance in Medicine. 2015;74(4):1116-24. http://dx.doi.org/10.1002/mrm.25482
113500	Radiopharmaceutical Radiation Dose Report	The procedure report is a Radiopharmaceutical Radiation Dose report
113502	Radiopharmaceutical Administration	Information pertaining to the administration of a radiopharmaceutical
113503	Radiopharmaceutical Administration Event UID	Unique identification of a single radiopharmaceutical administration event.
113505	Intravenous Extravasation Symptoms	Initial signs or symptoms of extravasation
113506	Estimated Extravasation Activity	The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site.
113507	Administered activity	The calculated activity at the Radiopharmaceutical Start Time when the radiopharmaceutical is administered to the patient. The residual activity (i.e., radiopharmaceutical not administered) , if measured, is reflected in the calculated value. The estimated extravasation is not reflected in the calculated value.
113508	Pre-Administration Measured Activity	Radioactivity measurement of radiopharmaceutical before or during the administration.
113509	Post-Administration Measured Activity	Radioactivity measurement of radiopharmaceutical after the administration.
113510	Drug Product Identifier	Registered drug establishment code for product, coding scheme example is NDC or RxNorm
113511	Radiopharmaceutical Dispense Unit Identifier	The human readable identification of the specific radiopharmaceutical dispensed quantity or dose ("dose" as unit of medication delivery, not radiation dose measure) to be administered to the patient.
113512	Radiopharmaceutical Lot Identifier	Identifies the vial, batch or lot number from which the individual dispense radiopharmaceutical quantity (dose) is produced. The Radiopharmaceutical Dispense Unit Identifier records the identification for each individual dose.
113513	Reagent Vial Identifier	Identifies the lot or unit serial number for the reagent component for the radiopharmaceutical.
113514	Radionuclide Vial Identifier	Identifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical.
113516	Prescription Identifier	Administered Product's Prescription Number
113517	Organ Dose Information	Information pertaining to the estimated absorbed radiation dose to an organ.
113518	Organ Dose	The absorbed radiation dose to organ
113520	MIRD Pamphlet 1	Reference authority MIRD Pamphlet No.1 (rev) ,Society of Nuclear Medicine, 1976
113521	ICRP Publication 53	Reference authority ICRP, 1988. Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18 (1-4).
113522	ICRP Publication 80	Reference authority ICRP, 1998. Radiation Dose to Patients from Radiopharmaceuticals (Addendum to ICRP Publication 53). ICRP Publication 80. Ann. ICRP 28 (3).
113523	ICRP Publication 106	Reference authority ICRP, 2008. Radiation Dose to Patients from Radiopharmaceuticals - Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann. ICRP 38 (1-2).
113526	MIRDOSE	Reference authority Stabin MG, Sparks RB, Crowe E (1994) MIRDOSE: personal computer software for internal dose assessment in nuclear medicine [Computer program]
113527	OLINDA-EXM	Reference authority Stabin MG, Sparks RB, Crowe E (2005) OLINDA/EXM: The Second-Generation Personal Computer Software for Internal Dose Assessment in Nuclear Medicine [Computer program]
113528	Package Insert	Reference authority The reported organ dose is based on radiopharmaceutical's package insert.
113529	Institutionally Approved Estimates	Reference authority The reported organ dose is based on Institutionally approved estimates from the Radioactive Drug Research Committee (RDRC) of the institution itself.
113530	Investigational New Drug	Reference authority The reported organ dose is based on an Investigation new drug.
113540	Activity Measurement Device	The type of device that performed the activity measurement.
113541	Dose Calibrator	The device that measures the radiation activity of the radiopharmaceutical
113542	Infusion System	Radiopharmaceutical Infusion System
113543	Generator	Radioisotope Generator
113550	Fasting Duration	The number hours the patient has gone without food.
113551	Hydration Volume	The amount of fluids the patient has consumed before the procedure.
113552	Recent Physical Activity	A description of physical activity the patient performed before the start of the procedure, such as that which may affect imaging agent biodistribution.
113560	Acute unilateral renal blockage	Blockage in one of the tubes (ureters) that drain urine from the kidneys
113561	Low Thyroid Uptake	5% or less Thyroid Uptake of Iodine
113562	High Thyroid Uptake	25% or higher Thyroid Uptake of Iodine
113563	Severely Jaundiced	The patient exhibits symptoms severe of jaundice and/or has a Bilirubin >10 mg/dL.
113568	Extravasation visible in image	Extravasation or paravenous administration of the product is visible in the images.
113570	Cockroft-Gault Formula estimation of GFR	The measurement method of the Glomerular Filtration Rate is Cockroft-Gault Formula
113571	CKD-EPI Formula estimation of GFR	The measurement method of the Glomerular Filtration Rate is CKD-EPI Formula
113572	Glomerular Filtration Rate (MDRD)	The measurement method of the Glomerular Filtration Rate is MDRD
113573	Glomerular Filtration Rate non-black (MDRD)	The measurement method of the Glomerular Filtration Rate is non-black MDRD
113574	Glomerular Filtration Rate black (MDRD)	The measurement method of the Glomerular Filtration Rate is black (MDRD)
113575	Glomerular Filtration Rate female (MDRD)	The measurement method of the Glomerular Filtration Rate is female (MDRD)
113576	Glomerular Filtration Rate Cystatin-based formula	The measurement method of the Glomerular Filtration Rate is Cystatin-based formula
113577	Glomerular Filtration Rate Creatinine-based formula (Schwartz)	The measurement method of the Glomerular Filtration Rate is Creatinine-based formula (Schwartz)
113601	Small: < 32.0 cm lateral thickness	Small body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image.
113602	Medium: 32.0-38.0 cm lateral thickness	Medium body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image.
113603	Large: > 38.0 cm lateral thickness	Large body thickness for calcium scoring adjustment. Lateral thickness is measured from skin-to-skin, at the level of the proximal ascending aorta, from an A/P localizer image.
113605	Irradiation Event Label	A human-readable label identifying an irradiation event.
113606	Label Type	The type of a human-readable label.
113607	Series Number	A number that identifies a Series. Corresponds to Series Number (0020,0011) of the PS3.3.
113608	Acquisition Number	A number that identifies an Acquisition. Corresponds to Acquisition Number (0020,0012) of the PS3.3.
113609	Instance Number	A number that identifies an Instance. Corresponds to Instance Number (0020,0013) of the PS3.3.
113611	Stationary Acquisition	Acquisition where the X-Ray source does not move in relation to the patient.
113612	Stepping Acquisition	Acquisition where the X-Ray source moves laterally in relation to the patient.
113613	Rotational Acquisition	Acquisition where the X-Ray source moves angularly in relation to the patient.
113620	Plane A	Primary plane of a Biplane acquisition equipment.
113621	Plane B	Secondary plane of a Biplane acquisition equipment.
113622	Single Plane	Single plane acquisition equipment.
113630	Continuous	Continuous X-Ray radiation is applied during an irradiation event.
113631	Pulsed	Pulsed X-Ray radiation is applied during an irradiation event.
113650	Strip filter	Filter with uniform thickness.
113651	Wedge filter	Filter with variation in thickness from one edge to the opposite edge.
113652	Butterfly filter	Filter with two triangular sections.
113653	Flat filter	Filter with uniform thickness that is for spectral filtering only. E.g., filter out low energy portion of the X-Ray that would only contribute to skin dose, but not to image.
113661	Outline of lobulations	A polyline defining the outline of a lobulated finding.
113662	Inner limits of fuzzy margin	A polyline defining the inner limits of a finding with fuzzy margin.
113663	Outer limits of fuzzy margin	A polyline defining the outer limits of a finding with fuzzy margin.
113664	Outline of spiculations	A polyline defining the outline of the spiculations of a finding.
113665	Linear spiculation	A polyline segment graphically indicating the location and direction of a spiculation of a finding.
113666	Pixelated spiculations	A collection of points indicating the pixel locations of the spiculations of a finding.
113669	Orthogonal location arc	Connected line segments indicating the center of location of a finding on an orthogonal view.
113670	Orthogonal location arc inner margin	Connected line segments indicating the inner margin of the location of a finding on an orthogonal view.
113671	Orthogonal location arc outer margin	Connected line segments indicating the outer location of a finding on an orthogonal view.
113680	Quality Control Intent	This procedure is intended to gather data that is used for calibration or other quality control purposes.
113681	Phantom	An artificial subject of an imaging study.	Retired. Replaced by (706342009, SCT, "Phantom").
113682	ACR Accreditation Phantom - CT	A phantom acceptable for the ACR Computed Tomography Accreditation program.
113683	ACR Accreditation Phantom - MR	A phantom acceptable for the ACR Magnetic Resonance Imaging Accreditation program.
113684	ACR Accreditation Phantom - Mammography	A phantom acceptable for the ACR Mammography Accreditation program.
113685	ACR Accreditation Phantom - Stereotactic Breast Biopsy	A phantom acceptable for the ACR Stereotactic Breast Biopsy Accreditation program.
113686	ACR Accreditation Phantom - ECT	A phantom acceptable for the ACR SPECT Accreditation program (but not for PET).
113687	ACR Accreditation Phantom - PET	A phantom acceptable for the ACR PET Accreditation program (but not for SPECT).
113688	ACR Accreditation Phantom - ECT/PET	A SPECT phantom with a PET faceplate acceptable for both the ACR SPECT and PET Accreditation programs.
113689	ACR Accreditation Phantom - PET Faceplate	A PET faceplate (made to fit an existing flangeless or flanged ECT phantom) acceptable for the ACR PET Accreditation program.
113690	IEC Head Dosimetry Phantom	A phantom used for CTDI measurement in head modes according to [IEC 60601-2-44], Ed.2.1 (Head 16 cm diameter Polymethyl methacrylate PMMA).
113691	IEC Body Dosimetry Phantom	A phantom used for CTDI measurement in body modes according to [IEC 60601-2-44], Ed.2.1 (Body 32cm diameter Polymethyl methacrylate PMMA).
113692	NEMA XR21-2000 Phantom	A phantom in accordance with NEMA standard XR-21-2000.
113701	X-Ray Radiation Dose Report	X-Ray Radiation Dose Report.
113702	Accumulated X-Ray Dose Data	X-Ray dose data accumulated over multiple irradiation events. E.g., for a study or a performed procedure step.
113704	Projection X-Ray	Imaging using a point X-Ray source with a diverging beam projected onto a 2 dimensional detector.
113705	Scope of Accumulation	Entity over which dose accumulation values are integrated.
113706	Irradiation Event X-Ray Data	X-Ray dose data for a single Irradiation Event.
113710	Niobium or Niobium compound	Material containing Niobium or a Niobium compound	Retired. Replaced by (767776000, SCT, "Niobium")
113711	Europium or Europium compound	Material containing Europium or a Europium compound	Retired. Replaced by (767775001, SCT, "Europium")
113720	Calibration Protocol	Describes the method used to derive the calibration factor.
113721	Irradiation Event Type	Denotes the type of irradiation event recorded.
113722	Dose Area Product Total	Total calculated Dose Area Product (in the scope of the including report).
113723	Calibration DateTime	Last calibration DateTime for the integrated dose meter or dose calculation.
113724	Calibration Responsible Party	Individual or organization responsible for calibration.
113725	Dose (RP) Total	Total Dose related to Reference Point (RP). (in the scope of the including report).
113726	Fluoro Dose Area Product Total	Total calculated Dose Area Product applied in Fluoroscopy Modes (in the scope of the including report).
113727	Acquisition Dose Area Product Total	Total calculated Dose Area Product applied in Acquisition Modes (in the scope of the including report).
113728	Fluoro Dose (RP) Total	Dose applied in Fluoroscopy Modes, related to Reference Point (RP). (in the scope of the including report).
113729	Acquisition Dose (RP) Total	Dose applied in Acquisition Modes, related to Reference Point (RP). (in the scope of the including report).
113730	Total Fluoro Time	Total accumulated clock time of Fluoroscopy in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated fluoroscopy irradiation events).
113731	Total Number of Radiographic Frames	Accumulated Count of exposure pulses (single or multi-frame encoded) created from irradiation events performed with high dose (acquisition).
113732	Fluoro Mode	Mode of application of X-Rays during Fluoroscopy.
113733	KVP	Applied X-Ray Tube voltage at peak of X-Ray generation, in kilovolts; Mean value if measured over multiple peaks (pulses).
113734	X-Ray Tube Current	Mean value of applied Tube Current.
113735	Exposure Time	Cumulative time the patient has received X-Ray exposure during the irradiation event	Retired. Replaced by (113824, DCM, "Exposure Time").
113736	Exposure	Mean value of X-Ray Current Time product.
113737	Distance Source to Reference Point	Distance to the Reference Point (RP) defined according to IEC 60601-2-43 or equipment defined.
113738	Dose (RP)	Dose applied at the Reference Point (RP).
113739	Positioner Primary End Angle	Positioner Primary Angle at the end of an irradiation event. For further definition see (112011, DCM, "Positioner Primary Angle").
113740	Positioner Secondary End Angle	Positioner Secondary Angle at the end of an irradiation event. For further definition see (112012, DCM, "Positioner Secondary Angle").
113742	Irradiation Duration	Clock time from the start of loading time of the first pulse until the loading time trailing edge of the final pulse in the same irradiation event. Note Loading time is defined in IEC 60601-1-3:2008, 3.37, and described in IEC 60601-2-54:2009, 203.4.101.3.
113743	Patient Orientation	Orientation of the Patient with respect to Gravity.
113744	Patient Orientation Modifier	Enhances or modifies the Patient orientation specified in Patient Orientation.
113745	Patient Table Relationship	Orientation of the Patient with respect to the Head of the Table.
113748	Distance Source to Isocenter	Distance from the X-Ray Source to the Equipment C-Arm Isocenter.(Center of Rotation).
113750	Distance Source to Detector	Measured or calculated distance from the X-Ray source to the detector plane in the center of the beam.
113751	Table Longitudinal Position	Table Longitudinal Position with respect to an arbitrary reference chosen by the equipment. Table longitudinal motion is positive towards the left of the patient assuming the patient is positioned HEAD FIRST SUPINE.	See “X-Ray Table Module Attribute Descriptions” in PS3.3 .
113752	Table Lateral Position	Table Lateral Position with respect to an arbitrary reference chosen by the equipment. Table lateral motion is positive towards the head of the patient assuming the patient is positioned HEAD FIRST.	See “X-Ray Table Module Attribute Descriptions” in PS3.3 .
113753	Table Height Position	Table Height Position with respect to an arbitrary chosen reference by the equipment in (mm). Table motion downwards is positive.
113754	Table Head Tilt Angle	Angle of the head-feet axis of the table in degrees relative to the horizontal plane. Positive values indicate that the head of the table is upwards.	See “Table Coordinate System” in PS3.3 .
113755	Table Horizontal Rotation Angle	Rotation of the table in the horizontal plane (clockwise when looking from above the table).	See “Table Coordinate System” in PS3.3 .
113756	Table Cradle Tilt Angle	Angle of the left-right axis of the table in degrees relative to the horizontal plane. Positive values indicate that the left of the table is upwards.	See “Table Coordinate System” in PS3.3 .
113757	X-Ray Filter Material	X-Ray absorbing material used in the filter.
113758	X-Ray Filter Thickness Minimum	The minimum thickness of the X-Ray absorbing material used in the filters.
113759	Table Longitudinal End Position	Table Longitudinal Position at the end of an irradiation event; see (113751, DCM, "Table Longitudinal Position").
113760	Table Lateral End Position	Table Lateral Position at the end of an irradiation event; see (113752, DCM, "Table Lateral Position").
113761	Table Height End Position	Table Height Position at the end of an irradiation event; see (113753, DCM, "Table Height Position").
113763	Calibration Uncertainty	Uncertainty of the 'actual' value.
113764	Acquisition Plane	Identification of Acquisition Plane with Biplane systems.
113766	Focal Spot Size	Nominal Size of Focal Spot of X-Ray Tube.
113767	Average X-Ray Tube Current	Average X-Ray Tube Current averaged over time for pulse or for continuous Fluoroscopy.
113768	Number of Pulses	Number of pulses applied by X-Ray systems during an irradiation event (acquisition run or pulsed fluoro).
113769	Irradiation Event UID	Unique identification of a single irradiation event.
113770	Column Angulation	Angle of the X-Ray beam in degree relative to an orthogonal axis to the detector plane.
113771	X-Ray Filters	Devices used to modify the energy or energy distribution of X-Rays.
113772	X-Ray Filter Type	Type of filter(s) inserted into the X-Ray beam. E.g., wedges.
113773	X-Ray Filter Thickness Maximum	The maximum thickness of the X-Ray absorbing material used in the filters.
113780	Reference Point Definition	System provided definition of the Reference Point used for Dose calculations.
113788	Collimated Field Height	Distance between the collimator blades in pixel column direction as projected at the detector plane.
113789	Collimated Field Width	Distance between the collimator blades in pixel row direction as projected at the detector plane.
113790	Collimated Field Area	Collimated field area at image receptor. Area for compatibility with IEC 60601-2-43.
113791	Pulse Rate	Pulse rate applied by equipment during Fluoroscopy.
113792	Distance Source to Table Plane	Measured or calculated distance from the X-Ray source to the table plane in the center of the beam.
113793	Pulse Width	(Average) X-Ray pulse width.
113794	Dose Measurement Device	Calibrated device to perform dose measurements.
113795	Acquired Image	Image acquired during a specified event.
113800	DLP to E conversion via MC computation	Effective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of Monte Carlo computations.
113801	CTDIfreeair to E conversion via MC computation	Effective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of Monte Carlo computations.
113802	DLP to E conversion via measurement	Effective Dose evaluation from the product of Dose Length Product (DLP) and the Effective Dose Conversion Factor (E/DLP in units of mSv/mGy-cm), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom.
113803	CTDIfreeair to E conversion via measurement	Effective Dose evaluation from the product of the Mean CTDIfreeair and the ratio E/CTDIfreeair (mSv/mGy), where the ratio is derived by means of dosimetric measurements with an anthropomorphic phantom.
113804	Sequenced Acquisition	The CT acquisition was performed by acquiring single or multi detector data while rotating the source about the gantry while the table is not moving. Additional slices are acquired by incrementing the table position and again rotating the source about the gantry while the table is not moving.
113805	Constant Angle Acquisition	The CT acquisition was performed by holding the source at a constant angle and moving the table to obtain a projection image. E.g., localizer.
113806	Stationary Acquisition	The CT acquisition was performed by holding the table at a constant position and acquiring multiple slices over time at the same location.
113807	Free Acquisition	The CT acquisition was performed while rotating the source about the gantry while the table movement is under direct control of a human operator or under the control of an analysis application. E.g., fluoro.
113808	ICRP Pub 60	Reference authority 1990 Recommendations of the International Commission on Radiological Protection (ICRP Publication 60, published as the Annals of the ICRP Vol. 21, No. 1-3, Pergamon Press,1991).
113809	Start of X-Ray Irradiation	Start DateTime of the first X-Ray Irradiation Event of the accumulation within a Study.
113810	End of X-Ray Irradiation	End DateTime of the last X-Ray Irradiation Event of the accumulation within a Study.
113811	CT Accumulated Dose Data	X-Ray dose accumulated over multiple CT irradiation events. E.g., for a study or a performed procedure step.
113812	Total Number of Irradiation Events	Total number of events during the defined scope of accumulation.
113813	CT Dose Length Product Total	The total dose length product for the defined scope of accumulation.
113814	CT Effective Dose Total	The total Effective Dose at the defined scope of accumulation.
113815	Patient Model	Identification of the reference-patient model used when Effective Dose is evaluated via Monte Carlo calculations or from a Dose Length Product conversion factor based on Monte Carlo calculations.
113816	Condition Effective Dose measured	References the physical phantom and the type of dosimeter used when measurements are done to establish Effective Dose Conversion Factors (E/DLP) or ratios E/CTDIfreeair.
113817	Effective Dose Phantom Type	Type of Effective Dose phantom used.
113818	Dosimeter Type	Type of dosimeter used.
113819	CT Acquisition	General description of the CT Irradiation event.
113820	CT Acquisition Type	Method of the CT acquisition.
113821	X-Ray Filter Aluminum Equivalent	Thickness of an equivalent filter in mm in Aluminum.
113822	CT Acquisition Parameters	General description of the acquisition parameters.
113823	Number of X-Ray Sources	Number of X-Ray sources.
113824	Exposure Time	Total time the patient has received X-Ray exposure during the irradiation event.
113825	Scanning Length	Length of the table travel during the entire tube loading, according to [IEC 60601-2-44] Note Scanning Length might be longer than the programmed acquisition length (Length of Reconstructable Volume)
113826	Nominal Single Collimation Width	The value of the nominal width referenced to the location of the isocenter along the z axis of a single row of acquired data in mm.
113827	Nominal Total Collimation Width	The value of the nominal width referenced to the location of the isocenter along the z axis of the total collimation in mm over the area of active X-Ray detection.
113828	Pitch Factor	For Spiral scanning: Pitch Factor = (Table Feed per Rotation (mm)) /(Nominal Total Collimation Width (mm)) For Sequenced scanning: Pitch Factor = (Table Feed per single Sequenced scan (mm)) /(Nominal Total Collimation Width (mm)).
113829	CT Dose	General description of CT dose values.
113830	Mean CTDIvol	"Mean CTDIvol" refers to the average value of the CTDIvol associated with this acquisition.
113831	CT X-Ray Source Parameters	Identification, tube-potential, tube-current, and exposure-time parameters associated with an X-Ray source during an acquisition.
113832	Identification of the X-Ray Source	Identifies the particular X-Ray source (in a multi-source CT system) for which the set of X-Ray source parameter values is reported.
113833	Maximum X-Ray Tube Current	Maximum X-Ray tube current.
113834	Exposure Time per Rotation	The exposure time for one rotation of the source around the object in s.
113835	CTDIw Phantom Type	A label describing the type of phantom used for CTDIW measurement according to [IEC 60601-2-44] (Head 16 cm diameter PMMA, Body 32 cm diameter PMMA).
113836	CTDIfreeair Calculation Factor	The CTDIfreeair Calculation Factor is the CTDIfreeair per mAs, expressed in units of mGy/mAs. The CTDIfreeair Calculation Factor may be used in one method calculating Dose.
113837	Mean CTDIfreeair	The average value of the free-in-air CTDI associated with this acquisition.
113838	DLP	Dose Length Product (DLP), expressed in mGy-cm, is an index characterizing the product of the CTDIvol and the length scanned. For Spiral scanning, DLP = CTDIvol ✕ Scanning Length. For Sequenced scanning, DLP = CTDIvol ✕ Nominal Total Collimation Width ✕ Cumulative Exposure Time / Exposure Time per Rotation. For Stationary and Free scanning, DLP = CTDIvol ✕ Nominal Total Collimation Width.
113839	Effective Dose	Effective dose in mSv.
113840	Effective Dose Conversion Factor	Effective Dose per DLP, reference value for Effective Dose calculation, expressed in mSv/mGY.cm.
113841	ICRP Pub 103	Effective Dose Reference authority 2007 Recommendations of the International Commission on Radiological Protection (ICRP Publication 103, published as the Annals of the ICRP Vol. 37, No. 2-4, Elsevier, 2007).
113842	X-Ray Modulation Type	The type of exposure modulation used for the purpose of limiting the dose.
113845	Exposure Index	Measure of the detector response to radiation in the relevant image region of an image acquired with a digital X-Ray imaging system as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro.
113846	Target Exposure Index	The target value used to calculate the Deviation Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro.
113847	Deviation Index	A scaled representation of the accuracy of the Exposure Index compared to the Target Exposure Index as defined in IEC 62494-1; see PS3.3 definition of Exposure Index Macro.
113850	Irradiation Authorizing	The clinician responsible for determining that the irradiating procedure was appropriate for the indications.
113851	Irradiation Administering	The person responsible for the administration of radiation.
113852	Irradiation Event	An irradiation event is the loading of X-Ray equipment caused by a single continuous actuation of the equipment's irradiation switch, from the start of the loading time of the first pulse until the loading time trailing edge of the final pulse. Any automatic on-off switching of the irradiation source during the event is not treated as separate events, rather the event includes the time between start and stop of irradiation as triggered by the user. E.g., a pulsed fluoro X-Ray acquisition shall be treated as a single irradiation event.
113853	Irradiation Event UID	Unique Identifier of an Irradiation Event.	Retired. Replaced by (113769, DCM, "Irradiation Event UID")
113854	Source of Dose Information	Method by which dose-related details of an Irradiation Event were obtained.
113855	Total Acquisition Time	Total accumulated acquisition clock time in the scope of the including report (i.e., the sum of the Irradiation Duration values for accumulated acquisition irradiation events).
113856	Automated Data Collection	Direct recording of data by a relevant system.
113857	Manual Entry	Recording of data by a human operator, including manual transcription of electronic data.
113858	MPPS Content	The data is taken from an MPPS SOP Instance.
113859	Irradiating Device	A device exposing a patient to ionizing radiation.
113860	15cm from Isocenter toward Source	15cm from the isocenter towards the X-Ray source; See IEC 60601-2-43.
113861	30cm in Front of Image Input Surface	30cm in front (towards the tube) of the input surface of the image receptor; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (3).
113862	1cm above Tabletop	1cm above the patient tabletop or cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (3).
113863	30cm above Tabletop	30cm above the patient tabletop of cradle; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (3).
113864	15cm from Table Centerline	15cm from the centerline of the X-Ray table and in the direction of the X-Ray source; See FDA Federal Performance Standard for Diagnostic X-Ray Systems §1020.32(d) (3).
113865	4.2cm above Breast Support Surface	4.2cm from the breast support surface in the direction orthogonal to the support surface. This point represents the entrance point for radiation to a standard 4.2cm thick compressed breast. See Department of Health and Human Services, Food and Drug Administration. Mammography quality standards; final rule. Federal Register. Oct. 28, 1997; 68(208):55852-55994; see 900.2(uu).
113866	Copied From Image Attributes	The data is copied from information present in the image Attributes. E.g., dose Attributes such as CTDIvol (0018,9345).
113867	Computed From Image Attributes	The data is computed from information present in the image Attributes. E.g., by using dosimetry information for the specific irradiating device make and model, applied to technique information such as KVP and mAs.
113868	Derived From Human-Readable Reports	The data is derived from human-readable reports. E.g., by natural language parsing of text reports, or optical character recognition from reports saved as images by the irradiating device.
113870	Person Name	The name of a specific person.
113871	Person ID	An identification number or code for a specific person.
113872	Person ID Issuer	The organization that issued a Person ID.
113873	Organization Name	The name of an organization.
113874	Person Role in Organization	The role played by a person in an organization.
113875	Person Role in Procedure	The role played by a person in a procedure.
113876	Device Role in Procedure	The role played by a device in a procedure.
113877	Device Name	The name used to refer to a device; usually locally unique.
113878	Device Manufacturer	Manufacturer of a device.
113879	Device Model Name	Model Name of a device.
113880	Device Serial Number	Serial Number of a device.
113890	All Planes	All planes of a multi-plane acquisition equipment.
113893	Length of Reconstructable Volume	The length from which images may be reconstructed (i.e., excluding any overranging performed in a spiral acquisition that is required for data interpolation). Value is distinct from (1113825, DCM, "Scanning Length"), which is the actual length of the table travel during the entire tube loading, according to [IEC 60601-2-44], and includes overranging. Also distinct from any actual Reconstructed Volume, which may depend on the slice thickness chosen for a particular reconstruction.
113895	Top Z Location of Reconstructable Volume	The Z location that is the top (highest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113896	Bottom Z Location of Reconstructable Volume	The Z location that is the bottom (lowest Z value) of the Reconstructable Volume. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113897	Top Z Location of Scanning Length	The Z location that is the top (highest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113898	Bottom Z Location of Scanning Length	The Z location that is the bottom (lowest Z value) of the scanning length. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113899	Exposed Range	The range along the z axis of the total volume irradiated, per [IEC 60601-2-44], Ed. 3, 203.115(b). The start and stop of loading corresponding to the outer edge of the full width half maximum of the free-in-air dose profile for the beam collimation used.
113900	Dose Check Alert Details	Report section about cumulative dose alerts during an examination.
113901	DLP Alert Value Configured	Flag denoting whether a DLP Alert Value was configured.
113902	CTDIvol Alert Value Configured	Flag denoting whether a CTDIvol Alert Value was configured.
113903	DLP Alert Value	Cumulative Dose Length Product value configured to trigger an alert; see the NEMA Dose Check Standard [NEMA XR 25-2019].
113904	CTDIvol Alert Value	Cumulative CTDIvol value configured to trigger an alert; see the NEMA Dose Check Standard [NEMA XR 25-2019].
113905	Accumulated DLP Forward Estimate	A forward estimate of the accumulated DLP plus the estimated DLP for the next Protocol Element Group; see the NEMA Dose Check Standard [NEMA XR 25-2019].
113906	Accumulated CTDIvol Forward Estimate	A forward estimate at a given location of the accumulated CTDIvol plus the estimated CTDIvol for the next Protocol Element Group; see the NEMA Dose Check Standard [NEMA XR 25-2019].
113907	Reason for Proceeding	Reason provided for proceeding with a procedure that is projected to exceed a configured dose value.
113908	Dose Check Notification Details	Report section about dose notifications during a protocol element.
113909	DLP Notification Value Configured	Flag denoting whether a DLP Notification Value was configured.
113910	CTDIvol Notification Value Configured	Flag denoting whether a CTDIvol Notification Value was configured.
113911	DLP Notification Value	Dose Length Product value configured to trigger a notification for a given protocol element.
113912	CTDIvol Notification Value	CTDIvol value configured to trigger a notification for a given protocol element.
113913	DLP Forward Estimate	A forward estimate of the DLP for the next Protocol Element Group; see the NEMA Dose Check Standard [NEMA XR 25-2019].
113914	CTDIvol Forward Estimate	A forward estimate of the CTDIvol for the next Protocol Element Group; see the NEMA Dose Check Standard [NEMA XR 25-2019].
113915	Alternative dose alert behavior active	Flag denoting whether alternative dose alert behavior has been active for CT guided interventional procedure according to the NEMA Dose Check Standard [NEMA XR 25-2019].
113921	Radiation Exposure	The amount of ionizing radiation to which the patient was exposed.
113922	Radioactive Substance Administered	Type, amount and route of radioactive substance administered.	Retired. Replaced by (440252007, SCT, "Administration of radiopharmaceutical").
113923	Radiation Exposure and Protection Information	Exposure to ionizing radiation and associated preventive measures used to reduce the exposure of parts of the body like lead apron or eye, thyroid gland or gonad protection.	Retired. Replaced by (73569-6, LN, "Radiation Exposure and Protection Information")
113930	Size Specific Dose Estimate	The Size-Specific Dose Estimate is a patient dose estimate that takes into account the size of the patient, such as described in [AAPM Report 204] or [AAPM Report 220].
113931	Measured Lateral Dimension	The side-to-side (left to right) dimension of the body part being scanned (per [AAPM Report 204]).
113932	Measured AP Dimension	The thickness of the body part being scanned, in the antero-posterior dimension (per [AAPM Report 204]).
113933	Derived Effective Diameter	The diameter of the patient at a given location along the Z-axis of the patient, assuming that the patient has a circular cross-section (per [AAPM Report 204]).
113934	AAPM 204 Lateral Dimension	The Size Specific Dose Estimate is computed using Table 1B (32cm phantom) or Table 2B (16cm phantom) of [AAPM Report 204].
113935	AAPM 204 AP Dimension	The Size Specific Dose Estimate is computed using Table 1C (32cm phantom) or Table 2C (16cm phantom) of [AAPM Report 204].
113936	AAPM 204 Sum of Lateral and AP Dimension	The Size Specific Dose Estimate is computed using Table 1A (32cm phantom) or Table 2A (16cm phantom) of [AAPM Report 204].
113937	AAPM 204 Effective Diameter Estimated From Patient Age	The Size Specific Dose Estimate is computed using Table 1D (32cm phantom) or Table 2D (16cm phantom) using an effective diameter estimated from the patient's age using Table 3 of [AAPM Report 204].
113940	System Calculated	Values calculated from other existing parameters.
113941	In Detector Plane	A segmented region of the detector surface within the irradiated area (but might not be near the center of the detector).
113942	X-Ray Reading Device	A device that creates digital images from X-Ray detectors (Direct, Indirect or Storage).
113943	X-Ray Source Data Available	Parameters related to the X-Ray source (generator, tube, etc) are available to the recording application.
113944	X-Ray Mechanical Data Available	Parameters related to the X-Ray Mechanical System (Stand, Table) are available to the recording application.
113945	X-Ray Detector Data Available	Parameters related to the X-Ray Detector are available to the recording application.
113946	Projection Eponymous Name	Describes the radiographic method of patient, tube and detector positioning to achieve a well described projection or view.
113947	Detector Type	Type of Detector used to acquire data. E.g., Images.
113948	Direct Detector	Detector that directly transforms the input signal to pixel values.
113949	Indirect Detector	Detector that transforms an intermediate signal into pixel values. E.g., a scintillator-based detector.
113950	Storage Detector	Storage detector that stores a signal that is later transformed by a reader into pixel values. E.g., a phosphor-based detector.
113951	Film	Film that is scanned to create pixel values.
113952	Table Mount	The cassette/detector is mounted in the patient table.
113953	Unmounted Detector	The cassette/detector is not mounted.. E.g., a cassette placed underneath the patient.
113954	Upright Stand Mount	The cassette/detector is mounted in an upright stand.
113955	C-Arm Mount	The cassette/detector is mounted on a c-arm.
113956	CR/DR Mechanical Configuration	Method of mounting or positioning a CR/DR cassette or detector.
113957	Fluoroscopy-Guided Projection Radiography System	An integrated projection radiography system capable of fluoroscopy.
113958	Integrated Projection Radiography System	A projection radiography system where the X-Ray detector, X-Ray Source and gantry components are integrated and the managing system is able to access details of each component.
113959	Cassette-based Projection Radiography System	A projection radiography system where the X-Ray detector, X-Ray Source and gantry components are not integrated. E.g., cassette-based CR and DR systems.
113961	Reconstruction Algorithm	Description of the algorithm used when reconstructing the image from the data acquired during the acquisition process.
113962	Filtered Back Projection	An algorithm for reconstructing an image from multiple projections by back-projecting the measured values along the line of the projection and filtering the result to reduce blurring.
113963	Iterative Reconstruction	An algorithm for reconstructing an image from multiple projections by starting with an assumed reconstructed image, computing projections from the image, comparing the original projection data and updating the reconstructed image based upon the difference between the calculated and the actual projections.
113964	At Surface of Patient	A point at the surface of the patient within the irradiated area where the X-Ray beam enters the patient (i.e. towards the tube).
113965	100cm from X-Ray Source	100cm from the X-Ray source along the central ray of the X-Ray beam.
113970	Procedure Step To This Point	The period of time from the start of a Procedure Step until the time point established by the context of the reference.
113980	Water Equivalent Diameter	The diameter of a cylinder of water having the same X-Ray attenuation as the patient for a specified reconstructed slice (e.g., as described in [AAPM Report 220]).
113981	Water Equivalent Diameter Representative Value	The Water Equivalent Diameter is a value at a single location sufficiently representative of the body region.
113982	Water Equivalent Diameter Integrated Across Scan Range	The Water Equivalent Diameter integrates values for a sample of reconstructed slices across the entire scan range.
113983	Water Equivalent Diameter From Raw Data	The Water Equivalent Diameter value is derived from Raw Data rather than reconstructed slices. See [AAPM Report 220].
113984	Water Equivalent Diameter From Localizer	The Water Equivalent Diameter value is derived from a Localizer image. See [AAPM Report 220].
113985	Series or Instance used for Water Equivalent Diameter estimation	Unique identifier of the Series or Instance(s) used for Water Equivalent Diameter estimation, whether it be a Series of reconstructed single slice images or one or more Enhanced Multi-frame images or a Raw Data Series or Instance.
113986	Z value of location of Water Equivalent Diameter estimation	The Z location used for Water Equivalent Diameter estimation at a single location whether it be computed using a reconstructed slice or Localizer or Raw Data. Specified as the Z component within the Patient Coordinate System defined by a specified Frame of Reference.
113987	AAPM 220	A report describing methods of calculation of diameters of cylinders of water having the same X-Ray attenuation as reconstructed CT slices of patients described in [AAPM Report 220].
113988	Estimated from Water Equivalent Diameter	The Size Specific Dose Estimate is calculated from a single Water Equivalent Diameter value using a conversion factor as described in [AAPM Report 204].
113989	Arithmetic Average of SSDE(z)	The Size Specific Dose Estimate is an arithmetic average of SSDE(z), calculated from Dw(z) at several z-positions over the reconstruction length. The z-positions may or may not correspond to reconstructed slices. See [IEC 62985].
113990	Arithmetic Average of Dw(z)	The Water Equivalent Diameter is an arithmetic average of Dw(z) at several z-positions over the reconstruction length. The z-positions may or may not correspond to reconstructed slices. See [IEC 62985].
113991	Dw Conversion Factor Coefficients	The a and b coefficients of an exponential function as described in [AAPM Report 204]. The function generates a conversion factor based on a Water Equivalent Diameter value (Dw). Multiplying the Dw value by the conversion factor produces a Size Specific Dose Estimate.
113992	Water Equivalent Diameter From Limited FOV Images	The Water Equivalent Diameter is derived from reconstructed images that do not cover the full FOV.
113993	Size Specific Dose Estimate At Longitudinal Position Z	Estimate of the average absorbed dose to the material contained in an axial plane at longitudinal position z of the object scanned. See [IEC 62985].
113994	Longitudinal Position Z	The patient relative longitudinal position at which other value(s) have been estimated.
113995	Water Equivalent Diameter At Longitudinal Position Z	Diameter of a cylinder of water having the same averaged absorbed dose as the material contained in an axial plane at longitudinal position z of the object scanned, calculable for a material of any composition, and quantifying the attenuation of any material in terms of the attenuation of water. See [IEC 62985].
114000	Not a number	Measurement not available: Not a number (per IEEE 754).
114001	Negative Infinity	Measurement not available: Negative Infinity (per IEEE 754).
114002	Positive Infinity	Measurement not available: Positive Infinity (per IEEE 754).
114003	Divide by zero	Measurement not available: Divide by zero (per IEEE 754).
114004	Underflow	Measurement not available: Underflow (per IEEE 754).
114005	Overflow	Measurement not available: Overflow (per IEEE 754).
114006	Measurement failure	Measurement not available: Measurement failure.
114007	Measurement not attempted	Measurement not available: Measurement not attempted.
114008	Calculation failure	Measurement not available: Calculation failure.
114009	Value out of range	Measurement not available: Value out of range.
114010	Value unknown	Measurement not available: Value unknown.
114011	Value indeterminate	Measurement not available: Value indeterminate.
114201	Time of flight	Measures the time-of-flight of a light signal between the camera and the subject for each point of the image.
114202	Interferometry	Interferometry is a family of techniques in which waves are superimposed in order to extract depth information about the scanned object.
114203	Laser scanning	Laser scanning describes the general method to sample or scan a surface using laser technology.
114204	Pattern projection	Projecting a narrow band of light onto a three-dimensionally shaped surface produces a line of illumination that appears distorted from other perspectives than that of the projector. It can be used for an exact geometric reconstruction of the surface shape.
114205	Shape from shading	A technique for estimating the surface normal of an object by observing that object under different lighting conditions.
114206	Shape from motion	A technique for estimating the surface normal of an object by observing that object under different motions.
114207	Confocal imaging	An optical imaging technique used to increase optical resolution and contrast of a micrograph by using point illumination and a spatial pinhole to eliminate out-of-focus light in specimens that are thicker than the focal plane. It enables the reconstruction of 3D structures from the obtained images.
114208	Point Cloud Algorithmic	Point cloud that was calculated by an algorithm.
114209	Turntable Scan Method	Scanning the object from different views by placing it on a rotating table.
114210	High resolution	Higher resolution with a longer acquisition time.
114211	Fast mode	Lower resolution with a shorter acquisition time.
114213	Iterative Closest Point	An algorithm employed to minimize the difference between two clouds of points. It iteratively revises the transformation (translation, rotation) needed to minimize the distance between the points of two point clouds.
114215	Freehand	Human controlled minimization of the distance between the points of two point clouds.
114216	Checkerboard	Scanning the object from different views by placing it in front of a checkerboard pattern.
120999	Device Description	Description in free form text describing the device.
121000	Unique Device Identifiers	Unique Device Identifiers (UDIs) of the entire equipment.
121001	Quotation Mode	Type of source for observations quoted from an external source.
121002	Quoted Source	Reference to external source of quoted observations.
121003	Document	Documentary source of quoted observations.
121004	Verbal	Verbal source of quoted observations.
121005	Observer Type	Type of observer that created the observations.
121006	Person	Human observer created the observations.
121007	Device	Automated device created the observations.
121008	Person Observer Name	Name of human observer that created the observations.
121009	Person Observer's Organization Name	Organization or institution with which the human observer is affiliated for the context of the current observation.
121010	Person Observer's Role in the Organization	Organizational role of human observer for the context of the current observation.
121011	Person Observer's Role in this Procedure	Procedural role of human observer for the context of the current observation.
121012	Device Observer UID	Unique identifier of automated device that created the observations.
121013	Device Observer Name	Institution-provided identifier of automated device that created the observations.
121014	Device Observer Manufacturer	Manufacturer of automated device that created the observations.
121015	Device Observer Model Name	Manufacturer-provided model name of automated device that created the observations.
121016	Device Observer Serial Number	Manufacturer-provided serial number of automated device that created the observations.
121017	Device Observer Physical Location During Observation	Location of automated device that created the observations whilst the observations were being made.
121018	Procedure Study Instance UID	Unique identifier for the Study or Requested Procedure.
121019	Procedure Study Component UID	Unique identifier for the Performed Procedure Step.
121020	Placer Number	Identifier for the Order (or Service Request) assigned by the order placer system.
121021	Filler Number	Identifier for the Order (or Service Request) assigned by the order filler system.
121022	Accession Number	A departmental Information System generated number that identifies the Imaging Service Request.
121023	Procedure Code	Type of procedure scheduled or performed.
121024	Subject Class	Type of observation subject.
121025	Patient	A patient is the subject of observations.
121026	Fetus	Fetus of patient is the subject of observations.
121027	Specimen	Specimen is the subject of observations.
121028	Subject UID	Unique Identifier of patient or fetus who is the subject of observations.
121029	Subject Name	Name of patient who is the subject of observations.
121030	Subject ID	Identifier of patient or fetus who is the subject of observations.
121031	Subject Birth Date	Birth Date of patient who is the subject of observations.
121032	Subject Sex	Sex of patient who is the subject of observations.
121033	Subject Age	Age of patient who is the subject of observations.
121034	Subject Species	Species of patient who is the subject of observations.
121035	Subject Breed	The breed of the subject.
121036	Mother of fetus	Name of mother of fetus that is the subject of observations.
121037	Fetus number		Retired. Replaced by (11951-1, LN, "Fetus ID").
121038	Number of Fetuses		Retired. Replaced by (55281-0, LN, "Number of Fetuses").
121039	Specimen UID	Unique Identifier of specimen that is the subject of observations.
121040	Specimen Accession Number	Accession Number of specimen that is the subject of observations	Retired.
121041	Specimen Identifier	Identifier of specimen that is the subject of observations.
121042	Specimen Type	Coded category of specimen that is the subject of observations	Retired. Replaced by (371439000, SCT, "Specimen Type")
121043	Slide Identifier	Identifier of specimen microscope slide that is the subject of observations	Retired. Replaced by (111700, DCM, "Specimen Container Identifier")
121044	Slide UID	Unique Identifier of specimen microscope slide that is the subject of observations	Retired.
121045	Language	The language of the content, being a language that is primarily used for human communication. E.g., English, French.
121046	Country of Language	The country-specific variant of language. E.g., Canada for Candadian French.
121047	Language of Value	The language of the value component of a name-value pair.
121048	Language of Name and Value	The language of both the name component and the value component of a name-value pair.
121049	Language of Content Item and Descendants	The language of the current Content Item (node in a tree of content) and all its descendants.
121050	Equivalent Meaning of Concept Name	A precoordinated coded concept or text meaning for the name component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded name and its concept modifier children.
121051	Equivalent Meaning of Value	A precoordinated coded concept or text meaning for the value component of a name-value pair that is equivalent to the post-coordinated meaning conveyed by the coded value and its concept modifier children.
121052	Presence of property	Whether or not the property concept being modified is present or absent.
121053	Present		Retired. Replaced by (52101004, SCT, "Present")
121054	Absent		Retired. Replaced by (272519000, SCT, "Absent")
121055	Path	A set of points on an image, that when connected by line segments, provide a polyline from which a linear measurement was inferred.
121056	Area outline	A set of points on an image, that when connected by line segments, provide a closed polyline that is the border of a defined region from which an area, or two-dimensional measurement, was inferred.
121057	Perimeter outline	A set of points on an image, that when connected by line segments, provide a closed polyline that is a two-dimensional border of a three-dimensional region's intersection with, or projection into the image.
121058	Procedure reported	The imaging procedure whose results are reported.
121059	Presence Undetermined	Presence or absence of a property is undetermined	Retired. Replaced by (373068000, SCT, "Undetermined")
121060	History		Retired. Replaced by (11329-0, LN, "History")
121061	Device Observer Manufacturer Class UID	Manufacturer-provided Class UID(s) of device that created the observations.
121062	Request		Retired. Replaced by (55115-0, LN, "Request")
121064	Current Procedure Descriptions		Retired. Replaced by (55111-9, LN, "Current Procedure Descriptions")
121065	Procedure Description	A description of the imaging procedure.
121066	Prior Procedure Descriptions		Retired. Replaced by (55114-3, LN, "Prior Procedure Descriptions")
121068	Previous Findings		Retired. Replaced by (18834-2, LN, "Previous Findings")
121069	Previous Finding	An observation found on a prior imaging study.
121070	Findings		Retired. Replaced by (59776-5, LN, "Findings")
121071	Finding	An observation found on an imaging study.
121072	Impressions		Retired. Replaced by (19005-8, LN, "Impressions")
121073	Impression	An interpretation in the clinical context of the finding(s) on an imaging study.
121074	Recommendations		Retired. Replaced by (18783-1, LN, "Recommendations")
121075	Recommendation	A recommendation for management or investigation based on the findings and impressions of an imaging study.
121076	Conclusions		Retired. Replaced by (55110-1, LN, "Conclusions")
121077	Conclusion	An interpretation in the clinical context of the finding(s) on an imaging study.
121078	Addendum		Retired. Replaced by (55107-7, LN, "Addendum")
121079	Baseline	Initial images used to establish a beginning condition that is used for comparison over time to look for changes. [Paraphrases NCI-PT (C1442488, UMLS, "Baseline"), which is defined as "An initial measurement that is taken at an early time point to represent a beginning condition, and is used for comparison over time to look for changes. For example, the size of a tumor will be measured before treatment (baseline) and then afterwards to see if the treatment had an effect. A starting point to which things may be compared."]
121080	Best illustration of finding	A selection of composite instances that best illustrates a particular finding. E.g., an image slice at the location of the largest extent of a tumor.
121081	Physician		Retired. Replaced by (309343006, SCT, "Physician")
121082	Nurse		Retired. Replaced by (106292003, SCT, "Nurse")
121083	Technologist		Retired. Replaced by (159016003, SCT, "Radiologic Technologist")
121084	Radiographer		Retired. Replaced by (159016003, SCT, "Radiographer")
121085	Intern		Retired. Replaced by (C1144859, UMLS, "Intern")
121086	Resident		Retired. Replaced by (405277009, SCT, "Resident")
121087	Registrar		Retired. Replaced by (158971006, SCT, "Registrar")
121088	Fellow	A medical practitioner undergoing sub-specialty training. E.g., during the period after specialty training (residency).
121089	Attending [Consultant]		Retired. Replaced by (405279007, SCT, "Attending")
121090	Scrub nurse		Retired. Replaced by (415506007, SCT, "Scrub nurse")
121091	Surgeon		Retired. Replaced by (304292004, SCT, "Surgeon")
121092	Sonologist	A medical practitioner with sub-specialty training in Ultrasound.
121093	Sonographer		Retired. Replaced by (C1954848, UMLS, "Sonographer")
121094	Performing	The person responsible for performing the procedure.
121095	Referring	The person responsible for referring the patient for the procedure.	Retired. Replaced by (C1709880, UMLS, "Referring physician").
121096	Requesting	The person responsible for requesting the procedure.
121097	Recording	The person responsible for recording the procedure or observation.
121098	Verifying	The person responsible for verifying the recorded procedure or observation.
121099	Assisting	The person responsible for assisting with the procedure.
121100	Circulating	The person responsible for making preparations for and monitoring the procedure.	Retired. Replaced by (413854007, SCT, "Circulating Nurse").
121101	Standby	The person responsible for standing by to assist with the precedure if required.
121102	Other sex	Other sex.
121103	Undetermined sex	Sex of subject undetermined at time of encoding.
121104	Ambiguous sex	Ambiguous sex.
121105	Radiation Physicist	Radiation Physicist.	Retired. Replaced by (C2985483, UMLS, "Radiation Physicist").
121106	Comment	Comment.
121109	Indications for Procedure	Indications for Procedure	Retired. Replaced by (18785-6, LN, "Indications for Procedure")
121110	Patient Presentation	Patient condition at the beginning of a healthcare encounter	Retired. Replaced by (55108-5, LN, "Patient Presentation")
121111	Summary	Summary of a procedure, including most significant findings	Retired. Replaced by (55112-7, LN, "Summary")
121112	Source of Measurement	Image or waveform used as source for measurement.
121113	Complications	Complications from a procedure	Retired. Replaced by (55109-3, LN, "Complications")
121114	Performing Physician	Physician who performed a procedure.
121115	Discharge Summary	Summary of patient condition upon Discharge from a healthcare facility.
121116	Proximal Finding Site	Proximal Anatomic Location for a differential measurement; may be considered subtype of term (363698007, SCT, "Finding Site"). E.g., distance or pressure gradient.
121117	Distal Finding Site	Distal Anatomic Location for a differential measurement; may be considered subtype of term (363698007, SCT, "Finding Site"). E.g., distance or pressure gradient.
121118	Patient Characteristics	Patient Characteristics (findings).
121120	Cath Lab Procedure Log	Time-stamped record of events that occur during a catheterization procedure.
121121	Room identification	Room identification.
121122	Equipment Identification	Equipment identification.
121123	Patient Status or Event	A recorded Patient Status or an event involving a patient.
121124	Procedure Action Item ID	Identification of a step, action, or phase of a procedure.
121125	DateTime of Recording of Log Entry	DateTime of Recording of an Entry in an Event Log.
121126	Performed Procedure Step SOP Instance UID	SOP Instance UID of a Performed Procedure Step.
121127	Performed Procedure Step SOP Class UID	SOP Class UID of a Performed Procedure Step.
121128	Procedure Action Duration	Duration of a step, action, or phase of a procedure.
121130	Start Procedure Action Item	Beginning of a step, action, or phase of a procedure.
121131	End Procedure Action Item	End of a step, action, or phase of a procedure.
121132	Suspend Procedure Action Item	Suspension of a step, action, or phase of a procedure.
121133	Resume Procedure Action Item	Resumption of a step, action, or phase of a procedure.
121135	Observation DateTime Qualifier	Concept modifier for the DateTime of Recording of an Entry in an Event Log.
121136	DateTime Unsynchronized	Recorded DateTime had its source in a system clock not synchronized to other recorded DateTimes.
121137	DateTime Estimated	Recorded DateTime is estimated.
121138	Image Acquired	Event of the acquisition of an image.
121139	Modality	Type of device, process or method used to acquire or derive data.
121140	Number of Frames	Number of Frames in a multi-frame image.
121141	Image Type	Descriptor of an Image.
121142	Acquisition Duration	Duration of the acquisition of an image or a waveform.
121143	Waveform Acquired	Event of the acquisition of an image.
121144	Document Title	Document Title.
121145	Description of Material	Description of Material used in a procedure.
121146	Quantity of Material	Quantity of Material used in a procedure.
121147	Billing Code	Billing Code for materials used in a procedure.
121148	Unit Serial Identifier	Unit or Device Serial Identifier.
121149	Lot Identifier	Lot Identifier.
121150	Device Code	Vendor or local coded value identifying a device.
121151	Lesion Identifier	Identification of a Lesion observed during an imaging procedure.
121152	Person administering drug/contrast	Person administering drug/contrast.
121153	Lesion Risk	Assessment of the risk a coronary lesion presents to the health of a patient.
121154	Intervention attempt identifier	Identifier for an attempted Intervention.
121155	Deployment	Use of a device to deploy another device.
121156	Percutaneous Entry Action	Action of a clinical professional at the site of percutaneous access to a patient's cardiovascular system.
121157	Begin Circulatory Support	The action or event of beginning circulatory support for a patient.
121158	End Circulatory Support	The action or event of ending circulatory support for a patient.
121160	Oxygen Administration Rate	Rate of Oxygen Administration.
121161	Begin Oxygen Administration	The action or event of beginning administration of oxygen to a patient.
121162	End oxygen administration	The action or event of ending administration of oxygen to a patient.
121163	By ventilator	Method of administration of oxygen to a patient by ventilator.
121165	Patient Assessment Performed	The action or event of assessing the clinical status of a patient.
121166	Begin Pacing	The action or event of beginning pacing support for a patient.
121167	End Pacing	The action or event of ending pacing support for a patient.
121168	Begin Ventilation	The action or event of beginning ventilation support for a patient.
121169	End Ventilation	The action or event of ending ventilation support for a patient.
121171	Tech Note	Procedural note originated by a technologist.
121172	Nursing Note	Procedural note originated by a nurse.
121173	Physician Note	Procedural note originated by a Physician.
121174	Procedure Note	General procedural note.
121180	Key Images	List of references to images considered significant	Retired. Replaced by (55113-5, LN, "Key Images")
121181	DICOM Object Catalog	List of references to DICOM SOP Instances.
121190	Referenced Frames	Individual frames selected as a subset of a multi-frame image.
121191	Referenced Segment	Segment selected as a subset of a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the identified segment.
121192	Device Subject	A device is the subject of observations.
121193	Device Subject Name	Name or other identifier of a device that is the subject of observations.
121194	Device Subject Manufacturer	Manufacturer of a device that is the subject of observations.
121195	Device Subject Model Name	Model Name of a device that is the subject of observations.
121196	Device Subject Serial Number	Serial Number of a device that is the subject of observations.
121197	Device Subject Physical Location during observation	Physical Location of a device that is the subject of observations during those observations.
121198	Device Subject UID	Unique Identifier of a device that is the subject of observations.
121200	Illustration of ROI	Illustration of a region of interest.
121201	Area Outline		Retired. Replaced by (121056, DCM, "Area Outline").
121202	Area of Defined Region		Retired. Replaced by (131184002, SCT, "Area of defined region").
121206	Distance	A one dimensional, or linear, numeric measurement between two points or features.
121207	Height	Vertical measurement value.
121208	Inter-Marker Distance	Distance between marks on a device of calibrated size. E.g., a ruler.
121210	Path		Retired. Replaced by (121055, DCM, "Path").
121211	Path length	A one dimensional, or linear, numeric measurement along a polyline.
121213	Perimeter Outline		Retired. Replaced by (121057, DCM, "Perimeter Outline").
121214	Referenced Segmentation Frame	Frame selected from a segmentation image, specifically the pixels/voxels identified as belonging to the classification of the segment encompassing the identified frame.
121216	Volume estimated from single 2D region	A three-dimensional numeric measurement that is approximate, based on a two-dimensional region in a single image.
121217	Volume estimated from three or more non-coplanar 2D regions	A three-dimensional numeric measurement that is approximate, based on three or more non-coplanar two-dimensional image regions.
121218	Volume estimated from two non-coplanar 2D regions	A three-dimensional numeric measurement that is approximate, based on two non-coplanar two-dimensional image regions.
121219	Volume of bounding three dimensional region	A three-dimensional numeric measurement of the bounding region of a three-dimensional region of interest in an image set.
121220	Volume of circumscribed sphere	A three-dimensional numeric measurement of the bounding sphere of a three-dimensional region of interest in an image set.
121221	Volume of ellipsoid	A three-dimensional numeric measurement of an ellipsoid shaped three-dimensional region of interest in an image set.
121222	Volume of sphere	A three-dimensional numeric measurement of a sphere shaped three-dimensional region of interest in an image set.
121223	Arm of angle	A line segment that is an arm of a pair of arms that defines an angle, whether or not those line segments share a common vertex.
121224	Acetabular angle	The angle on an AP radiograph of the pelvis between a line drawn parallel to the acetabular roof and a line drawn horizontally through the inferior aspect of both triradiate cartilages (Hilgenreiner's line).	Used to evaluate developmental dysplasia of the hip.
121225	Vector	An entity that has both a magnitude and a direction.
121226	Approximate spatial location	The approximate geometric location on an image or in space where an entity is located.	Intended for use when it is known that the source of the information, such as a crude hand-drawn pointer, is in the neighborhood of the entity, but is not expected to be accurate.
121227	Line segment length	The length of that part of a line (a straight object having no curvature) that is bounded by two distinct end points and contains every point on the line between those two end points, including both of the two end points.	Derived from https://en.wikipedia.org/wiki/Line_(geometry)#Line_segment.
121230	Path Vertex	Coordinates of a point on a defined path.
121231	Volume Surface	Surface of an identified or measured volume.
121232	Source series for segmentation	Series of image instances used as source data for a segmentation.
121233	Source image for segmentation	Image instances used as source data for a segmentation.
121242	Distance from nipple	Indicates the location of the area of interest as measured from the nipple of the breast.
121243	Distance from skin	Indicates the location of the area of interest as measured from the most direct skin point of the breast.
121244	Distance from chest wall	Indicates the location of the area of interest as measured from the chest wall.
121290	Patient exposure to ionizing radiation	Patient exposure to ionizing radiation (procedure).
121291	Results communicated	The act of communicating actionable findings to a responsible receiver.
121301	Simultaneous Doppler	Reference is to a Doppler waveform acquired simultaneously with an image.
121302	Simultaneous Hemodynamic	Reference is to a Hemodynamic waveform acquired simultaneously with an image.
121303	Simultaneous ECG	Reference is to a ECG waveform acquired simultaneously with an image.
121304	Simultaneous Voice Narrative	Reference is to a voice narrative recording acquired simultaneously with an image.
121305	Simultaneous Respiratory Waveform	A waveform representing chest expansion and contraction due to respiratory activity, measured simultaneously with the acquisition of this Image.
121306	Simultaneous Arterial Pulse Waveform	Arterial pulse waveform obtained simultaneously with acquisition of a referencing image.
121307	Simultaneous Phonocardiographic Waveform	Phonocardiographic waveform obtained simultaneously with acquisition of a referencing image.
121310	RT treatment plan for the position being verified	The referenced instance is an RT treatment plan of some type, which contains treatment positioning information, which has been verified using the information in the referencing instance.	The referenced Instance typically will be an RT Plan, RT Ion Plan or RT Radiation Set.
121311	Localizer	Image providing an anatomical reference on the patient under examination, for the purpose of defining the location of the ensuing imaging.
121312	Biopsy localizer	Image providing an anatomical reference on the patient under examination, for the purpose of planning or documenting a biopsy.
121313	Other partial views	Image providing a partial view of the target anatomy, when the target anatomy is too large for a single image.
121314	Other image of biplane pair	Image providing a view of the target anatomy in a different imaging plane, typically from a near perpendicular angle.
121315	Other image of stereoscopic pair	Image providing a view of the target anatomy in a different imaging plane, typically with a small angular difference.
121316	Images related to standalone object	Image related to a non-image information object.
121317	Spectroscopy	Image where signals are identified and separated according to their frequencies. E.g., to identify individual chemicals, or individual nuclei in a chemical compound.
121318	Spectroscopy Data for Water Phase Correction	MR spectroscopy data acquired to correct the phase of the diagnostic data for the phase signal of the Water.
121320	Uncompressed predecessor	An image that has not already been lossy compressed that is used as the source for creation of a lossy compressed image.
121321	Mask image for image processing operation	Image used as the mask for an image processing operation, such as subtraction.
121322	Source image for image processing operation	Image used as the source for an image processing operation.
121323	Source series for image processing operation	Series used as the source for an image processing operation.
121324	Source Image	Image used as the source for a derived or compressed image.
121325	Lossy compressed image	Image encoded with a lossy compression transfer syntax.
121326	Alternate SOP Class instance	SOP Instance encoded with a different SOP Class but otherwise equivalent data.
121327	Full fidelity image	Full fidelity image, uncompressed or lossless compressed.
121328	Alternate Photometric Interpretation image	Image encoded with a different photometric interpretation.
121329	Source image for montage	Image used as a source for a montage (stitched) image.
121330	Lossy compressed predecessor	An image that has previously been lossy compressed that is used as the source for creation of another lossy compressed image.
121331	Equivalent CDA Document	HL7 Document Architecture (CDA) Document that contains clinical content equivalent to the referencing Instance.
121332	Complete Rendering for Presentation	Instance that contains a displayable complete rendering of the referencing Instance.
121333	Partial Rendering for Presentation	Instance that contains a displayable partial rendering of the referencing Instance.
121334	Extended Rendering for Presentation	Instance that contains a displayable complete rendering of the referencing Instance, plus additional content such as inline rendering of referenced images.
121335	Source Document	Document whose content has been wholly or partially transformed to create the referencing document.
121338	Anatomic image	Image showing structural anatomic features.
121339	Functional image	Image showing physical or chemical activity.
121340	Spectral filtered image	Image providing the same view of the target anatomy acquired using only a specific imaging wavelength, frequency or energy.
121341	Device localizer	Image providing an anatomical reference on the patient under examination, for the purpose of documenting the location of device such as a diagnostic or therapeutic catheter.
121342	Dose Image	Image providing a graphic view of the distribution of radiation dose.
121346	Acquisition frames corresponding to volume	The referenced image is the source of spatially-related frames from which the referencing 3D volume data was derived.
121347	Volume corresponding to spatially-related acquisition frames	3D Volume containing the spatially-related frames in the referencing instance.
121348	Temporal Predecessor	Instance acquired prior to the referencing instance in a set of consecutively acquired instances.
121349	Temporal Successor	Instance acquired subsequent to the referencing instance in a set of consecutively acquired instances.
121350	Same acquisition at lower resolution	Image of the same target area at lower resolution acquired in the same acquisition process.
121351	Same acquisition at higher resolution	Image of the same target area at higher resolution acquired in the same acquisition process.
121352	Same acquisition at different focal depth	Image of the same target area at different focal depth (Z-plane) acquired in the same acquisition process.
121353	Same acquisition at different spectral band	Image of the same target area at different spectral band acquired in the same acquisition process.
121354	Imaged container label	Image specifically targeting the container label.
121358	For Processing predecessor	Source image from which FOR PRESENTATION images were created.
121360	Replaced report	The reference is to a predecessor report that has been replaced by the current report.
121361	Addended report	The reference is to a predecessor report to which the current report provides an addendum.
121362	Preliminary report	A report that precedes the final report and may contain only limited information; it may be time sensitive, and it is not expected to contain all the reportable findings.
121363	Partial report	A report that is not complete.
121370	Composed from prior doses	The dose object created was calculated by summation of existing, previously calculated, RT Dose instances.
121371	Composed from prior doses and current plan	The dose object created was calculated by summation of existing, previously calculated, RT Dose instances and dose newly calculated by the application. The newly calculated dose may or may not exist as an independent object.
121372	Source dose for composing current dose	RT Dose Instances used as source for calculated dose.
121373	RT Pre-Treatment Dose Check	An assessment of the dose delivery parameters performed before treatment.
121374	RT Pre-Treatment Consistency Check	An assessment of consistency with a previously quality-assured treatment plan performed before treatment.
121375	Assessment By Comparison	The basis of the assessment was a comparison object.
121376	Assessment By Rules	The basis of the assessment was a set of rules on expected values, ranges and relationships.
121377	Composed with radiobiological effects	The dose object created was calculated using previously calculated RT Dose Instances by taking radiobiological effects into account.
121378	Composed with weighting for fractions delivered	The dose object was calculated based on weighted contributions along the actual number of fractions delivered.
121380	Active Ingredient Undiluted Concentration	Concentration of the chemically or physically interesting (active) ingredient of a drug or contrast agent as delivered in product form from the manufacturer, typically in mg/ml.
121381	Contrast/Bolus Ingredient Opaque	X-Ray absorption of the active ingredient of a contrast agent ingredient is greater than the absorption of water (tissue).
121382	Quantity administered	Number of units of substance administered to a patient. E.g., tablets.
121383	Mass administered	Mass of substance administered to a patient.
121384	RT Plan Label	Human readable label of the radiotherapy plan.
121385	Current Fraction Number	The index of the fraction of the radiotherapy plan to be delivered.
121386	Number of Fractions Planned	The total number of prescribed radiotherapy fractions.
121387	Number of Fractions Completed	The number of fully completed radiotherapy fractions of the radiotherapy plan to be delivered. Partially completed fractions are not included.
121388	Checked-In Status	Whether or not the patient has been checked-in, i.e., are physically present and are waiting to be called in to the treatment room.
121389	Referenced Beam Number	The referenced beam number within the radiotherapy plan to be delivered.
121401	Derivation	Method of deriving or calculating a measured value. E.g., mean, or maximum of set.
121402	Normality	Assessment of a measurement relative to a normal range of values; may be considered subtype of term (363713009, SCT, "has interpretation").
121403	Level of Significance	Significance of a measurement.
121404	Selection Status	Status of selection of a measurement for further processing or use.
121405	Population description	Description of a population of measurements.
121406	Reference Authority	Bibliographic or clinical reference for a Description of a population of measurements.
121407	Normal Range description	Description of a normal range of values for a measurement concept.
121408	Normal Range Authority	Bibliographic or clinical reference for a Description of a normal range of values.
121410	User chosen value	Observation value selected by user for further processing or use, or as most representative.
121411	Most recent value chosen	Observation value is the recently obtained, and has been selected for further processing or use.
121412	Mean value chosen	Observation value is the mean of several measurements, and has been selected for further processing or use.
121414	Standard deviation of population	Standard deviation of a measurement in a reference population.
121415	Percentile Ranking of measurement	Percentile Ranking of an observation value with respect a reference population.
121416	Z-Score of measurement	Z-score of an observation value with respect a reference population, expressed as the dimensionless quantity (x-m) /s, where (x-m) is the deviation of the observation value (x) from the population mean (m), and s is the standard deviation of the population.
121417	2 Sigma deviation of population	2 Sigma deviation of a measurement in a reference population.
121420	Equation	Formula used to compute a derived measurement.
121421	Equation Citation	Bibliographic reference to a formula used to compute a derived measurement; reference may be to a specific equation in a journal article.
121422	Table of Values Citation	Bibliographic reference to a Table of Values used to look up a derived measurement.
121423	Method Citation	Bibliographic reference to a method used to compute a derived measurement.
121424	Table of Values	A Table of Values used to look up a derived measurement.
121425	Index	Factor (divisor or multiplicand) for normalizing a measurement. E.g., body surface area used for normalizing hemodynamic measurements.
121427	Estimated	Measurement obtained by observer estimation, rather than with a measurement tool or by calculation	Retired. Replaced by (414135002, SCT, "Estimated")
121428	Calculated	Measurement obtained by calculation	Retired. Replaced by (258090004, SCT, "Calculated")
121430	Concern	Identified issue about a state or process that has the potential to require intervention or management.
121431	DateTime Concern Noted	DateTime concern noted (noted by whom is determined by context of use).
121432	DateTime Concern Resolved	DateTime the concern was resolved.
121433	DateTime Problem Resolved	DateTime the problem was resolved.
121434	Service Delivery Location	Place at which healthcare services may be provided.
121435	Service Performer	Identification of a healthcare provider who performed a healthcare service; may be either a person or an organization.
121436	Medical Device Used	Type or identifier of a medical device used on, in, or by a patient.
121437	Pharmacologic and exercise stress test	Cardiac stress test using pharmacologic and exercise stressors	Retired. Replaced by (428813002, SCT, "Pharmacologic and exercise stress test")
121438	Paced stress test	Cardiac stress test using an implanted or external cardiac pacing device	Retired. Replaced by (428685003, SCT, "Stress test using cardiac pacing")
121439	Correction of congenital cardiovascular deformity	Procedure for correction of congenital cardiovascular deformity	Retired. Replaced by (428613004, SCT, "Correction of congenital cardiovascular deformity")
121701	RT Patient Setup	Process of placing patient in the anticipated treatment position, including specification and location of positioning aids, and other treatment delivery accessories.
121702	RT Patient Position Acquisition, single plane MV	Acquisition of patient positioning information, using single-plane megavoltage imaging.
121703	RT Patient Position Acquisition, dual plane MV	Acquisition of patient positioning information, using dual-plane megavoltage imaging.
121704	RT Patient Position Acquisition, single plane kV	Acquisition of patient positioning information, using single-plane kilovoltage imaging.
121705	RT Patient Position Acquisition, dual plane kV	Acquisition of patient positioning information, using dual-plane kilovoltage imaging.
121706	RT Patient Position Acquisition, dual plane kV/MV	Acquisition of patient positioning information, using dual-plane combination kilovoltage and megavoltage imaging.
121707	RT Patient Position Acquisition, CT kV	Acquisition of patient positioning information, using kilovoltage CT imaging. Note This code encompasses both Cone-Beam CT and conventional CT.
121708	RT Patient Position Acquisition, CT MV	Acquisition of patient positioning information, using megavoltage CT imaging. Note This code encompasses both Cone-Beam CT and conventional CT.
121709	RT Patient Position Acquisition, Optical	Acquisition of patient positioning information, using optical imaging.
121710	RT Patient Position Acquisition, Ultrasound	Acquisition of patient positioning information, using ultrasound imaging.
121711	RT Patient Position Acquisition, Spatial Fiducials	Acquisition of patient positioning information, using spatial fiducials.
121712	RT Patient Position Registration, single plane	Registration of intended and actual patient position prior to treatment delivery, using single-plane images.
121713	RT Patient Position Registration, dual plane	Registration of intended and actual patient position prior to treatment delivery, using dual-plane images.
121714	RT Patient Position Registration, 3D CT general	Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and an unspecified registration approach.
121715	RT Patient Position Registration, 3D CT marker-based	Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and a marker-based registration approach.
121716	RT Patient Position Registration, 3D CT volume-based	Registration of intended and actual patient position prior to treatment delivery, using 3D CT images and a volume-based registration approach.
121717	RT Patient Position Registration, 3D on 2D reference	Registration of intended and actual patient position prior to treatment delivery, using 3D verification images and 2D reference images.
121718	RT Patient Position Registration, 2D on 3D reference	Registration of intended and actual patient position prior to treatment delivery, using 2D verification images and 3D reference images.
121719	RT Patient Position Registration, Optical	Registration of intended and actual patient position prior to treatment delivery, using optical images.
121720	RT Patient Position Registration, Ultrasound	Registration of intended and actual patient position prior to treatment delivery, using ultrasound images.
121721	RT Patient Position Registration, Spatial Fiducials	Registration of intended and actual patient position prior to treatment delivery, using spatial fiducials.
121722	RT Patient Position Adjustment	Adjustment of patient position such that the patient is correctly positioned for treatment.
121723	RT Patient Position In-treatment-session Review	Review of patient positioning information in the process of delivering a treatment session.
121724	RT Treatment Simulation with Internal Verification	Simulated radiotherapy treatment delivery using verification integral to the Treatment Delivery System.
121725	RT Treatment Simulation with External Verification	Simulated radiotherapy treatment delivery using verification by a external Machine Parameter Verifier.
121726	RT Treatment with Internal Verification	Radiotherapy treatment delivery using verification integral to the Treatment Delivery System.
121727	RT Treatment with External Verification	Radiotherapy treatment delivery using verification by a external Machine Parameter Verifier.
121728	RT Treatment QA with Internal Verification	Quality assurance of a radiotherapy treatment delivery using verification integral to the Treatment Delivery System.
121729	RT Treatment QA with External Verification	Quality assurance of a radiotherapy treatment delivery using verification by a external Machine Parameter Verifier.
121730	RT Machine QA	Quality assurance of a Treatment Delivery Device.
121731	RT Treatment QA by RT Plan Dose Check	Perform Quality Assurance on an RT Plan by evaluating dosimetric content of the current RT Plan.
121732	RT Treatment QA by RT Plan Difference Check	Perform Quality Assurance on an RT Plan by comparing the content of previously quality-assessed RT Plans with the current RT Plan.
121733	RT Treatment QA by RT Ion Plan Dose Check	Perform Quality Assurance on an RT Ion Plan by evaluating dosimetric content of the current RT Ion Plan.
121734	RT Treatment QA with RT Ion Plan Difference Check	Perform Quality Assurance on an RT Ion Plan by comparing the content of previously quality-assessed RT Ion Plans by the current RT Ion Plan.
121735	RT Brachy Treatment	Brachytherapy Treatment Delivery.
121736	RT Image-Guided Patient Positioning and Treatment Delivery	Radiotherapy image-guided patient positioning and treatment delivery using verification integral to the Treatment Delivery System.
121737	RT Patient Position Acquisition, MR	Acquisition of radiotherapy patient positioning information, using magnetic resonance imaging.
121738	RT Patient Position Registration, MR	Registration of intended and actual patient position prior to treatment delivery, using MR images and an unspecified registration approach.
121740	Treatment Delivery Type	Indicates whether the treatment to be delivered is a complete fraction or a continuation of previous incompletely treated fraction.
122001	Patient called to procedure room	Patient called to procedure room.
122002	Patient admitted to procedure room	Patient admitted to procedure room.
122003	Patient given pre-procedure instruction	Patient given pre-procedure instruction.
122004	Patient informed consent given	Patient informed consent given.
122005	Patient advance directive given	Patient advance directive given.
122006	Nil Per Os (NPO) status confirmed	Nil Per Os (NPO) status confirmed.
122007	Patient assisted to table	Patient assisted to table.
122008	Patient prepped and draped	Patient prepped and draped.
122009	Patient connected to continuous monitoring	Patient connected to continuous monitoring.
122010	Patient transferred to holding area	Patient transferred to holding area.
122011	Patient transferred to surgery	Patient transferred to surgery.
122012	Patient transferred to CCU	Patient transferred to CCU.
122020	Patient disoriented	Patient disoriented.
122021	Patient reports nausea	Patient reports nausea.
122022	Patient reports discomfort	Patient reports discomfort.
122023	Patient reports chest pain	Patient reports chest pain.
122024	Patient reports no pain	Patient reports no pain.
122025	Patient alert	Patient alert.
122026	Patient restless	Patient restless.
122027	Patient sedated	Patient sedated.
122028	Patient asleep	Patient asleep.
122029	Patient unresponsive	Patient unresponsive.
122030	Patient has respiratory difficulty	Patient has respiratory difficulty.
122031	Patient coughed	Patient coughed.
122032	Patient disconnected from continuous monitoring	Patient disconnected from continuous monitoring.
122033	Hemostasis achieved	Hemostasis achieved.
122034	Hemostasis not achieved - oozing	Hemostasis not achieved - oozing.
122035	Hemostasis not achieved - actively bleeding	Hemostasis not achieved - actively bleeding.
122036	Patient given post-procedure instruction	Patient given post-procedure instruction.
122037	Patient discharged from department	Patient discharged from department or laboratory.
122038	Patient pronounced dead	Patient pronounced dead.
122039	Patient transferred to morgue	Patient transferred to morgue.
122041	Personnel Arrived	Identified personnel or staff arrived in procedure room.
122042	Personnel Departed	Identified personnel or staff departed procedure room.
122043	Page Sent To	Page sent to identified personnel or staff.
122044	Consultation With	Consultation with identified personnel or staff.
122045	Office called	Office of identified personnel or staff was called.
122046	Equipment failure	Equipment failure	Retired. Replaced by (110501, DCM, "Equipment failure")
122047	Equipment brought to procedure room	Equipment brought to procedure room.
122048	Equipment ready	Equipment ready for procedure.
122049	Equipment removed	Equipment removed from procedure room.
122052	Bioptome	Device for obtaining biopsy sample.
122053	Valvular Intervention	Valvular Intervention.
122054	Aortic Intervention	Aortic Intervention.
122055	Septal Defect Intervention	Septal Defect Intervention.
122056	Vascular Intervention	Vascular Intervention.
122057	Myocardial biopsy	Myocardial biopsy.
122058	Arterial conduit angiography	Arterial conduit angiography.
122059	Single plane Angiography	Single plane Angiography.
122060	Bi-plane Angiography	Bi-plane Angiography.
122061	Percutaneous Coronary Intervention	Percutaneous Coronary Intervention.
122062	15-Lead ECG	15-Lead electrocardiography	Retired. Replaced by (429163003, SCT, "15-Lead ECG")
122072	Pre-procedure log	Log of events occurring prior to the current procedure.
122073	Current procedure evidence	Analysis or measurements for current procedure (purpose of reference to evidence document).
122075	Prior report for current patient	Prior report for current patient.
122076	Consumable taken from inventory	Identifier of Consumable taken from inventory.
122077	Consumable returned to inventory	Identifier of Consumable returned to inventory.
122078	Remaining consumable disposed	Identifier of consumable whose remaining content has been disposed.
122079	Consumable unusable	Identifier of Consumable determined to be unusable.
122081	Drug start	Identifier of Drug whose administration has started.
122082	Drug end	Identifier of Drug whose administration has ended.
122083	Drug administered	Identifier of Drug administered as part of procedure.
122084	Contrast start	Identifier of Contrast agent whose administration has started.
122085	Contrast end	Identifier of Contrast agent whose administration has ended.
122086	Contrast administered	Identifier of Contrast agent administered.
122087	Infusate start	Identifier of Infusate whose administration has started.
122088	Infusate end	Identifier of Infusate whose administration has ended.
122089	Device crossed lesion	Action of a device traversing a vascular lesion.
122090	Intervention Action	Action of a clinical professional performed on a patient for therapeutic purpose.
122091	Volume administered	Volume of Drug, Contrast agent, or Infusate administered.
122092	Undiluted dose administered	Undiluted dose of Drug, Contrast agent, or Infusate administered.
122093	Concentration	Concentration of Drug, Contrast agent, or Infusate administered.
122094	Rate of administration	Rate of Drug, Contrast agent, or Infusate administration.
122095	Duration of administration	Duration of Drug, Contrast agent, or Infusate administration.
122096	Volume unadministered or discarded	Volume of Drug, Contrast agent, or Infusate unadministered or discarded.
122097	Catheter Curve	Numeric parameter of Curvature of Catheter.
122098	Transmit Frequency	Transmit Frequency.
122099	ST change from baseline	Measured change of patient electrocardiographic ST level relative to baseline measurement.
122101	Aneurysm on cited vessel	Anatomic term modifier indicating aneurysm on cited vessel is the subject of the finding.
122102	Graft to cited segment, proximal section	Anatomic term modifier indicating proximal section of graft to cited vessel is the subject of the finding.
122103	Graft to cited segment, mid section	Anatomic term modifier indicating mid section of graft to cited vessel is the subject of the finding.
122104	Graft to cited segment, distal section	Anatomic term modifier indicating distal section of graft to cited vessel is the subject of the finding.
122105	DateTime of Intervention	DateTime of Intervention.
122106	Duration of Intervention	Duration of Intervention.
122107	Baseline Stenosis Measurement	Lesion stenosis measured prior to any interventional procedure	Retired. Replaced by (408715008, SCT, "Lumen Diameter Stenosis"), post-coordinated with (128955008, SCT, "Baseline Phase")
122108	Post-Intervention Stenosis Measurement	Lesion stenosis measured after an interventional procedure	Retired. Replaced by (408715008, SCT, "Lumen Diameter Stenosis"), post-coordinated with (128960007, SCT, "Post-intervention Phase")
122109	Baseline TIMI Flow	Assessment of perfusion across a coronary lesion measured prior to any interventional procedure.
122110	Post-Intervention TIMI Flow	Assessment of perfusion across a coronary lesion measured after an interventional procedure.
122111	Primary Intervention Device	Indication that device is the primary (first and/or most significant) device used for interventional therapy of a particular pathology. E.g., lesion.
122112	Normal Myocardium	Normal Myocardium.
122113	Scarred Myocardium	Scarred Myocardium.
122114	Thinning Myocardium	Thinning Myocardium.
122120	Hemodynamics Report	Hemodynamics Report.
122121	Atrial pressure measurements	Atrial pressure measurements, report section.
122122	Ventricular pressure measurements	Ventricular pressure measurements, report section.
122123	Gradient assessment	Gradient assessment, report section.
122124	Blood velocity measurements	Blood velocity measurements, report section.
122125	Blood lab measurements	Blood lab measurements, report section.
122126	Derived Hemodynamic Measurements	Derived Hemodynamic Measurements, report section.
122127	Clinical Context	Clinical Context, report section.
122128	Patient Transferred From	Location from which the patient was transferred.
122129	PCI during this procedure	Indication that the procedure includes a percutaneous coronary intervention.
122130	Dose Area Product	Radiation dose times area of exposure.
122131	Degree of Thrombus	Finding of probability and/or severity of thrombus.
122132	Severity of Calcification	Severity of Calcification, property of lesion.
122133	Lesion Morphology	Lesion Morphology; form and/or structural properties of lesion.
122134	Vessel Morphology	Vessel Morphology; form and/or structural properties of vessel.
122138	Circulatory Support	Technique (device or procedure) of support for patient circulatory system; hemodynamic support.
122139	Reason for Study	Reason for Study.
122140	Comparison with Prior Study Done	Indication that the current study data has been compared with prior study data.
122141	Electrode Placement	Electrocardiographic electrode placement technique.
122142	Acquisition Device Type	Acquisition Device Type.
122143	Acquisition Device ID	Acquisition Device ID.
122144	Quantitative Analysis	Quantitative Analysis, report section.
122145	Qualitative Analysis	Qualitative Analysis, report section.
122146	Procedure DateTime	The date and time on which a procedure was performed on a patient.
122147	Clinical Interpretation	Clinical Interpretation, report section.
122148	Lead ID	ECG Lead Identifier.
122149	Beat Number	Beat Number; ordinal of cardiac cycle within an acquisition.
122150	Compound Statement	Complex coded semantic unit, consisting of several coded components.
122151	Trend	Trend (temporal progression) of a clinical condition, finding, or disease.
122152	Statement	Coded semantic unit.
122153	Statement Modifier	Coded modifier for a semantic unit.
122154	Conjunctive Term	Conjunctive term between semantic units.
122157	Probability	Probability.
122158	ECG Global Measurements	ECG Global Measurements, report section.
122159	ECG Lead Measurements	ECG Lead Measurements, report section.
122160	Derived Area, Non-Valve	Derived cross-sectional area of a vessel or anatomic feature, other than a cardiac valve.
122161	Pulmonary Flow	Rate of blood flow through Pulmonary artery.
122162	Systemic Flow	Rate of blood flow through the aorta.
122163	Discharge DateTime	DateTime of patient discharge from hospital admission.
122164	Coronary Artery Bypass During This Admission	Indication that a Coronary Artery Bypass operation was performed during the current hospital admission.
122165	DateTime of Death	DateTime of Death.
122166	Death During This Admission	Indication that the patient died during the current hospital admission.
122167	Death During Catheterization	Indication that the patient died during the current Catheterization procedure.
122170	Type of Myocardial Infarction	Finding of type of Myocardial Infarction.
122171	Coronary lesion > = 50% stenosis	Finding of Coronary lesion with greater than 50% stenosis.
122172	Acute MI Present	Finding of Acute Myocardial Infarction Presence as indication for interventional procedure.
122173	ST Elevation Onset DateTime	DateTime of first determination of elevated ECG ST segment, as indication of Myocardial Infarction.
122175	Number of lesion interventions attempted	Number of lesion interventions attempted during current procedure.
122176	Number of lesion interventions successful	Number of lesion interventions successful during current procedure, where the residual post intervention stenosis is less than or equal to 50% of the arterial luminal diameter, TIMI Flow is 3 and the minimal decrease in stenosis was 20%.
122177	Procedure Result	Overall success of interventional procedure.
122178	Lesion Intervention Information	Lesion Intervention Information, report section.
122179	Peri-procedural MI occurred	Indication that Myocardial Infarction occurred during current procedure.
122180	CK-MB baseline	Creatine Kinase-MB value at baseline (start of procedure).
122181	CK-MB peak	Creatine Kinase-MB highest value measured during procedure.
122182	R-R interval	Time interval between ECG R-wave peaks in subsequent cardiac cycles.
122183	Blood temperature	Blood temperature.
122185	Blood Oxygen content	Blood Oxygen content.
122187	Blood Carbon dioxide saturation	Blood Carbon dioxide saturation.
122188	Pulmonary Arterial Content (FCpa)	Pulmonary Arterial Content (FCpa).
122189	Pulmonary Venous Content (FCpv)	Pulmonary Venous Content (FCpv).
122190	Max dp/dt/P	Max dp/dt/P.
122191	Ventricular End Diastolic pressure	Ventricular End Diastolic pressure.
122192	Indicator appearance time	Elapsed time from injection of an indicator bolus until it is observed at another location.
122193	Maximum pressure acceleration	Maximum pressure acceleration.
122194	Ventricular Systolic blood pressure	Ventricular Systolic blood pressure.
122195	Pulse Strength	Pulse Strength; palpable strength of systolic flow.
122196	C wave pressure	The secondary peak pressure in the atrium during atrial contraction.
122197	Gradient pressure, average	Gradient pressure, average.
122198	Gradient pressure, peak	Gradient pressure, peak.
122199	Pressure at dp/dt max	Pressure at dp/dt max.
122201	Diastolic blood velocity, mean	Diastolic blood velocity, mean.
122202	Diastolic blood velocity, peak	Diastolic blood velocity, peak.
122203	Systolic blood velocity, mean	Systolic blood velocity, mean.
122204	Systolic blood velocity, peak	Systolic blood velocity, peak.
122205	Blood velocity, mean	Blood velocity, mean.
122206	Blood velocity, minimum	Blood velocity, minimum.
122207	Blood velocity, peak	Blood velocity, peak.
122208	x-descent pressure	Venous or atrial pressure minimum during ventricular systole, after A-wave.
122209	y-descent pressure	Venous or atrial pressure minimum when tricuspid valve opens during diastole, after V-wave.
122210	z-point pressure	Atrial pressure upon closure of tricuspid and mitral valves.
122211	Left Ventricular ejection time	Left Ventricular ejection time.
122212	Left Ventricular filling time	Left Ventricular filling time.
122213	Right Ventricular ejection time	Right Ventricular ejection time.
122214	Right Ventricular filling time	Right Ventricular filling time.
122215	Total Pulmonary Resistance	Total Pulmonary Resistance.
122216	Total Vascular Resistance	Total Vascular Resistance.
122217	Coronary Flow reserve	Coronary Flow reserve.
122218	Diastolic/Systolic velocity ratio	Diastolic/Systolic velocity ratio.
122219	Hyperemic ratio	Hyperemic ratio.
122220	Hemodynamic Resistance Index	Hemodynamic Resistance Index.
122221	Thorax diameter, sagittal	Thorax diameter, sagittal.
122222	Procedure Environmental Characteristics	Environmental characteristics in the procedure room.
122223	Room oxygen concentration	Oxygen concentration in the procedure room.
122224	Room temperature	Temperature in the procedure room.
122225	Room Barometric pressure	Barometric pressure in the procedure room.
122227	Left to Right Flow	Left to Right Flow.
122228	Right to Left Flow	Right to Left Flow.
122229	Arteriovenous difference	Arteriovenous oxygen content difference.
122230	10 Year CHD Risk	Framingham Study 10 Year CHD Risk.
122231	Comparative Average10 Year CHD Risk	Framingham Study Comparative Average10 Year CHD Risk.
122232	Comparative Low10 Year CHD Risk	Framingham Study Comparative Low10 Year CHD Risk.
122233	LDL Cholesterol Score Sheet for Men	Framingham Study LDL Cholesterol Score Sheet for Men.
122234	LDL Cholesterol Score Sheet for Women	Framingham Study LDL Cholesterol Score Sheet for Women.
122235	Total Cholesterol Score Sheet for Men	Framingham Study Total Cholesterol Score Sheet for Men.
122236	Total Cholesterol Score Sheet for Women	Framingham Study Total Cholesterol Score Sheet for Women.
122237	Corrected Sinus Node Recovery Time	Corrected Sinus Node Recovery Time.
122238	Max volume normalized to 50mmHg pulse pressure	Max volume normalized to 50mmHg pulse pressure.
122239	Oxygen Consumption	Oxygen Consumption.
122240	BSA = 0.003207WT^(0.7285-0.0188log(WT))*HT^0.3	Body Surface Area computed from patient height and weight: BSA = 0.003207WT[g]^(0.7285-0.0188log(WT[g]))*HT[cm]^0.3 [Boyd E, The growth of the surface area of the human body. Minneapolis: University of Minnesota Press, 1935, eq. (36) ].
122241	BSA = 0.007184WT^0.425HT^0.725	Body Surface Area computed from patient height and weight: BSA = 0.007184WT[kg]^0.425HT[cm]^0.725 [Dubois and Dubois, Arch Int Med 1916 17:863-71].
122242	BSA = 0.0235WT^0.51456HT^0.42246	Body Surface Area computed from patient height and weight: BSA = 0.0235WT[kg]^0.51456HT[cm]^0.42246 [Gehan EA, George SL, 'Estimation of human body surface area from height and weight', Cancer Chemother Rep 1970 54:225-35].
122243	BSA = 0.024265WT^0.5378HT^0.3964	Body Surface Area computed from patient height and weight: BSA = 0.024265WT[kg]^0.5378HT[cm]^0.3964 [Haycock G.B., Schwartz G.J., Wisotsky D.H. 'Geometric method for measuring body surface area: A height weight formula validated in infants, children and adults.' The Journal of Pediatrics 1978 93:1:62-66].
122244	BSA = (HT*WT/36)^0.5	Body Surface Area computed from patient height and weight: BSA = (HT[m]*WT[kg]/36)^0.5 [Mosteller, R.D. 'Simplified Calculation of Body Surface Area.' N Engl J Med 1987 Oct 22;317(17):1098].
122245	BSA = 1321+0.3433*WT	Body Surface Area computed from patient weight:BSA = 1321 + 0.3433 * WT[kg] (for pediatrics 3-30 kg) [Current, J.D. 'A Linear Equation For Estimating The Body Surface Area In Infants And Children', The Internet Journal of Anesthesiology. 1998. 2:2].
122246	BSA = 0.0004688WT^(0.8168-0.0154log(WT))	BSA = 0.0004688(1000WT)^(0.8168-0.0154log(1000WT)) Where (WT is weight in kilogram) Units = m2 Boyd, Edith. The Growth of the Surface Area of the Human Body(originally published in 1935 by the University of Minnesota Press), Greenwood Press, Westport, Connecticut, 1975, p. 102.Equation (35).
122247	VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf)	Equation for estimated oxygen consumption: VO2male = BSA (138.1 - 11.49 * loge(age) + 0.378 * HRf).
122248	VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf)	Equation for estimated oxygen consumption: VO2female = BSA (138.1 - 17.04 * loge(age) + 0.378 * HRf).
122249	VO2 = VeSTPD * 10 * (FIO2 - FE02)	Equation for estimated oxygen consumption: VO2 = VeSTPD * 10 * (FIO2 - FE02).
122250	VO2 = 152 * BSA	Equation for estimated oxygen consumption: VO2 = 152 * BSA.
122251	VO2 = 175 * BSA	Equation for estimated oxygen consumption: VO2 = 175 * BSA.
122252	VO2 = 176 * BSA	Equation for estimated oxygen consumption: VO2 = 176 * BSA.
122253	Robertson & Reid table	Robertson & Reid Table for estimated oxygen consumption.
122254	Fleisch table	Fleisch table for estimated oxygen consumption.
122255	Boothby table	Boothby table for estimated oxygen consumption.
122256	if (prem age< 3days) P50 = 19.9	Estimate of Oxygen partial pressure at 50% saturation for premature infants less than 3 days old: P50 = 19.9.
122257	if (age < 1day) P50 = 21.6	Estimate of Oxygen partial pressure at 50% saturation for infants less than 1 day old: P50 = 21.6.
122258	if (age < 30day) P50 = 24.6	Estimate of Oxygen partial pressure at 50% saturation for infants less than 30 days old: P50 = 24.6.
122259	if (age < 18y) P50 = 27.2	Estimate of Oxygen partial pressure at 50% saturation for patients less than 18 years old: P50 = 27.2.
122260	if (age < 40y) P50 = 27.4	Estimate of Oxygen partial pressure at 50% saturation for patients less than 40 years old: P50 = 27.4.
122261	if (age > 60y) P50 = 29.3	Estimate of Oxygen partial pressure at 50% saturation for patients more than 60 years old: P50 = 29.3.
122262	Area = Flow / 44.5 * sqrt(Gradient[mmHg])	Cardiac valve area computed from flow and pressure gradient: Area = Flow / 44.5 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951].
122263	MVA = Flow / 38.0 * sqrt(Gradient[mmHg])	Mitral valve area computed from flow and pressure gradient: Mitral valve Area = Flow / 38.0 * sqrt(Gradient[mmHg]) [Gorlin and Gorlin, Am Heart J, 1951].
122265	BMI = Wt / Ht ^ 2	Body Mass Index computed from weight and height: BMI = Wt/Ht^2.
122266	BSA = 0.007358WT^0.425HT^0.725	Body Surface Area computed from patient height and weight: BSA = 0.007358WT[kg]^0.425HT[cm]^0.725 (for East Asian adult, aged 15+ years) [Kanai Izumi, Masamitsu Kanai, 'Clinical examination method summary'].
122267	BSA = 0.010265WT^0.423HT^0.651	Body Surface Area computed from patient height and weight: BSA = 0.010265WT[kg]^0.423HT[cm]^0.651 (For East Asian child aged 12-14 years).
122268	BSA = 0.008883WT^0.444HT^0.663	Body Surface Area computed from patient height and weight: BSA = 0.008883WT[kg]^0.444HT[cm]^0.663 (For East Asian child aged 6-11 years).
122269	BSA = 0.038189WT^0.423HT^0.362	Body Surface Area computed from patient height and weight: BSA = 0.038189WT[kg]^0.423HT[cm]^0.362 (For East Asian child aged 1-5 years).
122270	BSA = 0.009568WT^0.473HT^0.655	Body Surface Area computed from patient height and weight: BSA = 0.009568WT[kg]^0.473HT[cm]^0.655 (For East Asian child aged 0-12 months).
122271	Skin Condition Warm	Skin Condition Warm.
122272	Skin Condition Cool	Skin Condition Cool.
122273	Skin Condition Cold	Skin Condition Cold.
122274	Skin Condition Dry	Skin Condition Dry.
122275	Skin Condition Clammy	Skin Condition Clammy.
122276	Skin Condition Diaphoretic	Skin Condition Diaphoretic.
122277	Skin Condition Flush	Skin Condition Flush.
122278	Skin Condition Mottled	Skin Condition Mottled.
122279	Skin Condition Pale	Skin Condition Pale.
122281	Airway unobstructed	Airway unobstructed.
122282	Airway partially obstructed	Airway partially obstructed.
122283	Airway severely obstructed	Airway severely obstructed.
122288	Not Visualized	Anatomy could not be visualized for the purpose of evaluation.
122291	Quantitative Arteriography Report	Quantitative Arteriography Report.
122292	Quantitative Ventriculography Report	Quantitative Ventriculography Report.
122301	Guidewire crossing lesion unsuccessful	Guidewire crossing lesion unsuccessful.
122302	Guidewire crossing lesion successful	Guidewire crossing lesion successful.
122303	Angioplasty balloon inflated	Angioplasty balloon inflated.
122304	Angioplasty balloon deflated	Angioplasty balloon deflated.
122305	Device deployed	Device deployed.
122306	Stent re-expanded	Stent re-expanded.
122307	Object removed	Object removed.
122308	Radiation applied	Radiation applied.
122309	Radiation removed	Radiation removed.
122310	Interventional device placement unsuccessful	Interventional device placement unsuccessful.
122311	Interventional device placed	Interventional device placed.
122312	Intervention performed	Intervention performed.
122313	Interventional device withdrawn	Interventional device withdrawn.
122319	Catheter Size	Catheter Size.
122320	Injectate Temperature	Injectate Temperature.
122321	Injectate Volume	Injectate Volume.
122322	Calibration Factor	Factor by which a measured or calculated value is multiplied to obtain the estimated real-world value.
122325	IVUS Report	Intravascular Ultrasound Report.
122330	EEM Diameter	External Elastic Membrane (EEM) diameter measured through the center point of the vessel. Center point of the vessel is defined as the center of gravity of the EEM area. The EEM is a discrete interface at the border between the media and the adventitia.
122331	Plaque Plus Media Thickness	The distance from intimal leading edge to the external elastic membrane along any line passing through the luminal center, which is defined as the center of gravity of the lumen area.
122332	Lumen Perimeter	Planimetered perimeter of the lumen.
122333	EEM Cross-Sectional Area	Vessel area measured at the External Elastic Membrane (EEM), a discrete interface at the border between the media and the adventitia.
122334	Plaque plus Media Cross-Sectional Area	Area within the EEM occupied by atheroma, regardless of lumen compromise. Plaque plus Media Area = EEM cross-sectional area - vessel lumen cross-sectional area.
122335	In-Stent Neointimal Cross-Sectional Area	Measurement of in-stent restenosis. In-Stent Intimal Area = Stent cross-sectional area - vessel lumen cross-sectional area.
122336	Vascular Volume measurement length	Longitudinal extent of the Vascular Volume Measurement. This is the distance from the distal edge to the proximal edge of the Volume measurement.
122337	Relative position	Longitudinal distance from the closest edge of a fiducial feature or reference location to the start of the vascular measurement. This value will be a positive if the measurement is distal to the fiducial feature or reference location, or negative if the measurement is proximal to the fiducial feature or reference location.
122339	Stent Volume Obstruction	In-Stent Neointimal Volume / Stent Volume.
122340	Fiducial feature	Reference, normally anatomical, which is used for locating the position of a measurement.
122341	Calcium Length	Longitudinal calcium length measurement.
122343	Lumen Eccentricity Index	Measurement of vessel lumen eccentricity. Lumen Eccentricity Index = (maximum vessel lumen diameter - minimum vessel lumen diameter) / maximum vessel lumen diameter. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area.
122344	Plaque plus Media Eccentricity Index	Plaque plus Media Eccentricity Index = (maximum Plaque plus media thickness - minimum Plaque plus media thickness) / maximum Plaque plus media thickness.
122345	Remodeling Index	Measurement of increase or decrease in EEM area that occurs during the development of atherosclerosis. Remodeling Index = Lesion EEM area / reference EEM area.
122346	Stent Symmetry Index	Measurement of stent circularity. Stent Symmetry Index = (maximum stent diameter - minimum stent diameter) / maximum stent diameter.
122347	Stent Expansion Index	Measurement of stent area relative to the reference lumen area. Stent Expansion Index = Minimum stent area / reference vessel lumen cross-sectional area.
122348	Lumen Shape Index	Measurement of vessel lumen eccentricity. Lumen Shape Index = (2p * sqrt(Vessel lumen cross-sectional area / p) / Lumen Perimeter) 2 Reference: Tobis & Yock, "Intravascular Ultrasound Imaging", Chapter 7.
122350	Lumen Diameter Ratio	Lumen diameter ratio = minimum vessel lumen diameter / maximum vessel lumen diameter, measured at the same cross section in the vessel. Lumen diameters are measured through the center point of the lumen, which is defined as the center of gravity of the lumen area.
122351	Stent Diameter Ratio	Stent diameter ratio = Minimum stent diameter / Maximum stent diameter, measured at the same cross section in the vessel. Stent diameters are measured through the center point of the stent, which is defined as the center of gravity of the stent area.
122352	EEM Diameter Ratio	EEM diameter ratio = minimum EEM diameter / maximum EEM diameter. Measured at the same cross section in the vessel.
122354	Plaque Burden	Fractional area within the External Elastic Membrane (EEM) occupied by atheroma. Plaque Burden = (EEM area - vessel lumen cross-sectional area) / EEM area.
122355	Arc of Calcium	Angular measurement of a Calcium deposit with the apex located at the center of the lumen, which is defined as the center of gravity of the lumen area.
122356	Soft plaque	Plaque characterized by low density or echogenicity.
122357	In-Stent Neointima	Abnormal thickening of the intima within the stented segment.
122360	True Lumen	Lumen surrounded by all three layers of the vessel-intima, media, and adventitia.
122361	False Lumen	A channel, usually parallel to the true lumen, which does not communicate with the true lumen over a portion of its length.
122363	Plaque Rupture	Plaque ulceration with a tear detected in a fibrous cap.
122364	Stent Gap	Length of gap between two consecutive stents.
122367	T-1 Worst	Worst stenosis - the stenosis with the smallest lumen size within a vessel segment.
122368	T-2 Secondary	2nd most severe stenosis within a vessel segment.
122369	T-3 Secondary	3rd most severe stenosis within a vessel segment.
122370	T-4 Secondary	4th most severe stenosis within a vessel segment.
122371	EEM Volume	External Elastic Membrane (EEM) volume measured within a specified region. The EEM is a discrete interface at the border between the media and the Adventitia.
122372	Lumen Volume	Lumen volume measured within a specified region.
122374	In-Stent Neointimal Volume	The amount of plaque between the lumen and stent, within the stent region; In-stent restenosis. In-Stent Neointimal Volume = Stent Volume - Lumen Volume.
122375	Native Plaque Volume	The amount of plaque between the stent and the EEM, within the stent region. Native Plaque Volume = EEM Volume - Stent Volume.
122376	Total Plaque Volume	Total amount of plaque between the EEM and the Lumen, over the entire region that is measured. Total Plaque Volume = EEM Volume - Lumen Volume.
122380	Proximal Reference	Proximal reference segment measurement site. Typically the site with the largest lumen proximal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches).
122381	Distal Reference	Distal reference segment measurement site. Typically the site with the largest lumen distal to a stenosis but within the same segment (usually within 10 mm of the stenosis with no major intervening branches).
122382	Site of Lumen Minimum	Site of the smallest lumen in a vessel. E.g., due to a stenotic lesion.
122383	Entire Pullback	Measurement region that encompasses the entire vessel imaged in a single pullback acquisition.
122384	Stented Region	Measurement region occupied by the stent.
122385	Proximal Stent Margin	Region starting at the proximal edge of the Stent and extending several millimeters (usually 5 mm) proximal to the Stent edge.
122386	Distal Stent Margin	Region starting at the distal edge of the Stent and extending several millimeters (usually 5 mm) distal to the Stent edge.
122387	Dissection Classification	Classification of dissections in a vessel.
122388	Intra-stent Dissection	Separation of neointimal hyperplasia from stent struts, usually seen only after treatment of in-stent restenosis.
122389	Vulnerable Plaque	Plaque with a thin cap fibrous atheroma that is at increased risk of rupture and thrombosis (or re-thrombosis) and rapid stenosis progression.
122390	Eroded Plaque	Plaque erosions with no structural defect (beyond endothelial injury) or gap in the plaque.
122391	Relative Stenosis Severity	Stenosis severity classifications of multiple lesions in a vessel.
122393	Restenotic Lesion	A finding of a previously treated lesion in which stenosis has reoccurred.
122394	Fibro-Lipidic Plaque	Loosely packed bundles of collagen fibers with regions of lipid deposition present. Region is cellular and no cholesterol clefts or necrosis are present. Some macrophage infiltration. Increase in extra cellular matrix.
122395	Necrotic-Lipidic Plaque	Area within the plaque with very low echogenicity separated from the lumen and surrounded by more echogenic structures (fibrous cap). Highly lipidic necrotic region with remnants of foam cells and dead lymphocytes present. No collagen fibers are visible and mechanical integrity is poor. Cholesterol clefts and micro calcifications are visible.
122397	Adventitial Dissection	Separation of the layers of an artery involving the adventitia
122398	Intimal Dissection	Separation of the layers of an artery involving the intima. Dissection limited to the intima or atheroma, and not extending to the media.
122399	Medial Dissection	Separation of the layers of an artery involving the media. Dissection in the arterial Media, extending into the media.
122400	Simultaneously Acquired	The referenced information was acquired simultaneously with the information in the object in which the reference occurs.
122401	Same Anatomy	Information acquired for the same anatomic region.
122402	Same Indication	Information acquired for the same indication. E.g., to elucidate the same diagnostic question.
122403	For Attenuation Correction	The referenced information was used to correct the data for differential attenuation through different anatomic tissue.
122404	Reconstructed	Value estimated for a vessel in the absence of a stenosis.
122405	Algorithm Manufacturer	Manufacturer of application used.
122406	Left Atrial Ejection Fraction by Angiography	Left Atrial Ejection Fraction by Angiography.
122407	Left Atrial ED Volume	Left Atrial End Diastolic Volume.
122408	Left Atrial ES Volume	Left Atrial End Systolic Volume.
122410	Contour Realignment	Contour repositioning of End Diastolic relative to End Systolic contour.
122411	Threshold Value	The minimum standard deviation to define the hypokinesis and hyperkinesis.
122417	Regional Abnormal Wall Motion	Report of differentiation of wall motion compared to normal.
122421	Calibration Object	Object used for Calibration.
122422	Calibration Method	Method used for Calibration.
122423	Calibration Object Size	Size of calibration object.
122428	Area Length Method	Method how long axis is positioned.
122429	Volume Method	Model for cardiac chamber volume calculation.
122430	Reference Method	Method to define original diameter of the artery.
122431	Regression Slope ED	Relation between calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used.
122432	Regression Offset ED	Correction factor for the calculated End Diastolic volume and ventricular End Diastolic volume. The specific meaning is dependent on volume method used.
122433	Regression Slope ES	Relation between calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used.
122434	Regression Offset ES	Correction factor for the calculated End Systolic volume and ventricular End Systolic volume. The specific meaning is dependent on volume method used.
122435	Regression Volume Exponent	Exponent of volume in regression formula.
122438	Reference Points	Container for spatial locations or coordinates used for calculation.
122445	Wall Thickness	Average thickness of the chamber wall in the current view.
122446	Wall Volume	Volume of the chamber wall estimated from the current view.
122447	Wall Mass	Mass of the chamber wall (myocardium).
122448	Wall Stress	Peak systolic stress of chamber wall.
122449	Centerline Wall Motion Analysis	Method to calculate wall motion [example: Sheehan, 1986].
122450	Normalized Chord Length	The length between End Diastolic and End Systolic contour perpendicular on the centerline normalized by a method dependent ventricular perimeter length. The centerline is the line equidistant between the End Diastolic and End Systolic contour [example: Sheehan, 1986].
122451	Abnormal Region	The report of the boundaries of the abnormal (hyperkinetic, hypokinetic, a-kinetic) regions associated with the territory of the artery [example: Sheehan, 1986].
122452	First Chord of Abnormal Region	The chord number specifying the begin of abnormal region [example: Sheehan, 1986].
122453	Last Chord of Abnormal Region	The chord number specifying the end of abnormal region [example: Sheehan, 1986].
122459	Territory Region Severity	Severity at the regional abnormality extent [example: Sheehan, 1986].
122461	Opposite Region Severity	Severity at the opposite regional abnormality extent [example: Sheehan, 1986].
122464	LAD Region in RAO Projection	Based on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 5 - 85. [Sheehan, 1986].
122465	RCA Region in ROA Projection	Based on a total number of chords of 100 and RAO project the range of chords belonging to this circumferential extent lies between 25 - 85. [Sheehan, 1986].
122466	Single LAD Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 66 (hypokinetic) and 67 - 80 (hyperkinetic). [Sheehan, 1986].
122467	Single RCA Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 51 - 80 (hypokinetic) and 10 - 50 (hyperkinetic). [Sheehan, 1986].
122468	Multiple LAD Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 10 - 58 (hypokinetic) and 59 -80 (hyperkinetic). [Sheehan, 1986].
122469	Multiple RCA Region in RAO Projection	Based on a total number of chords of 100 and RAO projection the range of chords belonging to this regional extent lies between 59 - 80 (hypokinetic) and 10 - 58 (hyperkinetic). [Sheehan, 1986].
122470	LAD Region in LAO Projection	Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 50 -100 (hypokinetic) and 20 - 49 (hyperkinetic). [Sheehan, 1986].
122471	RCA Region in LAO Projection	Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 19 - 67 (hypokinetic) and 68 - 100 (hyperkinetic). [Sheehan, 1986].
122472	CFX Region in LAO Projection	Based on a total number of chords of 100 and LAO projection the range of chords belonging to this regional extent lies between 38 -74 (hypokinetic) and 75 - 100 (hyperkinetic). [Sheehan, 1986].
122473	Circular Method	Method based on assumption that the image object is circular.
122474	Densitometric Method	Method based on the gray value distribution of the image.
122475	Center of Gravity	End Systolic contour realigned to End Diastolic contour based on the center of gravity.
122476	Long Axis Based	End Systolic contour realigned to End Diastolic contour based on the mid point of the long axis. The long axis end points are defined as the posterior and apex.
122477	No Realignment	No Contour Realignment applied.
122480	Vessel Lumen Cross-Sectional Area	Calculated Vessel Lumen Cross-Sectional Area based on the referenced method.
122481	Contour Start	Location of the beginning of a contour.
122482	Contour End	Location of the end of a contour.
122485	Sphere	Sphere visible in an image, which is used as a calibration or marker object.
122486	Geometric Isocenter	Object of interest in isocenter of image and pixel separation is calculated from geometric data.
122487	Geometric Non-Isocenter	Object of interest not in isocenter of image and pixel separation is calculated from geometric data and out of isocenter distances.
122488	Calibration Object Used	Object used for calibration. E.g., sphere.
122489	Curve Fitted Reference	Application dependent method to calculate the reference diameter based on the multiple diameter values.
122490	Interpolated Local Reference	Application dependent method to calculate reference by interpolation, based on the diameter of two or more user defined reference positions.
122491	Mean Local Reference	Application dependent method to calculate by averaging the reference, based on the diameter of one or more user defined reference positions.
122493	Radial Based Wall Motion Analysis	Method to calculate wall motion based on the lengths of the radials in the predefined regions [Ingels].
122495	Regional Contribution to Ejection Fraction	Contribution of Region to global Ejection factor based on radial or landmark based wall motion method.
122496	Radial Shortening	The reduction of area between End Systolic and End Diastolic based on radial wall motion analysis.
122497	Landmark Based Wall Motion Analysis	Method to calculate wall motion based on the move of landmarks on the wall [Slager].
122498	Slice Contribution to Ejection Fraction	Contribution to the ejection fraction of a specific slice region [Slager].
122499	Frame to Frame Analysis	Method to calculate volumes of heart chambers for every image in a range.
122501	Area of closed irregular polygon	The area is derived by considering a set of coordinates as a closed irregular polygon, accounting for inner angles. The exact method, such as by decomposition into triangles or quadrilaterals, is not specified, since it does not affect the numeric result, apart from the effect of numeric precision during computation of intermediate results.
122502	Area of a closed NURBS	The area is derived by using a set of coordinates as control points for a Non Uniform Rational B-Spline (NURBS).
122503	Integration of sum of closed areas on contiguous slices method for volume	Method of integrating the sum of the areas on adjacent slices across the slice interval to derive a total volume; each area is defined by a regular planar shape or by considering a set of coordinates as a closed irregular polygon, accounting for inner angles.
122505	Calibration	Procedure used to calibrate measurements or measurement devices.
122507	Left Contour	Left contour of lumen (direction proximal to distal).
122508	Right Contour	Right contour of lumen (direction proximal to distal).
122509	Diameter Graph	Ordered set of diameters values derived from contours (direction proximal to distal).
122510	Length Luminal Segment	Length Luminal Segment.
122511	Graph Increment	Increment value along X-axis in Diameter Graph.
122516	Site of Maximum Luminal	Location of the maximum lumen area in a lesion or vessel.
122517	Densitometric Luminal Cross-sectional Area Graph	Ordered set of cross-sectional Vessel Lumen Cross-Sectional Area values derived from contours (direction proximal to distal) based on densitometric method.
122528	Position of Proximal Border	Position of proximal border of segment relative to the contour start (proximal end of analysis area).
122529	Position of Distal Border	Position of distal border of segment relative to the contour start (proximal end of analysis area).
122542	Plaque Area	Longitudinal cross sectional area of plaque.
122544	Diameter Symmetry	Symmetry of stenosis (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 “Definition of Diameter Symmetry with Arterial Plaques” in PS3.17 .
122545	Area Symmetry	Symmetry of plaque (0 = complete asymmetry, 1 = complete symmetry); see Section T.2 “Definition of Diameter Symmetry with Arterial Plaques” in PS3.17 .
122546	Inflow Angle	The average slope of the diameter function between the position of the minimum luminal diameter and the position of the proximal border of the segment.
122547	Outflow Angle	The average slope of the diameter function between the position of the minimum luminal diameter and the position of the distal border of the segment.
122548	Stenotic Flow Reserve	The relation between coronary pressure and coronary flow.
122549	Poiseuille Resistance	Poiseuille Resistance at the location of the stenosis.
122550	Turbulence Resistance	Turbulence Resistance at the location of the stenosis.
122551	Pressure Drop at SFR	Pressure drop over the stenosis at maximum heart output.
122554	Segmentation Method	Method for selection of vessel sub-segments.
122555	Estimated Normal Flow	Estimate of the volume of blood flow in the absence of stenosis.
122558	Area Length Kennedy	Area Length method defined by Kennedy [Kennedy, 1970].
122559	Area Length Dodge	Area Length method defined by Dodge [Dodge, 1960].
122560	Area Length Wynne	Area Length method defined by Wynne [Wynne].
122562	Multiple Slices	Volume method based on multiple slice.
122563	Boak	Volume method defined by Boak [Boak].
122564	TS Pyramid	Volume method defined by Ferlinz [Ferlinz].
122565	Two Chamber	Volume method defined by Graham [Graham].
122566	Parallelepiped	Volume method defined by Arcilla [Arcilla].
122572	BSA^1.219	Corrected Body Surface area for indexing the hemodynamic measurements for a pediatric patient.
122574	Equidistant method	Method for selecting sub-segments that are all of the same length.
122575	User selected method	Manually selected start and end of sub-segment.
122582	Left ventricular posterobasal segment	Left ventricular posterobasal segment.
122600	Cardiovascular Analysis Report	Report of a Cardiovascular Analysis, typically from a CT or MR study.
122601	Ventricular Analysis	Ventricular Analysis.
122602	Myocardial Perfusion Analysis	Myocardial Perfusion Analysis.
122603	Calcium Scoring Analysis	Calcium Scoring Analysis.
122604	Flow Quantification	Flow Quantification Analysis.
122605	Vascular Morphological Analysis	Vascular Morphological Analysis.
122606	Vascular Functional Analysis	Vascular Functional Analysis.
122607	Thickening Analysis	Analysis of myocardial wall thickening.
122608	Absolute Values Of Ventricular Measurements	Section Heading for absolute values of ventricular measurements.
122609	Normalized Values Of Ventricular Measurements	Results of normalizing ventricular measurements.
122611	Reference Point	Reference Point of a measurement.
122612	Central breathing position	Central breathing position between inspiration and expiration.
122616	Peak Ejection Rate	Peak of the ventricular ejection rate.
122617	Peak Ejection Time	Time of the peak of ventricular ejection.
122618	Peak Filling Rate	Peak of the fluid filling rate.
122619	Peak Filling Time	Time interval until time of peak filling from a given reference point. E.g., end systole.
122620	Papillary Muscle Excluded	Papillary muscle was excluded from the measurement.
122621	Papillary Muscle Included	Papillary muscle was included in the measurement.
122624	Wall Thickness Ratio end-systolic to end-diastolic	The ratio of the end-systolic wall thickness compared to the end-diastolic wall thickness.
122627	Curve Fit Method	The method to smooth a ventricular volume as a function of time.
122628	Baseline Result Correction	Baseline correction used in the calculation of the results.
122631	Signal Earliest Peak Time	The time in a dynamic set of images at which the first peak of the signal is observed for the analyzed myocardial wall segments.
122633	Signal Increase Start Time	This is the time at which the signal begins to increase.
122634	Signal Time to Peak	Time interval between the beginning of the signal increase to the time at which the signal intensity reaches its first maximum in a dynamic set of images.
122635	MR Perfusion Peak	Peak of the MR perfusion signal.
122636	MR Perfusion Slope	Signal intensity as a function of time. It is the change in the signal intensity divided by the change in the time.
122637	MR Perfusion Time Integral	MR perfusion time integral from baseline (foot time) to earliest peak.
122638	Signal Baseline Start	First time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment.
122639	Signal Baseline End	Last time point in a dynamic set of images used in the calculation of the baseline signal intensity for each myocardial wall segment.
122640	Image Interval	The time delta between images in a dynamic set of images.
122642	Velocity Encoding Minimum Value	The minimum velocity encoded by the phase encoding gradient.
122643	Velocity Encoding Maximum Value	The maximum velocity encoded by the phase encoding gradient.
122645	Net Forward Volume	Forward volume-reverse volume.
122650	Area Based Method	Area Based Method for estimating volume or area.
122651	Diameter Based Method	Diameter Based Method for estimating volume, area or diameter.
122652	Volume Based Method	Volume Based Method for estimating volume.
122655	NASCET	A method of diameter measurements according to NASCET (North American Symptomatic Carotid Endarterectomy Trial).
122656	ECST	A method of diameter measurements according to ECST (European Carotid Surgery Trial).
122657	Agatston Score Threshold	Agatston Score Threshold.
122658	Calcium Mass Threshold	Calcium Mass Threshold.
122659	Calcium Scoring Calibration	Calcium Scoring Calibration.
122660	Calcium Volume	Calcium Volume.
122661	Calcium Mass	Calcium Mass.
122664	Late Contrast Enhancement	Delayed hyperenhancement of a tissue observed in an image acquired after injection of contrast media.
122665	Time interval since injection of contrast media	Time interval since injection of contrast media.
122666	Time relative to R-wave peak	Time relative to R-wave peak.
122667	Blood velocity vs. time of cardiac cycle	Relationship between blood velocity and time relative to R-wave peak.
122668	Time interval since detection of contrast bolus	Time interval since detection of contrast bolus.
122670	Papillary Muscle Included/Excluded	Indicates if the papillary muscle was included or excluded in the measurement.
122675	Anterior-Posterior	Anterior to Posterior direction.
122680	endoleak	Persistent flow of blood into the stent-grafting.
122683	Stent Fracture	Fracture of a stent.
122684	Stent Disintegration	Disintegration of a stent.
122685	Stent Composition	Material that a stent consists of.
122686	Parent Vessel Finding	Finding about the characteristics of the parent vessel of a vessel.
122687	Site of Lumen Maximum	Site of Maximal lumen diameter of a vessel.
122698	X-Concept	The physical domain (time, space, etc.) to the horizontal axis of the graphical presentation.
122699	Y-Concept	The physical domain (time, space, etc.) to the vertical axis of the graphical presentation.
122700	Indications for Pharmacological Stress	Indications for Pharmacological Stress.
122701	Procedure time base	Reference time for measurement of elapsed time in a procedure.
122702	Treadmill speed	Treadmill speed.
122703	Treadmill gradient	Treadmill gradient.
122704	Ergometer power	Ergometer power.
122705	Pharmacological Stress Agent Dose Rate	Pharmacological Stress Agent Dose Rate.
122706	Rating of Perceived Exertion	Rating of Perceived Exertion.
122707	Number of Ectopic Beats	Number of ectopic beats during a period of collection.
122708	Double Product	Heart rate times systolic blood pressure.
122709	Activity workload	Physical activity workload (intensity) measurement.
122710	Time since start of stage	Elapsed time at stage.
122711	Exercise duration after stress agent injection	Exercise duration after stress agent injection.
122712	Imaging Start DateTime	Imaging Start DateTime.
122713	Attenuation correction method	Attenuation correction method.
122715	Pharmacological Stress Agent Dose	Pharmacological Stress Agent Dose.
122716	Maximum Power Output Achieved	Maximum power output achieved during course of procedure.
122717	Peak activity workload	Peak physical activity intensity measurement during course of procedure.
122718	Peak Double Product	Peak Double Product measurement during course of procedure.
122720	OSEM algorithm	Ordered subsets expectation maximization reconstruction algorithm.
122721	Chang method	Chang attenuation correction method.
122726	Algorithmic attenuation correction	Attenuation correction not based on image-based attenuation maps.
122727	NM transmission attenuation correction	NM transmission attenuation correction.
122728	CT-based attenuation correction	CT-based attenuation correction.
122729	No Attenuation Correction	No attenuation correction.
122730	Bazett QTc Algorithm	Bazett QT Correction Algorithm; QT/(RR ^ 0.5); Bazett HC. "An analysis of the time-relations of electrocardiograms" Heart7:353-370 (1920).
122731	Hodges QTc Algorithm	Hodges QT Correction Algorithm; QT + 1.75 (heart rate-60); Hodges M, Salerno Q, Erlien D. "Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better." J Am Coll Cardiol1:694 (1983).
122732	Fridericia QTc Algorithm	Fridericia QT Correction Algorithm; QT/(RR ^ 0.333); Fridericia LS. "The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease" Acta Med Scand53:469-486 (1920).
122733	Framingham QTc Algorithm	Framingham QT Correction Algorithm; QT + 0.154 (1- RR); Sagie A, Larson MG, Goldberg RJ, et al. "An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)." Am J Cardiol70:797-801(1992).
122734	Borg RPE Scale	Borg Rating of Perceived Exertion Scale, range 6:20.
122735	Borg CR10 Scale	Borg category ratio scale, open ended range with nominal range 0:10.
122739	Overall study quality	Quality of a study for the purpose for which it was created.
122740	Excellent image quality	Quality of an image is excellent for the purpose for which it was created.
122741	Good image quality	Quality of an image is good for the purpose for which it was created.
122742	Poor image quality	Quality of an image is poor for the purpose for which it was created.
122743	Body habitus attenuation	Image attenuation due to body physique (overweight).
122744	Breast attenuation	Image attenuation due to breast tissue.
122745	Diaphragmatic attenuation	Image attenuation due to diaphragm.
122748	False positive defect finding	Finding of a defect is incorrect. E.g., from automated analysis.
122750	Non-diagnostic - low heart rate	ECG is non-diagnostic due to low heart rate.
122751	Non-diagnostic - resting ST abnormalities	ECG is non-diagnostic due to resting ST abnormalities.
122752	Non-diagnostic - ventricular pacing or LBBB	ECG is non-diagnostic due to ventricular pacing or Left Bundle Branch Block.
122753	Non-diagnostic ECG	ECG is non-diagnostic for presence of acute coronary syndrome.
122755	Strongly positive	Strongly positive finding.
122756	Strongly positive - ST elevation	Strongly positive finding - ST elevation.
122757	ST Depression - Horizontal	Finding of ST segment depression with no slope.
122758	ST Depression - Upsloping	Finding of ST segment depression with upslope.
122759	ST Depression - Downsloping	Finding of ST segment depression with downslope.
122760	Stress test score	Stress test score.
122762	Number of diseased vessel territories	Number of diseased vessel territories.
122764	Weight exceeds equipment limit	Patient weight exceeds equipment limit.
122768	Difference in Ejection Fraction	Difference in Ejection Fraction.
122769	Difference in ED LV Volume	Difference in End Diastolic Left Ventricular Volume.
122770	Ratio of achieved to predicted maximal oxygen consumption	Ratio of achieved to predicted maximal oxygen consumption.
122771	Ratio of achieved to predicted functional capacity	Ratio of achieved to predicted functional capacity.
122772	Aerobic index	Workload (Watts) at target heart rate divided by body weight.
122773	ST/HR Index	ST depression at peak exercise divided by the exercise-induced increase in heart rate [Kligfield P, Ameisen O, Okin PM. "Heart rate adjustment of ST segment depression for improved detection of coronary artery disease." Circulation 1989;79:245-55.].
122775	Agreement with prior findings	Agreement with prior findings.
122776	Disagreement with prior findings	Disagreement with prior findings.
122781	Rest thallium/stress technetium procedure	Nuclear Medicine Rest thallium/stress technetium procedure.
122782	Rest technetium/stress technetium 1 day procedure	Nuclear Medicine Rest technetium/stress technetium 1 day procedure.
122783	Rest technetium/stress technetium 2 day procedure	Nuclear Medicine Rest technetium/stress technetium 2 day procedure.
122784	Stress technetium/rest technetium 1 day procedure	Nuclear Medicine Stress technetium/rest technetium 1 day procedure.
122785	NM Myocardial Viability procedure	Nuclear Medicine Myocardial Viability procedure.
122791	PET Myocardial Perfusion, Rest only	Positron Emission Tomography Perfusion Imaging procedure, rest only.
122792	PET Myocardial Perfusion, Stress only	Positron Emission Tomography Perfusion Imaging procedure, stress only.
122793	PET Myocardial Perfusion, Rest and Stress	Positron Emission Tomography Perfusion Imaging procedure, rest and stress.
122795	PET Myocardial Viability, Rest only	Positron Emission Tomography Myocardial Viability procedure, rest only.
122796	PET Myocardial Viability, Stress only	Positron Emission Tomography Myocardial Viability procedure, stress only.
122797	PET Myocardial Viability, Rest and Stress	Positron Emission Tomography Myocardial Viability procedure, rest and stress.
122799	Anginal Equivalent	Group of symptoms heralding angina pectoris that does not include chest pain (dyspnea, diaphoresis, profuse vomiting in a diabetic patient, or arm or jaw pain).
123001	Radiopharmaceutical	Active ingredient (molecular) used for radioactive tracing.	Retired. Replaced by (349358000, SCT, "Radiopharmaceutical agent").
123003	Radiopharmaceutical Start DateTime	DateTime of radiopharmaceutical administration to the patient for imaging purposes.
123004	Radiopharmaceutical Stop DateTime	Ending DateTime of radiopharmaceutical administration to the patient for imaging purposes.
123005	Radiopharmaceutical Volume	Volume of radiopharmaceutical administered to the patient.
123006	Radionuclide Total Dose	Total amount of radionuclide administered to the patient at Radiopharmaceutical Start Time.
123007	Radiopharmaceutical Specific Activity	Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time.
123009	Radionuclide Syringe Counts	Pre-injection syringe acquisition count rate.
123010	Radionuclide Residual Syringe Counts	Syringe acquisition count rate following patient injection.
123011	Contrast/Bolus Agent	Contrast or bolus agent.
123012	Pre-Medication	Medication to be administered at the beginning of the Scheduled Procedure Step.
123014	Target Region	Anatomic Region to be imaged.
123015	Imaging Direction	Direction of imaging (includes view, transducer orientation, patient orientation, and/or projection).
123016	Imaging Conditions	Imaging condition for refinement of protocol (includes secondary posture, instruction, X-Ray / electron beam energy or nuclide, and ultrasound modes), as used in JJ1017 v3.0.
123019	Caudal 10 degree distal-cranioproximal oblique	Caudal 10 degree distal-cranioproximal oblique radiographic projection, defined per Smallwood et al.
123101	Neighborhood Analysis	Surface processing utilizing predefined weighting factors (i.e., kernels) applied to different data values depending on their location relative to other data values within the data domain. Includes Low Pass, High Pass, Gaussian, Laplacian, etc.
123102	Adaptive Filtering	Surface processing applied non-uniformly utilizing a priori knowledge of the system and/or relative locations of the data values within the data domain. Example: Neighborhood analysis where weighting factors are modified continuously based on predefined criteria.
123103	Edge Detection	Surface processing through the exploitation of discontinuities in the data values within their domain. Includes Gradient filters.
123104	Morphological Operations	Surface processing based on the connectivity of values based on the shape or structure of the data values within their domain. Includes erode, dilate, etc.
123105	Histogram Analysis	Surface processing applied to the distribution of the data values. Includes thresholding, Bayesian Classification, etc.
123106	Multi-Scale/Resolution Filtering	Surface processing accomplished through varying the data domain size. Include deformable models.
123107	Cluster Analysis	Surface processing accomplished by combining data values based on their relative location within their domain or value distribution. Includes K- and C-means, Fuzzy Analysis, Watershed, Seed Growing, etc.
123108	Multispectral Processing	Surface processing accomplished through the weighted combination of multiple sets of data. Includes Principle Component Analysis, linear and non-linear weighed combinations, etc.
123109	Manual Processing	Surface processing accomplished through human interaction. Region drawing.
123110	Artificial Intelligence	Surface processing using Artificial Intelligence techniques, such as Machine Learning, Neural Networks, etc.
123111	Deformable Models	Surface processing using Deformable Model techniques, such as Point Distribution Models, Level Sets, Simplex Meshes, etc.
125000	OB-GYN Ultrasound Procedure Report	Document Title of OB-GYN procedure report.
125001	Fetal Biometry Ratios	Report section for assessment of fetal growth using ratios and indexes.
125002	Fetal Biometry	Report section for assessment of fetal growth.
125003	Fetal Long Bones	Report section for assessment of fetal growth by long bone measurements.
125004	Fetal Cranium	Report section for assessment of fetal cranium growth.
125005	Biometry Group	Biometric assessment of.
125006	Biophysical Profile	Report section for assessment of biophysical observations that evaluate fetal well-being according to Manning, Antepartum Fetal Evaluation: Development of a Fetal Biophysical Profile Score, Am. J Obstet Gynecol, 1980;136:787.
125007	Measurement Group	A grouping of related measurements and calculations that share a common context.
125008	Fetus Summary	Report section for fetus specific procedure summary observations.
125009	Early Gestation	Report section for assessment of early gestation fetus.
125010	Identifier	A name to differentiate between multiple instances of some item.
125011	Pelvis and Uterus	Report section for assessment of pelvis and uterus.
125012	Growth Percentile rank	The rank of a measured growth indicator relative to a normal distribution expressed as a percentage.
125013	Growth Z-score	The rank of a measured growth indicator relative to a normal distribution expressed as the dimensionless quantity z = (x-m) /s where (x-m) is the deviation of the value x, from the distribution mean, m, and s is the standard deviation of the distribution.
125015	Fetus Characteristics	Fetus characteristics (findings section title).
125016	Fetal Measurements	Fetal Measurements (findings section title).
125021	Frame of Reference Identity	There is a defined equivalence between the Frame of Reference of the Registration SOP instance and the Frame of Reference of the referenced images.
125022	Fiducial Alignment	The registration is based on fiducials that represent patient or specimen features identified in each set of data.
125023	Acquisition Equipment Alignment	Registration based on a-priori knowledge of the acquisition geometry. This is not an object registration as in fiducial registration. Rather, it specifies a known spatial relationship.
125024	Image Content-based Alignment	Computed registration based on global image information.
125025	Visual Alignment	Registration by visually guided manipulation.
125026	Image Content and Fiducial Based Alignment	The registration is based on fiducials that represent patient or specimen features identified in each data set in combination with global image information.
125027	Deformed for Registration	Values are derived by sampling data from a Source Image into a Registered Reference Coordinate System based on a Deformable Spatial Registration Instance.
125028	Source Deformable Spatial Registration	Deformable Spatial Registration Instance used for image deformation.
125030	Inter-Hemispheric Plane	A plane fiducial that specifies the location of the plane separating the two hemispheres of the brain.
125031	Right Hemisphere Most Anterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the right brain hemisphere.
125032	Right Hemisphere Most Posterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the right brain hemisphere.
125033	Right Hemisphere Most Superior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the right brain hemisphere.
125034	Right Hemisphere Most Inferior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the Right brain hemisphere.
125035	Left Hemisphere Most Anterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the anterior limit of the left brain hemisphere.
125036	Left Hemisphere Most Posterior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the posterior limit of the left brain hemisphere.
125037	Left Hemisphere Most Superior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the superior limit of the left brain hemisphere.
125038	Left Hemisphere Most Inferior	A point fiducial that specifies the location in the plane perpendicular to the Anterior- Posterior-Commissure axis and tangential to the inferior limit of the left brain hemisphere.
125040	Background	That which is not part of an object.	E.g., background of an image (that which might be encoded with Pixel Padding Value, or a Segmentation Property Type.
125041	Registration Input	A segment for use as an input to an image registration process. E.g., to specify the bounding region for determining a Frame of Reference Transformation Matrix.
125100	Vascular Ultrasound Procedure Report	Root Document Title for ultrasound vascular evidence reports (worksheets).	Retired. Replaced by (39445-2, LN, "US Doppler Vessels Report".
125101	Vessel Branch	The particular vessel branch, such as the inferior, medial or lateral.
125102	Graft Type	A descriptor or elaboration of the type of graft.
125105	Measurement Orientation	A modifier to a 2D distance measurement to describe its orientation. E.g., a vascular distance measurement for a vessel plague could have a modifier Transverse or Longitudinal.
125106	Doppler Angle	The angle formed between the Doppler beam line and the direction of blood flow within a region of interest in the body defined by the sample volume.
125107	Sample Volume Depth	The depth of the center of the Doppler sample volume measured from skin line along the Doppler line.
125195	Pediatric Cardiac Ultrasound Report	Pediatric Cardiac Ultrasound Report (document title).
125196	Fetal Cardiac Ultrasound Report	Fetal Cardiac Ultrasound Report (document title).
125197	Adult Congenital Cardiac Ultrasound Report	Adult Congenital Cardiac Ultrasound Report (document title).
125200	Adult Echocardiography Procedure Report	Document title of adult echocardiography procedure (evidence) report.
125201	Illustration of Finding	An image that is a pictorial representation of findings. The concept is typically used as a purpose of reference to an image, such as a depiction of myocardium segments depicting wall motion function.
125202	LV Wall Motion Score Index	The average of all scored (non-zero) Left Ventricle segment wall motion scores.
125203	Acquisition Protocol	A type of clinical acquisition protocol for creating images or image-derived measurements. Acquisition protocols may be specific to a manufacturer's product.
125204	Area-length biplane	Method for calculating left ventricular volume from two orthogonal views containing the true long axis (usually the apical 4 and 2 chamber views). Volume = [pL₁ / 6] * [(4A₁) ¸ (pL₁) ] * [(4A₂) ¸ (pL₂) ].
125205	Area-Length Single Plane	Method for calculating left ventricular volume from a view containing the true long axis (usually the apical 4-chamber view). Volume = [8(A)²]¸[3pL].
125206	Cube	Method (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) that estimates the volume as the cube of diameter.
125207	Method of Disks, Biplane	Method of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis and using a disk diameter averaged from the two chamber and four chamber views.
125208	Method of Disks, Single Plane	Method of calculating volume based on the summation of disk volumes. The disk axis is parallel to the left ventricular long axis with disk diameter taken from the four-chamber view.
125209	Teichholz	Method (formula) for calculating left ventricle volumes and function derivatives (EF, SV, SI, etc.) Volume = [7.0/(2.4+D) ]*D³.
125210	Area by Pressure Half-Time	Mitral valve area (cm2) by Pressure Half-time = 220 (cm2.ms) / PHT (ms).
125211	Biplane Ellipse	Area = P/4 X d1 X d2 d1 = anterior/posterior axis d2 = medial/lateral axis Hagen-Ansert, Sandra L., Textbook of Diagnostic Ultrasound, ed. 3, The C.V.Mosby Co., 1989, p. 73. .
125212	Continuity Equation	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the velocity.
125213	Continuity Equation by Mean Velocity	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the mean velocity.
125214	Continuity Equation by Peak Velocity	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the peak velocity.
125215	Continuity Equation by Velocity Time Integral	For conduits in series ("in continuity"), volume flow is equal: A1V1 = A2V2. where V is the velocity time integral.
125216	Proximal Isovelocity Surface Area	Utilizes aliasing velocity (by color Doppler) of flow into an orifice (often regurgitant or stenotic) to measure instantaneous flow rate, orifice area, and flow volume. The instantaneous flow rate = (2πr²v_av ) * (απ) where v_av is the constant velocity known as aliasing velocity at radius r, v_p is the peak velocity at the orifice, and α is the angle in radians of the constant velocity surface. Estimated Orifice area = Flow rate / v_p , where v_p is the peak velocity at the orifice and the flow rate is the PISA peak flow rate. The volume flow is then the product of the orifice area and Velocity Time Integral.
125217	Full Bernoulli	ΔP = 4*(V1² - V2²).
125218	Simplified Bernoulli	ΔP = 4*V2.
125219	Doppler Volume Flow	Volume flow = Conduit CSA * (Velocity Time Integral).
125220	Planimetry	Direct measurement of an area by tracing an irregular perimeter.
125221	Left Ventricle Mass by M-mode	Mass = 1.04 * [(ST+LVID+PWT)³ - LVID³] * 0.8+ 0.6. Mass unit is grams and length in cm.
125222	Left Ventricle Mass by Truncated Ellipse	Mass = 1.05P ((b + t)² X (2/3 (a + t) + d - d³ /3(a + t)²) - b² (2/3a + d - d³ /3a²)) a = Semi-major axis from widest minor axis radius to apex. b = Short axis radius calculated from short axis cavity area t = Myocardial thickness calculated from short axis epicardial and cavity areas d = Truncated semi-major axis from widest short axis diameter to plane of mitral annulus. Mass unit is grams and length in cm. Schiller NB et al: Recommendations for quantification of the left ventricle by two-dimensional echocardiography, American Society of Echocardiography 2:364, 1989. .
125223	4 Point Segment Finding Scale	A four point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989.
125224	5 Point Segment Finding Scale	A five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989.
125225	5 Point Segment Finding Scale With Graded Hypokinesis	A five point, echocardiographic numeric scoring scheme of myocardium segments based on evaluation of wall motion and ventricle morphology, with severity of hypokinesis graded. Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, 2:358-367, 1989.
125226	Single Plane Ellipse	Method of estimating volume from a planar ellipse. Equivalent to Biplane Ellipse with an assumption that the ellipse in the orthogonal plane has identical major and minor diameters.
125227	Modified Simpson	Modified Simpson's Method of estimating ventricular volume, based on the method of disks with paired apical views. Schiller NB, et al. "Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms". J Am Soc Echocardiogr.1989 2(5):358-367. Sep-Oct.
125228	Bullet Method	Bullet method of estimating ventricular volume. Volume = 5/6 * L * S L: Left ventricle long axis length S: Left ventricle area, SAX view at level of Mitral Valve.
125230	Power Doppler	Color coded ultrasound images of blood flow, which depict the amplitude, or power, of Doppler signals.	Retired Replaced by (425704008, SCT, "Power Doppler")
125231	3D mode	Volumetric ultrasound imaging	Retired Replaced by (426865009, SCT, "3D mode")
125233	Start of drug dose administration	Onset of administration of dose of a drug.
125234	Start of contrast agent administration	Onset of contrast agent administration.
125235	Destruction of microbubbles	Destruction of ultrasonic contrast microbubbles by a high-energy ultrasound pulse.
125236	Onset of exercise	Instant at which exercise begins.
125237	Cessation of exercise	Instant at which exercise ends.
125238	Onset of stimulation	Instant at which stimulation begins.
125239	Cessation of stimulation	Instant at which stimulation ends.
125240	Line scan pattern	Ultrasound transducer scan pattern in which information is gathered along a line.
125241	Plane scan pattern	Ultrasound transducer scan pattern in which information is gathered within a plane.
125242	Volume scan pattern	Ultrasound transducer scan pattern in which information is gathered within a volume.
125251	Non-imaging Doppler ultrasound transducer geometry	Ultrasound transducer geometry characterized by a single scan line used for PW or CW Doppler scanning.
125252	Linear ultrasound transducer geometry	Ultrasonic transducer geometry characterized by parallel lines.
125253	Curved linear ultrasound transducer geometry	Ultrasonic transducer geometry characterized by radial lines normal to the outside of a curved surface.
125254	Sector ultrasound transducer geometry	Ultrasonic transducer geometry characterized by lines originating from a common apex.
125255	Radial ultrasound transducer geometry	Ultrasonic transducer geometry characterized by lines emanating radially from a single point.
125256	Ring ultrasound transducer geometry	Ultrasonic transducer geometry characterized by a circular ring of transducer elements.
125257	Fixed beam direction	Ultrasonic steering technique consisting of a single beam normal to the transducer face steered by the orientation of the probe.
125258	Mechanical beam steering	Ultrasonic steering technique consisting of mechanically directing the beam.
125259	Phased beam steering	Ultrasonic steering technique consisting of electronically-steered beams.
125261	External Transducer	Transducer is designed to be placed onto the surface of the subject.
125262	Transesophageal Transducer	Transducer is designed for insertion into the esophagus.
125263	Endovaginal Transducer	Transducer is designed for insertion into the vagina.
125264	Endorectal Transducer	Transducer is designed for insertion into the rectum.
125265	Intravascular Transducer	Transducer is designed for insertion into the subject via a catheter.
125266	Endocavitary Transducer	Transducer is designed for insertion into either the vaginal cavity or the rectal cavity.
125267	Intraoperative Transducer	Transducer is designed for insertion into the subject via an incision.
125270	Left Ventricle Mass by Area Length	method to measure the mass of the Left Ventricle via the ASE area-length method at end diastole. LV Mass = 1.05(5/6(A1(L+t)) - 5/6(A2*L)) A1 = Left Ventricle epicardial SAX area at the level of the papillary muscle tips at end diastole. A2 = Left Ventricle endocardial SAX area cavity area at the level of the papillary muscle tips at end diastole. L = Left Ventricle apical view long axis length at end diastole. t = Myocardial thickness can be computed as: t = sqrt (A1/3.14) - sqrt (A2/3.14) Reference: 1) Schiller, N.B., et al. "Recommendations for Quantification of the LV by Two-dimensional Echocardiography." J Am Soc Echo, Vol. 2, No. 5: 358-367, Sep-Oct 1989. 2) Reichek, N., et al. "Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two-dimensional Echocardiography: Initial Results." Circulation, Vol. 67, No. 2: 348-52, February 1983.
125271	Left Ventricle Mass by M-mode - adjusted by Height	Equation = Left Ventricle Mass by M-mode (in gram) / (Height (in meter)) ^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio.
125272	Left Ventricle Mass by Truncated Ellipse - adjusted by Height	Equation = Left Ventricle Mass by Truncated Ellipse / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio.
125273	Left Ventricle Mass by Area Length - adjusted by Height	Equation = Left Ventricle Mass by Area Length / Height^2.7 Reference: Giovanni De Simone, et al. "Effect of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacity to Predict Cardiovascular Risk". New York, New York and Cincinnati, Ohio.
125301	Pre-coordinated Measurements	Measurements that are described by a single pre-coordinated code.
125302	Post-coordinated Measurements	Measurements that are described by a collection of (generally atomic) post-coordinated codes.
125303	Adhoc Measurements	Measurements taken in an ad hoc fashion without any coordinated semantics.
125304	Untrackable Measurement	The source system of the measurement does not maintain a persistent pre-coordinated code by which different instances of the measurement can be associated and tracked over multiple procedures.
125305	Finding Observation Type	The type of observation made at the finding site, e.g., whether it is an observation of the structure of the finding site, an observation of the behavior of the finding site, or an observation of the blood flow at the finding site.
125306	Measurement Type	The type of derivation used to obtain the measurement value. E.g. whether it is taken directly, formed as a ratio, normalized against an index, or calculated using a more elaborate equation.
125307	Measured Property	The property that is being measured. Examples include mass, diameter, peak blood velocity.
125308	Measurement Divisor	The measurement which is the denominator of a measurement that is divided. This applies to measurements such as ratios or indexed values.
125309	Short Label	A brief label, suitable for display on a screen or report. (Not suitable for matching).
125310	Staged Measurements	Measurements that need to be associated with a specific stage in a procedure or acquisition protocol.
125311	Structure of the Finding Site	The subject of a measurement is the physical structure of the Finding Site, such as the mass or diameter.
125312	Behavior of the Finding Site	The subject of a measurement is the behavior of the Finding Site, such as the velocity or duration of motion.
125313	Indexed	The measurement has been normalized by dividing it by an index value (such as Body Surface Area).
125314	Fractional Change	The measurement is a change value expressed as a fraction of its baseline value. E.g. cardiac ejection fraction or fractional shortening.
125315	Calculated	The measurement is calculated by incorporating one or more measured values into an equation other than a ratio, fractional change or indexed calculation.
125316	Directly measured	The measurement is a direct output of the measurement tool.
125317	Right Ventricle Outflow Tract, Distal	The distal portion (at the Pulmonic Valve) of the Right Ventricle Outflow Tract.
125318	Right Ventricle Outflow Tract, Proximal	The proximal portion (subvalvular) of the Right Ventricle Outflow Tract.
125319	Right Ventricle Anterior Wall	The anterior wall of the right ventricle of the heart.
125320	Electromechanical Delay	The period of time between the onset of muscle activation and the onset of force or motion.
125321	Pre-ejection Period	The period between onset of ventricular contraction and the beginning of antegrade blood flow out of the ventricle.
125322	Atrial Diastolic Filling (D-wave)	The period of atrial diastolic filling.
125323	AR-wave	The period of retrograde flow into the pulmonary vein during atrial contraction.
125324	Full Cardiac Cycle	The period of the entire cardiac cycle. E.g. from End Systole of one heartbeat to End Systole of the next heartbeat.
125325	Dyssynchrony Index	The standard deviation over 12 left ventricle myocardial segments of the time to peak myocardial sustained systolic velocity of each segment. See Yu, et al., Circulation, 2002; 105: 438-445
125326	Effective Orifice Area	The effective area of an orifice (such as the mitral valve orifice) during bloodflow through the orifice.
125327	Excursion Distance	The distance traversed by some tissue over a defined period.
125328	Maximum Orifice Area	The maximum area of an orifice opening over a defined period.
125329	Peak Blood Pressure	The peak pressure of blood over a defined period at a defined location.
125330	Peak Tissue Velocity	The peak velocity of some tissue over a defined period
125331	PISA Radius	The radius of the proximal isovelocity surface area (PISA) of fluid flow approaching an orifice. It is commonly used to evaluate cardiac valve regurgitation.
125332	Regurgitation Jet Area	A cross-sectional area of a regurgitation jet, taken perpendicular to the primary flow.
125333	Regurgitation Jet Width	A width of a regurgitation jet taken perpendicular to the primary flow.
125334	Vena Contracta Width	The width of the vena contracta of a fluid flow.
125901	CARDIOsphere	CARDIOsphere™ ultrasonic contrast agent produced by POINT Biomedical.
125902	Echovist	Echovist® ultrasonic contrast agent produced by Schering AG.
125903	Imagify	Imagify™ ultrasonic contrast agent produced by Accusphere Inc.
125904	Levovist	Levovist® ultrasonic contrast agent produced by Schering AG.
125905	Sonazoid	Sonazoid™ ultrasonic contrast agent produced by Daiichi Pharmaceutical / General Electric.
125906	SonoVue	SonoVue™ ultrasonic contrast agent produced by Bracco Diagnostics.
125907	Targestar-B	Targestar™-B ultrasonic contrast agent produced by Targeson LLC.
125908	Targestar-P	Targestar™-P ultrasonic contrast agent produced by Targeson LLC.
126000	Imaging Measurement Report	A structured report containing the quantitative results of human or machine analysis of images.
126001	Oncology Measurement Report	A structured report containing the quantitative results of human or machine analysis of images for oncology evaluation.
126002	Dynamic Contrast MR Measurement Report	A structured report containing the quantitative results of human or machine analysis of DCE-MR.
126003	PET Measurement Report	A structured report containing the quantitative results of human or machine analysis of PET images.
126010	Imaging Measurements	Measurements made on images
126011	Derived Imaging Measurements	Measurements derived from measurements made on images.
126020	Multiparametric MRI	An MRI procedure in which multiple parameters including diffusion, dynamic contrast and T2 are measured.
126021	Multiparametric MRI of prostate	An MRI procedure of the prostate in which multiple parameters including diffusion, dynamic contrast and T2 are measured.	Retired. Replaced by (719178004, SCT, "Multiparametric MRI of prostate")
126022	Multiparametric MRI of whole body	An MRI procedure of the whole body in which multiple parameters including diffusion, dynamic contrast and T2 are measured.
126029	LWH method for volume of ellipsoid	Method of calculation of the volume of an ellipsoid as length * width * height * π / 6.
126030	Sum of segmented voxel method for volume	Method of summing the volumes of all the voxels (and partial voxels if the segment contains partially occupied voxels) included in the segment to derive a total volume.
126031	Peak Value Within ROI	Maximum average gray value that is calculated from a 1 cubic centimeter sphere placed within the region of interest. See Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors. Journal of Nuclear Medicine. 2009;50(Suppl 1):122S - 150S.
126032	Metabolic Volume	The volume of a lesion (e.g., a tumor) ascertained through information about its metabolic activity (e.g., SUV on PET). Abbreviated "MV". Synonymous with Metabolic Tumor Volume (MTV).
126033	Total Lesion Glycolysis	The total activity of a lesion obtained as the product of its volume and its glycolytic activity (on FDG-PET). The volume may be defined on the same modality (e.g., the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g., the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in glucose metabolism. Abbreviated TLG. Synonymnous with "Tumor Lesion Glycolysis".
126034	Glycolysis	The amount glycolytic activity summed across all voxels in a defined region or within a defined range of SUV (on FDG-PET).
126035	Total Lesion Proliferation	The total activity of a lesion obtained as the product of its volume and its proliferative activity (on FLT-PET). The volume may be defined on the same modality (e.g., the MV on FDG-PET by some thresholding or other technique) or on another spatially registered modality (e.g., the lesion outline segmented on CT or MR). Does not apply to other radiopharmaceuticals than those involved in cellular proliferation. Abbreviated TLP. Synonymnous with "Tumor Lesion Proliferation".
126036	Proliferative Activity	The amount proliferative activity summed across all voxels in a defined region or within a defined range of SUV (on FLT-PET).
126037	Standardized Added Metabolic Activity (SAM)	A background-corrected, partial volume independent version of TLG. SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448.
126038	Standardized Added Metabolic Activity (SAM) Background	The background value (VOI2-VOI1) used to calculate Standardized Added Metabolic Activity (SAM). SAM is calculated by drawing a volume of interest (VOI1) around the tumour and a larger VOI (VOI2) around VOI1. Subtracting the background activity in VOI2-VOI1 from VOI1 yields SAM. See Mertens et al. "Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases". Eur J Nucl Med Mol Imaging (2012) 39:1441-1448.
126039	Lesion to Background SUV Ratio	The ratio of the SUV within a tumor to the SUV of a pre-defined background region. A more general concept than Tumor to Background Ratio (TBR).
126040	Background for Lesion to Background SUV Ratio	The SUV of a pre-defined background region used to compute Lesion to Background SUV Ratio.
126050	Fractal Dimension	A statistical index of complexity comparing how detail in a fractal pattern changes with the scale at which it is measured; a ratio of the change in detail to the change in scale.
126051	Skewness	Measure of the asymmetry of the probability distribution of a real-valued random variable about its mean.
126052	Kurtosis	Measure of the peakedness of the probability distribution of a real-valued random variable.
126060	Joint Entropy of GLCM	The zero order entropy of a Gray Level Co-occurrence Matrix (GLCM). A measure of disorder. Abbreviated ENT. See F_{cm.joint.entr} in [IBSI Features].	Retired. Replaced by (TU9B, IBSI, "Joint Entropy of GLCM").
126061	Root Angular Second Moment of GLCM	The square root of the Angular Second Moment (ASM) of a Gray Level Co-occurrence Matrix (GLCM). A measure of orderliness. See http://www.fp.ucalgary.ca/mhallbey/equations.htm.	Sometimes referred to as "energy", "uniformity" or "uniformity of energy" but then potentially confused with ASM. Not defined in [IBSI Features]
126062	Inverse Difference Moment of GLCM	The Inverse Difference Moment (homogeneity) of a Gray Level Co-occurrence Matrix (GLCM). Abbreviated IDM. See F_{cm.inv.diff.mom} in [IBSI Features].	Other concepts are sometimes referred to as "homogeneity", e.g., the "inverse difference", which is calculated from the absolute value of differences rather than square of them. Retired. Replaced by (WF0Z, IBSI, "Inverse Difference Moment of GLCM").
126063	Contrast of GLCM	The sum of squares of a Gray Level Co-occurrence Matrix (GLCM). A measure of gray level variations. Abbreviated CON. See F_cm.contrast in [IBSI Features].	Distinct from "joint (sum of squares) variance" and "dissimilarity". Retired. Replaced by (ACUI, IBSI, "Contrast of GLCM").
126064	Dissimilarity of GLCM	The dissimilarity of a Gray Level Co-occurrence Matrix (GLCM). Abbreviated DIS. See F_{cm.dissimilarity} in [IBSI Features].	Distinct from "contrast", which uses square rather than absolute value of difference. Retired. Replaced by (8S9J, IBSI, "Dissimilarity of GLCM").
126065	Angular Second Moment of GLCM	The Angular Second Moment of a Gray Level Co-occurrence Matrix (GLCM). Abbreviated ASM. See F_cm.energy in [IBSI Features].	Sometimes referred to as "energy", "uniformity" or "uniformity of energy" but then potentially confused with square root of ASM. Retired. Replaced by (8ZQL, IBSI, "Angular Second Moment of GLCM").
126066	Correlation of GLCM	A measure of the linear dependency of gray levels on those of neighbouring pixels of a Gray Level Co-occurrence Matrix (GLCM). Abbreviated COR. See F_cm.corr in [IBSI Features].	Correlation is NaN for a constant image. Retired. Replaced by (NI2N, IBSI, "Correlation of GLCM").
126067	Gray Level Co-occurrence Matrix	A tabulation of how often different combinations of pixel values (gray levels) occur in an image. Abbreviated GLCM. See [IBSI Features].
126070	Subject Time Point Identifier	An identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point for a specific patient.
126071	Protocol Time Point Identifier	An identifier of a specific time point in a continuum, which is unique within an appropriate local context (such as an entire organization, system or treatment protocol), which identifies the time point "slot" within a treatment protocol using the same value for all patients in the protocol.
126072	Time Point Type	A pre-defined type of a specific time point in a continuum.
126073	Time Point Order	A number indicating the order of a time point relative to other time points in the same continuum.
126074	Posttreatment	The time after the treatment of interest.
126075	Eligibility	For the purpose of determining eligibility for a protocol.	Similar but not identical to (21954-3, LN, "Protocol eligibility status Cancer"), since not constrained to cancer, etc.
126080	RECIST 1.0	Response Evaluation Criteria in Solid Tumors version 1.0. See [RECIST] in Normative References.	More specific than (112022, DCM, "RECIST") or (C1709926, UMLS, "RECIST") or (C49164, NCIt, "RECIST") in that a specific version is specified.
126081	RECIST 1.1	Response Evaluation Criteria in Solid Tumors Version 1.1. See Eisenhauer et al. "New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (version 1.1)." European Journal of Cancer 45, no. 2 (n.d.): 228-47. doi:10.1016/j.ejca.2008.10.026.	More specific than (112022, DCM, "RECIST") or (C1709926, UMLS, "RECIST") or (C49164, NCIt, "RECIST") in that a specific version is specified.
126100	Real World Value Map used for measurement	A reference to the Real World Value Map applied to the stored image pixel values before their use for a measurement
126200	Image Library Group	A container that groups common information about a set of images used as evidence to produce a report.
126201	Acquisition Date	The date the acquisition of data started
126202	Acquisition Time	The time the acquisition of data started
126203	PET Radionuclide Incubation Time	The time between the start of injection of the PET radionuclide and the start of acquisition of the PET data.
126220	R2-Coefficient	Coefficient of determination, R². An indication of goodness of fit.
126221	Chi-square	Pearson's Χ² test.
126222	D-W	Durbin-Watson statistic for detecting serial correlation in residuals. See http://en.wikipedia.org/wiki/Durbin%E2%80%93Watson_statistic.
126223	AIC	Akaike information criterion. A measure of the balance between goodness of fit and number of free parameters. See Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control. 1974 Dec;19(6):716-23. http://dx.doi.org/10.1109/TAC.1974.1100705.
126224	BIC	Bayesian information criterion. A measure of the balance between goodness of fit and model complexity. See http://en.wikipedia.org/wiki/Bayesian_information_criterion.
126300	Perfusion analysis by Stable Xenon CT technique	Perfusion analysis by Stable Xenon CT technique
126301	Perfusion analysis by IV Iodinated Contrast CT technique	Perfusion analysis by IV Iodinated Contrast CT technique
126302	Perfusion analysis by Arterial Spin Labeling MR technique	Perfusion analysis by Arterial Spin Labeling (ASL) MR technique
126303	Perfusion analysis by Susceptibility MR technique	Perfusion analysis by Susceptibility (T2*) MR technique
126310	Least Mean Square (LMS) deconvolution	Least Mean Square (LMS) deconvolution
126311	Singular Value Decomposition (SVD) deconvolution	Singular Value Decomposition (SVD) deconvolution
126312	Ktrans	K^trans, the volume transfer constant of a tracer diffusion kinetic model, specifically the volume transfer constant between blood plasma and extravascular extracellular space (EES) See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999.
126313	kep	k_ep, the rate constant between extravascular extracellular space (EES) and blood plasma See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999.
126314	ve	v_e, the fractional (not absolute) volume of extravascular extracellular space (EES) per unit volume of tissue See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999.
126320	IAUC	The initial area under the contrast agent concentration-time curve
126321	IAUC60	The initial area under the contrast agent concentration-time curve at 60 seconds after the onset time
126322	IAUC90	The initial area under the contrast agent concentration-time curve at 90 seconds after the onset time
126323	IAUC180	The initial area under the contrast agent concentration-time curve at 180 seconds after the onset time
126324	IAUCBN	The initial area under the contrast agent concentration-time curve, normalized with the corresponding arterial input function, such that IAUC_BN = IAUC / IAUC_AIF.
126325	IAUCBN60	The initial area under the contrast agent concentration-time curve at 60 seconds after the onset time, normalized with the corresponding arterial input function, such that IAUC60_BN = IAUC60 / IAUC60_AIF.
126326	IAUCBN90	The initial area under the contrast agent concentration-time curve at 90 seconds after the onset time, normalized with the corresponding arterial input function, such that IAUC90_BN = IAUC90 / IAUC90_AIF.
126327	AUCBN180	The initial area under the contrast agent concentration-time curve at 180 seconds after the onset time, normalized with the corresponding arterial input function, such that IAUC180_BN = IAUC180 / IAUC180_AIF.
126330	tau_m	τ_m. The mean intracellular water lifetime (τ_i). Used in the Shutter-Speed Model (SSM) of tracer kinetics.
126331	vp	v_p. The fractional (not absolute) blood plasma volume per unit volume of tissue. See Tofts et al, "Estimating Kinetic Parameters From Dynamic Contrast-Enhanced T1-Weighted MRI of a Diffusable Tracer: Standardized Quantities and Symbols", Journal of Magnetic Resonance Imaging, vol. 10, pp. 223-232, 1999.
126340	Standard Tofts Model	A tracer diffusion kinetic model in which the permeability is assumed to be isodirectional. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997. Mathematically equivalent to the model proposed by Kety in a non-MRI context, hence sometimes refered to as the Tofts-Kety (TK) model. See Kety SS. The Theory and Applications of the Exchange of Inert Gas at the Lungs and Tissues. Pharmacological Reviews. 1951 Mar 1;3(1):1-41.
126341	Extended Tofts Model	A tracer diffusion kinetic model in which the permeability is not assumed to be isodirectional, and which includes the contribution of tracer in the blood plasma to the total tissue concentration. See P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", Journal of Magnetic Resonance Imaging, vol. 7, pp. 91-101, 1997.
126342	Model-free concentration-time quantitification	A semiquantitative analysis of the contrast-enhancement concentration versus time curve that avoids the use of a pharmacokinetic model. E.g., integration to compute the initial area under the curve.
126343	First Pass Leakage Profile (FPLP) Model	A tracer diffusion kinetic model that accounts for the tumor leakage profile during the first pass of contrast. See Li, Ka-Loh, Xiao Ping Zhu, John Waterton, and Alan Jackson. "Improved 3D Quantitative Mapping of Blood Volume and Endothelial Permeability in Brain Tumors." Journal of Magnetic Resonance Imaging 12, no. 2 (2000): 347-357. doi:10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7.
126344	Shutter-Speed Model (SSM)	A tracer diffusion kinetic model that does not assume that intercompartmental water molecule exchange is infinitely fast. See Li, Xin, Wei Huang, Thomas E. Yankeelov, Alina Tudorica, William D. Rooney, and Charles S. Springer. "Shutter-Speed Analysis of Contrast Reagent Bolus-Tracking Data: Preliminary Observations in Benign and Malignant Breast Disease." Magnetic Resonance in Medicine 53, no. 3 (2005): 724-29. doi:10.1002/mrm.20405.
126345	Gamma Capillary Transit Time (GCCT) Model	A tracer diffusion kinetic model that mathematically unifies the Tofts, Extended Tofts, Adiabatic Tissue Homogeneity, and Two Compartment Exchange models See Schabel MC. A unified impulse response model for DCE-MRI. Magnetic Resonance in Medicine. 2012;68(5):1632-46. doi:10.1002/mrm.24162.
126346	Adiabatic Tissue Homogeneity (ATH) Model	An adiabatic approximation to the tissue homogeneity tracer diffusion kinetic model, which assumes that the tracer concentration in parenchymal tissue changes slowly relative to that in capillaries. See St. Lawrence KS, Lee T-Y. An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation. J Cereb Blood Flow Metab. 1998 Dec;18(12):1365-77. doi:10.1097/00004647-199812000-00011.
126347	Two Compartment Exchange (2CX) Model	A tracer diffusion kinetic that incorporates the extracellular space of the lesion as a peripheral compartment, connected to the central (plasma) compartment by linear exchange processes in both directions. See Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging. Journal of Computer Assisted Tomography. 1991;15(4):621-8.
126350	T1 by Multiple Flip Angles	T1 measurement by Multiple Flip Angles (MFA) (variable saturation) method
126351	T1 by Inversion Recovery	T1 measurement by Inversion Recovery (IR) method
126352	T1 by Fixed Value	Calculation was performed using a fixed value of T1 rather than a measured value. The value could be encoded as the value of (126353, DCM, "T1 Used For Calculation").
126353	T1 Used For Calculation	The fixed value of T1 used for a calculation.
126360	AIF Ignored	No Arterial Input Function was used.
126361	Population Averaged AIF	A population-averaged Arterial Input Function.
126362	User-defined AIF ROI	An Arterial Input Function computed from a user-defined Region of Interest.
126363	Automatically Detected AIF ROI	An Arterial Input Function computed from an automatically detected Region of Interest.
126364	Blind Estimation of AIF	A data-driven blind source separation (BSS) algorithm that estimates AIF from individuals without any presumed AIF model and initialization. See Lin, Yu-Chun, Tsung-Han Chan, Chong-Yung Chi, Shu-Hang Ng, Hao-Li Liu, Kuo-Chen Wei, Yau-Yau Wai, Chun-Chieh Wang, and Jiun-Jie Wang. "Blind Estimation of the Arterial Input Function in Dynamic Contrast-Enhanced MRI Using Purity Maximization." Magnetic Resonance in Medicine 68, no. 5 (November 1, 2012): 1439-49. doi:10.1002/mrm.24144.
126370	Time of Peak Concentration	The time at which the concentration-time curve achieves its peak for the first time. Used as a concept name for a value or as a method. E.g., used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi:10.1118/1.1288669.
126371	Bolus Arrival Time	The nominal time at which arrival of a contrast bolus is detected, which is used as a reference point for subsequent calculations. Used as a concept name for a value or as a method. No specific computational method is implied by this general definition. Abbreviated BAT.
126372	Time of Leading Half-Peak Concentration	The time at which the concentration-time curve achieves half of its peak density for the first time. Used as a concept name for a value or as a method. E.g., used as a method of calculation for BAT. See Shpilfoygel Med Phys 2008. doi:10.1118/1.1288669.
126373	Temporal Derivative Exceeds Threshold	A method of determining BAT that involves computing the temporal derivative of the concentration-time curve and selecting the time when the temporal derivative exceeds a specified threshold. See Shpilfoygel Med Phys 2008. doi:10.1118/1.1288669.
126374	Temporal Derivative Threshold	A threshold applied to the temporal derivative of the concentration-time curve. E.g., used to establish BAT. See Shpilfoygel Med Phys 2008. doi:10.1118/1.1288669.
126375	Maximum Slope	The maximum rate of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387.
126376	Maximum Difference	The maximum degree of signal intensity change within a measured region of a time-activity curve. See Boonsirikamchai, Piyaporn, Harmeet Kaur, Deborah A. Kuban, Edward Jackson, Ping Hou, and Haesun Choi. "Use of Maximum Slope Images Generated From Dynamic Contrast-Enhanced MRI to Detect Locally Recurrent Prostate Carcinoma After Prostatectomy: A Practical Approach." American Journal of Roentgenology 198, no. 3 (March 1, 2012): W228-W236. doi:10.2214/AJR.10.6387.
126377	Tracer Concentration	Tracer concentration in tissue. E.g., in a DCE-MR experiment, the concentration of contrast agent in mmol/l.
126380	Contrast Longitudinal Relaxivity	The degree to which a paramagnetic contrast agent can enhance the proton longitudinal relaxation rate constant (R1, 1/T1), normalized to the concentration of the contrast agent. Also referred to as r1. Typically expressed in units of l/mmol/s.
126390	Absolute Regional Blood Flow	The absolute flow rate of blood perfusing a region as volume per mass per unit of time. The mass divisor may be approximated by a measurement of volume assuming a tissue density of 1.
126391	Absolute Regional Blood Volume	The absolute volume of blood perfusing a region as volume per mass. The mass divisor may be approximated by a measurement of volume assuming a tissue density of 1.
126392	Oxygen Extraction Fraction	The percent of the oxygen removed from the blood by tissue during its passage through the capillary network. For example, as measured by blood oxygenation level dependent (BOLD) MR. See He, Xiang, and Dmitriy A. Yablonskiy. "Quantitative BOLD: Mapping of Human Cerebral Deoxygenated Blood Volume and Oxygen Extraction Fraction: Default State." Magnetic Resonance in Medicine 57, no. 1 (2007): 115-26.
126393	R1	The longitiudinal relaxation rate constant for the decay of longitiudinal magnetization caused by spin-lattice relaxation. The inverse of longitudinal relaxation time, i.e., R1 = 1/T1.
126394	R2	The transverse relaxation rate constant for the decay of transverse magnetization caused by spin-spin relaxation. The inverse of transverse relaxation time, i.e., R2 = 1/T2.
126395	R2*	The transverse relaxation rate constant for the decay of transverse magnetization caused by a combination of spin-spin relaxation and magnetic field inhomogeneity. The inverse of transverse relaxation time, i.e., R2* = 1/T2*.
126396	Magnetic Susceptibility	Magnetic Susceptibility is a measure of the amount of magnetization induced in a material when placed in an external magnetic field. It is the quantity encoded as the voxel intensity in Quantitative Susceptibility Map (QSM) images. It is a dimensionless quantity, usually recorded with units of parts per millions (ppm). See Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magnetic Resonance in Medicine. 2013;69(2):467-76. http://dx.doi.org/10.1002/mrm.24272. See Wang Y, Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magnetic Resonance in Medicine. 2015;73(1):82-101. http://dx.doi.org/10.1002/mrm.25358.
126397	Relative Regional Blood Flow	The relative flow rate of blood perfusing a region. Obtained by dividing the absolute flow rate of blood perfusing a region by the absolute flow rate of blood perfusing a reference region.
126398	Relative Regional Blood Volume	The relative volume of blood perfusing a region. Obtained by dividing the absolute volume of blood perfusing a region by the absolute volume of blood perfusing a reference region.
126400	Standardized Uptake Value	A ratio of locally measured radioactivity concentration versus the injected radioactivity distributed evenly throughout the whole body. This general concept encompasses all specific methods of calculating the whole body volume of distribution, such as using body weight, lean body mass, body surface area, etc.
126401	SUVbw	Standardized Uptake Value calculated using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126402	SUVlbm	Standardized Uptake Value calculated using lean body mass by James method. The patient size correction factor for males is 1.10 * weight - (120 or 128) * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521, except that either 120 or 128 may be used as the multiplier parameter for males). Unfortunately, Sugawara used a parameter of 120 rather than 128, propagating an error in Morgan DJ, Bray KM. Lean Body Mass as a Predictor of Drug Dosage: Implications for Drug Therapy. Clinical Pharmacokinetics. 1994;26(4):292-307, which misquoted the original LBM definition that used 128 in James WPT, Waterlow JC. Research on Obesity: A Report of the DHSS/MRC Group. London: Her Majesty’s Stationery Office; 1976. Implementations differ in whether they have used 120 or 128 when using this code. See Kelly M. SUV: Advancing Comparability and Accuracy. Siemens; 2009. Available from: http://www.mpcphysics.com/documents/SUV_Whitepaper_Final_11.17.09_59807428_2.pdf.
126403	SUVbsa	Standardized Uptake Value calculated using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126404	SUVibw	Standardized Uptake Value calculated using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126405	SUVlbm(Janma)	Standardized Uptake Value calculated using lean body mass by Janmahasatian method. The patient size correction factor for males is 9.27E3 * weight / (6.68E3 + 216 * weight / (height^2)) and for females is 9.27E3 * weight / (8.78E3 + 244 * weight / (height^2)). Defined in Janmahasatian et al. Quantification of Lean Bodyweight. Clin Pharmacokinet. 2005 Oct 1;44(10):1051-65. at http://dx.doi.org/10.2165/00003088-200544100-00004 and its role in SUVlbm(Janma) calculation is discussed in Tahari et al. Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging. Journal of Nuclear Medicine. 2014 Sep 1;55(9):1481-4. at http://jnm.snmjournals.org/content/55/9/1481.
126406	SUVlbm(James128)	Standardized Uptake Value calculated using lean body mass by James method, using the originally published 128 multiplier for males. The patient size correction factor for males is 1.10 * weight - 128) * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2.
126410	SUV body weight calculation method	Method of calculating Standardized Uptake Value using body weight. The patient size correction factor for males and females is body weight. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126411	SUV lean body mass calculation method	Method of calculating Standardized Uptake Value using lean body mass. The patient size correction factor for males is 1.10 * weight - (120 or 128) * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521 Unfortunately, Sugawara used a parameter of 120 rather than 128, propagating an error in Morgan DJ, Bray KM. Lean Body Mass as a Predictor of Drug Dosage: Implications for Drug Therapy. Clinical Pharmacokinetics. 1994;26(4):292-307, which misquoted the original LBM definition that used 128 in James WPT, Waterlow JC. Research on Obesity: A Report of the DHSS/MRC Group. London: Her Majesty’s Stationery Office; 1976. Implementations differ in whether they have used 120 or 128 when using this code. See Kelly M. SUV: Advancing Comparability and Accuracy. Siemens; 2009. Available from: http://www.mpcphysics.com/documents/SUV_Whitepaper_Final_11.17.09_59807428_2.pdf.
126412	SUV body surface area calculation method	Method of calculating Standardized Uptake Value using body surface area. The patient size correction factor for males and females is weight^ 0.425 * height^0.725 * 0.007184. Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126413	SUV ideal body weight calculation method	Method of calculating Standardized Uptake Value using ideal body weight. The patient size correction factor for males is 48.0 + 1.06 * (height - 152) and for females is 45.5 + 0.91 * (height - 152). Defined in Sugawara et al. Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction.Radiology, 1999 at http://radiology.rsna.org/content/213/2/521
126414	SUV lean body mass calculation Janmahasatian method	Janmahasatian method of calculating Standardized Uptake Value using lean body mass. The patient size correction factor for males is 9.27E3 * weight / (6.68E3 + 216 * weight / (height^2)) and for females is 9.27E3 * weight / (8.78E3 + 244 * weight / (height^2)). Defined in Janmahasatian et al. Quantification of Lean Bodyweight. Clin Pharmacokinet. 2005 Oct 1;44(10):1051-65. at http://dx.doi.org/10.2165/00003088-200544100-00004 and its role in SUVlbm(Janma) calculation is discussed in Tahari et al. Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging. Journal of Nuclear Medicine. 2014 Sep 1;55(9):1481-4. at http://jnm.snmjournals.org/content/55/9/1481.
126415	SUV lean body mass calculation method using 128 multiplier	James method of calculating Standardized Uptake Value using lean body mass with the originally published 128 multiplier for males. The patient size correction factor for males is 1.10 * weight - 128) * (weight/height) ^2, and for females is 1.07 * weight - 148 * (weight/height) ^2.
126500	Pittsburgh compound B C^11^	A beta-amyloid PET radiotracer that is an analog of thioflavin T.
126501	Florbetaben F^18^	A beta-amyloid PET radiotracer.
126502	T807 F^18^	A PHF-tau PET radiotracer.
126503	Flubatine F^18^	A nicotinic α4β2 receptor (nAChR) PET radiotracer.
126509	Lutetium^177^ n-acetylaspartylglutamate	A radioconjugate consisting of n-acetylaspartylglutamate labeled with lutetium Lu 177 used as a radiotracer.
126510	Monoclonal Antibody (mAb) ^64^Cu	A Cu 64 Monoclonal Antibody (mAb) PET Radiotracer.
126511	Monoclonal Antibody (mAb) ^89^Zr	A Zr 89 Monoclonal Antibody (mAb) PET Radiotracer.
126512	Trastuzumab ^89^Zr	A Zr 89 Trastuzumab PET Radiotracer.
126513	Cetuximab ^89^Zr	A Zr 89 Cetuximab PET Radiotracer.
126514	J591 ^89^Zr	A Zr 89 J591 PET Radiotracer.
126515	cU36 ^89^Zr	A Zr 89 cU36 PET Radiotracer.
126516	Bevacizumab ^89^Zr	A Zr 89 Bevacizumab PET Radiotracer.
126517	cG250-F(ab')(2) ^89^Zr	A Zr 89 cG250-F(ab')(2) PET Radiotracer.
126518	R1507 ^89^Zr	A Zr 89 R1507 PET Radiotracer.
126519	E4G10 ^89^Zr	A Zr 89 E4G10 PET Radiotracer.
126520	Df-CD45 ^89^Zr	A Zr 89 Df-CD45 PET Radiotracer.
126600	^44^Scandium	^44^Scandium
126601	^51^Manganese	^51^Manganese
126602	^70^Arsenic	^70^Arsenic
126603	^90^Niobium	^90^Niobium
126604	^191m^Iridium	^191m^Iridium
126605	^43^Scandium	^43^Scandium
126606	^152^Terbium	^152^Terbium
126607	^52m^Manganese	^52m^Manganese
126700	ATSM Cu^60^	A Cu 60 ATSM PET radiotracer.
126701	ATSM Cu^61^	A Cu 61 ATSM PET radiotracer.
126702	ATSM Cu^62^	A Cu 62 ATSM PET radiotracer.
126703	Choline C^11^	A C 11 Choline PET radiotracer.
126704	Fallypride C^11^	A C 11 Fallypride PET radiotracer.
126705	Fallypride F^18^	An F 18 Fallypride PET radiotracer.
126706	FLB 457 C^11^	A C 11 FLB 457 PET radiotracer.
126707	Fluorotriopride F^18^	An F 18 Fluorotriopride PET radiotracer.
126708	Fluoromisonidazole (FMISO) F^18^	An F 18 Fluoromisonidazole PET radiotracer.
126709	Glutamine C^11^	A C 11 Glutamine PET radiotracer.
126710	Glutamine C^14^	A C 14 Glutamine PET radiotracer.
126711	Glutamine F^18^	An F 18 Glutamine PET radiotracer.
126712	Flubatine F^18^	An F 18 Flubatine PET radiotracer.	Retired. Replaced with (126503, DCM, "Flubatine F^18^").
126713	2FA F^18^	An F 18 2FA PET radiotracer.
126714	Nifene F^18^	An F 18 Nifene PET radiotracer.
126715	CLR1404 I^124^	An I 124 cancer targeted phospholipid ether PET radiotracer.
126716	CLR1404 I^131^	An I 131 cancer targeted phospholipid ether PET radiotracer.
126717	THK5351 F^18^	A PET radiotracer used for tau brain imaging. See Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, et al. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. Journal of Nuclear Medicine. 2016 Feb 1;57(2):208-14. doi:10.2967/jnumed.115.164848	Retired. Replaced with (C4279748, UMLS, "THK5351 F^18^").
126718	Flurpiridaz F^18^	A PET radiotracer used for myocardial perfusion imaging. See Yu M, Nekolla SG, Schwaiger M, Robinson SP. The Next Generation of Cardiac Positron Emission Tomography Imaging Agents: Discovery of Flurpiridaz F-18 for Detection of Coronary Disease. Seminars in Nuclear Medicine. 2011 Jul;41(4):305-13. doi:10.1053/j.semnuclmed.2011.02.004 See SNMMI. Flurpiridaz. http://interactive.snm.org/docs/PET_PROS/flurpiridaz_%2007_30_12_Final.pdf
126719	RO6924963 ^11^C	A PET radiotracer used for tau brain imaging. See Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, et al. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 May 4; doi:10.2967/jnumed.118.209916. http://jnm.snmjournals.org/content/early/2018/05/03/jnumed.118.209916
126720	RO6931643 ^11^C	A PET radiotracer used for tau brain imaging. See Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, et al. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 May 4; doi:10.2967/jnumed.118.209916. http://jnm.snmjournals.org/content/early/2018/05/03/jnumed.118.209916
126721	Obinituzimab ^89^Zr	A Zr 89 Obinituzimab PET Radiotracer.
126722	Benralizumab ^89^Zr	A Zr 89 Benralizumab PET Radiotracer.
126723	Ocaratuzumab ^89^Zr	A Zr 89 Ocaratuzumab PET Radiotracer.
126724	Glembatumumab vedotin ^89^Zr	A Zr 89 Glembatumumab vedotin PET Radiotracer.
126725	Pinatuzumab vedotin ^89^Zr	A Zr 89 Pinatuzumab vedotin PET Radiotracer.
126726	Polatuzumab vedotin ^89^Zr	A Zr 89 Polatuzumab vedotin PET Radiotracer.
126727	Blinatumomab ^89^Zr	A Zr 89 Blinatumomab PET Radiotracer.
126728	Pegdinetanib ^89^Zr	A Zr 89 Pegdinetanib PET Radiotracer.
126729	AGN-150998 ^89^Zr	A Zr 89 AGN-150998 PET Radiotracer.
126730	MEDI-551 ^89^Zr	A Zr 89 MEDI-551 PET Radiotracer.
126731	GA201 ^89^Zr	A Zr 89 GA201 PET Radiotracer.
126732	Ecromeximab ^89^Zr	A Zr 89 Ecromeximab PET Radiotracer.
126733	Roledumab ^89^Zr	A Zr 89 Roledumab PET Radiotracer.
126734	XmAb5574 ^89^Zr	A Zr 89 XmAb5574 PET Radiotracer.
126735	Brentuximab ^89^Zr	A Zr 89 Brentuximab PET Radiotracer.
126736	Panitumumab ^89^Zr	A Zr 89 Panitumumab PET Radiotracer.
126737	Rituximab ^89^Zr	A Zr 89 Rituximab PET Radiotracer.
126738	Mogamulizumab ^89^Zr	A Zr 89 Mogamulizumab PET Radiotracer.
126739	Ublituximab ^89^Zr	A Zr 89 Ublituximab PET Radiotracer.
126740	Margetuximab ^89^Zr	A Zr 89 Margetuximab PET Radiotracer.
126741	SAR3419 ^89^Zr	A Zr 89 SAR3419 PET Radiotracer.
126742	Ranibizumab ^89^Zr	A Zr 89 Ranibizumab PET Radiotracer.
126746	cMAb U36 ^89^Zr	A Zr 89 cMAb U36 PET Radiotracer.
126747	DN30 ^89^Zr	A Zr 89 DN30 PET Radiotracer.
126748	Fresolimumab ^89^Zr	A Zr 89 Fresolimumab PET Radiotracer.
126749	TRC105 ^89^Zr	A Zr 89 TRC105 PET Radiotracer.
126750	7E11 ^89^Zr	A Zr 89 7E11 PET Radiotracer.
126751	7D12 ^89^Zr	A Zr 89 7D12 PET Radiotracer.
126752	28H1 ^89^Zr	A Zr 89 28H1 PET Radiotracer.
126753	Nanocolloidal albumin ^89^Zr	A Zr 89 nanocolloidal albumin PET Radiotracer. See Heuveling et al. Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with ⁸⁹Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients. J Nucl Med. 2013 Apr;54(4):585-9. doi:10.2967/jnumed.112.115188. http://jnm.snmjournals.org/content/54/4/585.long
126754	Anti-B220 ^89^Zr	A Zr 89 Anti-B220 PET Radiotracer.
126755	RO5323441 ^89^Zr	A Zr 89 RO5323441 PET Radiotracer.
126756	RO542908 ^89^Zr	A Zr 89 RO542908 PET Radiotracer.
126757	RO6958948 ^18^F	A PET radiotracer used for tau brain imaging. See Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, et al. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 May 4; doi:10.2967/jnumed.118.209916. http://jnm.snmjournals.org/content/early/2018/05/03/jnumed.118.209916
126758	PSMA-1007 F^18^	A PET radiotracer targeting PMSA used for prostate cancer imaging. See Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W, et al. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2017 Apr 1;44(4):678–88. doi:10.1007/s00259-016-3573-4. http://link.springer.com/article/10.1007/s00259-016-3573-4
126759	PSMA-617 Ga^68^	A PET radiotracer targeting PMSA used for prostate cancer imaging. See Afshar-Oromieh A, Hetzheim H, Kratochwil C, Benesova M, Eder M, Neels OC, et al. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions. J Nucl Med. 2015 Nov 1;56(11):1697–705. doi: 10.2967/jnumed.115.161299. http://jnm.snmjournals.org/content/56/11/1697
126760	Df-FK ^89^Zr	A Zr 89 Df-FK peptide PET Radiotracer. See Jacobsen O et al. MicroPET Imaging of Integrin α_vβ₃ Expressing Tumors Using ⁸⁹Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/
126761	Df-FK-PEG(3) ^89^Zr	A Zr 89 Df-FK-PEG(3) peptide PET Radiotracer. See Jacobsen O et al. MicroPET Imaging of Integrin α_vβ₃ Expressing Tumors Using ⁸⁹Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/
126762	Df-[FK](2) ^89^Zr	A Zr 89 Df-[FK](2) peptide PET Radiotracer. See Jacobsen O et al. MicroPET Imaging of Integrin α_vβ₃ Expressing Tumors Using ⁸⁹Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/
126763	Df-[FK](2)-3PEG(4) ^89^Zr	A Zr 89 Df-[FK](2)-3PEG(4) peptide PET Radiotracer. See Jacobsen O et al. MicroPET Imaging of Integrin α_vβ₃ Expressing Tumors Using ⁸⁹Zr-RGD Peptides. Mol Imaging Biol. 2011 Dec; 13(6): 1224-1233. doi:10.1007/s11307-010-0458-y. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137711/
126764	Iodinated I^125^ DPA-713	An I125 translocator protein (TSPO) SPECT tracer. See Wang H, Pullambhatla M, Guilarte TR, Mease RC, Pomper MG. Synthesis of [¹²⁵I]IodoDPA-713, a New Probe for Imaging Inflammation. Biochem Biophys Res Commun. 2009 Nov 6;389(1):80–3. doi:10.1007/10.1016/j.bbrc.2009.08.102 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764231/
126765	DPA-713 ^11^C	A C11 translocator protein (TSPO) PET tracer. See Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, et al. Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans. J Nucl Med. 2009 Aug;50(8):1276–82. doi:10.2967/jnumed.109.062265 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883612/
126766	DPA-714 ^18^F	An F18 translocator protein (TSPO) PET tracer. See Vicidomini C, Panico M, Greco A, Gargiulo S, Coda ARD, Zannetti A, et al. In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET. Nuclear Medicine and Biology. 2015 Mar 1;42(3):309–16. doi:10.1016/j.nucmedbio.2014.11.009
126801	IEC61217 Patient Support Continuous Yaw Angle	Patient Support isocentric rotation (in the IEC FIXED REFERENCE Coordinate System) as defined by [IEC 61217]. DICOM represents this value as a Continuous Rotation Angle in degrees.
126802	IEC61217 Table Top Continuous Pitch Angle	Pitch of the Table Top (in the IEC TABLE TOP Coordinate System) as defined by [IEC 61217]. DICOM represents this value as a Continous Rotation Angle in degrees.
126803	IEC61217 Table Top Continuous Roll Angle	Roll of the Table Top (in the IEC TABLE TOP Coordinate System) as defined by [IEC 61217]. DICOM represents this value as a Continous Rotation Angle in degrees.
126804	IEC61217 Table Top Eccentric Axis Distance	Eccentric axis offset, in mm (in the IEC PATIENT SUPPORT Coordinate System) as defined by [IEC 61217].
126805	IEC61217 Table Top Continuous Eccentric Angle	Table Top eccentric rotation (in the IEC TABLE TOP ECCENTRIC Coordinate System) as defined by [IEC 61217]. DICOM represents this value as a Continuous Rotation Angle in degrees.
126806	IEC61217 Table Top Lateral Position	Lateral displacement of the table top, in mm (in the IEC TABLE TOP Coordinate System) as defined by [IEC 61217].
126807	IEC61217 Table Top Longitudinal Position	Longitudinal displacement of the table top, in mm (in the IEC TABLE TOP Coordinate system) as defined by [IEC 61217].
126808	IEC61217 Table Top Vertical Position	Vertical displacement of the table top, in mm (in the IEC TABLE TOP Coordinate System) as defined by [IEC 61217].
126809	IEC61217 Gantry Continuous Roll Angle	Rotation of the gantry (around the Y-axis of the IEC FIXED REFERENCE Coordinate System) as defined by [IEC 61217]. DICOM represents this value as a Continuous Rotation Angle in degrees.
126810	IEC61217 Gantry Continuous Pitch Angle	Pitch angle of rotation of the gantry around the X-axis of the IEC GANTRY Coordinate System. This parameter is not specifically defined by [IEC 61217], but is consistent with [IEC 61217]. DICOM represents this value as a Continuous Rotation Angle in degrees.
126811	IEC61217 Gantry Continuous Yaw Angle	Yaw angle of rotation of the gantry around the Z-axis of the IEC GANTRY Coordinate System This parameter is not specifically defined by [IEC 61217], but is consistent with [IEC 61217]. DICOM represents this value as a Continuous Rotation Angle in degrees.
126830	left first	The body position of the imaging subject relative to the imaging equipment is with the subject's left side positioned towards the front of the equipment viewed from the front
126831	right first	The body position of the imaging subject relative to the imaging equipment is with the subject's right side positioned towards the front of the equipment viewed from the front
126832	posterior first	The body position of the imaging subject relative to the imaging equipment is with the subject's posterior (dorsal) side positioned towards the front of the equipment viewed from the front
126833	anterior first	The body position of the imaging subject relative to the imaging equipment is with the subject's anterior (ventral) side positioned towards the front of the equipment viewed from the front
126850	ILCR	The International Laboratory Code Registry (ILCR) of the Institute of Laboratory Animal Research (ILAR). See http://dels.nas.edu/global/ilar/lab-codes.
127001	Preclinical Small Animal Imaging Acquisition Context	A description of the conditions present during acquisition of images of small animals during preclinical research.
127005	Animal handling during specified phase	The conditions present related to the handling of an animal during a specified phase.
127006	Phase of animal handling	A specified phase of handling of an animal (e.g., transport, preparation).
127010	Biosafety conditions	A description of biosafety conditions (e.g., present during small animal handling for research).
127011	Reason for biosafety controls	The reason that biosafety controls are in place.
127040	Heating conditions	A description of heating conditions (e.g., present during small animal handling for research).
127050	Circadian effects	A description of Circadian effects (e.g., present during small animal handling for research).
127060	Nose cone	A form of face mask that fits over the nose used for delivery of inhalational anesthesia (usually for small animals)
127061	Nasal cannula	Cannula inserted in the nose used for delivery of inhalational anesthesia or other inhaled gases.
127070	Retro-orbital route	A route of administration of a substance via the retro-orbital venous sinus. Yardeni T et al. (2011). Retro-orbital injections in mice. Lab Animal, 40(5), 155-160. doi:10.1038/laban0511-155. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158461/
127101	In home cage	The phase of handling of an animal that provides their normal environment between procedures.
127102	During transport	The phase of handling of an animal that is transport between environments.
127103	Staging prior to imaging	The phase of handling of an animal that is staging prior to an imaging procedure (e.g., after removal from their home environment and transport cage, and awaiting preparation, induction or imaging). During this phase the animals are not subject to intervention (e.g., injection, catheterization) (cf. 127104, DCM, "Preparation for imaging")).
127104	Preparation for imaging	The phase of handling of an animal that is preparation prior to an imaging procedure that involves handling and intervention (e.g., such as injection, catheterization) (cf. 127103, DCM, "Staging prior to imaging")).
127110	Housing role	The phase of handling of an animal during which the housing conditions are applicable.
127120	Animal housing	The manner in which animals are housed.
127121	Animal room type	The room type in which racks of animal cages are housed.
127122	Animal room identifier	The identifier of the room in which racks of animal cages are housed.
127125	Housing manufacturer	The manufacturer of the animal housing.
127126	Housing rack product name	The manufacturer's product name of the animal housing rack.
127127	Housing rack product code	The manufacturer's product code of the animal housing rack.
127128	Housing unit product name	The manufacturer's product name of the animal housing unit (or bottom of unit if separate lid).
127129	Housing unit product code	The manufacturer's product code of the animal housing unit (or bottom of unit if separate lid).
127130	Housing unit lid product name	The manufacturer's product name of the animal housing unit lid.
127131	Housing unit lid product code	The manufacturer's product code of the animal housing unit lid.
127140	Number of racks per room	The number of animal housing racks per room.
127141	Number of housing units per rack	The number of animal housing units per rack.
127142	Housing unit location in rack	The location of the housing unit in the rack.
127143	Number of animals within same housing unit	The number of animals in a single housing (e.g., in a single cage, or in an animal carrier for imaging).
127144	Sex of animals within same housing unit	The sex of multiple animals contained in a single housing (cage).
127145	Sex of handler	The sex of the animal handler(s).
127146	Mixed sex	A group consisting of individuals of both sexes (both males and females). E.g., a group of animals in a cage, group of animal handlers.
127150	Total duration in housing	The total period of time that a subject spends in specified housing conditions.
127151	Housing change interval	The period of time between changes of housing conditions.
127152	Manual handling interval	The period of time between episodes of manual handling of the subject.
127153	Housing unit movement	A description of the manner in which the housing unit is moved (e.g., how a cage is transported).
127160	Housing unit width	The width of the housing unit (e.g., cage).
127161	Housing unit height	The height of the housing unit (e.g., cage).
127162	Housing unit length	The length of the housing unit (e.g., cage).
127170	Housing individually ventilated	Whether or not the housing unit (e.g., cage) is individually ventilated.
127172	Air changes	How frequently the entire volume of air within a defined space is replaced (e.g., within an animal cage).
127175	Housing unit reuse	Whether or not the housing unit has been previously used for different animals.
127177	Unused	The device (e.g., animal housing unit aka. cage) has not previously been used for different animals.
127178	Reused	The device (e.g., animal housing unit aka. cage) has previously been used for different animals.
127180	Bedding manufacturer	The manufacturer of the bedding material.
127181	Bedding product name	The manufacturer's product name of the bedding material.
127182	Bedding product code	The manufacturer's product code of the bedding material.
127183	Bedding volume	The volume of bedding material.
127184	Bedding mass	The mass of bedding material.
127185	Bedding depth	The depth of bedding material.
127190	Enrichment material	Material provided to enrich the environment of a small animal for the purpose of reducing stress, improving health and/or improving reproducibility of results. E.g., nesting material.
127191	Enrichment manufacturer	The manufacturer of the material provided to enrich the environment of a small animal.
127192	Enrichment material present	Whether or not material is provided to enrich the environment of a small animal for the purpose of reducing stress, improving health and/or improving reproducibility of results. E.g., nesting material.
127193	Exerciser device present	Whether or not an exerciser device is present.
127195	Shelter type	The type of shelter provided for small animals within their housing.
127196	Shelter manufacturer	The manufacturer of the small animal shelter.
127197	Shelter product name	The manufacturer's product name of the small animal shelter.
127198	Shelter product code	The manufacturer's product code of the small animal shelter.
127200	Feed manufacturer	The manufacturer of the feed.
127201	Feed product name	The manufacturer's product name of the feed.
127202	Feed product code	The manufacturer's product code of the feed.
127205	Feed source	The source of animal feed.
127210	Feedback temperature regulation	Temperature is regulated by feedback from a temperature sensor used to control an active heating or cooling device.
127214	Total duration of light-dark cycle	The total duration of single light-dark cycle (e.g., usually 24 hours).
127215	Lights on time of day	The time of day when the lights are turned on.
127220	Igloo	Igloo shaped small animal shelter
127221	Red translucent igloo	Red translucent igloo-shaped small animal shelter
127230	Aspen chip bedding	Animal bedding material made from aspen chips.
127231	Aspen shaving bedding	Animal bedding material made from aspen shavings.
127232	Corn cob bedding	Animal bedding material made from (milled) corn cobs.
127233	Paper-based bedding	Animal bedding material made from paper.
127234	Pine chip bedding	Animal bedding material made from pine chips.
127235	Pine shaving bedding	Animal bedding material made from pine shavings.
127240	Carrier temperature sensor	A device for measuring the temperature of the carrier (holder) used for small animal imaging as a means of monitoring or regulating the animal's temperature (e.g., a non-magnetic thermocouple embedded in or attached to the carrier for MRI).
127250	Forced air heater	A method or device that uses forced hot air to maintain the body temperature of a subject.
127251	Heated imaging device	An imaging device that contains an integrated method of temperature regulation for maintaining the body temperature of the imaging subject.
127252	Heated patient support	A device that physically supports the patient and contains an integrated method of temperature regulation for maintaining the body temperature of the imaging subject (e.g., the carrier used for imaging a small animal such as a mouse).
127253	Heated water blanket	A blanket that uses circulating hot water to maintain the body temperature of a subject.
127254	Pre-heated pad	A pad that is pre-heated before use that is used to maintain the body temperature of a subject (e.g., pre-heated in a microwave or autoclave).
127255	Unheated	No mechanism is used to maintain the body temperature of a subject.
127270	NIH31	NIH Open Formula Rat and Mouse Ration - 18% Crude Protein Autoclavable. Specification at http://www.ors.od.nih.gov/sr/dvr/Documents/SSFiles/nih31-137j2004.pdf.
127271	NIH07	NIH07 open-formula, natural-ingredient rodent diet.
127272	AIN76	AIN76 purified diet.
127273	AIN93G	AIN93 growth diet.
127274	AIN93M	AIN93 maintenance diet.
127290	Reverse osmosis purified water	Water that has been purified by reverse osmosis.
127291	Reverse osmosis purified, HCl acidified water	Water that has been purified by reverse osmosis and HCl acidified.
127300	Anesthesia Method Set	Information about different anesthesia methods used during a procedure (from AQI Schema AnesthesiaMethodSetType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AnesthesiaMethodSetType.html).
127301	Anesthesia Method	Information about a single anesthesia method used during a procedure (from AQI Schema AnesthesiaMethodType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AnesthesiaMethodType.html).
127302	Anesthesia Category	Category of anesthesia technique used during a procedure (from AQI Schema AnesthesiaCategoryCodeType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AnesthesiaCategoryCodeType.html).
127303	Anesthesia SubCategory	Details of anesthesia technique used during a procedure (from AQI Schema AnesthesiaMethodType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AnesthesiaMethodType.html).
127310	Airway Management Set	Information about airway management used during a procedure (from AQI Schema AirwayManagementSetType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AirwayManagementSetType.html).
127312	Airway Management Method	Type of airway management used during a procedure (from AQI Schema AirwayManagementMethodCodeType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AirwayManagementMethodCodeType.html).
127313	Airway Sub-Management Method	Subtype of airway management of airway management used during a procedure (from AQI Schema AirwayManagementSubMethodCodeType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/AirwayManagementSubMethodCodeType.html).
127320	Medications Set	Set of medications applied during the anesthesia (from AQI Schema MedicationsSetType; see http://www.aqihq.org/qcdrDataSample/prodFiles/2018%20Files/AQISchDoc/MedicationsSetType.html).
127330	Carrier gas	A gas that delivers an inhalational anesthetic to a subject (e.g., air, oxygen).
127370	Animal housing room	A room for keeping and raising animals for observation or research (vivarium).
127371	Preparation room	A room for preparing a subject (such as a research small animal) prior to a procedure (such as an imaging procedure).
127372	Imaging procedure room	A room in which an imaging procedure is performed.
127390	Locally manufactured product	A product that is locally manufactured (i.e., within the facility or institution).
127391	Food treat	A food item that is out of the ordinary and provides pleasure.
127400	Exogenous substance	A substance from a source external to a subject. E.g., a homograft or xenograft (including tumor cells or tissue), fibrils, viruses, cytokines or toxins.
127401	Tissue of origin	The tissue from which a substance originated. E.g., the tissue or organ from which a homograft or xenograft (including tumor cells or tissue) was obtained.
127402	Taxonomic rank of origin	The taxonomic rank value (e.g., genus, subgenus, species or subspecies) from which a substance originated. E.g., the species of animal from which a homograft or xenograft (including tumor cells or tissue) was obtained.
127411	Strain	An identifier of a group of animals that is genetically uniform.
127412	Strain description	A description of a group of animals that is genetically uniform.
127413	Nomenclature	A system of names or descriptions used in a particular field.
127414	Genetic modifications	An identifier of a specific variation of a targeted gene or introduced transgene.
127415	Genetic modifications description	A description of a specific variation of a targeted gene or introduced transgene.
127450	Stereotactic coordinates	The three dimensional coordinates that identify a (usually small) target within the body. E.g., for the purpose of ablation, biopsy, lesion, injection, stimulation, implantation or radiosurgery.
127451	Position reference indicator	The part of the imaging target that was used as a reference point associated with a specific Frame of Reference. The Position Reference Indicator may or may not coincide with the origin of the fixed frame of reference related to the Frame of Reference. For a Patient-related Frame of Reference, this is an anatomical reference point, often a well-known surface anatomical point.
127460	Tumor graft	Tumor cells or tissue or other material obtained from a donor intended to be implanted in a research subject.
127801	Embryonic Kidney	The kidney of an embryo. E.g., used as the source of human embryonic kidney cell lines, though the concept is not specifically human.
127851	Human alpha synuclein preformed fibrils	Preformed fibrils of human alpha synuclein.
127852	Mouse alpha synuclein preformed fibrils	Preformed fibrils of mouse alpha synuclein.
127853	Human Tau preformed fibrils	Preformed fibrils of human Tau.
127854	Mouse Tau preformed fibrils	Preformed fibrils of mouse Tau.
127855	Non-ionic iodinated contrast agent	An iodine containing X-Ray contrast agent that does not dissociate in water, therefore, is lower in osmolality, and has a significantly lower incidence of adverse reactions than ionic iodinated contrast agents.	Retired. Replaced by (RID38696, RADLEX, "Non-ionic iodinated contrast agent"). Replaces (96388005, SCT, "Non-ionic iodinated contrast agent"), which is retired in SNOMED CT (Duplicate).
127856	Heart valve flail	Unrestricted motion of a heart valve. E.g., a prolapsing mitral valve leaflet may be classified as non-flail or flail (abnormal leaflet coaptation or ruptured chordae).
127857	Glucose Measurement Date	The date that a glucose measurement was performed.
127858	Glucose Measurement Time	The time that a glucose measurement was performed.
127901	SPECT of whole body	A nuclear medicine imaging procedure using a single photon emissive radionuclide with tomographic reconstruction, over an anatomical extent of the entire body.
127902	SPECT CT of whole body	A nuclear medicine imaging procedure using a single photon emissive radionuclide with tomographic reconstruction combined with transmissive X-Ray computed tomography for attenuation compensation, over an anatomical extent of the entire body.
128001	Add Addendum to Report	The task is to add an addendum to an existing report.
128002	Modality to Read	The imaging study to be read involves the specified modality
128003	Reader Specialty	The specialty of the reader of the imaging study
128004	Report Requested	The type of report that is being requested.
128005	Final Report	A final report is a report that is expected to contain all information and all the reportable findings.
128006	Abdominal Imaging Specialty	A medical specialty concerned with abdominal imaging.
128007	Cardiac Imaging Specialty	A medical specialty concerned with cardiac imaging.
128008	Head and Neck Imaging Specialty	A medical specialty concerned with head and neck imaging.
128009	Musculoskeletal Imaging Specialty	A medical specialty concerned with musculoskeletal imaging.
128010	Neurology Specialty	A medical specialty concerned with neurology.
128011	Neuroradiologic Imaging Specialty	A medical specialty concerned with neuroradiologic imaging.
128012	OB/Gyn Imaging Specialty	A medical specialty concerned with obstetric and gynecologic imaging.
128013	Oncologic Imaging Specialty	A medical specialty concerned with oncologic imaging.
128014	Oncology Specialty	A medical specialty concerned with oncology.
128015	Thoracic Imaging Specialty	A medical specialty concerned with thoracic imaging.
128016	Pediatric Imaging Specialty	A medical specialty concerned with pediatric imaging.
128017	Vascular Imaging Specialty	A medical specialty concerned with vascular imaging.
128040	FWP by GA, Campbell, 1991	Fetal body weight growth percentile estimated from gestational age by method of Campbell 1991. See Campbell WA, Nardi D, Vintzileos AM, Rodis JF, Turner GW, Egan JF. Transverse Cerebellar Diameter/Abdominal Circumference Ratio Throughout Pregnancy: A Gestational Age-Independent Method to Assess Fetal Growth. Obstetrics & Gynecology. 1991;77(6):893-6. Available at: http://journals.lww.com/greenjournal/Fulltext/1991/06000/Transverse_Cerebellar_Diameter_Abdominal.19.aspx.	Replaces the use of LN:33183-5.
128041	FWP by GA, Hadlock, 1991	Fetal body weight growth percentile estimated from gestational age by method of Hadlock 1991. See Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology. 1991 Oct 1;181(1):129-33. DOI:10.1148/radiology.181.1.1887021. Available at: http://dx.doi.org/10.1148/radiology.181.1.1887021.	Replaces the incorrect use of LN:33183-5.
128120	Plane through Superior Extent	A plane passing through the superior extent (i.e., towards the head) of the referenced feature
128121	Plane through Inferior Extent	A plane passing through the inferior extent (i.e., towards the feet) of the referenced feature
128122	Plane through Proximal Extent	A plane passing through the proximal extent (i.e., towards the torso) of the referenced feature
128123	Plane through Distal Extent	A plane passing through the distal extent (i.e., towards the end of the extremity) of the referenced feature
128124	Plane through Medial Extent	A plane passing through the medial extent (i.e., towards the midline of the body) of the referenced feature
128125	Plane through Lateral Extent	A plane passing through the lateral extent (i.e., away from the midline of the body) of the referenced feature
128126	Plane through Leftmost Extent	A plane passing through the leftmost extent of the referenced feature
128127	Plane through Rightmost Extent	A plane passing through the rightmost extent of the referenced feature
128128	Plane through Anterior Extent	A plane passing through the anterior extent of the referenced feature
128129	Plane through Posterior Extent	A plane passing through the posterior extent of the referenced feature
128130	Plane through Center	A plane passing approximately through the center of the referenced feature
128137	Geometric Centerpoint	The geometric center point of a feature, such as an organ, implanted device or morphologic anomaly.
128138	Center of Mass	The center of mass of a feature, such as an organ, implanted device or morphologic anomaly
128139	Seed point	Point in an image or space from which segmentation is initiated, e.g., by region growing.	May be selected by a human or an algorithm. Not necessarily the center of the feature being segmented.
128140	Representative point	Point in an image or space that is representative (serves as an example or type for others of the same classification) of a feature, such as an organ, implanted device or morphologic anomaly.	Not necessarily the center of the feature being segmented.
128141	Boundary point	Point in an image or space on the boundary of a feature, such as an organ, implanted device or morphologic anomaly.
128144	Impaired Renal Function	The procedure is contraindicated for patients with impaired renal function.
128151	Laser Cross-hairs	Positioning the patient based on alignment of laser cross-hairs.
128160	Acquired Volume	The anatomical region represented in the acquired data.
128170	Abdominal Radiology	Organizational department or section responsible for Abdominal Radiology
128171	Biomedical Engineering	Organizational department or section responsible for Biomedical Engineering
128172	Cardiovascular Radiology	Organizational department or section responsible for Cardiovascular Radiology
128173	Information Technology	Organizational department or section responsible for Information Technology
128174	Medical Physics	Organizational department or section responsible for Medical Physics
128175	Musculoskeletal Radiology	Organizational department or section responsible for Musculoskeletal Radiology
128177	Pediatric Radiology	Organizational department or section responsible for Pediatric Radiology
128179	Thoracic Radiology	Organizational department or section responsible for Thoracic Radiology
128180	For RT Workflow	Instances available as input for a general radiotherapeutic workflow.
128181	Diagnostic Source Images	Instances used to make a diagnosis.
128182	Segmentation Result	Instances created during a segmentation session.
128183	Registration Result	Instances created during a spatial registration.
128184	Pre-Planning Result	Instances created during preparation prior to planning.
128185	RT Prescription Result	Instances created for prescription of a radiotherapeutic treatment.
128186	Dose Calculation Image Series	Image instances that represent an image series that is intended to be the primary input for the dose calculation. Any parameters required for dose calculation (such as electron density) is derived from this series.
128187	Coordinate Alignment Image Series	Image instances that represent an image series from which the display coordinate system for a radiotherapeutic treatment planning is derived. Typically this series does not provide the parameters required for the dose calculation.
128188	RT Treatment Simulation Result	Instances created during the simulation of a radiotherapeutic treatment delivery session. May also include input objects actually used.
128189	RT Planning Result	Instances created during the planning of a radiotherapeutic treatment. May also include input objects actually used.
128190	Dosimetric Result	Instances created during the creation of the dosimetric result of a radiotherapeutic treatment plan. May also include input objects actually used.
128191	Patient Setup Verification Result	Instances created during the verification of the patient’s treatment position. May also include input objects actually used.
128192	RT Treatment Session Result	Instances created during the treatment session. May also include input objects actually used.
128193	RT Treatment Course Summary	Instances created during a treatment course. May also include input objects actually used.
128194	RT Treatment QA Result	Instances created during evaluation of the treatment delivery quality. May also include input objects actually used.
128195	For Diagnosis	Instances available to make a diagnosis.
128196	For Segmentation	Instances available for segmentation.
128197	For RT Prescription	Instances available for prescribing a radiotherapeutic treatment delivery.
128198	For RT Treatment Planning	Instances available for creating a radiotherapeutic treatment plan.
128199	For Plan Comparison	Instances available for comparing plans.
128200	For RT Plan Summation	Instances available to combine radiotherapeutic plans or doses.
128201	For Physician Review	Instances available for review by a physician.
128202	For Physicist Review	Instances available for review by a physicist.
128203	For Tumor Board	Instances available for review of a tumor board.
128204	For Plan Quality Assurance	Instances available to perform quality assurance of a radiotherapeutic treatment delivery plan.
128205	For Machine Quality Assurance	Instances available to perform quality assurance of one of the hardware or software components involved in a radiotherapeutic treatment delivery.
128206	For Patient Setup Verification	Instances available for verification of the patient treatment position.
128207	For Clinical Trial Submission	Instances available for submission for a clinical trial study.
128208	For Tumor Registry	Instances available for submission to a tumor registry.
128209	RT Workflow Input Used	Instances used as an input of a general radiotherapeutic workflow.
128210	RT Prescription Input Used	Instances used for prescribing a radiotherapeutic treatment delivery.
128211	RT Treatment Planning Input Used	Instances used to create a radiotherapeutic treatment plan.
128212	RT Plan Summation Input Used	Instances used to combine radiotherapeutic plans or doses.
128213	Physician Review Input Used	Instances used for review by a physician.
128214	Physicist Review Input Used	Instances used for review by a physicist.
128215	Plan Quality Assurance Input Used	Instances used to perform quality assurance of a radiotherapeutic treatment delivery plan.
128216	Machine Quality Assurance Input Used	Instances used to perform quality assurance of one of the hardware or software components involved in a radiotherapeutic treatment delivery.
128217	Patient Setup Verification Input Used	Instances used during verification of the patient treatment position.
128218	Diagnosis Input Used	Instances used to make a diagnosis.
128219	Contouring Input Used	Instances used for segmentation.
128220	Plan Comparison Input Used	Instances used for comparing plans.
128221	Tumor Board Input Used	Instances used for review of a tumor board.
128222	Tumor Registry Input Used	Instances submitted to a tumor registry.
128223	Clinical Trial Submission Input Used	Instances submitted to a clinical trial study.
128224	Source measurement	Measurement used as the source for derivation.
128225	Source report	Report used as the source for derivation.
128226	Source raw data	Raw Data used as the source for derivation.
128227	Source real world value map	Real world value map used as the source for derivation. E.g., the map applied to source images before processing them, such as for a threshold based segmentation operation.
128228	Source segmentation	Segmentation used as the source for derivation. E.g., the binary segmentation that was converted to a labelmap segmentation, or vice versa.
128230	Pulse Sequence Name	Name of an MR pulse sequence for annotation purposes. Potentially vendor-specific name.
128250	Structural image for image processing	A structural image used for image processing.
128251	Flow image for image processing	A flow image used for image processing.
128252	OCT-A amplitude decorrelation	OCT angiography method that de-correlates the amplitudes between two consecutive B-scans from the narrowed spectral bands was computed, and all the decorrelation values within certain repeated B-scans were averaged to visualize blood vessels. Methods and algorithms for optical coherence tomography-based angiography: a review and comparison. Anqi Zhang ; Qinqin Zhang ; Chieh-Li Chen ; Ruikang K. Wang (2015). See http://biomedicaloptics.spiedigitallibrary.org/article.aspx?articleid=2464650#QuantitativeComparisons.
128253	OCT-A complex variance	OCT angiography method based on variations in the complex (amplitude and phase) OCT signal from repeated B-scans at the same location. There are a number of factors that may cause a change in the OCT signal frequency relative to the signal due to static tissue background. These factors include, for example, the Doppler effect that induces optical frequency shift and the change in backscattering due to the particles that are moving in and out of the OCT-probe volume during imaging. The changes in signal frequency cause the changes in both the amplitude and the phase of the OCT signal. Comparison of the complex (amplitude and phase) signal from repeated B-scans at the same location provides an image that has higher contrast in areas of erythrocyte motion. This method is referred to as OCT-based micro-angiography - complex (OMAGC).
128254	OCT-A speckle variance	OCT angiography method that analyzes the temporal or spatial statistics of the intensity of speckle from OCT images and identifies blood vessels.
128255	OCT-A correlation mapping	OCT angiography method that differentiates flow regions. Static regions usually have high correlation values while flow regions have lower correlation values.
128256	Doppler OCT-A	OCT angiography method that utilizes the Doppler phase resolved information to provide the velocity of flow. Sometimes referred to as the phase variance method.
128257	Retina depth encoded vasculature flow	Image using pseudo colors to illustrate multiple OPTENF images obtained at various depth levels within the retina from the OPT flow volume.
128258	Retina depth encoded structural reflectance map	Image using pseudo colors to illustrate multiple OPTENF images obtained at various depth levels within the retina from the OPT structural volume.
128259	Retina vasculature flow	Image that illustrates the vasculature flow within the entire retina. Generated from the OPT flow volume with pixels approximately from inner limiting membrane (ILM) to photoreceptor inner segment/ellipsoid region (ISe).
128260	Retina structural reflectance map	Image that illustrates the OCT structural reflectance within the entire retina. Generated from the OPT structural volume with pixels approximately from inner limiting membrane (ILM) to photoreceptor inner segment/ellipsoid region (ISe).
128261	Vitreous vasculature flow	Image that illustrates the vasculature flow within the vitreous. Generated from the OPT flow volume with pixels approximately from a selected location anterior to ILM, to ILM. This space/potential space is referred clinically as the Vitreo-retinal Interface (VRI).
128262	Vitreous structural reflectance map	Image that illustrates the OCT structural reflectance within the vitreous. Generated from the OPT structural volume with pixels approximately from a selected location that is anterior to ILM, to ILM. This space/potential space is referred clinically as the Vitreo-retinal Interface (VRI).
128263	Radial peripapillary vasculature flow	Image that illustrates the OCT vasculature flow within the RNFL around the optic disk. Generated from the OPT flow volume with pixels approximately from ILM to the outer boundary of the RNFL.
128264	Radial peripapillary structural reflectance map	Image that illustrates the OCT structural reflectance within the RNFL around the optic disk. Generated from the OPT structural volume with pixels approximately from ILM to the outer boundary of the RNFL.
128265	Superficial retina vasculature flow	Image that illustrates the vasculature flow within the anterior layers of retina. Generated from the OPT flow volume with pixels approximately from ILM to ganglion cell layer/inner plexiform layer (GCL/IPL).
128266	Superficial retina structural reflectance map	Image that illustrates the OCT structural reflectance within the anterior layers of retina. Generated from the OPT structural volume with pixels approximately from ILM to ganglion cell layer/inner plexiform layer (GCL/IPL).
128267	Middle inner retina vasculature flow	Image that illustrates the vasculature flow in the capillaries that connect the superficial and deeper capillary beds. Generated from the OPT flow volume with pixels approximately at the level of the IPL. Sometimes referred to as the intermediate retina flow.
128268	Middle inner structural reflectance map	Image that illustrates the OCT structural reflectance in the capillaries that connect the superficial and deeper capillary beds. Generated from the OPT structural volume with pixels approximately at the level of the IPL. Sometimes referred to as the intermediate retina flow.
128269	Deep retina vasculature flow	Image that illustrates the vasculature flow at the level of the plexiform layers within the retina. Generated from the OPT flow volume with pixels approximately from inner plexiform layer (IPL) to outer plexiform layer (OPL).
128270	Deep retina structural reflectance map	Image that illustrates the structural reflectance at the level of the plexiform layers within the retina. Generated from the OPT structural volume with pixels approximately from inner plexiform layer (IPL) to outer plexiform layer (OPL).
128271	Outer retina vasculature flow	Image that illustrates the vasculature flow at the level of the posterior layers of the retina (outer retina). Generated from the OPT flow volume with pixels approximately in the translucent layers, from OPL to ISe. Sometimes referred to as flow in the deep avascular structure. Note For normal eyes, this image would not show detectable vascular flow.
128272	Outer retina structural reflectance map	Image that illustrates the structural reflectance at the level of the posterior layers of the retina (outer retina). Generated from the OPT structural volume with pixels approximately in the translucent layers, from OPL to ISe.
128273	Choriocapillaris vasculature flow	Image that illustrates the vasculature flow at the level of the chroriocapillaris. Generated from the OPT flow volume with pixels approximately below the retinal pigment epithelium (RPE) encompassing the thickness of choriocapillaris.
128274	Choriocapillaris structural reflectance map	Image that illustrates the structural reflectance at the level of the chroriocapillaris. Generated from the OPT structural volume with pixels approximately below the retinal pigment epithelium (RPE) encompassing the thickness of choriocapillaris.
128275	Choroid vasculature flow	Image that illustrates the vasculature flow at the level of the choroid. Generated from the OPT flow volume with pixels approximately below RPE, encompassing the thickness of choroid.
128276	Choroid structural reflectance map	Image that illustrates the structural reflectance at the level of the choroid. Generated from the OPT structural volume with pixels approximately below RPE, encompassing the thickness of choroid.
128277	Whole eye vasculature flow	Image that illustrates the vasculature flow at the entire posterior segment, including retina and choroid. Generated from the OPT flow volume with pixels encompassing the entire OCT scan.
128278	Whole eye structural reflectance map	Image that illustrates the structural reflectance from the entire posterior segment, including retina and choroid. Generated from the OPT structural volume with pixels encompassing the entire OCT scan.
128279	Cube B-scan pattern	A series of densely spaced, parallel B-scans of the same length covering an area.
128280	Raster B-scan pattern	A series of sparsely spaced, parallel B-scans of the same length covering an area.
128281	Line B-scan pattern	A single line B-scan.
128282	Radial B-scan pattern	A series of B-scans arranged in a radial pattern of the same length covering an area.
128283	Cross B-scan pattern	A pair of horizontal and vertical B-scans in a cross pattern.
128284	Circle B-scan pattern	A single circular pattern B-scan.
128285	Concentric circle B-scan pattern	A series of concentric circular pattern B-scans with various diameters.
128286	Circle-raster B-scan pattern	A series of concentric circular pattern B-scans with various diameters combined with a series of raster B-scan patterns.
128287	Circle-radial B-scan pattern	A series of concentric circular pattern B-scans with various diameters combined with a series of radial B-scan patterns.
128288	Grid B-scan pattern	A series of vertical and horizontal B-scans.
128289	Outer surface of RNFL	Retinal surface located approximately at the outer boundary of the retinal nerve fiber layer (RNFL).
128290	Outer surface of GCL	Retinal surface approximately at the outer boundary of the Ganglion Cell Layer (GCL).
128291	Outer surface of IPL	Retinal surface located approximately at the outer boundary of the Inner Plexiform Layer (IPL).
128292	Outer surface of INL	Retinal surface located approximately at the outer boundary of the Inner Nuclear Layer (INL).
128293	Outer surface of OPL	Retinal surface located approximately at the outer boundary of the Outer Plexiform Layer (OPL).
128294	Outer surface of HFL	Retinal surface located approximately at the outer boundary of the Henle Fiber Layer (HFL) when present.
128295	Surface between Inner and Outer Segments of the photoreceptors	Retinal surface approximately located at the boundary between the Inner Segments and Outer Segments of the photoreceptors.
128296	Surface of the interdigitation zone between retina and RPE	Retinal surface located approximately at the retina-RPE interdigitation zone when present.
128297	Inner surface of the RPE	Inner surface of the Retinal Pigment Epithelium (RPE).
128298	Surface of the center of the RPE	Segmentation surface located approximately at the center of the Retinal Pigment Epithelium (RPE).
128299	Outer surface of the RPE	Outer surface of the Retinal Pigment Epithelium (RPE).
128300	Outer surface of Bruch’s Membrane	Retinal surface located approximately at the outer boundary of the Bruch’s Membrane (BM).
128301	Surface of the choroid-sclera interface	Retinal surface located approximately at the choroid-sclera interface (SC).
128302	Outer surface of the CC	Retinal surface located approximately at the outer boundary of the choriocapillaris (CC).
128303	OCT B-scan analysis	Values are derived from performing analysis on OCT B-scans
128304	OCT-A one-sided ratio (lesser)	OCT angiography method that utilizes a one-sided ratio on a pixel by pixel basis between various combinations of B-scan repetitions. The ratio is inverted when necessary such that values are less than or equal to one. Individual ratio calculations are averaged or combined across eligible frame combinations for each pixel in the OCT image.
128305	OCT-A one-sided ratio (greater)	OCT angiography method that utilizes a one-sided ratio on a pixel by pixel basis between various combinations of B-scan repetitions. The ratio is inverted when necessary such that values are greater than or equal to one. Individual ratio calculations are averaged or combined across eligible frame combinations for each pixel in the OCT image.
128306	Avascular complex flow	Image that illustrates the vascular flow within the posterior layers of the retina, approximately from the posterior border of the outer plexiform layer (OPL) to the level of Bruch’s Membrane (BM). For normal eyes, this image would not show detectable vascular flow.
128307	Avascular complex map	Image that illustrates the structural reflectance within the posterior layers of the retina, approximately from the outer plexiform layer (OPL) to the level of Bruch’s Membrane (BM).
128308	Superficial vascular plexus flow	Image that illustrates the vascular flow within the anterior layers of retina, approximately from the posterior border of the retinal nerve fiber layer (RNFL) to the inner plexiform layer (IPL).
128309	Superficial vascular plexus map	Image that illustrates the structural reflectance within the anterior layers of retina, approximately from the posterior border of the retinal nerve fiber layer (RNFL) to inner plexiform layer (IPL).
128310	Deep capillary plexus flow	Image that illustrates the vascular flow within the plexiform layers of the retina, approximately from within the inner Nuclear layer (INL) to posterior border of the outer plexiform layer (OPL)
128311	Deep capillary plexus map	Image that illustrates the structural reflectance within the plexiform layers of the retina, approximately from within the Inner Nuclear Layer (INL) to posterior border of the outer plexiform layer (OPL).
128312	RNFL vascular plexus flow	Image that illustrates the vascular flow within the retinal nerve fiber layer (RNFL), approximately from inner limiting membrane (ILM) to the outer boundary of the RNFL.
128313	RNFL vascular plexus map	Image that illustrates the structural reflectance within the retinal nerve fiber layer (RNFL), approximately from inner limiting membrane (ILM) to the outer boundary of the RNFL.
128314	User selected volume flow	Image that illustrates the vascular flow within a volume selected by the user
128315	User selected volume structure map	Image that illustrates the structural reflectance within a volume selected by the user
128316	ORCC vasculature flow	Image that illustrates the vasculature flow within the posterior layers of the retina (including the outer retina), approximately from the posterior boundary of the outer plexiform layer (OPL) to the inner choriocapillaris (CC).
128317	ORCC structural reflectance map	Image that illustrates the structural reflectance within the posterior layers of the retina (including the outer retina), approximately from posterior boundary of the outer plexiform layer (OPL) to the inner choriocapillaris (CC).
128320	Inner surface of the ellipsoid zone	Inner surface of the retinal ellipsoid zone, also known as the photoreceptor inner segment/outer segment (IS/OS) junction
128321	Midline of the ellipsoid zone	Segmentation surface located approximately midway between the inner and outer surfaces of the retinal ellipsoid zone
128322	Outer surface of the ellipsoid zone	Outer surface of the retinal ellipsoid zone, also known as the photoreceptor inner segment/outer segment (IS/OS) junction
128323	Inner surface of the interdigitation zone	Inner surface of the retinal interdigitation zone
128324	Outer surface of the interdigitation zone	Outer surface of the retinal interdigitation zone
128401	Patient Radiation Dose Report	Report title for the report of estimated absorbed energy from ionizing radiation to a patient.
128402	Radiation Dose Estimate	Estimate of absorbed energy from ionizing radiation.
128403	Radiation Dose Estimate Name	Name used to identify a radiation dose estimate.
128404	Anthropomorphic Model	A mathematical description of a patient model for estimating radiation dose that describes or is thought of as having a human form or human attributes.
128405	Breast Thickness	Thickness of the breast.
128406	BREP Radiation Transport Model	Boundary based representation of the model for the estimation of radiation transport and absorbed dose in materials.
128407	DgN	Normalized Mean Glandular Dose (DgN) is the conversion value used to calculate the absorbed dose from radiation to the fibroglandular tissue component of the breast from the exposure in air.
128408	Patient AP Dimension	The size of a patient in the anterior-posterior dimension.
128409	Patient Lateral Dimension	The size of a patient in the lateral dimension.
128410	SSDE Conversion Factor	Conversion factor for Size Specific Dose Estimate (SSDE) calculations from CTDIvol.
128411	Backscatter	Scattering of radiation in a direction opposite to that of the incident radiation.
128412	Radiation Dose Estimate Representation	The description of the representation of the estimated absorbed energy to an organ, a set of organs or the whole body, e.g., surface segmentation, mesh, parametric map, RT dose , Secondary Capture SOP Instances, etc.
128413	Distribution Representation	The form of the representation used to describe the distribution of the radiation dose.
128414	Radiation Dose Representation Data	The absorbed energy data estimated by the method.
128415	Radiation Dose Estimate Methodology	The methodology and parameters used to estimate the radiation dose to an organ, the whole body or a phantom.
128416	SR Instance Used	Reference to an SR instance used.
128417	Patient Model Type	The type of model used to define the shape, size, location of objects, etc. to represent a patient or phantom for use in radiation transport analysis.
128418	Simple Object Model	A simple object (e.g., cylinder) used to model a patient or organ.
128420	Radiation Transport Model Type	The type of model used to estimate energy transport and absorbed dose in materials.
128421	Geometric Radiation Transport Model	A model that uses geometrical shapes for the estimation of radiation transport and absorbed dose in materials.
128422	Voxelized Radiation Transport Model	A model that uses volumetric elements for the estimation of radiation transport and absorbed dose in materials.
128423	Mesh Radiation Transport Model	A model that uses a mesh structure representation for the estimation of radiation transport and absorbed dose in materials.
128424	NURBS Radiation Transport Model	A model that uses surfaces of a non-uniform rational B-spline (NURBS) based representation for the estimation of radiation transport and absorbed dose in materials.
128425	Patient Radiation Dose Model Data	The data from the model used to estimate radiation dose to a patient or organ.
128426	Patient Radiation Dose Model Reference	Rationale or reference to the methodology for the model used in the estimation of radiation dose.
128427	Patient Model Demographics	The demographics for which the patient model used by the radiation dose estimation method is intended.
128428	Model Minimum Age	The minimum age used in the patient model in the radiation dose estimation method.
128429	Event UID Used	Unique Identifier of an event used.
128430	Model Maximum Age	The maximum age used in the patient model in the radiation dose estimation method.
128431	Beam Block	A material placed in the radiation beam that is used to completely attenuate the beam in a specific region of the field of view.
128433	Tissue Air Ratio	Ratio of the absorbed dose at a given depth in tissue to the absorbed dose at the same point in air.
128434	Radiation Dose Estimate Parameters	The parameters used in the algorithms for determining the radiation dose to a patient, organs, or any material.
128436	Radiation Dose Composite Parameters	Reference to the SOP Instance that describes the parameters and values used in the algorithms for determining the radiation dose to a patient, organs, or any material.
128437	Model Patient Sex	The sex used in the patient model in the radiation dose estimation method.
128438	Model Minimum Weight	The minimum weight used in the patient model in the radiation dose estimation method.
128439	Model Minimum Height	The minimum height used in the patient model in the radiation dose estimation method.
128441	Model Maximum Weight	The maximum weight used in the patient model in the radiation dose estimation method.
128442	Model Maximum Height	The maximum height used in the patient model in the radiation dose estimation method.
128444	Spatial Registration Reference	Reference to the Spatial Registration instance or Deformable Spatial Registration instance.
128446	Registration Method	Name of the method used to register the frame of reference for two or more sets of data.
128447	Spatial Fiducials	Reference to Spatial Fiducials SOP Instance.
128452	Correction Factor	A factor used to make an adjustment to a calculation to account for deviations.
128453	Curve Fit Parameter	A value used in a mathematical function to create a curve or a function that approximates a set of data.
128455	Homogeneity Factor	A value used to describe the uniformity or composition of data or a material that relates to the same degree of variability.
128456	Patient Model Registration	The spatial registration used in the patient model in the radiation dose estimation method.
128457	X-Ray Beam Attenuator	Attenuator in the radiation beam that may alter the estimated radiation dose to the patient, organs, or phantoms.
128458	Attenuator Category	The type of object in the radiation beam that may alter the estimated radiation dose to the patient, organs, or phantoms.
128459	Table	The table a patient is sitting, standing, or lying on and that is in the radiation beam such that it may alter the estimated radiation dose to the patient, organs, or phantoms.
128460	Table Core	The core material of a table a patient is sitting, standing, or lying on and that is in the radiation beam such that it may alter the estimated radiation dose to the patient, organs, or phantoms.
128461	Table Outer Liner	The outer shell of a table a patient is sitting, standing, or lying on and that is in the radiation beam such that it may alter the estimated radiation dose to the patient, organs, or phantoms.
128462	Table Pad	The padding on a table a patient is sitting, standing, or lying on and that is in the radiation beam such that it may alter the estimated radiation dose to the patient, organs, or phantoms.
128464	Radiation Dose Estimate Parameter Type	Parameters used in mathematical, simulation, or empirical calculations for radiation dose estimation.	Retired
128465	Equivalent Attenuator Material	The equivalent material used to estimate the reduction in radiation intensity.
128468	Attenuator Description	An explanation of the actual attenuator material used in the estimation of radiation dose.
128469	Equivalent Attenuator Thickness	The thickness of a specified material that provides the same attenuation as the actual attenuator.
128470	X-Ray Attenuator Model Data	The stored data from the model used to represent the X-Ray beam attenuator.
128472	X-Ray Beam Attenuator Model	Model of the attenuator used in the estimation of radiation dose.
128474	X-Ray Beam Attenuator Model Reference	Reference to the methodology or rationale for the model of the beam attenuator used in the estimation of radiation dose.
128475	X-Ray Beam Attenuator Model Registration	Spatial registration of the beam attenuator model.
128476	Radiation Dose Estimate Method	The container for the radiation dose estimation methods and parameters.
128477	Radiation Dose Estimate Method Type	Type of method used to estimate the radiation dose to a patient, organs or phantoms.
128479	Tabular Data Algorithm	Algorithms that use a table of values indexed by a key.
128480	Analytical Algorithm	Algorithms that use mathematical models that have a deterministic result.
128481	Empirical Algorithm	Algorithms that use mathematical models that use parameters derived from observation.
128482	Radiation Dose Estimate Method Reference	A reference to the methodology or rationale for the estimation methodology used for the estimation of radiation dose.
128484	Isodose	Representation of radiation dose of equal intensity as a surface, curve, or line.
128485	Skin Dose Map	Representation of radiation dose intensity at the surface on the skin.
128487	3D Dose Map	Representation of radiation dose as a 3D shape or object.
128488	Dose Gradient	Representation of the change in radiation dose with respect to the change in another variable. Often represented as a change with respect to time or distance.
128492	Physical Support	Material that is in radiation beam that is used to provide physical support to the patient or other objects.
128494	Patient Segmented Model	A model for estimating radiation dose defined from the actual patient anatomy or characteristics.
128496	Dose Point Cloud	Radiation dose represented as a distribution of points.
128497	Measured Radiation Dose	The measured amount of energy that is deposited in a material by ionizing radiation.
128500	Patient Radiation Dose Model	A computational representation of a human body or other object used to simulate the attenuation of radiation in human tissue.
128511	Reference to Uncertainty Determination Method	A reference to the methodology used to determine the uncertainty in the estimation of radiation dose.
128512	Equivalent Dose	Absorbed dose to a tissue or organ multiplied by a quality factor to normalize the dose to the type of radiation that is depositing the dose.
128513	Absorbed Dose	Energy from ionizing radiation absorbed per unit mass.
128522	Normalization Factor	A factor that is used to make an adjustment to a calculation to normalize the data.
128523	Offset Factor	A factor that is used to make an adjustment to a calculation to translate or move the data in a defined manner.
128526	Tissue Fraction	The amount of a specific tissue content, either mass or volume, in a material.
128527	Distance Correction	A correction factor for a measurement of distance or location.
128528	Conversion Factor	A numerical ratio to express a measurement from one unit to another unit.
128531	Maximum Absorbed Radiation Dose	The largest absorbed radiation dose amount estimated.
128532	Minimum Absorbed Radiation Dose	The smallest absorbed radiation dose value estimated.
128533	Mean Absorbed Radiation Dose	The average value of the absorbed radiation dose estimated.
128534	Mode Absorbed Radiation Dose	The absorbed radiation dose value estimated that occurs most frequently.
128535	Maximum Equivalent Radiation Dose	The largest equivalent radiation dose value estimated.
128536	Minimum Equivalent Radiation Dose	The smallest equivalent radiation dose value estimated.
128537	Mean Equivalent Radiation Dose	The average value of the equivalent radiation dose estimated.
128538	Mode Equivalent Radiation Dose	The equivalent radiation dose value estimated that occurs most frequently.
128539	Median Absorbed Radiation Dose	The central value of the absorbed radiation dose estimated.
128540	Median Equivalent Radiation Dose	The central value of the equivalent radiation dose estimated.
128551	Is Repeated Acquisition	This acquisition of data (e.g., for constructing an image) is a repeat of an earlier acquisition that was for some reason unsatisfactory.
128552	Reason for Repeating Acquisition	The reason that data (e.g., for constructing an image) was acquired again.
128553	Patient motion	The acquired data is unsatisfactory because the patient moved.
128554	Suboptimal contrast timing	The acquired data is unsatisfactory because the contrast timing was not adequate.
128601	Appropriate for the indications	The protocol is appropriate for the indications recorded in the protocol instance.	The American Academy of Orthopaedic Surgeons (AAOS) defines an appropriate procedure as one for which the expected health benefits exceed the expected health risks by a wide margin.
128602	Consistent with labeling of the device	The protocol is consistent with the regulatory product labeling of the device recorded in the protocol instance.
128603	Approved for use at the institution	The protocol is approved for use at the institution recorded in the protocol instance.
128604	Approved for use in the clinical trial	The protocol is approved for use in the clinical trial recorded in the protocol instance.
128605	Approved for use on pregnant patients	The protocol is specifically approved for use on pregnant patients.
128606	Appropriate for the device	The protocol is appropriate for execution on the device recorded in the protocol instance (which may identify an individual device by serial number or may identify a family of devices). I.e. the protocol has incorporated model-specific parameters and optimizations as necessary.
128607	Inside operational limits of the device	The protocol specifies parameters that are within the operational limits of the device recorded in the protocol instance. I.e. execution of the protocol is not expected to damage or exceed the operational limits of the device.
128608	Optimized for the device instance	The protocol is optimized for the characteristics of the specific instance of the device recorded in the protocol instance. I.e. the protocol has incorporated model-specific parameters and optimizations as necessary.
128609	Disapproved for any use	The protocol is explicitly disapproved, or approval of the protocol has been withdrawn.
128610	Deprecated protocol	The protocol is no longer to be used. E.g. it has been replaced by another protocol.
128611	Approved for experimental use	The protocol is approved for use in experimental procedures.
128612	Disapproved for experimental use	The protocol is disapproved for use in experimental procedures.
128613	Eligible for reimbursement	The protocol is understood to be eligible for reimbursement by a given payer.
128614	Eligible for reimbursement on per patient basis	The protocol is understood to be eligible for reimbursement on a per patient basis by a given payer.
128615	Ineligible for reimbursement	The protocol is understood to be ineligible for reimbursement by a given payer.
128617	Disapproved for use on pregnant patients	The protocol is explicitly disapproved for use on pregnant patients.
128618	Inappropriate for the device	The protocol is inappropriate for execution on the device recorded in the protocol instance (which may identify an individual device by serial number or may identify a family of devices).
128619	Outside operational limits of the device	The protocol specifies parameters that are not within the operational limits of the device recorded in the protocol instance. I.e. execution of the protocol may damage or exceed the operational limits of the device.
128620	Not optimized for the device instance	The protocol is not optimized for the characteristics of the specific instance of the device recorded in the protocol instance.
128621	Inappropriate for the indications	The protocol is inappropriate for the indications recorded in the protocol instance.	The American Academy of Orthopaedic Surgeons (AAOS) defines an appropriate procedure as one for which the expected health benefits exceed the expected health risks by a wide margin.
128622	Inconsistent with labeling of the device	The protocol is inconsistent with the regulatory product labeling of the device recorded in the protocol instance.
128623	Disapproved for use at the institution	The protocol is disapproved for use at the institution recorded in the approval instance.
128624	Disapproved for use in the clinical trial	The protocol is disapproved for use in the clinical trial recorded in the protocol instance.
128670	Head of Radiology	The senior ranking radiologist in the organization
128671	Chair of Protocol Committee	The chair of a committee tasked with reviewing and approving protocols in the organization.
128673	Administrator of Radiology Department	The administrative head of a department that provides radiology services.
128674	Lead Radiologic Technologist	The senior ranking radiologic technologist in the organization.
128675	Head of Cardiology	The senior ranking cardiologist in the organization.
128676	Representative of Protocol Committee	A representative of a committee tasked with reviewing and approving protocols in the organization.
128677	Representative of Ethics Committee	A representative of a committee tasked with evaluating medical ethics. E.g. Institutional Review Board.
128701	3D Gel	A volume of gel that changes physical characteristics when exposed to ionizing radiation.
128702	Diode Array	A number of semiconductor devices that generates current when exposed to ionizing radiation. The devices are arranged systematically in a regular pattern.
128703	Ion Chamber Array	A number of devices that measures charge from the ions produced in a medium when exposed to ionizing radiation. The devices are arranged systematically in a regular pattern.
128704	Diode	A semiconductor device that generates current when exposed to ionizing radiation.
128705	Liquid Ion Chamber	An ion chamber that uses a liquid as the medium.
128706	OSLD	Optically Stimulated Luminescent Dosimeter. It is a crystal that when exposed to green light, emits blue light in proportion to the amount of ionizing radiation it has been exposed to.
128707	Ion Chamber	A device that measures charge from the ions produced in a medium when exposed to ionizing radiation.
128708	Diamond Detector	A semiconductor detector that uses diamond as the medium.
128709	RPLGD	A radiophotoluminescence glass dosimeter. It is a solid state cumulative radiation dosimeter usually made of silver-activated phosphate glass. The silver atoms act as radiophotoluminescence centers excited by ionizing radiation. The number of centers excited is proportional to the absorbed dose to the RPLGD.
128710	For Teaching File Export	Instances that have been selected for export to a teaching file.
128711	For Clinical Trial Export	Instances that have been selected for export for a clinical trial.
128712	Additional Teaching File Information	The title of a document containing additional teaching file information.
128713	For Research Collection Export	Instances that have been selected for export to a research collection.
128714	For Publication Export	Instances that have been selected for export for publication.
128715	Delay export until final report is available	Delay export until final report is available.
128716	Delay export until clinical information is available	Delay export until clinical information is available.
128717	Delay export until confirmation of diagnosis is available	Delay export until confirmation of diagnosis is available.
128718	Delay export until histopathology is available	Delay export until histopathology is available.
128719	Delay export until other laboratory results are available	Delay export until other laboratory results are available.
128720	Delay export until patient is discharged	Delay export until patient is discharged.
128721	Delay export until patient dies	Delay export until patient dies.
128722	Delay export until expert review is available	Delay export until expert review is available.
128723	Teaching File Category	The category that describes the subject matter of a teaching file. E.g., a selection from the American Board of Radiology (ABR) subject headings.
128724	Level of Difficulty	The level of difficult that the material represents. E.g., advanced.
128725	Primary level	The teaching material is of a primary level of difficulty.
128726	Intermediate level	The teaching material is of an intermediate level of difficulty.
128727	Advanced level	The teaching material is of an advanced level of difficulty.
128728	Musculoskeletal imaging subject matter	The subject matter pertains to musculoskeletal imaging.
128729	Pulmonary imaging subject matter	The subject matter pertains to pulmonary imaging.
128730	Cardiovascular imaging subject matter	The subject matter pertains to cardiovascular imaging.
128731	Gastrointestinal imaging subject matter	The subject matter pertains to gastrointestinal imaging.
128732	Genitourinary imaging subject matter	The subject matter pertains to genitourinary imaging.
128733	Neuroimaging subject matter	The subject matter pertains to neuroimaging .
128734	Vascular and interventional imaging subject matter	The subject matter pertains to vascular and interventional imaging.
128735	Nuclear medicine imaging subject matter	The subject matter pertains to nuclear medicine imaging.
128736	Ultrasound imaging subject matter	The subject matter pertains to ultrasound imaging.
128737	Pediatric imaging subject matter	The subject matter pertains to pediatric imaging.
128738	Breast imaging subject matter	The subject matter pertains to breast imaging.
128739	UDI	The entire Human Readable Form of the Unique Device Identifier as defined by the Issuing Agency.	See Section 10.29.1 “Unique Device Identifier” in PS3.3 .
128740	Longitudinal Temporal Offset from Event	An offset in time from a particular event of significance. In the context of a clinical trial, this is often the time since enrollment, or the baseline imaging study.
128741	Longitudinal Temporal Event Type	The type of event to which a temporal offset is relative.
128750	Equipment Landmark	A well-known landmark of the equipment that is visible by the operator.
128751	Center of Table Head	An equipment landmark on the X-Ray Table head located on the table top plane, centered in the left-right direction of the table.
128752	Equipment Landmark X Position	The X coordinate of the Equipment Landmark in the Table Coordinate System.
128753	Equipment Landmark Z Position	The Z coordinate of the Equipment Landmark in the Table Coordinate System.
128754	Patient Location Fiducial	A patient fiducial used to establish the patient location relative to equipment.
128756	Equipment Landmark to Patient Fiducial Z Distance	The distance in the Z direction from the Equipment Landmark to the Patient Location Fiducial in the Table Coordinate System. Positive when the direction from the Equipment Landmark to the Patient Location Fiducial lies in the positive Z direction.
128757	Positioner Isocenter Primary Angle	Angle in the XY plane of the isocenter reference system between the Y axis and a plane containing the Z axis and the X-Ray center beam (deg).	Corresponds to Positioner Isocenter Primary Angle (0018,9463). See “Positioner Coordinate System” in PS3.3 .
128758	Positioner Isocenter Secondary Angle	Angle, in the plane containing the Z axis of the isocenter reference system and the X-Ray center beam, between the XY plane and the X-Ray center beam (deg).	Corresponds to Positioner Isocenter Secondary Angle (0018,9464). See “Positioner Coordinate System” in PS3.3 .
128759	Positioner Isocenter Detector Rotation Angle	Rotation of the X-Ray detector plane (deg).	Corresponds to Positioner Isocenter Detector Rotation Angle (0018,9465). See “Positioner Coordinate System” in PS3.3 .
128760	Positioner Isocenter Primary End Angle	Position of the X-Ray center beam in the isocenter reference system in the X direction (deg) at the end of an irradiation event.	See (128757, DCM, "Positioner Isocenter Primary Angle").
128761	Positioner Isocenter Secondary End Angle	Position of the X-Ray center beam in the isocenter reference system in the Z direction (deg) at the end of an irradiation event.	See (128758, DCM, "Positioner Isocenter Secondary Angle").
128762	Positioner Isocenter Detector Rotation End Angle	Rotation of the X-Ray detector plane (deg) at the end of an irradiation event.	See (128759, DCM, "Positioner Isocenter Detector Rotation Angle").
128763	Table Head Tilt End Angle	Angle of the head-feet axis of the table (deg) relative to the horizontal plane at the end of an irradiation event.	See (113754, DCM, "Table Head Tilt Angle").
128764	Table Horizontal Rotation End Angle	Rotation of the table in the horizontal plane (deg) at the end of an irradiation event.	See (113755, DCM, "Table Horizontal Rotation Angle").
128765	Table Cradle Tilt End Angle	Angle of the left-right axis of the table (deg) relative to the horizontal plane at the end of an irradiation event.	See (113756, DCM, "Table Cradle Tilt Angle").
128766	Table X Position to Isocenter	X position of the Table Reference Point with respect to the Isocenter (mm).	See “Table Coordinate System” in PS3.3 .
128767	Table Y Position to Isocenter	Y position of the Table Reference Point with respect to the Isocenter (mm).	See “Table Coordinate System” in PS3.3 .
128768	Table Z Position to Isocenter	Z position of the Table Reference Point with respect to the Isocenter (mm).	See “Table Coordinate System” in PS3.3 .
128769	Table X End Position to Isocenter	X position of the Table Reference Point with respect to the Isocenter (mm) at the end of an irradiation event.	See (128766, DCM, "Table X Position to Isocenter").
128770	Table Y End Position to Isocenter	Y position of the Table Reference Point with respect to the Isocenter (mm) at the end of an irradiation event.	See (128767, DCM, "Table Y Position to Isocenter").
128771	Table Z End Position to Isocenter	Z position of the Table Reference Point with respect to the Isocenter (mm) at the end of an irradiation event.	See (128768, DCM, "Table Z Position to Isocenter").
128772	Reference Basis	The anatomical feature or point of reference on which the reference location is based.
128773	Reference Geometry	Characterizes the geometry of the reference location (e.g., a plane or point).
128774	Person Observer's Login Name	Login name (user ID) of human observer who created the observations.
128775	Identifier within Person Observer's Role	An alphanumeric designator of an individual within a role.
128776	Gray Level Run Length Matrix	The tabulation of gray level run lengths in a particular direction in an image. Abbreviated GLRLM. See [IBSI Features].
128777	Gray Level Size Zone Matrix	A tabulation of counts of the number of groups of connected voxels with a specific discretized gray level value and size. Abbreviated GLSZM. See [IBSI Features].
128778	Gray Level Distance Zone Matrix	A tabulation of counts of the number of groups (or zones) of linked voxels that share a specific discretised grey level value and possess the same distance to ROI edge. Abbreviated GLDZM. See [IBSI Features].
128779	Neighbourhood Grey Tone Difference Matrix	A matrix containing the sum of grey level differences of pixels/voxels with a discretised grey level and average discretised grey level of neighbouring pixels/voxels within a specified Chebyshev distance. Abbreviated NGTDM. See [IBSI Features].
128780	Neighbouring Grey Level Dependence Matrix	A tabulation of the counts of dependent (within a specified coarseness parameter) neighbouring discretised grey levels within a specified Chebyshev distance. Abbreviated NGLDM. See [IBSI Features].
128781	Joint Maximum of GLCM	The probability corresponding to the most common gray level co-occurrence in the GLCM. Abbreviated MAX. See F_cm.joint.max in [IBSI Features].	Retired. Replaced by (GYBY, IBSI, "Joint Maximum of GLCM").
128782	Joint Average of GLCM	The gray level weighted sum of joint probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.joint.avg in [IBSI Features].	Retired. Replaced by (60VM, IBSI, "Joint Average of GLCM").
128783	Joint Variance of GLCM	The sum of squares of the difference from the joint average of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.joint.var in [IBSI Features].	Retired. Replaced by (UR99, IBSI, "Joint Variance of GLCM").
128784	Difference Average of GLCM	The average for the diagonal probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.diff.avg in [IBSI Features].	Retired. Replaced by (TF7R, IBSI, "Difference Average of GLCM").
128785	Difference Variance of GLCM	The variance for the diagonal probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.diff.var in [IBSI Features].	Retired. Replaced by (D3YU, IBSI, "Difference Variance of GLCM").
128786	Difference Entropy of GLCM	The entropy for the diagonal probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.diff.entr in [IBSI Features].	Retired. Replaced by (NTRS, IBSI, "Difference Entropy of GLCM").
128787	Sum Average of GLCM	The average for the cross-diagonal probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.sum.avg in [IBSI Features].	Retired. Replaced by (ZGXS, IBSI, "Sum Average of GLCM").
128788	Sum Variance of GLCM	The variance for the cross-diagonal probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.sum.var in [IBSI Features].	Retired. Replaced by (OEEB, IBSI, "Sum Variance of GLCM").
128789	Sum Entropy of GLCM	The entropy for the cross-diagonal probabilities of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.sum.entr in [IBSI Features].	Retired. Replaced by (P6QZ, IBSI, "Sum Entropy of GLCM").
128790	Inverse Difference of GLCM	The inverse difference of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.inv.diff in [IBSI Features].	Sometimes referred to as "homogeneity" but that term is historically used to refer to the "inverse difference moment", which is calculated from the square of differences rather than absolute value of them. Retired. Replaced by (IB1Z, IBSI, "Inverse Difference of GLCM").
128791	Inverse Difference Normalized of GLCM	The normalized inverse difference of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.inv.diff.norm} in [IBSI Features].	The US not UK spelling of "normalized" is used to be consistent with the DICOM convention, rather than the IBSI spelling. Retired. Replaced by (NDRX, IBSI, "Normalized Inverse Difference of GLCM").
128792	Inverse Difference Moment Normalized of GLCM	The normalized inverse difference moment of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.inv.diff.mom.norm} in [IBSI Features].	The US not UK spelling of "normalized" is used to be consistent with the DICOM convention, rather than the IBSI spelling. Retired. Replaced by (1QCO, IBSI, "Normalized Inverse Difference Moment of GLCM").
128793	Inverse Variance of GLCM	The inverse variance of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.inv.var in [IBSI Features].	Retired. Replaced by (E8JP, IBSI, "Inverse Variance of GLCM").
128794	Autocorrelation of GLCM	The autocorrelation of a Gray Level Co-occurrence Matrix (GLCM). See F_cm.auto.corr in [IBSI Features].	Retired. Replaced by (QWB0, IBSI, "Autocorrelation of GLCM").
128795	Cluster Tendency of GLCM	The cluster tendency of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.clust.tend} in [IBSI Features].	Retired. Replaced by (DG8W, IBSI, "Cluster Tendency of GLCM").
128796	Cluster Shade of GLCM	The cluster shade of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.clust.shade} in [IBSI Features].	Retired. Replaced by (7NFM, IBSI, "Cluster Shade of GLCM").
128797	Cluster Prominence of GLCM	The cluster prominence of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.clust.prom} in [IBSI Features].	Retired. Replaced by (AE86, IBSI, "Cluster Prominence of GLCM").
128798	First Measure of Information Correlation of GLCM	The first measure of information correlation of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.info.corr.1} in [IBSI Features].	Retired. Replaced by (R8DG, IBSI, "First Measure of Information Correlation of GLCM").
128799	Second Measure of Information Correlation of GLCM	The second measure of information correlation of a Gray Level Co-occurrence Matrix (GLCM). See F_{cm.info.corr.2} in [IBSI Features].	Retired. Replaced by (JN9H, IBSI, "Second Measure of Information Correlation of GLCM").
128801	Short Runs Emphasis	A measure of the distribution of short runs in a gray level run length matrix. Abbreviated SRE. See F_rlm.sre in [IBSI Features].	Retired. Replaced by (22OV, IBSI, "Short Runs Emphasis").
128802	Long Runs Emphasis	A measure of the distribution of long runs in a gray level run length matrix. Abbreviated LRE. See F_rlm.lre in [IBSI Features].	Retired. Replaced by (W4KF, IBSI, "Long Runs Emphasis").
128803	Low Gray Level Run Emphasis	A measure of the distribution of low gray level values in a gray level run length matrix. Abbreviated LGRE. See F_rlm.lgre in [IBSI Features].	Retired. Replaced by (IBSI, IBSI, "Low Gray Level Run Emphasis").
128804	High Gray Level Run Emphasis	A measure of the distribution of high gray level values in a gray level run length matrix. Abbreviated HGRE. See F_rlm.hgre in [IBSI Features].	Retired. Replaced by (G3QZ, IBSI, "High Gray Level Run Emphasis").
128805	Short Run Low Gray Level Emphasis	A measure of the joint distribution of short runs and low gray level values in a gray level run length matrix. Abbreviated SRLGE. See F_rlm.srlge in [IBSI Features].	Retired. Replaced by (HTZT, IBSI, "Short Run Low Gray Level Emphasis").
128806	Short Run High Gray Level Emphasis	A measure of the joint distribution of short runs and high gray level values in a gray level run length matrix. Abbreviated SRHGE. See F_rlm.srhge in [IBSI Features].	Retired. Replaced by (GD3A, IBSI, "Short Run High Gray Level Emphasis").
128807	Long Run Low Gray Level Emphasis	A measure of the joint distribution of long runs and low gray level values in a gray level run length matrix. Abbreviated LRLGE. See F_rlm.lrlge in [IBSI Features].	Retired. Replaced by (IVPO, IBSI, "Long Run Low Gray Level Emphasis").
128808	Long Run High Gray Level Emphasis	A measure of the the joint distribution of long runs and high gray level values in a gray level run length matrix. Abbreviated LRHGE. See F_rlm.lrhge in [IBSI Features].	Retired. Replaced by (3KUM, IBSI, "Long Run High Gray Level Emphasis").
128809	Gray Level Nonuniformity in Runs	A measure of the similarity of gray level values throughout the image in a gray level run length matrix. Abbreviated RLM.GLNU. See F_rlm.glnu in [IBSI Features].	Retired. Replaced by (R5YN, IBSI, "Gray Level Nonuniformity in Runs").
128810	Gray Level Nonuniformity in Runs Normalized	A normalized measure of the similarity of gray level values throughout the image in a gray level run length matrix. See F_{rlm.glnu.norm} in [IBSI Features].	The US not UK spelling of "normalized" is used to be consistent with the DICOM convention, rather than the IBSI spelling. Retired. Replaced by (OVBL, IBSI, "Normalized Gray Level Nonuniformity in Runs").
128811	Run Length Nonuniformity	A measure of the the similarity of the length of runs throughout the image in a gray level run length matrix. Abbreviated RLNU. See F_rlm.rlnu in [IBSI Features].	Retired. Replaced by (W92Y, IBSI, "Run Length Nonuniformity").
128812	Run Length Nonuniformity Normalized	A normalized measure of the the similarity of the length of runs throughout the image in a gray level run length matrix. See F_{rlm.rlnu.norm} in [IBSI Features].	The US not UK spelling of "normalized" is used to be consistent with the DICOM convention, rather than the IBSI spelling. Retired. Replaced by (IC23, IBSI, "Normalized Run Length Nonuniformity").
128813	Run Percentage	A measure of the homogeneity and distribution of runs of an image in a specific direction in a gray level run length matrix. Abbreviated RPC. See F_rlm.r.perc in [IBSI Features].	Retired. Replaced by (9ZK5, IBSI, "Run Percentage").
128814	Gray Level Variance in Runs	The variance in runs for the gray levels in a gray level run length matrix. See F_rlm.gl.var in [IBSI Features].	Retired. Replaced by (8CE5, IBSI, "Gray Level Variance in Runs").
128815	Run Length Variance	The variance in runs for run lengths in a gray level run length matrix. See F_rlm.rl.var in [IBSI Features].	Retired. Replaced by (SXLW, IBSI, "Run Length Variance").
128816	Run Entropy	The entropy of runs in a gray level run length matrix. See F_rlm.rl.entr in [IBSI Features].	Retired. Replaced by (HJ9O, IBSI, "Run Entropy").
128821	Small Zone Emphasis	A feature that emphasizes small zones from a gray level size zone matrix. Abbreviated SZE. See F_szm.sze in [IBSI Features].	Retired. Replaced by (5QRC, IBSI, "Small Zone Emphasis").
128822	Large Zone Emphasis	A feature that emphasizes large zones from a gray level size zone matrix. Abbreviated LZE. See F_szm.lze in [IBSI Features].	Retired. Replaced by (48P8, IBSI, "Large Zone Emphasis").
128823	Low Gray Level Zone Emphasis	A feature that emphasizes low gray level zones from a gray level size zone matrix. Abbreviated LGZE. See F_szm.lgze in [IBSI Features].	Retired. Replaced by (XMSY, IBSI, "Low Gray Level Zone Emphasis").
128824	High Gray Level Zone Emphasis	A feature that emphasizes high gray level zones from a gray level size zone matrix. Abbreviated LGZE. See F_szm.hgze in [IBSI Features].	Retired. Replaced by (5GN9, IBSI, "High Gray Level Zone Emphasis").
128825	Small Zone Low Gray Level Emphasis	A feature that emphasizes small zone sizes and low gray levels from a gray level size zone matrix. Abbreviated SZLGE. See F_szm.szlge in [IBSI Features].	Retired. Replaced by (5RAI, IBSI, "Small Zone Low Gray Level Emphasis").
128826	Small Zone High Gray Level Emphasis	A feature that emphasizes small zone sizes and high gray levels from a gray level size zone matrix. Abbreviated SZHGE. See F_szm.szhge in [IBSI Features].	Retired. Replaced by (HW1V, IBSI, "Small Zone High Gray Level Emphasis").
128827	Large Zone Low Gray Level Emphasis	A feature that emphasizes large zone sizes and low gray levels from a gray level size zone matrix. Abbreviated LZLGE. See F_szm.lzlge in [IBSI Features].	Retired. Replaced by (YH51, IBSI, "Large Zone Low Gray Level Emphasis").
128828	Large Zone High Gray Level Emphasis	A feature that emphasizes large zone sizes and high gray levels from a gray level size zone matrix. Abbreviated LZHGE. See F_szm.lzhge in [IBSI Features].	Retired. Replaced by (J17V, IBSI, "Large Zone High Gray Level Emphasis").
128829	Gray Level Nonuniformity of Zone Counts	The distribution of zone counts over the gray values in a gray level size zone matrix. Abbreviated SZM.GLNU. See F_szm.glnu in [IBSI Features].	Retired. Replaced by (JNSA, IBSI, "Gray Level Nonuniformity of Size Zone Counts").
128830	Gray Level Nonuniformity of Zone Counts Normalized	The normalized distribution of zone counts over the gray values in a gray level size zone matrix. See F_{szm.glnu.norm} in [IBSI Features].	The US not UK spelling of "normalized" is used to be consistent with the DICOM convention, rather than the IBSI spelling. Retired. Replaced by (Y1RO, IBSI, "Normalized Gray Level Nonuniformity of Size Zone Counts").
128831	Zone Size Nonuniformity	The distribution of zone counts over the different zone sizes in a gray level size zone matrix. Abbreviated ZSNU. See F_szm.zsnu in [IBSI Features].	Retired. Replaced by (4JP3, IBSI, "Zone Size Nonuniformity").
128832	Zone Size Nonuniformity Normalized	The normalized distribution of zone counts over the different zone sizes in a gray level size zone matrix. See F_{szm.zsnu.norm} in [IBSI Features].	The US not UK spelling of "normalized" is used to be consistent with the DICOM convention, rather than the IBSI spelling. Retired. Replaced by (VB3A, IBSI, "Normalized Zone Size Nonuniformity").
128833	Zone Percentage	The fraction of the number of realised zones relative to the maximum number of potential zones in a gray level size zone matrix. Abbreviated ZPERC. See F_szm.z.perc in [IBSI Features].	Retired. Replaced by (P30P, IBSI, "Size Zone Percentage").
128834	Gray Level Variance in Zones	The variance ithe variance in zone counts for the gray levels in a gray level size zone matrix. See F_szm.gl.var in [IBSI Features].	Retired. Replaced by (BYLV, IBSI, "Gray Level Variance in Size Zones").
128835	Zone Size Variance	The variance in zone counts for the different zone sizes in a gray level size zone matrix. See F_szm.zs.var in [IBSI Features].	Retired. Replaced by (3NSA, IBSI, "Zone Size Variance").
128836	Zone Size Entropy	The entropy of zone sizes in a gray level size zone matrix. See F_szm.zs.entr in [IBSI Features].	Retired. Replaced by (GU8N, IBSI, "Zone Size Entropy").
129001	Eligibility Reader	Person who looks at and interprets medical images against defined criteria for the purpose of establishing eligibility of the subject of said images to be enrolled in a research experiment or a clinical trial.
129002	Designator	Person who designates locations on medical images (such as the location of lesions) for other persons or devices to measure or interpret. E.g., for the purpose of consistent target lesion selection for application of therapeutic response criteria by multiple independent readers.
129003	Image Quality Controller	Person who reviews medical images to evaluate the compliance of said images with quality criteria.
129004	Results Quality Controller	Person who reviews results derived from medical images to evaluate the compliance of said results with quality criteria.
129010	Edited Model	A reference to a predecessor model that has been edited to produce the current model. For example: inclusion of more organs, completion of a partial segmentation, insertion of a bisection plane to allow interior inspection, or addition of support material.
129011	Component Model	A reference to a predecessor model that contributed to the creation of the current combined model. This includes simple assembly of discrete pieces as well as more complex combination. For example: by Boolean mathematical and similar operations.
129012	Educational Intent	Intended for educational purposes. For example: patient or care-giver education/informed consent, or training residents and fellows.
129013	Planning Intent	Intended to be used to assist with procedure planning
129014	Tool Fabrication	Intended to be used to manufacture a patient-matched tool that is employed during a medical procedure. For example: drill/cutting guides, immobilizers, radiation shields, and plate bending templates.
129015	Prosthetic Fabrication	Intended to be used to manufacture a fully external prosthetic/orthotic
129016	Implant Fabrication	Intended to be used to manufacture a wholly or partially internal implant
129017	Simulation Intent	Intended to be used for simulation and/or practice of a surgery or other medical procedure. "Simulation" is not used for patient-matched simulation, as this would be covered by "Diagnostic Intent" or "Planning Intent".
129018	US 3D CAM model	A 3D manufacturing model derived from ultrasound imaging.
129019	Mixed Modality 3D CAM model	A 3D manufacturing model derived from images from multiple different modalities.
129020	Photogrammetric Imaging 3D CAM model	A 3D manufacturing model derived from measurements made from photographs.
129021	Laser Scanning 3D CAM model	A 3D manufacturing model derived from laser scanning measurements.
129100	Fat fraction	The fraction of fat present, derived using Dixon or other techniques.
129101	Water/fat in phase	Water/Fat In Phase signal, derived using Dixon or other techniques.
129102	Water/fat out of phase	Water/Fat Out of phase signal, derived using Dixon or other techniques.
129103	Water fraction	The fraction of water present, derived using Dixon or other techniques.
129104	Perfusion image analysis	Analysis of perfusion images.
129105	Diffusion image analysis	Analysis of diffusion images.
129106	Diffusion tractography	Estimation of the course of fiber tracts by analysis of anisotropic diffusion.
129201	Image used for Treatment Planning	Images that have been used in the treatment planning process.
129202	Image used for Dose Calculation	Images that have been used for dose calculation in the treatment planning process.
129203	Image Acquired during Treatment	Images that have been acquired during a treatment session.
129204	Image used as Reference Image for Treatment	Images that are used in a treatment session as reference images to position the patient.
129210	Registration used in Planning	Registrations that have been used in the treatment planning process
129211	Registration created during Treatment	Registrations that have been created in the execution of a treatment session.
129212	Dose from prior Treatment	Dose volume from prior treatment(s).
129301	Coil Marker	A coil-shaped marker visible in an image.
129303	Cylinder Marker	A cylinder-shaped marker visible in an image.
129305	Wire Marker	A thread or rod-shaped marker visible in an image.
129306	Transponder Marker	A marker that receives a radio signal and transmits a response.
129308	MR Marker	A marker containing a substance that produces a distinctive signal on MR images.
129309	Infrared Reflector Marker	Infrared reflecting external marker, e.g., attached to skin or stereotactic frame.
129310	Visible Reflector Marker	Visible light reflecting external marker, e.g., attached to skin or stereotactic frame.
129320	Effective Atomic Number	The average atomic number for a compound or mixture of materials. There are a variety of methods for estimating this value for a given compound.
129321	Modified Hounsfield Unit	Modified pixel values within the Hounsfield Unit Value range.
129322	Value-based Image	Each real-world value mapped pixel represents a certain value for a specified material (the exact interpretation of the value range has to be defined by the user).
129323	Material Specific Image	Each real-world value mapped pixel value represents a property the attenuation of a material such as attenuation, concentration or density.
129324	Material Removed Image	Image with the attenuation contribution of one or more materials removed. For pixels that did not contain any of the removed material(s), the pixel values are unchanged.
129325	Material Highlighted Image	Image where pixel values have been modified to highlight a certain target material by partially suppressing the background and/or by enhancing the modified material.
129326	Material Suppressed Image	Image where pixel values have been modified to partially suppress the modified material (opposite to Material Highlighted image).
129327	Material Recalculated Image	Image where pixels are recalculated by a vendor-specific method.
129328	Volume Occupancy Image	Each real-world value mapped pixel represents a fraction, by volume, occupied by the material.
129329	Mass Occupancy Image	Each real-world value mapped pixel represents a fraction, by mass, occupied by the material.
130001	Minimum Surface Radiation Dose	An objective to achieve a radiation dose which is greater than or equal to the specified radiation dose at the surface of a volume.
130002	Maximum Surface Radiation Dose	An objective to achieve a radiation dose which is less than or equal to the specified radiation dose at the surface of a volume.
130003	Minimum Radiation Dose	An objective to achieve a radiation dose which is greater than or equal to the specified radiation dose throughout a volume.
130004	Maximum Radiation Dose	An objective to achieve a radiation dose which is less than or equal to the specified radiation dose throughout a volume.
130005	Minimum Mean Radiation Dose	An objective to achieve a mean radiation dose over the volume which is greater than or equal to the specified radiation dose.
130006	Maximum Mean Radiation Dose	An objective to achieve a mean radiation dose over the volume which is less than or equal to the specified radiation dose.
130007	Minimum Equivalent Uniform Dose	An objective to achieve an equivalent uniform dose (EUD) which is greater than or equal to the specified radiation dose.
130008	Maximum Equivalent Uniform Dose	An objective to achieve an equivalent uniform dose (EUD) which is less than or equal to the specified radiation dose.
130009	Prescription Radiation Dose	An objective to achieve a radiation dose which is equal to the specified radiation dose throughout the volume.
130010	Minimum Conformity Index	An objective to achieve a conformity index which is greater than or equal to the specified conformity index for a radiation dose which is equal to the specified radiation dose throughout the volume. Minimum Conformity Index as defined in [Feuvret], page 335.
130011	Minimum Healthy Tissue Conformity Index	An objective to achieve a healthy tissue conformity index which is greater than or equal to the specified healthy tissue conformity index for a radiation dose which is equal to the specified radiation dose throughout the volume. Minimum Healthy Tissue Conformity Index as defined in [Feuvret], page 335.
130012	Minimum Conformation Number	An objective to achieve a conformation number which is greater than or equal to the specified conformation number greater for a radiation dose which is equal to the specified radiation dose throughout the volume. Minimum Conformation Number as defined in [Feuvret], page 335.
130013	Maximum Homogeneity Index	An objective to achieve a homogeneity index which is less than or equal to the specified homogenity index for a radiation dose which is equal to the specified radiation dose throughout the volume. Maximum Homogeneity Index as defined in [Feuvret], page 335.
130014	Minimum Percent Volume at Radiation Dose	An objective to achieve a radiation dose which is greater than or equal to the specified radiation dose for at least a specified volume percentage.
130015	Maximum Percent Volume at Radiation Dose	An objective to achieve a radiation dose which is less than or equal to the specified radiation dose for at least a specified "volume percentage.
130016	Minimum Absolute Volume at Radiation Dose	An objective to achieve a radiation dose which is greater than or equal to the specified radiation dose for at least a specified volume size.
130017	Maximum Absolute Volume at Radiation Dose	An objective to achieve a radiation dose which is less than or equal to the specified radiation dose for at least a specified volume size.
130018	Minimize Meterset	An objective to minimize the total Meterset.
130019	Specified Radiation Dose	The radiation dose value for a Dosimetric Objective.
130020	Specified Volume Size	The specified volume size of an anatomical region in a Dosimetric Objective.
130021	Specified Volume Percentage	The percentage which represents a fractional parameter used by a Dosimetric Objective.
130022	Radiation Characteristics Note	Free text note describing characteristics of the radiation.
130023	Beam Shaping Note	Free text note describing the devices and techniques used to shape the radiation beam.
130024	Treatment Planning Note	Free text note to describe suggestions or advice to treatment planning.
130025	Special Procedure Note	Free text note describing additional activities that address individual patient needs.
130026	Patient Positioning Note	Free text note describing the process to position the patient for the procedure.
130027	4D Radiation Treatment Note	Free text note describing management of patient motion during the radiation treatment.
130028	Patient Setup Note	Free text note describing the setup of the patient on the patient support device(s).
130029	Previous Treatment Note	Free text note describing previously delivered treatments.
130030	Planning Imaging Note	Free text note describing the intended use of images for planning.
130031	Delivery Verification Note	Free text note describing how delivery is to be verified.
130032	Simulation Note	Free text note describing preferred simulation procedures.
130033	Radiation Therapy Particle	Particle used for Radiotherapy treatment.
130034	RT Beam Energy	Energy of the Radiotherapy treatment beam.
130035	Patient Positioning Procedure Note	Free text note describing the procedure "for acquiring and applying information about patient position.
130036	QA Process Note	Free text note describing the Quality Assurance Process for the treatment of the patient.
130037	Ion Therapy Particle	Particle for a radiotherapeutic treatment using beams of energetic protons, positive ions or other particles.
130038	Brachytherapy Isotope	Isotope for a radiotherapeutic treatment where a decaying radiation source is placed inside or next to a target area, called Brachytherapy.
130039	Adaptive Radiation Therapy Note	Free text note describing how adaptive radiotherapy is to be performed.
130040	Teletherapy Isotope	Isotope for a radiotherapeutic treatment where a decaying radiation source is placed outside the body.
130041	RT Target	Volume containing tissues to be irradiated to a specified radiation dose, typically encompassing a tumor, and possibly including surrounding subclinical disease, and margin(s) to account for uncertainties in patient positioning and organ motion.
130042	RT Dose Calculation Structure	Non-target structure or volume used when calculating the radiation dose, e.g., during an optimzation process. This may be a structure whose proximity to the target and/or radiosensitivity restrict the radiation dose deliverable to the target.
130043	RT Geometric Information	Points or volumes used as spatial references, e.g., treatment or imaging device isocenter or fiducial markers.
130044	Fixation or Positioning Device	Device used to reproducibly position or limit the motion of a patient or portion of a patient during treatment.
130045	Brachytherapy Device	Device used to deliver Brachtherapy treatments. This includes both devices containing radioactive sources (seeds, eye plaques) and devices used to position radioactive sources (source applicators, channels etc.).
130046	Non-specific Volume	A volume that does not represent a named physical entity.
130047	External Body Structure	A volume representing the external shape of the patient body used in radiotherapeutic procedures.
130048	Unclassified Volume	A volume that does not correspond to an identifiable physical entity and has user specified boundaries.
130049	CTV Nodal	Clinical Target Volume encompassing diseased lymph node(s) , with margin to include surrounding sub-clinical disease as defined in [ICRU Report 50].
130050	CTV Primary	Clinical Target Volume encompassing primary tumor(s) , with margin to include surrounding sub-clinical disease as defined in [ICRU Report 50].
130051	GTV Nodal	Gross Tumor Volume encompassing diseased lymph nodes as defined in [ICRU Report 50].
130052	GTV Primary	Gross Tumor Volume encompassing primary tumor(s) as defined in [ICRU Report 50].
130053	PTV Nodal	Planning Target Volume encompassing a nodal CTV, with margin to account for uncertainty in patient positioning and organ motion as defined in [ICRU Report 50].
130054	PTV Primary	Planning Target Volume encompassing a primary CTV, with margin to account for uncertainty in patient positioning and organ motion as defined in [ICRU Report 50].
130055	Entire Body Target Volume	Entire Body as a target volume for radiotherapy treatment. The usual term for a treatment technique irradiating this target is Full Body Irradiation.
130056	ITV	Internal Target Volume encompassing the CTV, with margin to account for internal motion, often delineated using multiple images, e.g., acquired over a breathing cycle, cardiac cycle, etc, as defined in [ICRU Report 50].
130057	Planning Organ At Risk Volume	Volume encompassing the Organ At Risk (Planning organ at Risk Volume (PRV)) with margin to account for uncertainty in patient positioning and organ motion as defined in [ICRU Report 50].
130058	Avoidance Volume	Volume to which delivered radiation dose should be minimized or limited as defined in [ICRU Report 62].
130059	Treated Volume	Volume enclosed by an isodose surface appropriate to achieve the purpose of treatment (e.g., tumor eradication or palliation) as defined in [ICRU Report 50].
130060	Organ At Risk	Normal tissue that receives undesired radiation and may be damaged by the radiation treatment as defined in [ICRU Report 50]. The treatment is typically planned to limit the radiation dose to such an organ.
130061	Radiation Dose Shaping Volume	A volume used to express dosimetric constraints for shaping the radiation dose distribution.
130062	Conformality Shell	A volume surrounding the target to achive a high radiation dose gradient using a low radiation dose constraint.
130063	Radiation Dose Normalization Point	A point for which a specific radiation dose value is chosen. The rest of the radiation dose distribution is normalized against" this value.
130064	Radiation Dose Reference Point	A point at which the radiation dose is observed.
130065	Dose Calculation Bounding Volume	Volume for which radiation dose is calculated.
130066	Radiation Interaction Volume	Volume in which the interaction of radiation with matter is taken into account.
130067	Patient Anatomy Model	The external boundary of patient tissue without additional devices.
130068	Extended Patient Anatomy Model	The external boundary of patient tissue plus devices that may be attached or adjacent to the body (such as Bolus, Patient Support Devices, Patient Immobilization Devices).
130069	Patient Setup Point	Point at which the patient is initially positioned prior to any other positioning procedure.
130070	Room Laser Patient Setup Point	A reference point used for patient setup based on room lasers.
130071	Moveable Laser Patient Setup Point	A reference point used for patient setup based on movable lasers.
130072	Reference Acquisition Point	A reference point at which patient position verification references are acquired.
130073	Isocentric Treatment Location Point	A point representing the machine isocenter.
130074	Specified Conformity Index	The Conformity Index for a Dosimetric Objective as defined in [Feuvret], page 335.
130075	Specified Healthy Tissue Conformity Index	The Healthy Tissue Conformity Index for a Dosimetric Objective as defined in [Feuvret], page 335.
130076	Specified Conformation Number	The Conformation Number for a Dosimetric Objective as defined in [Feuvret], page 335.
130077	Specified Homogeneity Index	The Homogeneity Index for a Dosimetric Objective as defined in [Feuvret], page 335.
130078	Brachytherapy Source Applicator	Source applicator used in brachytherapy treatment delivery
130079	Brachytherapy Channel Shield	Channel shield device used in brachytherapy treatment delivery
130080	Brachytherapy Channel	Channel device used in brachytherapy treatment delivery
130081	Unclassified Combination	A logical combination of two or more volumes for which the combination is not classified.
130082	Relative Mass Density	Ratio of the mass density of a material relative to the mass density of water.
130083	Relative Electron Density	Ratio of the electron density of a material relative to the electron density of water.
130084	Effective Z	The average atomic number of a material.
130085	Effective Z per A	Ratio of effective atomic number to mass (AMU ^-1) for a material.
130086	Relative Linear Stopping Power	Ratio of the linear stopping power of a material to the linear stopping power of water.
130087	Reference Energy	An energy value which qualifies a quantity or parameter whose value is defined in respect to this energy.
130088	Linear Cell Kill Factor	Linear Cell Kill Factor (α) as defined in J. Deacon et al (Rad. Onc 2(4) : 317-323, 1984), page 318-
130089	Quadratic Cell Kill Factor	Quadratic Cell Kill Factor (β) as defined in J. Deacon et al (Rad. Onc 2(4) : 317-323, 1984), page 318.
130090	High Dose Fraction Linear Cell Kill Factor	High Dose Fraction Linear Cell Kill Factor (γ) as defined in Frederick W. McKenna et (J. Med. Phys, 36(2) : 100-106, 2011), page 102.
130091	Half-time for Tissue Repair	Half-time for Tissue Repair as defined in R Singh R, et al. (Medical Dosimetry 28(4) : 225-259, 2003), page 256.
130092	High Dose Fraction Transition Dose	High Dose Fraction Transition Dose as defined in Astrahan, M. (Med. Phys., 35(9) : 4161-4172, 2008), page 4164.
130093	Atomic Number	The atomic number of an element, i.e. the number of protons found in the nucleus of an atom.
130094	Elemental Composition Atomic Mass Fraction	The fractional weight of the element in a compound.
130095	alpha gEUD Value	Tissue-specific parameter that describes the volume effect of radiation dose delivered to a volume. See AAPM Report 166 (http://www.aapm.org/pubs/reports/RPT_166.pdf) for additional information.
130096	Single Fraction	A treatment consisting of a single treatment fraction, e.g., for stereotactic treatments.
130097	Standard Fractionation	A treatment consisting of a one treatment fraction per day, typically 1.8-2.0 Gy per treatment fraction.
130098	Hypo-fractionation	A treatment consisting of a reduced number of treatment fractions relative to a standard fractionation, typically with a higher radiation dose per fraction.
130099	Hyper-fractionation	A treatment consisting of an increased number of fractions relative to a standard fractionation, typically two per day with smaller radiation dose per fraction.
130100	Continuous Temporary	A treatment consisting of a continuous delivery using a temporary implant.
130101	Continuous Permanent	A treatment consisting of a continuous delivery using a permanent implant.
130102	Static Beam	A treatment technique in which the field shape and the source position do not change during delivery.
130103	Arc Beam	A treatment technique in which the field shape does not change during delivery while the source position follows an arc.
130104	Conformal Arc Beam	A treatment technique in which the field shape changes during delivery while the source position follows an arc.
130105	Step and Shoot Beam	A treatment technique in which the field shape does not change during an exposure. Several field shapes may be used in different exposures at the same source position.
130106	Sliding Window Beam	A treatment technique in which the field shape continously changes during an exposure at the same source position.
130107	VMAT	A treatment technique in which the field shape, gantry speed and radiation dose rate changes during delivery while the source position follows an arc. Volumetric Modulated Arc Therapy (VMAT).
130108	Helical Beam	A treatment technique in which the field shape continously changes during delivery while the source position follows a continous arc in parallel to a simultaneous patient support movement.
130109	Topographic Beam	A treatment technique in which the field shape and the source position do not change during" delivery while the patient support is moving.
130110	Headframe	A device attached to the tabletop that is also screwed into the skull of the patient's head to position and orient the head in a prescribed geometry relative to the tabletop. The device is commonly known as a "halo".
130111	Head Mask	A device that is placed over the patient's face and attached to the tabletop to prevent the patient from moving relative to the tabletop.
130112	Head and Neck Mask	A device that is placed over the patient's face and neck and attached to the tabletop to prevent the patient from moving relative to the tabletop.
130113	Mold	A device that is modified by pressure (molded) to fit another object (such as the patient"s anatomy) and then used to control the reproducibility of the patient"s treatment position.
130114	Cast	A device that is fabricated from a mold of another object (like the patient"s anatomy) and then used to control the reproducibility of the patient"s treatment position.
130116	Breast Board	A device placed on the tabletop to support the chest and arms of a patient in a prescribed position and orientation.
130117	Body Frame	A device placed beneath a patient to support the whole body in a prescribed position and orientation relative to the table top.
130118	Vacuum Mold	A device placed beneath a patient to support a body part in a prescribed position and orientation relative to the table top. It is commonly a bag containing low density polystyrene spheres that becomes semi-hard when vacuum is applied conforming to the bottom surface of the patient.
130119	Whole Body Pod	A device placed beneath a patient to support the whole body in a prescribed position and orientation relative to the table top. It is commonly shaped like a hollow half cylinder. The space between the patient and the wall is commonly filled with a dual component foam that hardens conforming to the bottom surface of the patient.
130120	Rectal Balloon	A flexible fluid container inserted into the rectum to maintain an immovable geometry during treatment.
130121	Vaginal Cylinder	An intracavity cylinder inserted into the vagina to achieve greater radiation dose control and radiation dose shaping. Radioactive sources are inserted into the cylinder for treatment.
130123	Aperture Block	A device, typically made of a low temperature alloy, such as Lipowitz"s metal, that provides an opening in a beam block with constant attenuation across an area of the beam to prevent or reduce radiation dose delivery to normal tissues.
130124	Accessory Tray	A device placed into a machine slot or an applicator to which accessories are attached.
130125	Radiotherapy Applicator	A device placed into a radiotherapy machine slot which provide slot to add other devices and/or to limit the beam.
130126	Radiation transport-based methods	A category of methods for the calculation of effective dose that are based on radiation transport and are used to predict the Relative Biological Effectiveness of an ion beam based on the quality of the radiation used. [Wambersie A, RBE, reference RBE and clinical RBE: Applications of these concepts in hadron therapy, Strahlentherapie und Onkologie 1999 June, 175(2) : 39-43] [Paganetti H, et al., Relative biological effectiveness (RBE) values for proton beam therapy, Int J Rad. Onc Biol Phys, 2002 June; 53(2) : 407-421]
130127	Fractionation-based or temporally-based methods	A category of methods for the calculation of effective dose that are based on Fractionation or temporal patterns and are used to predict the Biologically Effective Dose. [Thames HD, Hendry JH. Fractionation in radiotherapy. New York: Taylor & Francis; 1987] [Barendsen, G.W (1982) Dose fractionation, dose rate and iso-effect relationships for normal tissue responses, Int. J. Radiat. Oncol. Biol. Phys. 8 (11) : 1981-1997.]
130128	Local Effect Model	The Local Effect Model (LEM) method used to predict the Relative Biological Effectiveness of dose delivered using ion beams. [Grun, R. Friedrich, T. Elasasser, T. Kramer, M. Zink, K. Karger, C. P. Durante, M. Engenhard-Cabillic, R. Scholz, M. (2012) "Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy" Physics in Medicine and Biology 57: 7261 - 7274.]
130129	Microdosimetric Kinetic Model	The Microdosimetric Kinetic Model (MKM) " used to predict the Relative Biological Effectiveness of dose delivered using ion beams. [Inaniwa, T. Furukawa, T. Kase, Y. Matsufuji, N. Toshito, T. Matsumoto, Y. Furusawa, Y. Node, K. (2010) "Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model" Physics in Medicine and Biology 55: 6721 - 6737.]
130130	Equivalent 2-Gray Fractions Model	The linear quadratic model usedto compute the equivalent Biologically Effective Dose (BED) delivered in 2 Gray dose fractions. [Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989 Aug; 62 (740) : 679-94.]
130131	Linear-Quadratic Model	The linear quadratic model usedto compute the equivalent Biologically Effective Dose (BED) delivered at an infinitely low dose-rate. [Fowler JF, Br J Radiol. 1989; 62: 679-694]
130132	Linear-Quadratic Model with Time Factor	The modified linear quadratic model with time factor method usedto compute the equivalent Biologically Effective Dose (BED) delivered at an infinitely low dose-rate, taking into account tumor repopulation during treatment. [Fowler JF, Semin. Radiat. Oncol. 1992; 2(1) : 16-21]
130133	Linear-Quadratic-Linear Model	The linear-quadratic-linear dose-response model usedto compute the equivalent Biologically Effective Dose (BED) delivered at an infinitely low dose-rate, taking into account linear cell survival with high dose fractions. [Astrahan M, Med.Phys. 2008; 35: 4161-4172]
130134	Linear-Quadratic Model for Low-Dose Rate Brachytherapy	The linear-quadratic dose-response model modified for low-dose rate brachytherapy used to compute the equivalent Biologically Effective Dose (BED) delivered at an infinitely low dose-rate. [Sing R, Al-Hallaq H, Med.Dosim. 2003; 28(4) : 225-259]
130135	Historical RT Prescription	A Radiotherapy prescription prescribed prior to the current prescription.
130136	RT Prescription Input Images	Image Instances available as input for prescribing a Radiotherapy treatment prescription.
130137	RT Treatment Planning Input Images	Image Instances available as input for planning a Radiotherapy treatment plan.
130138	Multiple Fixed Sources	A treatment technique using multiple decaying radiation sources at fixed spatial locations.
130139	Synchronized Robotic Treatment	A treatment technique using a robotic delivery device with real-time motion tracking and compensation.
130140	Non-Synchronized Robotic Treatment	A treatment technique using a robotic delivery device without real-time motion tracking and compensation.
130141	^3^Helium nucleus	Ionized helium atom with 2 protons and 1 neutron.
130142	^4^Helium nucleus	Ionized helium atom with 2 protons and 2 neutrons.
130143	^12^Carbon nucleus	Ionized carbon atom with 6 protons and 6 neutrons.
130144	^16^Oxygen nucleus	Ionized oxygen atom with 8 protons and 8 neutrons.
130150	Pressure above warning limit	The injector device detected a pressure above the warning threshold, generated a warning and did not automatically terminate the administration.
130151	Pressure above adjustment limit	The injector device detected a pressure above the adjustment limit, took compensating action and did not automatically terminate the administration.
130152	Flow rate above warning limit	The injector device detected a flow rate above the warning threshold, generated a warning and did not automatically terminate the administration.
130153	Flow rate above adjustment limit	The injector device detected a flow rate above the adjustment limit, took compensating action and did not automatically terminate the administration.
130154	Terminated due to request from operator	The injector device terminated the administration due to detection of an abort request by the operator.
130155	Fixed duration pause ended	The device detected that a pause duration has been reached and the device resumed automatically.
130156	Terminated due to pressure above termination limit	The injector device detected a pressure above the termination limit and automatically terminated the administration.
130157	Terminated due to flow rate above termination limit	The injector device detected a flow rate above the termination limit and automatically terminated the administration.
130158	Terminated due to excessive duration pause	The Injector device detected that a pause duration has exceeded limit and the injector device terminated the administration.
130159	Terminated due to injector communication loss	The injector device detected a communication loss and automatically terminated the administration.
130160	Terminated due to unspecified injector failure	The injector device detected an unspecified failure and automatically terminated the administration.
130161	Keep vein open started	The injector device started saline flow for the purpose of keeping vein open.
130162	Keep vein open ended	The injector device ended saline flow for the purpose of keeping vein open.
130163	Syringe attached	The injector device detected that a syringe was attached to the injector.
130164	Syringe detached	The injector device detected that a syringe was detached from the injector.
130165	Total Keep Vein Open Volume Administered	Total volume of flush delivered by the keep vein open function of the injector.
130168	Automatic Programmed Administration Phase	An administration phase where fluid is being delivered by an injector system according to the programmed instructions.
130169	Automatic Programmed Delay Phase	An administration phase where fluid delivery is stopped by the injector system until a programmed time elapses.
130170	Automatic with Manual Hold Phase	An administration phase where the fluid is delivered automatically by an injector system and stopped under manual control by the operator.	Retired
130171	Automated Manual Inject Phase	An administration phase where the fluid is delivered by the injector system under manual control by the operator. E.g., Cardiac Cath.
130172	Manually Triggered Injection Information	Information only available if injection was triggered manually.
130173	Automated Administration	An administration mode where the fluid is delivered by a mechanical injector system.
130174	Manual Administration	An administration mode where the substance is delivered manually E.g., Clinician manual injection of an Imaging Agent or oral consumption by a patient.
130175	Air detected	The injector device detected air in the tubing or syringe before or during the Imaging Agent administration and did not automatically terminate the administration.
130176	Terminated due to air detected	The injector device detected air in the tubing or syringe and terminated the administration.
130177	Terminated by scanner	The injector device received instruction from scanner to terminate the administration and terminated the administration.
130178	Terminated due to critical battery level	The injector device detected critical battery level and terminated the administration.
130179	Terminated due to consumable removal	The injector device detected removal of a consumable from the injector device and terminated the administration.
130181	Administration Mode	A code that specifies how the Imaging Agent is administered to the patient.
130182	Planned Imaging Agent Administration Procedure Report	A report of the planned patient-specific Imaging Agent administration steps.
130183	Imaging Agent Information	Description of a specific Imaging Agent that was planned or was administered.
130184	Osmolality at 37C	Number of osmoles of solute per kilogram of solvent at 37°C.
130185	Osmolarity at 37C	Number of osmoles of solute per liter (L) at 37°C.
130186	Viscosity at 37C	A measure of a resistance of a fluid to gradual deformation by stress, measured at 37°C.
130187	Imaging Agent Warmed	Indicates if an Imaging Agent was warmed prior to the administration procedure.
130188	Contrast Transverse Relaxivity	The degree to which a paramagnetic contrast agent can enhance the proton transverse relaxation rate constant (R2, 1/T2), normalized to the concentration of the contrast agent. Also referred to as r2. Typically expressed in units l/mmol/s.
130189	Is Ionic	Indicates whether the Imaging Agent is Ionic or non-ionic.
130190	Dosing Factor	Indicates normalized dose of Imaging Agent per kg of patient weight. Typically recommended by the vendor. For e.g,. grams Iodine per Kg (gI / Kg).
130191	Imaging Agent Component Usage	Information about use of Imaging Agent component(s).
130192	Imaging Agent Administration Steps	Information about list of administration steps for administering Imaging Agent.
130193	Pressure Limit	A limit set at the power injector device indicating the maximum allowed pressure planned for administering the Imaging Agent.
130194	Time after the start of injection	Time after the start of injection of a delivered Imaging Agent administration.
130195	Imaging Agent Administration Step	An individual administration step in the Imaging Agent administration plan.
130196	Imaging Agent Administration Step Identifier	Identifies a step in an Imaging Agent administration plan.
130197	Imaging Agent Administration Delay	Time difference between the nominal start of the administration step and the actual start of Imaging Agent administration.
130198	Scan Delay	Time delay for start of image acquisition after start of Imaging Agent administration.
130199	Imaging Agent Administration Steps Description	Description of Imaging Agent administration plan.
130200	Imaging Agent Administration Protocol Name	Protocol name for Imaging Agent administration.
130202	Imaging Agent Administration Phase	Information about a delivery phase of an Imaging Agent administration step.
130203	Imaging Agent Administration Phase Identifier	Identifies a phase in an Imaging Agent administration step.
130204	Imaging Agent Administration Phase Type	Type of phase in an Imaging Agent administration step.
130205	Initial Volume of Imaging Agent in Container	The volume of the Imaging Agent in an Imaging Agent container before administration.
130206	Residual Volume of Imaging Agent in Container	The volume of the Imaging Agent remaining in the Imaging Agent container after administration.
130207	Rise Time	Time for the injector to build up from zero to the set pressure.
130208	Starting Flow Rate of administration	Flow rate at the start of an administration of the Imaging Agent.
130209	Ending Flow Rate of administration	Flow rate at the end of an administration of the Imaging Agent.
130210	Bolus Shaping Curve	A vendor-specific code indicating the shape of the flow rate curve within an administration phase.
130211	Imaging Agent Administration Completion Status	The status of the Imaging Agent administration procedure at completion as reported by the automated injector or by the administering person.
130212	Imaging Agent Administration Adverse Events	Information about adverse events occurring during administration of an Imaging Agent.
130214	Estimated Extravasation Volume	The estimated volume lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site.
130215	Adverse Event Detection DateTime	Date and Time when an adverse event was noticed by the observer.
130216	Referenced Imaging Agent Administration Step UID	The unique identifier of the Imaging Agent administration step being referenced.
130217	Referenced Imaging Agent Administration Phase Identifier	The identifier of an Imaging Agent administration phase being referenced.
130218	Programmable Injector Device	An injector device that can be configured to execute a series of phases automatically.
130219	Number of Injector Heads	Number of injector heads or pumps (single, dual or many) in an injector device.
130220	Administration discontinued	Whether the agent administration was discontinued.
130221	Imaging Agent Volume per Unit of Presentation	The volume of Imaging Agent in one unit of presentation. The capacity of the unit of presentation may be larger than this.
130222	Imaging Agent Administration Consumable	Information about the Imaging Agent accessory or consumable used for performing the Imaging Agent administration.
130223	Imaging Agent Administration Consumable Type	Type of consumable used for performing the Imaging Agent administration.
130224	Consumable is New	If the consumable is installed newly during the preparation process for this Imaging Agent Administration.
130226	Planned Imaging Agent Administration	Information about the Imaging Agent administration steps that is patient-specific.
130227	Performed Imaging Agent Administration	Information about the Imaging Agent administration steps that were delivered to a patient.
130228	Contrast Volume Limit	The maximum volume of contrast agent allowed to be administered. This is typically specified by the prescribing health care professional for patient safety and quality purposes.
130229	Flow Rate vs Time	Graph depicting the measurement of flow rate of fluid against time.
130230	Pressure vs Time	Graph depicting the measurement of pressure of fluid against time.
130231	Barcode Value	The alphanumeric string from reading a barcode.
130232	Imaging Agent Administration Graph	Information about two-dimensional graph data for a syringe or pump.
130233	Imaging Agent Administration Injector Events	Information about events that occurred at an injector during an Imaging Agent administration.
130234	Imaging Agent Administration Injector Event Type	Type of event that occurred at an injector during an Imaging Agent administration.
130235	Injector Event Detection DateTime	Date and time when an injector event was detected.
130236	Planned Imaging Agent Administration SOP Instance	Reference to a Planned Imaging Agent Administration SOP instance.
130237	Imaging Agent Administration Activity	Information about the activity in an Imaging Agent administration phase. In an Automated Injection system this describes the activity of one of the pump or syringe units used.
130238	Imaging Agent Component	Information about a component of an Imaging Agent.
130239	Component Volume	Volume of one agent component in a mixture of multiple components.
130240	Total Phase Volume Administered	Total volume administered by all syringes/pump actions during a single phase.
130241	Total Step Volume Administered	Total volume administered by all syringes/pump actions within all phases during a single Step.
130242	Total number of manually triggered injections	Total number of times that an injection was triggered manually.
130244	Peak Flow Rate in Phase Activity	Peak flow rate value detected at a specific location (syringe or pump) during a specific activity of an administration phase.
130245	Peak Pressure in Phase Activity	Peak pressure value detected at a location (syringe or pump) during a single administration phase activity.
130246	Imaging Agent Administration Performed Step UID	Unique identification of a single performed Imaging Agent administration step actually delivered on a specific occasion
130247	Patency Test Injection	An injection of an inactive agent to test for blockages or leakages in the delivery path, usually performed prior to an administration of an imaging or therapeutic agent.
130248	Transit Time Test Injection	An injection of a bolus of Imaging Agent to determine the appropriate delay time for a diagnostic administration.
130249	Diagnostic Administration	Administration of an Imaging Agent for the purpose of enhancing contrast in an image.
130250	Administration Step Type	Type of step in an Imaging Agent administration. For example, a test administration or a diagnostic administration.
130251	Flush Administration	Injection of an inactive fluid to clear the administration path of an active agent.
130252	Negative exponential	A curve that decays exponentially from a specified start value, at a specified decay rate.
130253	Linear Curve	A curve that changes linearly from a specified start value to a specified end value. Note Note: The start value and the end value may be the same, indicating a flat curve.
130254	Imaging Agent Identifier	Identifies an Imaging Agent uniquely within a set of Imaging Agents. The Imaging Agent may be a single component or a mix of multiple components.
130255	Referenced Imaging Agent Identifier	The identifier of an Imaging Agent being referenced.
130257	Consumable Catheter Type	Type of catheter used for Imaging Agent administration.
130259	Contrast Reaction Prophylactic Agent	A pharmaceutical agent administered as a pre-medication to prevent contrast reactions.
130261	Imaging Agent Administration Performed Phase UID	Unique identification of a single Imaging Agent administration performed phase.
130262	Referenced Imaging Agent Administration Phase UID	The unique identifier of the Imaging Agent administration performed phase being referenced
130263	Automatic Programmed Wait Phase	A non time-determined administration phase that is not automatically terminated, where fluid delivery is stopped until manually resumed.
130264	Imaging Agent Administration Injector Phase Identifier	The Imaging Agent Administration Injector Phase Identifier used for presenting this Phase to the User Interface of the injector. Not necessarily the same as the Imaging Agent Administration Phase Identifier of the IAASR Plan.
130265	Imaging Agent Administration Phase with Manual Hold	Indicator for marking this phase as a Automated Administration Phase, which has undergone a manual hold during execution.
130266	Programmed hold started	A programmed administration phase initiated an injector hold/wait state.
130267	Manual hold started	A manual intervention of the technologist initiated an injector hold/wait state.
130268	Manual resume from hold	A manual intervention of the technologist has resumed injector fluid administration. It does not matter if the hold/wait state was initiated programmed or manually.
130269	Terminated hold due to timeout	The injector terminated injection processing from hold/wait after exceeding a time limit.
130290	Median	Towards the mid-sagittal plane of the body.
130300	Skin of paraspinal area of the neck	Structure of skin of paraspinal area of the neck.
130301	Skin of paraspinal area of the superior back	Structure of skin of paraspinal area of the superior back.
130302	Skin of upper paraspinal region	Structure of skin of upper paraspinal region.
130303	Skin of mid paraspinal region	Structure of skin of mid paraspinal region.
130304	Skin of lower paraspinal region	Structure of skin of lower paraspinal region.
130305	Skin of anterior helix of ear	Structure of skin of anterior helix of ear.
130306	Skin of caruncle of eye	Structure of skin of caruncle of eye.
130307	Skin of inferior helix of ear	Structure of skin of inferior helix of ear.
130308	Skin of inferior posterior surface of the pinna	Structure of skin of inferior posterior surface of the pinna.
130309	Skin of lateral part of dorsum of foot	Structure of skin of lateral part of dorsum of foot.
130310	Skin of lower antihelix of ear	Structure of skin of lower antihelix of ear.
130311	Skin of lower eyelid margin	Structure of skin of lower eyelid margin.
130312	Skin of infraalar groove	Structure of skin of infraalar groove.
130313	Skin of medial part of dorsum of foot	Structure of skin of medial part of dorsum of foot.
130314	Skin of paranasal cheek	Structure of skin of paranasal cheek.
130315	Skin of posterior helix of ear	Structure of skin of posterior helix of ear.
130316	Skin of posterior lobule of the ear	Structure of skin of posterior lobule of the ear.
130317	Skin of sole of forefoot	Structure of skin of sole of forefoot.
130318	Skin of superior antihelix of ear	Structure of skin of superior antihelix of ear.
130319	Skin of superior posterior helix of ear	Structure of skin of superior posterior helix of ear.
130320	Skin of superior posterior surface of the pinna	Structure of skin of superior posterior surface of the pinna.
130321	Skin of upper antihelix of ear	Structure of skin of upper antihelix of ear.
130322	Skin of upper eyelid margin	Structure of skin of upper eyelid margin.
130323	Skin of mid back	Structure of skin of mid back.
130324	Functional condition present during acquisition	A functional condition present during acquisition, such as phonation, weight bearing, voiding of the bladder or hemodynamic physiological challenges.
130330	Jaw Pair	RT beam limiting device jaw pair
130331	Leaf Pairs	RT beam limiting device multi-element leaf pairs
130332	Variable Circular Collimator	A circular, aperture size adjustable beam limiting device for an RT treatment device.
130333	Single Leaves	RT beam limiting device multi-element unpaired leaves
130334	X Orientation	Oriented in the X direction of a defined coordinate system.
130335	Y Orientation	Oriented in the Y direction of a defined coordinate system.
130340	Physical Compensator	Physical RT external beam compensator to compensate for inhomogeneity.
130341	Total Body Irradiation	RT Treatment irradiating the body of the Patient in part or in whole.
130342	Total Skin Irradiation	RT Treatment irradiating the surface of the skin of the Patient in part or in whole.
126812	Isocentric Patient Support Continuous Pitch Angle	Patient SupportContinuous Pitch Angle at the isocenter position about the x-axis of the Equipment Coordinate System.
126813	Isocentric Patient Support Continuous Roll Angle	Patient Support Continuous Roll Angle at the isocenter position about the y-axis of the Equipment Coordinate System.
126814	Isocentric Patient Support Continuous Yaw Angle	Patient Support Continuous Yaw Angle at the isocenter position about the z-axis of the Equipment Coordinate System.
126815	Isocentric Patient Support Lateral Position	Patient Support Lateral Position along the x-axis of the Equipment Coordinate System.
126816	Isocentric Patient Support Longitudinal Position	Patient Support Longitudinal Position along the y-axis of the Equipment Coordinate System.
126817	Isocentric Patient Support Vertical Position	Patient Support Vertical Position along the z-axis of the Equipment Coordinate System.
130343	Electron Fixed Aperture	A type of device (or cone) for electron treatments that attaches to the applicator carriage of an RT treatment device for the purpose of holding an aperture and a bolus close to the patient's skin. Several beam applicators may be available to reduce the weight of apertures lifted by therapists, decrease the aperture/bolus-to-skin distance, and reduce leakage radiation.
130344	Photon Fixed Aperture	A type of device (or cone) for photon treatments that is attached to the radiation head of an RT treatment device into which beam modifiers are installed.
130345	Intraoperative Fixed Aperture	A type of device which is used to delimit the radiation of an RT treatment device in case of an intraoperative radiotherapeutic treatment.
130346	Hard Wedge	A physical device placed inside the radiation head used to modify the fluence distribution across the field.
130347	Motorized Wedge	A physical device manually placed between the radiation head and the patient used to modify the fluence distribution across the field. It is motorized and can be inserted/extracted from the beam path.
130348	Dynamic Wedge	An effective wedge generated by the movement of a jaw across the treatment field while delivering radiation.
130349	Graticule	Mechanical grid to embed scaling information in a radiographic image
130350	Reticle	Mechanical crosshair to embed a crosshair representing axes and scaling information in a radiographic image
130351	Image Detector	An electronic radiographic imaging device
130352	Film Holder	Mechanical device to hold imaging film
130353	Winston-Lutz Pointer	A spherical mechanical indicator used for alignment
130354	Bowtie Filter	A bowtie-shaped filter used in imaging
130355	Flattening Filter Beam	Beam that uses a filter to produce a nearly uniform intensity profile.
130356	Non-Flattening Filter Beam	Beam that does not use a filter to produce a nearly uniform intensity profile.
130357	Partial Flattening Filter Beam	Beam that uses a filter to produce a nearly uniform region across part of the intensity profile.
128678	Physics Assistant	A medical professional capable of developing a radiotherapy plan from a Physicians prescription and assisting in radiation machine calibration and other radiotherapy quality assurance work under supervision of a Medical Physicist.
130358	Nominal Radiation Source Location	The point location defined as the nominal source of radiation.
130359	Treatment Machine Isocenter	The center point of the treatment machine through which all beam central axes pass under all gantry angles.
130360	Fixed Laser Setup Point	A fixed point at which initial patient setup is performed based on lasers.
130361	Radiotherapy Treatment Device	A device delivering radiotherapy treatments.
130362	Head Node Set	Set of Robotic Nodes that can be used for targets associated with the patient's head.
130363	Body Node Set	Set of Robotic Nodes that can be used for targets within the patient's body, excluding the head.
130364	Trigeminal Node Set	Set of Robotic Nodes that can be used for targets near the patient's trigeminal nerve.
130365	QA Node Pair	Two Robotic Nodes for Quality Assurance, for example daily checks.
130366	QA Node	Single Robotic Node for Quality Assurance.
130370	RTV Rendition	DICOM objects communicated in time-synchronized flows using DICOM-RTV, intended for a simultaneous presentation.
130371	RTV Audio and Video Rendition	Audio and Video DICOM objects communicated in time-synchronized flows using DICOM-RTV, intended for a simultaneous presentation.
130372	RTV Stereo Video Rendition	Two Video DICOM objects communicated in time-synchronized flows using DICOM-RTV, intended for a stereo video.
130373	RTV Audio and Stereo Video Rendition	Audio and two Video DICOM objects communicated in time-synchronized flows using DICOM-RTV, intended for a stereo video.
130400	Geometric purpose of region	The purpose of defining a region. E.g., to define a bounding box, center or outline.
130401	Visual explanation	A visual explanation of how an algorithm produced its results. E.g., for a machine learning application, a class activation or saliency map.
130402	Class activation	Values are derived using global average pooling in convolutional neural networks to produce a localization map highlighting the important regions in the image for predicting a class. The class activation map (CAM) indicates the discriminative image regions used by the network to identify a class.	Zhou B, Khosla A, Lapedriza A, Oliva A, Torralba A. Learning Deep Features for Discriminative Localization. IEEE Conference on Computer Vision and Pattern Recognition (CVPR). 2016. p 2921–9. http://dx.doi.org/10.1109/CVPR.2016.319
130403	Gradient-weighted class activation	Values are derived using the gradients of a target class flowing into the final convolutional layer of a convolutional neural network to produce a localization map highlighting the important regions in the image for predicting a class. The gradient-weighted class activation map (Grad-CAM) indicates the discriminative image regions used by the network to identify a class.	Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D. Grad-CAM: Visual Explanations from Deep Networks via Gradient-based Localization. 2016. http://arxiv.org/abs/1610.02391
130404	Saliency	Values are derived using a single back-propagation pass through a network to produce a localization map highlighting the spatial support of a given class in a given image.	Simonyan K, Vedaldi A, Zisserman A. Deep Inside Convolutional Networks: Visualising Image Classification Models and Saliency Maps. 2013. http://arxiv.org/abs/1312.6034
130405	Patient-Attached Dose Control Object	An object which is attached to the patient to attenuate the therapeutic dose (such as a Bolus or a lead shield).
130406	Non-uterine leiomyosarcoma	A leiomyosarcoma (sarcoma containing large spindle cells of smooth muscle) occuring at a site other than the uterus.
130407	Bone and soft tissue	Body structures of bone and soft tissue.
130408	Perivascular adipose tissue fat attenuation index	A measure of weighted attenuation shifts within perivascular adipose tissue, computed as a weighted measure of attenuation in concentric layers of perivascular tissue around the arterial wall, capturing the respective perivascular attenuation gradients. Abbreviated "FAI". See Antoniades C, Kotanidis CP, Berman DS. State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue? Journal of Cardiovascular Computed Tomography. 2019 Mar 29;0(0). Available from: http://www.journalofcardiovascularct.com/article/S1934-5925(18)30618-X/abstract.
130410	Patient position	A channel monitoring the patient’s position.
130411	Patient rotation longitudinal	A channel monitoring the patient’s rotation around the body’s longitudinal (head – feet) axis.
130412	Patient elevation	A channel monitoring the angle of elevation of the patient against horizontal.
130413	Hyperventilation begin	Begin of deepened or accelerated breathing.
130414	Hyperventilation end	End of deepened or accelerated breathing.
130415	Post-hyperventilation	Point in time after end of hyperventilation.
130416	Airflow Thermistor	Airflow measured by a thermistor sensor.
130417	Airflow Thermocouple	Airflow measured by a thermocouple sensor.
130418	Airflow Nasal Prong	Airflow measurement by a nasal prong.
130419	Airflow PVDF	Airflow measurement by a nasal piezoelectric polyvinylidenefluoride sensor.
130420	Airflow CPAP	Airflow measurement by a Continuous Positive Airway Pressure device.
130421	Airflow	Airflow measured by an unspecified method or device.
130422	PAP Pressure	Pressure delivered by a positive airway pressure device like a CPAP or BiPAP machine.
130423	PAP Leak Pressure	Pressure of air leaking from a positive airway pressure device like a CPAP or BiPAP machine.
130424	PAP Tidal Volume	Tidal volume during breathing when subject is using a positive airway pressure device like a CPAP or BiPAP machine.
130425	Esophageal Pressure	Pressure in the esophagus measured by esophageal manometry.
130426	Respiratory Pressure	Respiratory pressure measured with an unspecified method or device.
130427	Thoracic Respiratory Inductance	Respiratory effort delivered by a respiratory inductance plethysmography (RIP) belt applied on the patient’s thorax.
130428	Abdominal Respiratory Inductance	Respiratory effort delivered by a respiratory inductance plethysmography (RIP) belt applied on the patient’s abdomen.
130429	Thoracic Respiratory PVDF	Respiratory effort delivered by a piezoelectric polyvinylidenefluoride sensor belt applied on the patient’s thorax.
130430	Abdominal Respiratory PVDF	Respiratory effort delivered by a piezoelectric polyvinylidenefluoride sensor belt applied on the patient’s abdomen.
130431	Thoracic Respiratory Effort	Respiratory effort measured by an unspecified method or device on the patient’s thorax.
130432	Abdominal Respiratory Effort	Respiratory effort measured by an unspecified method or device on the patients abdomen.
130433	Respiratory Effort	Respiratory effort measured by an unspecified method or device.
130434	CO2 Transcutaneous	Partial pressure of carbon dioxide in the respiratory gases measured transcutaneously.
130435	CO2 Waveform End-tidal Main-stream	Partial pressure of carbon dioxide measured in the end-tidal main-stream respiratory gases.
130436	CO2 Trend End-tidal Main-stream	Partial pressure of carbon dioxide measured in the end-tidal main-stream respiratory gases averaged over time.
130437	CO2 Waveform End-tidal Side-stream	Partial pressure of carbon dioxide measured in the end-tidal side-stream respiratory gases.
130438	CO2 Trend End-tidal Side-stream	Partial pressure of carbon dioxide measured in the end-tidal side-stream respiratory gases averaged over time.
130439	CO2 Waveform Main-stream	Partial pressure of carbon dioxide measured in the main-stream respiratory gases.
130440	CO2 Waveform Side-stream	Partial pressure of carbon dioxide measured in the side-stream respiratory gases.
130441	CO2 Trend Main-stream	Partial pressure of carbon dioxide measured in the main-stream respiratory gases averaged over time.
130442	CO2 Trend Side-stream	Partial pressure of carbon dioxide measured in the side-stream respiratory gases averaged over time.
130443	CO2 Respiration	Partial pressure of carbon dioxide in the respiratory gases measured using an unspecified method or device.
130444	RT Treatment with Ad Hoc Planning	Radiotherapy treatment delivery where treatment parameters are defined at the treatment device, rather than specified by a treatment plan.
130445	Imaging Agent Administration Step Sequence Number	The order in which Imaging Agent administration steps are planned to be performed.
130450	Operator decision to terminate treatment	Decision was made by the operator of the equipment to discontinue treatment.
130451	Patient decision to terminate treatment	Decision was made by the patient to discontinue treatment.
130452	Physician decision to terminate treatment	Decision was made by the physician to discontinue treatment.
130453	Treatment Terminated	Treatment delivery of this RT Radiation was terminated.
130454	Resolved by overriding Interlock	An out-of-tolerance delivery parameter was accepted or re-specified and treatment delivery was continued.
130455	Resolved by repositioning Patient	The patient was re-positioned and treatment delivery was continued.
130456	Bolus Present	A bolus is confirmed to be present.
130457	Cone Present	A cone is confirmed to be present.
130458	Block Present	A block is confirmed to be present.
130459	Applicator Present	An applicator is confirmed to be present.
130460	Headframe Present	A headframe is confirmed to be present.
130461	Inappropriate Patient Orientation	The patient could not be positioned on the patient positioning device in a way, that the shape of treatment area has an unacceptable orientation to match the intended target area.
130462	Inappropriate Patient Position	The patient could not be positioned on the patient positioning device in a way, that the that the shape of treatment area radiated the intended target area.
130463	Machine Not Available	The machine intended to be used for treatment was not available.
130464	Change in Patient Anatomy	The patientÂ´s anatomy is found to be inconsistent with the patient model used during planning to the extent that treatment delivery was impacted.
130465	Machine Calibration Adjustment	A re-calibration of the treatment device impacted the treatment delivery.
130466	Unavailability of a Beam Modifier	A planned Beam Modifier was not available at the time of treatment.
130467	Machine Capability License Expired	A capability of the treatment device was not available because the corresponding license expired.
130468	Beam Targeting Tolerance Violation	Beam targeting parameters have been adjusted in a way that violated a clinical tolerance.
130469	Meterset Tolerance Violation	A Meterset value has been adjusted in a way that violated a clinical tolerance.
130470	Delivery Rate Tolerance Violation	A Delivery Rate has been adjusted in a way that violated a clinical tolerance.
130471	Jaw Position Tolerance Violation	Jaw positions exceeded the machine tolerance.
130472	MLC Position Tolerance Violation	One or more MLC leave positions exceeded the machine tolerance.
130473	Source Position Tolerance Violation	The Source Position angle exceeded the machine tolerance.
130474	Dose Rate Tolerance Violation	The dose rate exceeded the machine tolerance.
130475	Primary Fluence Monitoring System Interlock	An interlock triggered by the primary fluence-monitoring system.
130476	Secondary Fluence Monitoring System Interlock	An interlock triggered by the secondary fluence-monitoring system (also known as Secondary Dose Monitoring System [IEC 60601-2-1]).
130477	Timer Interlock	An interlock triggered by a controlling timer.
130478	Door Interlock	An interlock triggered by a door being open.
130479	Patient Motion Interlock	An interlock triggered by patient movement.
130480	Family history of non-melanoma skin cancer	Information about non-melanoma skin cancers in blood relatives of the patient.
130481	Family history of melanoma in situ	Information about in situ melanoma in blood relatives of the patient.
130482	History of non-melanoma skin cancer	Information about non-melanoma skin cancers in the patient.
130483	Number of malignant melanomas	The number of malignant melanomas the patient has had diagnosed.
130484	Number of melanomas in situ	The number of in situ melanomas the patient has had diagnosed.
130485	Firm skin lesion	A skin lesion that is firm on palpation.
130486	Raised skin lesion	A lesion that is raised from the skin surface on palpation.
130487	Number of first-degree relatives affected by malignant melanoma	The number of direct relatives (i.e., parent, sibling, offspring) who have malignant melanoma.
130488	Region in Space	A continuous part of space, not necessarily associated with a particular image.
130489	Referenced Region of Interest Identifier	A reference to an identifier of a Region of Interest. For example, the value of ROI Number (3006,0022) within an Item of Structure Set ROI Sequence (3006,0020) in an Instance of RT Structure Set Storage SOP Class.
130490	Centerline	A path along the long axis of an elongated finding or feature, which is equidistant from its surface, such as along the center of the lumen of a vessel.
130491	Stimulation Mode	Mode of stimulation used when applying stimulation techniques during procedure.
130492	Stimulus Sample Position	The sample number where the first stimulation event takes place.	Sample position in waveform recordings starts at 1.
130493	Stimulus Time Offset	The time offset where the stimulation starts, relative to the start time of the recorded waveform data.
130494	Number of Stimulus Events	How many stimulation events took place.
130495	Frequency of Stimulus Events	The frequency with which periodic stimulation occurs.
130500	Accumulated Dose Data	Description of dosimetric-related values that can be summarized for the entire scope of accumulation.
130501	Irradiation Event Summary Data	Description of dosimetric-related values that can be summarized for a single irradiation event.
130502	Reference Point Dosimetry	Description of the reference point definition and accumulated dose values at the reference point.
130503	Is Rejected Acquisition	This acquisition of data (e.g., for constructing an image) was for some reason unsatisfactory.
130504	Reason for Rejecting Acquisition	The reason that data (e.g., for constructing an image) was rejected.
130505	Irradiation Details	Description of the radiation dose characteristics independent of an irradiation event.
130506	RDSR Frame of Reference Origin	The component that is used to define the origin of the RDSR RCS.
130507	RDSR Frame of Reference Description	The description of the RDSR reference coordinate system. It should include a description of where the origin is, as well as the orientation of the coordinate system.
130508	Radiation Source Characteristics	Description of the radiation source characteristics
130509	X-Ray Filter Thickness	The thickness of the X-Ray filter
130510	Reported Value Type	Describes if a reported value is a mean, median, maximum, minimum, etc.
130511	Radiation Technique	Description of radiation technique details
130512	Filtration	Description of a filter
130513	Attenuators	Description of attenuators
130514	Radiation Output	Description of the output measurement point dose accumulation timing and values.
130515	Air Kerma at Output Measurement Point	The air kerma (in mGy) accumulated at the output measurement point during a given period of time.
130516	Radiation Field Area	Description of the radiation field area and corresponding timing and source index.
130517	Radiation Field Outline	A list of three-dimensional coordinates that describe the perimeter of the radiation field. The points shall be coplanar and are limited to describing either polygons or ellipses.
130518	Value Timing	Specifies when a value was determined within a period of time.
130519	X-Ray Source Reference Coordinate System	Description of the X-Ray source coordinate reference system and the transformation matrix that relates it to the RDSR reference coordinate system
130520	Transformation Matrix	A transformation matrix that relates one coordinate system to another
130521	Center of Rotation	The point about which an object rotates
130522	Rotation Plane Normal Point	A point defining a vector relative to the center of rotation that defines a normal vector of the rotation plane
130523	Rotation Angle	The angle about the center of rotation for a rotating object
130524	Beam Position	Description of component positions described in the X-Ray source reference coordinate system
130525	Output Measurement Point Position	The three-dimensional coordinate of the output measurement position. The output measurement position is described in the X-Ray source reference coordinate system.
130526	Reference Point Position	The three-dimensional coordinate of the reference point position. The reference point position is described in the X-Ray source reference coordinate system. The reference point may be at the same position as the output measurement point.
130527	Identification of the Attenuator	Textual identification for each attenuator described. The identifier is used to link the description of the attenuator to its position described in the beam position or attenuator position template. The identifier shall not change during the scope of accumulation described in 10040, and shall not be repeated.
130528	Attenuator Position	Description of positions and corresponding timing for attenuators
130529	Patient Attenuation Characteristics	Description of various patient attenuation characteristics that may be known by the system and may change during the course of the scope of accumulation
130530	Procedure Characteristics	Description of various procedure characteristics that may change during a study and may be useful to aid in dosimetry or quality assurance
130531	Attenuator Characteristics	Characteristics of an X-Ray attenuator used as either a filter or attenuating object in the X-Ray beam. Includes a description of actual or equivalent material, as well as thickness information.
130532	Duration of Time Period	All the points in time throughout a defined period of time
130533	Beginning of Time Period	The point in time at the beginning of a defined period of time
130534	End of Time Period	The point in time at the end of a defined period of time
130535	Middle of Time Period	The point in time at the middle of a defined period of time
130536	Room Origin	The origin of the Frame of Reference is defined as part of the room in which the equipment is located
130537	Equipment Origin	The origin of the Frame of Reference is defined as part of the equipment
130538	Patient Support Origin	The origin of the Frame of Reference is defined as part of the patient support
130539	Isocenter Origin	The origin of the Frame of Reference is defined as the isocenter of the imaging system
130540	Patient Coordinate System Origin	The origin of the RDSR Frame of Reference is defined as the origin of the patient coordinate system in the images.
130541	10 cm Dosimetry Phantom	A dosimetry phantom consisting of a 100 mm diameter polymethyl methacrylate (PMMA) cylinder. The phantom will be at least 140 mm in length. The phantom will be longer than the length of the sensitive volume of the radiation detector used for measurements. The phantom will have five holes just large enough to accept a radiation detector and will be parallel to the axis of symmetry: one hole at the center, and four holes with their centers 10 mm below the surface of the phantom at 90° intervals. For the holes not used during a measurement, properly fitting insert parts made of PMMA will be used.
130542	Magnetic field strength	Nominal field strength of MR magnet.
130543	Endorectal coil used	Indication of whether endorectal coil was used during MR examination.
130544	Endorectal coil type	Type of the endorectal coil used during MR examination.
130545	Inflatable endorectal coil fill substance	Substance used to fill endorectal coil in order to suppress distortion artifacts during MR examination.
130546	Cross-sectional scan plane orientation	Orientation of the plane defining image acquisition.
130547	Dynamic contrast-enhanced temporal resolution	Time between acquisition of imaging samples corresponding to the same tissue location during dynamic contrast-enhanced examination.
130548	Genitourinary History	Clinical history of the patient related to the genitourinary health.
130549	Imaging Study Quality	Assessment of the imaging study related to its quality, as defined by the compliance with the technical acquisition requirements or as perceived by the reader.
130550	Imaging Series Quality	Assessment of a specific imaging series related to its quality, as defined by the compliance with the technical acquisition requirements or as perceived by the reader.
130551	Reporting system	Standard or guideline used to perform structured evaluation of imaging study.
130552	Prostate MRI relevant procedure information	Information relevant for evaluation of prostate MR imaging study.
130553	Prostate Imaging Findings	Findings identified in prostate images
130554	Overall Prostate Finding	Finding relating to the overall assessment of the prostate gland
130555	Localized Prostate Finding	Finding relating to the localized entities within the prostate gland
130556	Prostate relational measurements	Measurements relating localized findings to the prostate gland
130557	Distance from neurovascular bundle	Distance between a finding and a neurovascular bundle
130558	Lesion capsular contact length	Length of the portion of the lesion abutting the prostate capsule as observed in the image.
130559	Extra-prostatic Finding	Finding identified in prostate MRI that is located outside of the prostate gland.
130560	PI-RADS Localized Abnormality Assessment	Evaluation of a localized abnormality within the gland using Prostate Imaging Reporting and Data System (PI-RADS®) guidelines.
130561	PI-RADS T2WI Lesion Assessment	Assessment of the lesions characteristics based on its appearance in T2-weighted MR images following the Prostate Imaging Reporting and Data System (PI-RADS®) guidelines.
130562	PI-RADS DWI Lesion Assessment	Assessment of the lesions characteristics based on its appearance in diffusion-weighted MR images following the Prostate Imaging Reporting and Data System (PI-RADS®) guidelines.
130563	PI-RADS DCE Lesion Assessment	Assessment of the lesions characteristics based on its appearance in Dynamic Contrast-enhanced MR images following the Prostate Imaging Reporting and Data System (PI-RADS®) guidelines.
130564	PI-RADS v2.0	Prostate Imaging Reporting and Data System (PI-RADS®) version 2.0. [PI-RADS].
130565	PI-RADS v2.1	Prostate Imaging Reporting and Data System (PI-RADS®) version 2.1 [PI-RADS v2.1].
130566	Diffusion-weighted Acquisition Highest b-value image	Image from a diffusion-weighted acquisition corresponding to the highest b-value.
130567	Dynamic Contrast-Enhanced Acquisition	Image acquisition that involves injection of a contrast agent into the bloodstream.
130568	Dynamic Contrast-Enhanced Acquisition Subtraction image	Image obtained as a difference in image intensities between two phases of a dynamic contrast-enhanced acquisition.
130569	Utricle cyst	Area of focal dilatation that occurs within the prostatic utricle.
130570	Protocol not followed	Imaging protocol was not followed.
130571	Coil placement concern	Based on image appearance, the coil was not placed correctly.
130572	Coil selection concern	Incorrect coil was selected during MR acquisition.
130573	Study performed did not match request	The imaging procedure performed did not correspond to what was re